Methods For Determining Fraction Of Fetal Nucleic Acids In Maternal Samples

Abstract

The invention provides compositions and methods for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal nucleic acids. The fraction of fetal nucleic acids can be used in determining the presence or absence of fetal aneuploidy.

Description

CROSS-REFERENCE

[0001] This Application claims priority to U.S. Provisional Application Ser. No. 61/296,358 entitled "Methods for Determining Fraction of Fetal Nucleic Acids in Maternal Samples", filed on Jan. 19, 2010; U.S. Provisional Application Ser. No. 61/360,837 entitled "Methods for Determining Fraction of Fetal Nucleic Acids in Maternal Samples", filed on Jul. 1, 2010; U.S. Provisional Application Ser. No. 61/407,017 entitled "Method for Determining Copy Number Variations", filed on Oct. 26, 2010; and U.S. Provisional Application Ser. No. 61/455,849 entitled "Simultaneous determination of Aneuploidy and Fetal Fraction", filed on Oct. 26, 2010; which are incorporated herein by reference in their entirety.

SEQUENCE LISTING

[0002] The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jan. 13, 2011, is named 32770201.txt and is 238,572 bytes in size.

FIELD OF THE INVENTION

[0003] The present invention relates to methods and compositions for detecting fetal nucleic acids in a maternal sample and determining the fraction of cell-free fetal nucleic acid circulating in a maternal sample.

BACKGROUND OF THE INVENTION

[0004] Invasive prenatal tests are potentially harmful to the mother and to the fetus. Therefore, there is a need for the development of noninvasive prenatal tests. Maternal blood can contain fetal cells (see e.g., U.S. Patent Application Publication No. 20080070792) and cell-free fetal DNA (see e.g., Huang et al. (2008), Methods in Molecular Biology, 444:203-208). While circulating fetal cells present an attractive target for non invasive prenatal diagnostics, particularly for the diagnosis of fetal sex and chromosomal abnormalities by simple karyotyping, the scarcity of intact fetal cells in the maternal circulation (around one cell per ml of maternal blood), low efficiency of enrichment (Bianchi et al., Am J Hum Genet 61:822-829 [1997]) and difficulties with chromosomal analysis associated with abnormally dense nuclei in some cells (Babochkina et al., Hematological 90:740-745 [2005]), have favored research on cell-free DNA.

[0005] The establishment of the concentrations of cell-free fetal DNA (cfDNA) in maternal plasma in healthy pregnant women has formed the platform on which fetal DNA abnormalities in pregnancy-associated disorders can be studied. The finding of a gradual increase in fetal DNA concentration in maternal serum as gestation progresses has been shown to precede complications associated with preterm labor. A five-fold increase in fetal DNA concentration has also been found in the serum obtained from women affected by preeclampsia. Other pregnancy-related disorders that have been linked to an elevated concentration of cfDNA include hyperemesis gravidarum (severe morning sickness), invasive placentation (in which the placenta contacts the maternal bloodstream), intrauterine growth restriction, feto-maternal hemorrhage and polyhydramnios. (Wright C.F. and Burton H., Human Reproduction Update 15(1):139-151 [2009]).

[0006] Quantitative analysis of cell free DNA by real-time PCR strategies has also indicated that the concentrations of circulatory fetal DNA are increased in pregnancies with fetal aneuploidies, most notably trisomy 21 (Lo et al., Clin Chem 45:1747-1751 [1999]). However, the fraction of fetal DNA in maternal cell-free plasma DNA is usually determined by comparing the amount of fetal-specific locus (such as the SRY locus on chromosome Y in male pregnancies) to that of a locus on any autosome that is common to both the mother and the fetus by using quantitative real-time PCR (Dahllan et al., Lancet 369:474-481 [2007]; Li et al., Clin Chem 1002-1011 [2004]; Fan et al., Proc Natl Acad Sci 105:16266-16271 [2008]).

[0007] Thus, there is a need for additional methods that would enable the determination of the fraction of fetal nucleic acid in both male and female pregnancies.

[0008] The method of the invention fulfills the need in providing the means to determine fetal fraction that is independent of the gender of the fetus. The method can be applied for determining simultaneously the presence or absence of a chromosomal aneuploidy or other copy number variation, and may be used in conjunction with nay known methods that are used to determine aneuploidies in maternal sample.

SUMMARY OF THE INVENTION

[0009] The invention provides compositions and methods for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal nucleic acids. The fraction of fetal nucleic acids can be used in determining the presence or absence of fetal aneuploidy.

[0010] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. In another embodiment, the plurality of polymorphic nucleic acids can be located on different autosomes other than chromosomes 13, 18 and 21. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0011] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0012] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0013] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0014] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22 For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0015] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0016] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0017] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0018] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0019] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0020] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0021] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0022] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0023] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0024] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0025] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0026] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0027] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0028] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0029] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0030] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0031] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0032] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0033] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0034] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20S1082, D20S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0035] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20S1082, D20S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0036] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0037] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0038] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0039] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0040] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0041] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0042] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0043] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0044] In one embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0045] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0046] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises providing a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0047] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0048] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA e.g. cell-free DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic target nucleic acids in the mixture of fetal and maternal genomic DNA; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein sequencing comprises an amplification and provides a plurality of sequence tags; and (c) based on the sequencing, determining the fraction, wherein determining the fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising of at least one polymorphic nucleic acid. The plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP). Alternatively, the plurality of polymorphic target nucleic acids comprises at least one short tandem repeat (STR). In some embodiments, the at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In other embodiments, the at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators. Alternatively, the massively parallel sequencing is sequencing-by-ligation or single molecule sequencing. The maternal sample is selected from blood, plasma, serum, urine and saliva. Preferably, the maternal sample is a plasma sample.

[0049] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal plasma sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic nucleic acids in said mixture of fetal and maternal nucleic acids, wherein each of said at least one polymorphic nucleic acid comprises an STR; (b) determining the amount of fetal and maternal STR alleles at least one polymorphic nucleic acid; and (c) determining said fraction using said amount of fetal and maternal STR alleles. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The method is a fetal gender-independent method.

[0050] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal plasma sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic nucleic acids in said mixture of fetal and maternal nucleic acids, wherein each of said at least one polymorphic nucleic acid comprises an STR; (b) determining the amount of fetal and maternal STR alleles at least one polymorphic nucleic acid; and (c) determining said fraction using said amount of fetal and maternal STR alleles. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids are located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The method further comprises preamplifying the mixture of fetal and maternal nucleic acids. The method is a fetal gender-independent method.

[0051] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal plasma sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic nucleic acids in said mixture of fetal and maternal nucleic acids, wherein each of said at least one polymorphic nucleic acid comprises an STR; (b) determining the amount of fetal and maternal STR alleles at least one polymorphic nucleic acid; and (c) determining said fraction using said amount of fetal and maternal STR alleles. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The method further comprises resolving the size of the STRs using capillary electrophoresis. The method is a fetal gender-independent method.

[0052] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal plasma sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic nucleic acids in said mixture of fetal and maternal nucleic acids, wherein each of said at least one polymorphic nucleic acid comprises an STR; (b) determining the amount of fetal and maternal STR alleles at least one polymorphic nucleic acid; and (c) determining said fraction using said amount of fetal and maternal STR alleles. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The method further comprises preamplifying the mixture of fetal and maternal nucleic acids, and resolving the size of the STRs using capillary electrophoresis. The method is a fetal gender-independent method.

[0053] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal plasma sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic nucleic acids in said mixture of fetal and maternal nucleic acids, wherein each of said at least one polymorphic nucleic acid comprises an STR; (b) determining the amount of fetal and maternal STR alleles at least one polymorphic nucleic acid; and (c) determining said fraction using said amount of fetal and maternal STR alleles. The plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes. For example, the plurality of polymorphic nucleic acids are located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. Optionally, the at least one STR can be the panel of STRs comprising CSF1PO, D13S317, D16 S539, D18S51, D21S11, D2S1338, D7S820 and FGA. The method is a fetal gender-independent method.

[0054] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal plasma sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic nucleic acids in said mixture of fetal and maternal nucleic acids, wherein each of said at least one polymorphic nucleic acid comprises an STR; (b) determining the amount of fetal and maternal STR alleles at least one polymorphic nucleic acid; and (c) determining said fraction using said amount of fetal and maternal STR alleles. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The method further comprises preamplifying the mixture of fetal and maternal nucleic acids. The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. Optionally, the at least one STR can be the panel of STRs comprising CSF1PO, D13S317, D16S539, D18S51, D21S11, D2S1338, D7S820 and FGA. The method is a fetal gender-independent method.

[0055] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal plasma sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic nucleic acids in said mixture of fetal and maternal nucleic acids, wherein each of said at least one polymorphic nucleic acid comprises an STR; (b) determining the amount of fetal and maternal STR alleles at least one polymorphic nucleic acid; and (c) determining said fraction using said amount of fetal and maternal STR alleles. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids are located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The method further comprises resolving the size of the STRs using capillary electrophoresis. The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. Optionally, the at least one STR can be the panel of STRs comprising CSF1PO, D13S317, D16S539, D18S51, D21S11, D2S1338, D7S820 and FGA.

[0056] In another embodiment, the invention provides a method for determining the fraction of fetal nucleic acids in a maternal plasma sample comprising a mixture of fetal and maternal genomic DNA, wherein the method comprises the steps of: (a) amplifying a plurality of polymorphic nucleic acids in said mixture of fetal and maternal nucleic acids, wherein each of said at least one polymorphic nucleic acid comprises an STR; (b) determining the amount of fetal and maternal STR alleles at least one polymorphic nucleic acid; and (c) determining said fraction using said amount of fetal and maternal STR alleles. The plurality of polymorphic nucleic acids are located on a plurality of different chromosomes. In one embodiment, the plurality of polymorphic nucleic acids can be located on chromosomes 1-22. For example, the plurality of polymorphic nucleic acids can be located on a plurality of different chromosomes other than chromosomes 13, 18, 21, X or Y. The method further comprises preamplifying the mixture of fetal and maternal nucleic acids, and resolving the size of the STRs using capillary electrophoresis. The at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. Optionally, the at least one STR can be the panel of STRs comprising CSF1PO, D13S317, D16 S539, D18S51, D21S11, D2S1338, D7S820 and FGA.

[0057] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture. The set of primers does not amplify a sequence on the Y chromosome.

[0058] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture. The polymorphic nucleic acid comprises an STR, a SNP and/or a tandem SNP.

[0059] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture. The polymorphic nucleic acid comprises an STR selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113; and/or a SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), rs530022 (SEQ ID NOS 55 & 56); and/or a tandem SNP rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959 rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427).

[0060] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample by massively parallel sequencing the fetal and maternal cfDNA in the maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture.

[0061] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture. The polymorphic nucleic acid comprises an STR, a SNP and/or a tandem SNP.

[0062] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample by massively parallel sequencing the fetal and maternal cfDNA in the maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture. The polymorphic nucleic acid comprises an STR selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113; a SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56); and/or a tandem SNP rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427).

[0063] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture. The set of primers does not amplify a sequence on the Y chromosome.

[0064] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in the mixture. The set of primers does not amplify a sequence on the Y chromosome. The polymorphic nucleic acid comprises an STR, a SNP and/or a tandem SNP.

[0065] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture. The polymorphic nucleic acid comprises an STR selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113; a SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56); and/or a tandem SNP rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427).

[0066] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample by massively parallel sequencing the fetal and maternal cIDNA in the maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture.

[0067] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture. The set of primers does not amplify a sequence on the Y chromosome. The polymorphic nucleic acid comprises an STR, a SNP and/or a tandem SNP.

[0068] In another embodiment, the invention provides a composition for determining the fraction of fetal cfDNA in a maternal sample by massively parallel sequencing the fetal and maternal cIDNA in the maternal sample, e.g. a plasma sample, wherein the composition comprises at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture. The polymorphic nucleic acid comprises an STR selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113; a SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56); and/or a tandem SNP rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959 rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427).

[0069] In another embodiment, the invention provides a kit that comprises the composition of the invention as described above and in the following.

INCORPORATION BY REFERENCE

[0070] All patents, patent applications, and other publications, including all sequences disclosed within these references, referred to herein are expressly incorporated by reference, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated by reference. All documents cited are, in relevant part, incorporated herein by reference. However, the citation of any document is not to be construed as an admission that it is prior art with respect to the present invention.

BRIEF DESCRIPTION OF THE DRAWINGS

[0071] The novel features of the invention are set forth with particularity in the appended claims. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:

[0072] FIG. 1 is a flowchart of a method 100 for determining the fetal fraction in a maternal test sample comprising a mixture of fetal and maternal nucleic acids using massively parallel sequencing methods or size separation of polymorphic nucleic acid sequences.

[0073] FIG. 2 is a bar diagram showing the identification of fetal and maternal polymorphic sequences (SNPs) used to determine fetal fraction in a test sample. The total number of sequence reads (Y-axis) mapped to the SNP sequences identified by rs numbers (X-axis), and the relative level of fetal nucleic acids (*) are shown.

[0074] FIG. 3 is a flowchart outlining alternative embodiments of the method for determining fetal fraction by massively parallel sequencing shown in FIG. 1.

[0075] FIG. 4 illustrates STR markers used in the AmpF.lamda.STR.RTM. Identifiler.RTM. PCR Amplification Kit.

[0076] FIG. 5 illustrates STR markers used in the AmpF.lamda.STR.RTM. MiniFiler.RTM. PCR Amplification Kit.

[0077] FIG. 6 illustrates the correlation of fetal fraction determined by massively parallel sequencing size separation of polymorphic sequences comprising SNPs and STRs.

[0078] FIG. 7 illustrates an embodiment of use of fetal fraction for determining cutoff thresholds for aneuploidy detection.

DETAILED DESCRIPTION OF THE INVENTION

[0079] The invention provides compositions and methods for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal nucleic acids. The fraction of fetal nucleic acids can be used in determining the presence or absence of fetal aneuploidy.

[0080] Unless otherwise indicated, the practice of the present invention involves conventional techniques commonly used in molecular biology, microbiology, protein purification, protein engineering, protein and DNA sequencing, and recombinant DNA fields, which are within the skill of the art. Such techniques are known to those of skill in the art and are described in numerous standard texts and reference works. All patents, patent applications, articles and publications mentioned herein are hereby expressly incorporated herein by reference in their entirety.

[0081] Numeric ranges are inclusive of the numbers defining the range. It is intended that every maximum numerical limitation given throughout this specification includes every lower numerical limitation, as if such lower numerical limitations were expressly written herein. Every minimum numerical limitation given throughout this specification will include every higher numerical limitation, as if such higher numerical limitations were expressly written herein. Every numerical range given throughout this specification will include every narrower numerical range that falls within such broader numerical range, as if such narrower numerical ranges were all expressly written herein.

[0082] The headings provided herein are not limitations of the various aspects or embodiments of the invention which can be had by reference to the Specification as a whole. Accordingly, as indicated above, the terms defined immediately below are more fully defined by reference to the specification as a whole.

[0083] Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Various scientific dictionaries that include the terms included herein are well known and available to those in the art. Although any methods and materials similar or equivalent to those described herein find use in the practice or testing of the present invention, some preferred methods and materials are described. Accordingly, the terms defined immediately below are more fully described by reference to the Specification as a whole. It is to be understood that this invention is not limited to the particular methodology, protocols, and reagents described, as these may vary, depending upon the context they are used by those of skill in the art.

DEFINITIONS

[0084] As used herein, the singular terms "a", "an," and "the" include the plural reference unless the context clearly indicates otherwise. Unless otherwise indicated, nucleic acids are written left to right in 5' to 3' orientation and amino acid sequences are written left to right in amino to carboxy orientation, respectively.

[0085] As used herein, the singular terms "a", "an," and "the" include the plural reference unless the context clearly indicates otherwise. Unless otherwise indicated, nucleic acids are written left to right in 5' to 3' orientation and amino acid sequences are written left to right in amino to carboxy orientation, respectively.

[0086] The term "portion" when used in reference to the amount of sequence information of fetal and maternal nucleic acid molecules in a biological sample herein refers to the amount of sequence information of fetal and maternal nucleic acid molecules in a biological sample that in sum amount to less than the sequence information of <1 human genome.

[0087] The terms "polynucleotide", "nucleic acid" and "nucleic acid molecules" are used interchangeably and refer to a covalently linked sequence of nucleotides (i.e., ribonucleotides for RNA and deoxyribonucleotides for DNA) in which the 3' position of the pentose of one nucleotide is joined by a phosphodiester group to the 5' position of the pentose of the next, include sequences of any form of nucleic acid, including, but not limited to RNA, DNA and cfDNA molecules. The term "polynucleotide" includes, without limitation, single- and double-stranded polynucleotide.

[0088] The term "copy number variation" herein refers to variation in the number of copies of a nucleic acid sequence that is 1 kb or larger present in a test sample in comparison with the copy number of the nucleic acid sequence present in a qualified sample. A "copy number variant" refers to the 1 kb or larger sequence of nucleic acid in which copy-number differences are found by comparison of a sequence of interest in test sample with that present in a qualified sample. Copy number variants/variations include deletions, including microdeletions, insertions, including microinsertions, duplications, multiplications, inversions, translocations and complex multi-site variants. CNV encompass chromosomal aneuploidies and partial aneuplodies.

[0089] As used herein, the term "fetal fraction" is used interchangeably with "fraction of fetal nucleic acid", which refers to the fraction of fetal nucleic acid in a sample comprising fetal and maternal nucleic acid Similarly, the term "minor fraction" or "minor component" herein refers to the lesser fraction of the total genetic material that is present in a sample containing genetic material derived from separate sources e.g. individuals.

[0090] As used herein the term "allele" refers to one specific form of a genetic sequence (such as a gene) within a cell, a sample, an individual or within a population, the specific form differing from other forms of the same gene in the sequence of at least one, and frequently more than one, variant sites within the sequence of the gene. The sequences at these variant sites that differ between different alleles are termed "variants", "polymorphisms", or "mutations". In general, polymorphism is used to refer to variants that have a frequency of at least 1% in a population, while the term mutation is generally used for variants that occur at a frequency of less than 1% in a population. In diploid organisms such as humans, at each autosomal specific chromosomal location or "locus" an individual possesses two alleles, a first inherited from one parent and a second inherited from the other parent, for example one from the mother and one from the father. An individual is "heterozygous" at a locus if it has two different alleles at the locus. An individual is "homozygous" at a locus if it has two identical alleles at that locus.

[0091] The term "enrich" herein refers to the process of amplifying polymorphic target nucleic acids contained in a portion of a maternal sample, and combining the amplified product with the remainder of the maternal sample from which the portion was removed.

[0092] As used herein, the term "genotyping" refers to the determination of the genetic information an individual carries at one or more positions in the genome. For example, genotyping may comprise the determination of which allele or alleles an individual carries for a single SNP or the determination of which allele or alleles an individual carries for a plurality of SNPs. For example, a particular nucleotide in a genome may be a T in some individuals and a C in other individuals. Those individuals who have a T at the position have the T allele and those who have a C have the C allele. In a diploid organism the individual will have two copies of the sequence containing the polymorphic position so the individual may have a T allele and a C allele or alternatively two copies of the T allele or two copies of the C allele. Those individuals who have two copies of the C allele are homozygous for the C allele, those individuals who have two copies of the T allele are homozygous for the T allele, and those individuals who have one copy of each allele are heterozygous. The alleles are often referred to as the A allele, often the major allele, and the B allele, often the minor allele. The genotypes may be AA (homozygous A), BB (homozygous B) or AB (heterozygous). Genotyping methods generally provide for identification of the sample as AA, BB or AB.

[0093] As used herein the term "chromosome" refers to the heredity-bearing gene carrier of a living cell which is derived from chromatin and which comprises DNA and protein components (especially histones). The conventional internationally recognized individual human genome chromosome numbering system is employed herein. The size of an individual chromosome can vary from one type to another with a given multi-chromosomal genome and from one genome to another. In the case of the human genome, the entire DNA mass of a given chromosome is usually greater than about 100,000,000 bp. For example, the size of the entire human genome is about 3.times.10.sup.9 bp. The largest chromosome, chromosome no. 1, contains about 2.4.times.10.sup.8 by while the smallest chromosome, chromosome no. 22, contains about 5.3.times.10.sup.7 bp.

[0094] The term "aneuploidy" herein refers to the occurrence of one or more extra or missing chromosomes.

[0095] As used herein the term "chromosomal region" is a portion of a chromosome. The actual physical size or extent of any individual chromosomal region can vary greatly. The term "region" is not necessarily definitive of a particular one or more genes because a region need not take into specific account the particular coding segments (exons) of an individual gene.

[0096] As used herein the term "genetic marker" refers to a sequence of DNA that has a specific location on a chromosome that can be measured in a laboratory. The term "genetic marker" can also be used to refer to, e.g., a cDNA and/or an mRNA encoded by a genomic sequence, as well as to that genomic sequence. To be useful, a marker needs to have two or more alleles or variants. Markers can be either direct, that is, located within the gene or locus of interest (i.e., candidate gene), or indirect, that is closely linked with the gene or locus of interest (presumably due to a location which is proximate to, but not inside the gene or locus of interest). Moreover, markers can also include sequences which either do or do not modify the amino acid sequence of a gene.

[0097] As used herein, the term "maternal sample" refers to a biological sample obtained from a pregnant subject, and comprises a mixture of fetal and maternal nucleic acids. A "pregnant subject" is not limited to a human being, but may also include other organisms including but not limited to mammals, plants, bacteria or cells derived from any of the above.

[0098] The term "whole genome amplification" or "WGA" as used herein generally refers to a method for amplification of a limited DNA sample in a non-specific manner, in order to generate a new sample that is indistinguishable from the original but with a higher DNA concentration. The ideal whole genome amplification technique would amplify a sample up to a microgram level while maintaining the original sequence representation. The DNA of the sample may include an entire genome or a portion thereof. Degenerate oligonucleotide-primed PCR (DOP), primer extension PCR technique (PEP) including modified improved primer extension Preamplification (mIPEP), and multiple displacement amplification (MDA), are examples of whole genome amplification methods.

[0099] The term "short tandem repeat" or "STR" as used herein refers to a class of polymorphisms that occurs when a pattern of two or more nucleotides are repeated and the repeated sequences are directly adjacent to each other. The pattern can range in length from 2 to 10 base pairs (bp) (for example (CATG)n in a genomic region) and is typically in the non-coding intron region. By examining several STR loci and counting how many repeats of a specific STR sequence there are at a given locus, it is possible to create a unique genetic profile of an individual.

[0100] The term "primer," as used herein refers to an isolated oligonucleotide which is capable of acting as a point of initiation of synthesis when placed under conditions in which synthesis of a primer extension product which is complementary to a nucleic acid strand is induced, (i.e., in the presence of nucleotides and an inducing agent such as DNA polymerase and at a suitable temperature and pH). The primer is preferably single stranded for maximum efficiency in amplification, but may alternatively be double stranded. If double stranded, the primer is first treated to separate its strands before being used to prepare extension products. Preferably, the primer is an oligodeoxyribonucleotide. The primer must be sufficiently long to prime the synthesis of extension products in the presence of the inducing agent. The exact lengths of the primers will depend on many factors, including temperature, source of primer, use of the method, and the parameters used for primer design, as disclosed herein.

[0101] The term "primer pair" or "primer set" refers to a set of primers including a 5' "upstream primer" or "forward primer" that hybridizes with the complement of the 5' end of the DNA sequence to be amplified and a 3' "downstream primer" or "reverse primer" that hybridizes with the 3' end of the sequence to be amplified. As will be recognized by those of skill in the art, the terms "upstream" and "downstream" or "forward" and "reverse" are not intended to be limiting, but rather provide illustrative orientation in particular embodiments. A primer pair is said to be "unique" if it can be employed to specifically amplify a particular target nucleotide sequence in a given amplification mixture.

[0102] A "polymorphic marker" or "polymorphic site" is a locus at which nucleotide sequence divergence occurs. The locus may be as small as one base pair. Illustrative markers have at least two alleles, each occurring at frequency of greater than 1%, and more typically greater than 10% or 20% of a selected population. A polymorphic site may be as small as one base pair. Polymorphic markers include restriction fragment length polymorphism (RFLPs), variable number of tandem repeats (VNTR's), hypervariable regions, minisatellites, dinucleotide repeats, trinucleotide repeats, tetranucleotide repeats, simple sequence repeats, deletions, and insertion elements such as Alu. The first identified allelic form is arbitrarily designated as the reference form and other allelic forms are designated as alternative or variant alleles. The allelic form occurring most frequently in a selected population is sometimes referred to as the wild type form. Diploid organisms may be homozygous or heterozygous for allelic forms. A diallelic polymorphism has two forms. A triallelic polymorphism has three forms. A polymorphism between two nucleic acids can occur naturally, or be caused by exposure to or contact with chemicals, enzymes, or other agents, or exposure to agents that cause damage to nucleic acids, for example, ultraviolet radiation, mutagens or carcinogens. The terms "polymorphic locus" and "polymorphic site" are herein used interchangeably.

[0103] The terms "polymorphic target nucleic acid", "polymorphic sequence", "polymorphic target nucleic acid sequence" and "polymorphic nucleic acid" are used interchangeably herein to refer to a nucleic acid sequence e.g. a DNA sequence, that comprises one or more polymorphic sites e.g one SNP or a tandem SNP. Polymorphic sequences according to the present technology can be used to specifically differentiate between maternal and non-maternal alleles in the maternal sample comprising a mixture of fetal and maternal nucleic acids.

[0104] A "single nucleotide polymorphism" (SNP) occurs at a polymorphic site occupied by a single nucleotide, which is the site of variation between allelic sequences. The site is usually preceded by and followed by highly conserved sequences of the allele (e.g., sequences that vary in less than 1/100 or 1/1000 members of the populations). A SNP usually arises due to substitution of one nucleotide for another at the polymorphic site. A transition is the replacement of one purine by another purine or one pyrimidine by another pyrimidine. A transversion is the replacement of a purine by a pyrimidine or vice versa. SNPs can also arise from a deletion of a nucleotide or an insertion of a nucleotide relative to a reference allele. Single nucleotide polymorphisms (SNPs) are positions at which two alternative bases occur at appreciable frequency (>1%) in the human population, and are the most common type of human genetic variation.

[0105] As used herein, the term "short tandem repeat" or "STR" as used herein refers to a class of polymorphisms that occurs when a pattern of two or more nucleotides are repeated and the repeated sequences are directly adjacent to each other. The pattern can range in length from 2 to 10 base pairs (bp) (for example (CATG)n in a genomic region) and is typically in the non-coding intron region. By examining several STR loci and counting how many repeats of a specific STR sequence there are at a given locus, it is possible to create a unique genetic profile of an individual.

[0106] As used herein, the term "miniSTR" herein refers to tandem repeat of four or more base pairs that spans less than about 300 base pairs, less than about 250 base airs, less than about 200 base pairs, less than about 150 base pairs, less than about 100 base pairs, less than about 50 base pairs, or less than about 25 base pairs. "miniSTRs" are STRs that are amplifiable from cIDNA templates.

[0107] The term "tandem SNPs" herein refers to two or more SNPs that are present within a polymorphic target nucleic acid sequence.

[0108] The terms "plurality of polymorphic target nucleic acids", "polymorphic nucleic acids" and "polymorphic sequences" are used interchangeably herein and refer to a number of nucleic acid sequences each comprising at least one polymorphic site e.g. one SNP, such that at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, or 40 or more different polymorphic sites are amplified from the polymorphic target nucleic acids to identify and/or quantify fetal alleles present in maternal samples comprising fetal and maternal nucleic acids.

[0109] As used herein, the term "substantially cell free" encompasses preparations of the desired sample from which components that are normally associated with it are removed. For example, a plasma sample is rendered essentially cell free by removing blood cells e.g. red cells, that are normally associated with it. In some embodiments, substantially free samples are processed to remove cells that would otherwise contribute to the desired genetic material that is to be tested for an abnormality

[0110] As used herein the term "chromosome" refers to the heredity-bearing gene carrier of a living cell which is derived from chromatin and which comprises DNA and protein components (especially histones). The conventional internationally recognized individual human genome chromosome numbering system is employed herein. The size of an individual chromosome can vary from one type to another with a given multi-chromosomal genome and from one genome to another. In the case of the human genome, the entire DNA mass of a given chromosome is usually greater than about 100,000,000 bp. For example, the size of the entire human genome is about 3.times.10.sup.9 bp. The largest chromosome, chromosome no. 1, contains about 2.4.times.10.sup.8 by while the smallest chromosome, chromosome no. 22, contains about 5.3.times.10.sup.7 bp.

[0111] The term "oligonucleotide" is used to refer to a nucleic acid that is relatively short, generally shorter than 200 nucleotides, more particularly, shorter than 100 nucleotides, most particularly, shorter than 50 nucleotides. Typically, oligonucleotides are single-stranded DNA molecules.

[0112] The term "primer" refers to an oligonucleotide that is capable of hybridizing (also termed "annealing") with a nucleic acid and serving as an initiation site for nucleotide (RNA or DNA) polymerization under appropriate conditions (i.e., in the presence of four different nucleoside triphosphates and an agent for polymerization, such as DNA or RNA polymerase or reverse transcriptase) in an appropriate buffer and at a suitable temperature. The appropriate length of a primer depends on the intended use of the primer, but primers are typically at least 7 nucleotides long and, more typically range from 10 to 30 nucleotides, or even more typically from 15 to 30 nucleotides, in length. Other primers can be somewhat longer, e.g., 30 to 50 nucleotides long.

[0113] The term "allele call" as used herein, refers to successful characterization of an allele by a given analysis method. If the analysis provides successful characterization of both alleles of a gene locus of a DNA sample, it is said that two allele calls are made. If one allele is characterized while the other allele is not characterized, it is said that one allele call is made. If neither of the two alleles is successfully characterized, no allele calls are made.

[0114] The term "allele" as used herein, is any one of a number of viable DNA codings occupying a given locus (position) on a chromosome. Usually alleles are DNA (deoxyribonucleic acid) sequences that code for a gene, but sometimes the term is used to refer to a non-gene sequence. An individual's genotype for that gene is the set of alleles it happens to possess. In a diploid organism, one that has two copies of each chromosome, two alleles make up the individual's genotype.

[0115] The term "reaction mixture" as used herein refers to a mixture containing sufficient components to carry out an amplification reaction.

[0116] The term "sequence tag density" herein refers to the number of sequence reads that are mapped to a reference genome sequence e.g. the sequence tag density for chromosome 21 is the number of sequence reads generated by the sequencing method that are mapped to chromosome 21 of the reference genome. The term "sequence tag density ratio" herein refers to the ratio of the number of sequence tags that are mapped to a chromosome of the reference genome e.g. chromosome 21, to the length of the reference genome chromosome 21.

[0117] The terms "threshold value" and "qualified threshold value" herein refer to any number that is calculated using a qualifying data set and serves as a limit of diagnosis of a copy number variation e.g. an aneuploidy, in an organism. If a threshold is exceeded by results obtained from practicing the invention, a subject can be diagnosed with a copy number variation e.g. trisomy 21.

[0118] The term "read" refers to a DNA sequence of sufficient length (e.g., at least about 30 bp) that can be used to identify a larger sequence or region, e.g. that can be aligned and specifically assigned to a chromosome or genomic region or gene.

[0119] The term "sequence tag" is herein used interchangeably with the term "mapped sequence tag" to refer to a sequence read that has been specifically assigned i.e. mapped, to a larger sequence e.g. a reference genome, by alignment. Mapped sequence tags are uniquely mapped to a reference genome i.e. they are assigned to a single location to the reference genome. Tags that can be mapped to more than one location on a reference genome i.e. tags that do not map uniquely, are not included in the analysis.

[0120] The terms "aligned", "alignment", or "aligning" refer to one or more sequences that are identified as a match in terms of the order of their nucleic acid molecules to a known sequence from a reference genome. Such alignment can be done manually or by a computer algorithm, examples including the Efficient Local Alignment of Nucleotide Data (ELAND) computer program distributed as part of the Illumina Genomics Analysis pipeline. The matching of a sequence read in aligning can be a 100% sequence match or less than 100% (non-perfect match).

[0121] The term "reference genome" refers to any particular known genome sequence, whether partial or complete, of any organism or virus which may be used to reference identified sequences from a subject. For example, a reference genome used for human subjects as well as many other organisms is found at the National Center for Biotechnology Information at www.ncbi.nlm.nih.gov. A "genome" refers to the complete genetic information of an organism or virus, expressed in nucleic acid sequences.

[0122] The term "artificial target sequences genome" herein refers to a grouping of known sequences that encompass alleles of known polymorphic sites. For example, a "SNP reference genome" is an artificial target sequences genome comprising a grouping of sequences that encompass alleles of known SNPs.

[0123] The term "clinically-relevant sequence" herein refers to a nucleic acid sequence that is known or is suspected to be associated or implicated with a genetic or disease condition. Determining the absence or presence of a clinically-relevant sequence can be useful in determining a diagnosis or confirming a diagnosis of a medical condition, or providing a prognosis for the development of a disease.

[0124] The term "mixed sample" herein refers to a sample containing a mixture of nucleic acids, which are derived from different genomes.

[0125] The term "original maternal sample" herein refers to a biological sample obtained from a pregnant subject e.g. a woman, who serves as the source from which a portion is removed to amplify polymorphic target nucleic acids. The "original sample" can be any sample obtained from a pregnant subject, and the processed fractions thereof e.g. a purified cfDNA sample extracted from a maternal plasma sample. The term "original maternal sample" herein refers to a biological sample obtained from a pregnant subject e.g. a woman, who serves as the source from which a portion is removed to amplify polymorphic target nucleic acids. The "original sample" can be any sample obtained from a pregnant subject, and the processed fractions thereof e.g. a purified cfDNA sample extracted from a maternal plasma sample.

[0126] The term "biological fluid" herein refers to a liquid taken from a biological source and includes, for example, blood, serum, plasma, sputum, lavage fluid, cerebrospinal fluid, urine, semen, sweat, tears, saliva, and the like. As used herein, the terms "blood," "plasma" and "serum" expressly encompass fractions or processed portions thereof. Similarly, where a sample is taken from a biopsy, swab, smear, etc., the "sample" expressly encompasses a processed fraction or portion derived from the biopsy, swab, smear, etc.

[0127] The terms "maternal nucleic acids" and "fetal nucleic acids" herein refer to the nucleic acids of a pregnant female subject and the nucleic acids of the fetus being carried by the pregnant female, respectively.

[0128] The term "corresponding to" herein refers to a nucleic acid sequence e.g. a gene or a chromosome, that is present in the genome of different subjects, and which does not necessarily have the same sequence in all genomes, but serves to provide the identity rather than the genetic information of a sequence of interest e.g. a gene or chromosome.

[0129] The term "group of chromosomes" herein refers to two or more chromosomes.

[0130] The term "subject" herein refers to a human subject as well as a non-human subject such as a mammal, an invertebrate, a vertebrate, a fungus, a yeast, a bacteria, and a virus. Although the examples herein concern human cells and the language is primarily directed to human concerns, the concept of this invention is applicable to genomes from any plant or animal, and is useful in the fields of veterinary medicine, animal sciences, research laboratories and such.

DESCRIPTION

[0131] The methods described herein enable the determination of the fraction of the minor fetal nucleic acid component in a sample comprising a mixture of fetal and maternal nucleic acids. In particular, the method enables the determination of the fraction of cfDNA contributed by a fetus to the mixture of fetal and maternal cfDNA in a maternal sample e.g. a plasma sample. The difference between the maternal and fetal fraction is determined by the relative contribution of a polymorphic allele derived from the fetal genome to the contribution of the corresponding polymorphic allele derived from the maternal genome. Polymorphic sequences can be used in conjunction with clinically-relevant diagnostic tests as a positive control for the presence of cfDNA in order to highlight false-negative or false-positive results stemming from low levels of cfDNA below the identification limit The methods described are independent of the gender of the fetus, and are useful across a range of gestational ages.

[0132] FIG. 1 provides a flow diagram of an embodiment of method of the invention 100 for determining the fraction of fetal nucleic acids in a maternal biological sample by massively parallel sequencing of PCR-amplified polymorphic target nucleic acids. In step 110 a maternal sample comprising a mixture of fetal and maternal nucleic acids is obtained from a subject. The sample is a maternal sample that is obtained from a pregnant female, for example a pregnant woman. Other maternal samples can be from mammals, for example, cow, horse, dog, or cat. If the subject is a human, the sample can be taken in the first or second trimester of pregnancy. Any maternal biological sample can be used a source of fetal and maternal nucleic acids which are contained in cells or that are "cell-free". In some embodiments, it is advantageous to obtain a maternal sample that comprises cell-free nucleic acids e.g. cfDNA. Preferably, the maternal biological sample is a biological fluid sample. A biological fluid includes, as non-limiting examples, blood, plasma, serum, sweat, tears, sputum, urine, sputum, ear flow, lymph, saliva, cerebrospinal fluid, ravages, bone marrow suspension, vaginal flow, transcervical lavage, brain fluid, ascites, milk, secretions of the respiratory, intestinal and genitourinary tracts, and leukophoresis samples. In some embodiments, the biological fluid sample is a sample that is easily obtainable by non-invasive procedures e.g. blood, plasma, serum, sweat, tears, sputum, urine, sputum, ear flow, and saliva. In some embodiments, the biological sample is a peripheral blood sample, or the plasma and/or the serum fractions thereof. In another embodiment, the sample is a mixture of two or more biological samples e.g. a biological sample can comprise two or more of a biological fluid samples. As used herein, the terms "blood," "plasma" and "serum" expressly encompass fractions or processed portions thereof. In some embodiments, the biological sample is processed to obtain a sample fraction e.g. plasma, that contains the mixture of fetal and maternal nucleic acids. A sample that can be used to determine the genotype of one or more fetal alleles can be any sample that contains fetal cells or fetal nucleic acid. For example, maternal serum or plasma sample comprising fetal and maternal cell-free nucleic acids (e.g., DNA or RNA) can be used to determine the genotypes of fetal alleles. In one embodiment, the sample can comprise a fetal cell, e.g., a fetal nucleated red blood cell or a trophoblast.

[0133] In step 120, the mixture of fetal and maternal nucleic acids is further processed from the sample fraction e.g. plasma, to obtain a sample comprising a purified mixture of fetal and maternal nucleic acids e.g. cIDNA. Cell-free nucleic acids, including cell-free DNA, can be obtained by various methods known in the art from biological samples including but not limited to plasma, serum and urine (Fan et al., Proc Natl Acad Sci 105:16266-16271 [2008]; Koide et al., Prenatal Diagnosis 25:604-607 [2005]; Chen et al., Nature Med. 2: 1033-1035 [1996]; Lo et al., Lancet 350: 485-487 [1997). To separate cIDNA from cells, fractionation, centrifugation (e.g., density gradient centrifugation), DNA-specific precipitation, or high-throughput cell sorting and/or separation methods can be used. Examples of methods for processing fluid samples have been previously disclosed, e.g., U.S. Patent Application Nos. 20050282293, 20050224351, and 20050065735, which are herein incorporated by reference in their entireties. Commercially available kits for manual and automated separation of cfDNA are available (Roche Diagnostics, Indianapolis, Ind., Qiagen, Valencia, Calif., Macherey-Nagel, Duren, Del.). In some instances, it can be advantageous to fragment the nucleic acid molecules in the nucleic acid sample. Fragmentation can be random, or it can be specific, as achieved, for example, using restriction endonuclease digestion. Methods for random fragmentation are well known in the art, and include, for example, limited DNAse digestion, alkali treatment and physical shearing. In one embodiment, sample nucleic acids are obtained as cfDNA, which is not subjected to fragmentation. In other embodiments, the sample nucleic acids are obtained as genomic DNA, which is subjected to fragmentation into fragments of approximately 500 or more base pairs, and to which NGS methods can be readily applied.

[0134] In step 130, a portion of the purified mixture of fetal and maternal cIDNA is used for amplifying a plurality of polymorphic target nucleic acids each comprising a polymorphic site. In some embodiments, the target nucleic acids each comprise a SNP. In other embodiments, each of the target nucleic acids comprises a pair of tandem SNPs. In yet other embodiments, each the target nucleic acids comprises an STR. Polymorphic sites that are contained in the target nucleic acids include without limitation single nucleotide polymorphisms (SNPs), tandem SNPs, small-scale multi-base deletions or insertions, called IN-DELS (also called deletion insertion polymorphisms or DIPs), Multi-Nucleotide Polymorphisms (MNPs) Short Tandem Repeats (STRs), restriction fragment length polymorphism (RFLP), or a polymorphism comprising any other change of sequence in a chromosome. In some embodiments, the polymorphic sites that are encompassed by the method of the invention are located on autosomal chromosomes, thereby enabling the determination of fetal fraction independently of sex of the fetus. Polymorphisms associated with chromosomes other than chromosome 13, 18, 21 and Y can also be used in the methods described herein.

[0135] Polymorphisms can be indicative, informative, or both. Indicative polymorphisms indicate the presence of fetal cell-free DNA in a maternal sample. For example, the more there is of a particular genetic sequence, e.g. a SNP, the more a method will translate its presence into a particular color intensity, density of color, or some other property which is detectable and measurable and indicative of the presence, absence, and quantity of a particular fragment of DNA and/or particular polymorphism e.g. SNP of the embryo. Informative polymorphisms yield information about the fetus--for example, the presence or absence of a disease, genetic abnormality, or any other biological information such as the stage of gestation or gender. With regard to the present invention, the methods are not conducted using all possible SNPs in a genome, but use those which are said to be "informative". "Informative SNPs" in this instance are those which identify differences in the sequence of the mother and the fetus. Any polymorphic site that can be encompassed by the reads generated by the sequencing methods described herein can be used to determine the fetal fraction.

[0136] In one embodiment, a portion of the mixture of fetal and maternal nucleic acids in the sample e.g. cfDNA, is used as template for amplifying target nucleic acids that comprise at least one SNP. In some embodiments, each target nucleic acid comprises a single i.e. one SNP. Target nucleic acid sequences comprising SNPs are available from publicly accessible databases including, but not limited to Human SNP Database at world wide web address wi.mit.edu, NCBI dbSNP Home Page at world wide web address ncbi.nlm nih.gov, world wide web address lifesciences.perkinelmer.com, Applied Biosystems by Life Technologies.TM. (Carlsbad, Calif.) at world wide web address appliedbiosystems.com, Celera Human SNP database at world wide web address celera.com, the SNP Database of the Genome Analysis Group (GAN) at world wide web address gan.iarc.fr. In one embodiment, the SNPs chosen for enriching the fetal and maternal cfDNA are selected from the group of 92 individual identification SNPs (IISNPs) described by Pakstis el al. (Pakstis et el. Hum Genet 127:315-324 [2010]), which have been shown to have a very small variation in frequency across populations (F.sub.st<0.06), and to be highly informative around the world having an average heterozygosity .gtoreq.0.4. SNPs that are encompassed by the method of the invention include linked and unlinked SNPs. Other useful SNPs applicable or useful for the methods described herein are disclosed in U.S. Pat. Application Nos. 20080070792, 20090280492, 20080113358, 20080026390, 20080050739, 20080220422, and 20080138809, which are herein incorporated by reference in their entireties. Each target nucleic acid comprises at least one polymorphic site e.g. a single SNP, that differs from that present on another target nucleic acid to generate a panel of polymorphic sites e.g. SNPs, that contain a sufficient number of polymorphic sites of which at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 11, at least 12, at least 13, at least 14, at least 15, at least 16, at least 17, at least 18, at least 19, at least 20, at least 25, at least 30, at least 40 or more are informative. For example, a panel of SNPs can be configured to comprise at least one informative SNP. In one embodiment, the SNPs that are targeted for amplification are selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In one embodiment, the panel of SNPs comprises at least 3, at least 5, at least 10, at least 13, at least 15, at least 20, at least 25, at least 30 or more SNPs. In one embodiment, the panel of SNPs comprises rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), and rs2567608 (SEQ ID NOS 25 & 26). The polymorphic nucleic acids comprising the SNPs can be amplified using exemplary primer pairs provided in Example 3, and disclosed as SEQ ID NOs:57-112.

[0137] In other embodiments, each target nucleic acid comprises two or more SNPs i.e. each target nucleic acid comprises tandem SNPs. Preferably, each target nucleic acid comprises two tandem SNPs. The tandem SNPs are analyzed as a single unit as short haplotypes, and are provided herein as sets of two SNPs. To identify suitable tandem SNP sequences, the International HapMap Consortium database can be searched (The International HapMap Project, Nature 426:789-796 [2003]). The database is available on the world wide web at hapmap.org. In one embodiment, tandem SNPs that are targeted for amplification are selected from the following sets of tandem pairs of SNPS rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The polymorphic nucleic acids comprising the tandem SNPs can be amplified using primer pairs that amplify polymorphic sequences comprising the tandem SNPs. Examples of primer pairs that can be used to amplify the tandem SNPs disclosed herein are SEQ ID NOs:197-310 as provided in Example 8.

[0138] In one embodiment, a portion of the mixture of fetal and maternal nucleic acids in the sample e.g. cfDNA, is used as template for amplifying target nucleic acids that comprise at least one STR. In some embodiments, each target nucleic acid comprises a single i.e. one STR. STR loci are found on almost every chromosome in the genome and may be amplified using a variety of polymerase chain reaction (PCR) primers. Tetranucleotide repeats have been preferred among forensic scientists due to their fidelity in PCR amplification, although some tri- and pentanucleotide repeats are also in use. A comprehensive listing of references, facts and sequence information on STRs, published PCR primers, common multiplex systems, and related population data are compiled in STRBase, which may be accessed via the World Wide Web at ibm4.carb.nist.gov:8800/dna/home.htm. Sequence information from GenBank.RTM. (http://www2.ncbi.nlm nih.gov/cgi-bin/genbank) for commonly used STR loci is also accessible through STRBase. Commercial kits available for the analysis of STR loci generally provide all of the necessary reaction components and controls required for amplification. STR multiplex systems allow the simultaneous amplification of multiple nonoverlapping loci in a single reaction, substantially increasing throughput. With multicolor fluorescent detection, even overlapping loci can be multiplexed. The polymorphic nature of tandem repeated DNA sequences that are widespread throughout the human genome have made them important genetic markers for gene mapping studies, linkage analysis, and human identity testing. Because of the high polymorphism of STRs, most individuals will be heterozygous i.e. most people will possess two alleles (versions) of each--one inherited from each parent with a different number of repeats. The PCR products comprising the STRs can be separated and detected using manual, semi-automated or automated methods. Semi-automated systems are gel-based and combine electrophoresis, detection and analysis into one unit. On a semiautomated system, gel assembly and sample loading are still manual processes; however, once samples are loaded onto the gel, electrophoresis, detection and analysis proceed automatically. Data collection occurs in "real time" as fluorescently labeled fragments migrate past the detector at a fixed point and can be viewed as they are collected. As the name implies, capillary electrophoresis is carried out in a microcapillary tube rather than between glass plates. Once samples, gel polymer and buffer are loaded onto the instrument, the capillary is filled with gel polymer and the sample is loaded automatically. Therefore, the non-maternally inherited fetal STR sequence will differ in the number of repeats from the maternal sequence. Amplification of these STR sequences can result in one or two major amplification products corresponding to the maternal alleles (and the maternally inherited fetal allele) and one minor product corresponding to the non-maternally inherited fetal allele. This technique was first reported in 2000 (Pertl et al., Human Genetics 106:45-49 [2002]) and has subsequently been developed using simultaneous identification of multiple different STR regions using real-time PCR (Liu et al., Acta Obset Gyn Scand 86:535-541 [2007]). Various sized PCR amplicons have been used to discern the respective size distributions of circulating fetal and maternal DNA species, and have shown that the fetal DNA molecules in the plasma of pregnant women are generally shorter than maternal DNA molecules (Chan et al., Clin Chem 50:8892 [2004]). Size fractionation of circulating fetal DNA has confirmed that the average length of circulating fetal DNA fragments is <300 bp, while maternal DNA has been estimated to be between about 0.5 and 1 Kb (Li et al., Clin Chem, 50: 1002-1011 [2004]). The invention provides a method for determining the fraction of fetal nucleic acid in a maternal sample comprising determining the amount of copies of at least one fetal and one maternal allele at a polymorphic miniSTR site, which can be amplified to generate amplicons that are of lengths about the size of the circulating fetal DNA fragments e.g. less than about 250 base pairs. In one embodiment, the fetal fraction can be determined by a method that comprises sequencing at least a portion of amplified polymorphic target nucleic acids each comprising a miniSTR. Fetal and maternal alleles at an informative STR site are discerned by their different lengths i.e. number of repeats, and the fetal fraction can be calculated as a percent ratio of the amount of fetal maternal alleles at that site. The method can use one or a combination of any number of informative miniSTRs to determine the fraction of fetal nucleic acid. For example, any one or a combination of any number of miniSTRs, for example the miniSTRs disclosed in Table 7 and FIGS. 4 and 5, can be used. In one embodiment, the fraction of fetal nucleic acid in a maternal sample is performed using a method that includes determining the number of copies of the maternal and fetal nucleic acid present in the maternal sample by amplifying at least one autosomal miniSTR chosen from CSF1PO, FGA, TH01, TPDX, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, Penta D, Penta E, D2S1338, D1S1677, D2S441, D4S2364, D10S1248, D14S1434, D22S1045, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. In another embodiment, the at least one autosomal miniSTR is the group of miniSTRs CSF1PO, FGA, D13S317, D16S539, D18S51, D2S1338, D21S11, D2S1338 and D7S820. In one embodiment, the method comprises determining the number of copies of at least one fetal and at least one maternal allele at least at one polymorphic miniSTR that is amplified to generate amplicons that are less than about 300 bp, less than about 250 bp, less than about 200 bp, less than about 150 bp, less than about 100 bp, or less than about 50 bp. In another embodiment, the amplicons that are generated by amplifying the miniSTRs are less than about 300 bp. In another embodiment, the amplicons that are generated by amplifying the miniSTRs are less than about 250 bp. In another embodiment, the amplicons that are generated by amplifying the miniSTRs are less than about 200 bp. Amplification of the informative allele includes using miniSTR primers, which allow for the amplification of reduced-size amplicons to detect STR alleles that are less than about 500 bp, less than about 450 bp, less than about 400 bp, less than about 350 bp, less than about 300 base pairs (bp), less than about 250 bp, less than about 200 bp, less than about 150 bp, less than about 100 bp, or less than about 50 bp. The reduced-size amplicons generated using the miniSTR primers are known as miniSTRs that are identified according to the marker name corresponding to the locus to which they have been mapped. In one embodiment, the miniSTR primers include mini STR primers that have permitted the maximum size reduction in amplicon size for all 13 CODIS STR loci in addition to the D2S1338, Penta D, and pentaE found in commercially available STR kits (Butler et al., J Forensic Sci 48:1054-1064 [2003]), miniSTR loci that are unlinked to the CODIS markers as described by Coble and Butler (Coble and Butler, J Forensic Sci 50:43-53 [2005]), and other minSTRs that have been characterized at NIST. Information regarding the miniSTRs characterized at NIST is accessible via the world wide web at cstl.nist.gov/biotech/strbase/newSTRs.htm. Any one pair or a combination of two or more pairs of miniSTR primers can be used to amplify at least one miniSTR.

[0139] In one embodiment, exemplary primer sets that can be used to amplify STRs in maternal cIDNA samples include the primer sets provided in Example 9 and disclosed as SEQ ID NOs:113-196.

[0140] Gender identification (sex-typing) in commonly performed in conjunction with STR typing using PCR products generated from the Amelogenin gene that occurs on both the X- and Y-chromosome. Amelogenin is not an STR locus, but it produces X and Y chromosome specific PCR products. A commonly used PCR primer set first published by Sullivan et al. (1993) (Sullivan et al., BioTechniques 15:637-641 [1993]) targets a 6 by deletion that occurs on the X-chromosome, which enables amplicons generated from the X- and Y-chromosome to be distinguished from one another when electrophoretic separation is performed to separate STR alleles. Most commercial STR kits utilize the Sullivan et al. (1993) primers or minor modifications. Since females are X,X, only a single peak is observed when testing female DNA whereas males, which possess both X and Y chromosomes, exhibit two peaks with a standard Amelogenin test. In one embodiment, the method to determine the fraction of fetal nucleic acid in a maternal sample comprises coamplifying Ameleogenin with at least one miniSTR. In another embodiment, the method does not comprise coamplifying Amelogenin with miniSTR loci.

[0141] Amplification of the target nucleic acids in the mixture of fetal and maternal nucleic acid e.g. cfDNA, is accomplished any method that uses PCR or variations of the method including but not limited to digital PCR, real time PCR (RT-PCR), TaqMan PCR System (Applied Biosystems), SNPlex or GenPlex methods, asymmetric PCR, helicase-dependent amplification, hot-start PCR, qPCR, solid phase PCR, and touchdown PCR. Alternatively, replication of target nucleic acid sequences can be obtained by enzyme-independent methods e.g. chemical solid-phase synthesis using the phosphoramidites. Amplification of the target sequences is accomplished using primer pairs each capable of amplifying a target nucleic acid sequence comprising the polymorphic site e.g. SNP, in a multiplex PCR reaction. Multiplex PCR reactions include combining at least 2, at least three, at least 3, at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 40 or more sets of primers in the same reaction to quantify the amplified target nucleic acids comprising at least two, at least three, at least 5, at least 10, at least 15, at least 20, at least 25, at least 30, at least 40 or more polymorphic sites in the same sequencing reaction. Any panel of primer sets can be configured to amplify at least one informative polymorphic sequence.

[0142] In step 140 of method 100 (FIG. 1), a portion or all of the amplified polymorphic sequences are used to prepare a sequencing library for sequencing in a parallel fashion as described. In one embodiment, the library is prepared for sequencing-by-synthesis using Illumina's reversible terminator-based sequencing chemistry.

[0143] In step 140, sequence information that is needed for determining fetal fraction is obtained using any of the known DNA sequencing methods. In one embodiment, the method described herein employs next generation sequencing technology (NGS) in which clonally amplified DNA templates or single DNA molecules are sequenced in a massively parallel fashion within a flow cell (e.g. as described in Volkerding et al. Clin Chem 55:641-658 [2009]; Metzker M Nature Rev 11:31-46 [2010]). In addition to high-throughput sequence information, NGS provides digital quantitative information, in that each sequence read is a countable "sequence tag" representing an individual clonal DNA template or a single DNA molecule. This quantification allows NGS to expand the digital PCR concept of counting cell-free DNA molecules (Fan et al., Proc Natl Acad Sci USA 105:16266-16271 [2008]; Chiu et al., Proc Natl Acad Sci USA 2008; 105:20458-20463 [2008]). The sequencing technologies of NGS include pyrosequencing, sequencing-by-synthesis with reversible dye terminators, sequencing by oligonucleotide probe ligation and real time sequencing.

[0144] Some of the sequencing technologies are available commercially, such as the sequencing-by-hybridization platform from Affymetrix Inc. (Sunnyvale, Calif.) and the sequencing-by-synthesis platforms from 454 Life Sciences (Bradford, Conn.), Illumina/Solexa (Hayward, Calif.) and Helicos Biosciences (Cambridge, Mass.), and the sequencing-by-ligation platform from Applied Biosystems (Foster City, Calif.), as described below. In addition to the single molecule sequencing performed using sequencing-by-synthesis of Helicos Biosciences, other single molecule sequencing technologies are encompassed by the method of the invention and include the SMRT.TM. technology of Pacific Biosciences, the Ion Torrent technology, and nanopore sequencing being developed for example, by Oxford Nanopore Technologies.

[0145] While the automated Sanger method is considered as a `first generation` technology, Sanger sequencing including the automated Sanger sequencing, can also be employed by the method of the invention. Additional sequencing methods that comprise the use of developing nucleic acid imaging technologies e.g. atomic force microscopy (AFM) or transmission electron microscopy (TEM), are also encompassed by the method of the invention. Exemplary sequencing technologies are described below.

[0146] In one embodiment, the DNA sequencing technology that is used in the method of the invention is the Helicos True Single Molecule Sequencing (tSMS) (e.g. as described in Harris T. D. et al., Science 320:106-109 [2008]). In the tSMS technique, a DNA sample is cleaved into strands of approximately 100 to 200 nucleotides, and a polyA sequence is added to the 3' end of each DNA strand. Each strand is labeled by the addition of a fluorescently labeled adenosine nucleotide. The DNA strands are then hybridized to a flow cell, which contains millions of oligo-T capture sites that are immobilized to the flow cell surface. The templates can be at a density of about 100 million templates/cm.sup.2. The flow cell is then loaded into an instrument, e.g., HeliScope.TM. sequencer, and a laser illuminates the surface of the flow cell, revealing the position of each template. A CCD camera can map the position of the templates on the flow cell surface. The template fluorescent label is then cleaved and washed away. The sequencing reaction begins by introducing a DNA polymerase and a fluorescently labeled nucleotide. The oligo-T nucleic acid serves as a primer. The polymerase incorporates the labeled nucleotides to the primer in a template directed manner. The polymerase and unincorporated nucleotides are removed. The templates that have directed incorporation of the fluorescently labeled nucleotide are discerned by imaging the flow cell surface. After imaging, a cleavage step removes the fluorescent label, and the process is repeated with other fluorescently labeled nucleotides until the desired read length is achieved. Sequence information is collected with each nucleotide addition step.

[0147] In one embodiment, the DNA sequencing technology that is used in the method of the invention is the 454 sequencing (Roche) (e.g. as described in Margulies, M. et al. Nature 437:376-380 [2005]). 454 sequencing involves two steps. In the first step, DNA is sheared into fragments of approximately 300-800 base pairs, and the fragments are blunt-ended. Oligonucleotide adaptors are then ligated to the ends of the fragments. The adaptors serve as primers for amplification and sequencing of the fragments. The fragments can be attached to DNA capture beads, e.g., streptavidin-coated beads using, e.g., Adaptor B, which contains 5'-biotin tag. The fragments attached to the beads are PCR amplified within droplets of an oil-water emulsion. The result is multiple copies of clonally amplified DNA fragments on each bead. In the second step, the beads are captured in wells (pico-liter sized). Pyrosequencing is performed on each DNA fragment in parallel. Addition of one or more nucleotides generates a light signal that is recorded by a CCD camera in a sequencing instrument. The signal strength is proportional to the number of nucleotides incorporated. Pyrosequencing makes use of pyrophosphate (PPi) which is released upon nucleotide addition. PPi is converted to ATP by ATP sulfurylase in the presence of adenosine 5' phosphosulfate. Luciferase uses ATP to convert luciferin to oxyluciferin, and this reaction generates light that is discerned and analyzed.

[0148] In one embodiment, the DNA sequencing technology that is used in the method of the invention is the SOLiD technology (Applied Biosystems). In SOLiD sequencing-by-ligation, genomic DNA is sheared into fragments, and adaptors are attached to the 5' and 3' ends of the fragments to generate a fragment library. Alternatively, internal adaptors can be introduced by ligating adaptors to the 5' and 3' ends of the fragments, circularizing the fragments, digesting the circularized fragment to generate an internal adaptor, and attaching adaptors to the 5' and 3' ends of the resulting fragments to generate a mate-paired library. Next, clonal bead populations are prepared in microreactors containing beads, primers, template, and PCR components. Following PCR, the templates are denatured and beads are enriched to separate the beads with extended templates. Templates on the selected beads are subjected to a 3' modification that permits bonding to a glass slide. The sequence can be determined by sequential hybridization and ligation of partially random oligonucleotides with a central determined base (or pair of bases) that is identified by a specific fluorophore. After a color is recorded, the ligated oligonucleotide is cleaved and removed and the process is then repeated.

[0149] In one embodiment, the DNA sequencing technology that is used in the method of the invention is the single molecule, real-time (SMRT.TM.) sequencing technology of Pacific Biosciences. In SMRT sequencing, the continuous incorporation of dye-labeled nucleotides is imaged during DNA synthesis. Single DNA polymerase molecules are attached to the bottom surface of individual zero-mode wavelength identifiers (ZMW identifiers) that obtain sequence information while phospholinked nucleotides are being incorporated into the growing primer strand. A ZMW is a confinement structure which enables observation of incorporation of a single nucleotide by DNA polymerase against the background of fluorescent nucleotides that rapidly diffuse in an out of the ZMW (in microseconds). It takes several milliseconds to incorporate a nucleotide into a growing strand. During this time, the fluorescent label is excited and produces a fluorescent signal, and the fluorescent tag is cleaved off. Identification of the corresponding fluorescence of the dye indicates which base was incorporated. The process is repeated.

[0150] In one embodiment, the DNA sequencing technology that is used in the method of the invention is nanopore sequencing (e.g. as described in Soni G V and Meller A. Clin Chem 53: 1996-2001 [2007]). Nanopore sequencing DNA analysis techniques are being industrially developed by a number of companies, including Oxford Nanopore Technologies (Oxford, United Kingdom). Nanopore sequencing is a single-molecule sequencing technology whereby a single molecule of DNA is sequenced directly as it passes through a nanopore. A nanopore is a small hole, of the order of 1 nanometer in diameter. Immersion of a nanopore in a conducting fluid and application of a potential (voltage) across it results in a slight electrical current due to conduction of ions through the nanopore. The amount of current which flows is sensitive to the size and shape of the nanopore. As a DNA molecule passes through a nanopore, each nucleotide on the DNA molecule obstructs the nanopore to a different degree, changing the magnitude of the current through the nanopore in different degrees. Thus, this change in the current as the DNA molecule passes through the nanopore represents a reading of the DNA sequence.

[0151] In one embodiment, the DNA sequencing technology that is used in the method of the invention is the chemical-sensitive field effect transistor (chemFET) array (e.g., as described in U.S. Patent Application Publication No. 20090026082). In one example of the technique, DNA molecules can be placed into reaction chambers, and the template molecules can be hybridized to a sequencing primer bound to a polymerase. Incorporation of one or more triphosphates into a new nucleic acid strand at the 3' end of the sequencing primer can be discerned by a change in current by a chemFET. An array can have multiple chemFET sensors. In another example, single nucleic acids can be attached to beads, and the nucleic acids can be amplified on the bead, and the individual beads can be transferred to individual reaction chambers on a chemFET array, with each chamber having a chemFET sensor, and the nucleic acids can be sequenced.

[0152] In one embodiment, the DNA sequencing technology that is used in the method of the invention is the Halcyon Molecular's method that uses transmission electron microscopy (TEM). The method, termed Individual Molecule Placement Rapid Nano Transfer (IMPRNT), comprises utilizing single atom resolution transmission electron microscope imaging of high-molecular weight (150 kb or greater) DNA selectively labeled with heavy atom markers and arranging these molecules on ultra-thin films in ultra-dense (3 nm strand-to-strand) parallel arrays with consistent base-to-base spacing. The electron microscope is used to image the molecules on the films to determine the position of the heavy atom markers and to extract base sequence information from the DNA. The method is further described in PCT patent publication WO 2009/046445. The method allows for sequencing complete human genomes in less than ten minutes.

[0153] In one embodiment, the DNA sequencing technology is the Ion Torrent single molecule sequencing, which pairs semiconductor technology with a simple sequencing chemistry to directly translate chemically encoded information (A, C, G, T) into digital information (0, 1) on a semiconductor chip. In nature, when a nucleotide is incorporated into a strand of DNA by a polymerase, a hydrogen ion is released as a byproduct. Ion Torrent uses a high-density array of micro-machined wells to perform this biochemical process in a massively parallel way. Each well holds a different DNA molecule. Beneath the wells is an ion-sensitive layer and beneath that an ion sensor. When a nucleotide, for example a C, is added to a DNA template and is then incorporated into a strand of DNA, a hydrogen ion will be released. The charge from that ion will change the pH of the solution, which can be identified by Ion Torrent's ion sensor. The sequencer essentially the world's smallest solid-state pH meter--calls the base, going directly from chemical information to digital information. The Ion personal Genome Machine (PGM.TM.) sequencer then sequentially floods the chip with one nucleotide after another. If the next nucleotide that floods the chip is not a match. No voltage change will be recorded and no base will be called. If there are two identical bases on the DNA strand, the voltage will be double, and the chip will record two identical bases called. Direct identification allows recordation of nucleotide incorporation in seconds.

[0154] Other sequencing methods include digital PCR and sequencing by hybridization. Digital polymerase chain reaction (digital PCR or dPCR) can be used to directly identify and quantify nucleic acids in a sample. Digital PCR can be performed in an emulsion. Individual nucleic acids are separated, e.g., in a microfluidic chamber device, and each nucleic can is individually amplified by PCR. Nucleic acids can be separated such there is an average of approximately 0.5 nucleic acids/well, or not more than one nucleic acid/well. Different probes can be used to distinguish fetal alleles and maternal alleles. Alleles can be enumerated to determine copy number. In sequencing by hybridization, the hybridization comprises contacting the plurality of polynucleotide sequences with a plurality of polynucleotide probes, wherein each of the plurality of polynucleotide probes can be optionally tethered to a substrate. The substrate might be flat surface comprising an array of known nucleotide sequences. The pattern of hybridization to the array can be used to determine the polynucleotide sequences present in the sample. In other embodiments, each probe is tethered to a bead, e.g., a magnetic bead or the like. Hybridization to the beads can be identified and used to identify the plurality of polynucleotide sequences within the sample.

[0155] In one embodiment, the method employs massively parallel sequencing of millions of DNA fragments using Illumina's sequencing-by-synthesis and reversible terminator-based sequencing chemistry (e.g. as described in Bentley et al., Nature 6:53-59 [2009]). Template DNA can be genomic DNA e.g. cfDNA. In some embodiments, genomic DNA from isolated cells is used as the template, and it is fragmented into lengths of several hundred base pairs. In other embodiments, cfDNA is used as the template, and fragmentation is not required as cIDNA exists as short fragments. For example fetal cIDNA circulates in the bloodstream as fragments of <300 bp, and maternal cfDNA has been estimated to circulate as fragments of between about 0.5 and 1 Kb (Li et al., Clin Chem, 50: 1002-1011 [2004]). Illumina's sequencing technology relies on the attachment of fragmented genomic DNA to a planar, optically transparent surface on which oligonucleotide anchors are bound. Template DNA is end-repaired to generate 5'-phosphorylated blunt ends, and the polymerase activity of Klenow fragment is used to add a single A base to the 3' end of the blunt phosphorylated DNA fragments. This addition prepares the DNA fragments for ligation to oligonucleotide adapters, which have an overhang of a single T base at their 3' end to increase ligation efficiency. The adapter oligonucleotides are complementary to the flow-cell anchors. Under limiting-dilution conditions, adapter-modified, single-stranded template DNA is added to the flow cell and immobilized by hybridization to the anchors. Attached DNA fragments are extended and bridge amplified to create an ultra-high density sequencing flow cell with hundreds of millions of clusters, each containing .about.1,000 copies of the same template. The cluster amplified DNA molecules are sequenced using a robust four-color DNA sequencing-by-synthesis technology that employs reversible terminators with removable fluorescent dyes. High-sensitivity fluorescence identification is achieved using laser excitation and total internal reflection optics. Short sequence reads of about 20-40 by e.g. 36 bp, are aligned against a repeat-masked reference genome and genetic differences are called using specially developed data analysis pipeline software. After completion of the first read, the templates can be regenerated in situ to enable a second read from the opposite end of the fragments. Thus, either single-end or paired end sequencing of the DNA fragments is used according to the method. Partial sequencing of DNA fragments present in the sample is performed, and sequence tags comprising reads of predetermined length e.g. 36 bp, that are mapped to a known reference genome are counted.

[0156] The length of the sequence read is associated with the particular sequencing technology. NGS methods provide sequence reads that vary in size from tens to hundreds of base pairs. In some embodiments of the method described herein, the sequence reads are about 20 bp, about 25 bp, about 30 bp, about 35 bp, about 40 bp, about 45 bp, about 50 bp, about 55 bp, about 60 bp, about 65 bp, about 70 bp, about 75 bp, about 80 bp, about 85 bp, about 90 bp, about 95 bp, about 100 bp, about 110 bp, about 120 bp, about 130, about 140 bp, about 150 bp, about 200 bp, about 250 bp, about 300 bp, about 350 bp, about 400 bp, about 450 bp, about 500 bp, about 550 bp or about 600 bp. It is expected that technological advances will enable single-end reads of greater than 500 bp enabling for reads of greater than about 1000 bp when paired end reads are generated. In one embodiment, the sequence reads are 36 bp. Other sequencing methods that can be employed by the method of the invention include the single molecule sequencing methods that can sequence nucleic acids molecules >5000 bp. The massive quantity of sequence output is transferred by an analysis pipeline that transforms primary imaging output from the sequencer into strings of bases. A package of integrated algorithms performs the core primary data transformation steps: image analysis, intensity scoring, base calling, and alignment.

[0157] In one embodiment, partial sequencing of amplified target polymorphic nucleic acids is performed, and sequence tags comprising reads of predetermined length e.g. 36 bp, that map to a known reference genome are counted. Only sequence reads that uniquely align to a reference genome are counted as sequence tags. In one embodiment, the reference genome is an artificial target sequences genome that comprises the sequences of the polymorphic target nucleic acids e.g. SNPs. In one embodiment, the reference genome is an artificial SNP reference genome. In another r embodiment, the reference genome is an artificial STR reference genome. In yet another embodiment, the reference genome is an artificial tandem-STR reference genome. Artificial reference genomes can be compiled using the sequences of the target polymorphic nucleic acids. Artificial reference genomes can comprise polymorphic target sequence each comprising one or more different types of polymorphic sequences. For example, an artificial reference genome can comprise polymorphic sequences comprising SNP alleles and/or STRs. In one embodiment, the reference genome is the human reference genome NCBI36/hg18 sequence, which is available on the world wide web at genome.ucsc.edu/cgi-bin/hgGateway?org=Human&db=hg18&hgsid=166260105). Other sources of public sequence information include GenBank, dbEST, dbSTS, EMBL (the European Molecular Biology Laboratory), and the DDBJ (the DNA Databank of Japan). In another embodiment, the reference genome comprises the human reference genome NCBI36/hg18 sequence and an artificial target sequences genome, which includes the target polymorphic sequences e.g. a SNP genome. Mapping of the sequence tags is achieved by comparing the sequence of the mapped tag with the sequence of the reference genome to determine the chromosomal origin of the sequenced nucleic acid (e.g. cIDNA) molecule, and specific genetic sequence information is not needed. A number of computer algorithms are available for aligning sequences, including without limitation BLAST (Altschul et al., 1990), BLITZ (MPsrch) (Sturrock & Collins, 1993), FASTA (Person & Lipman, 1988), BOWTIE (Langmead et al., Genome Biology 10:R25.1-R25.10 [2009]), or ELAND (Illumina, Inc., San Diego, Calif., USA). In one embodiment, one end of the clonally expanded copies of the plasma cIDNA molecules is sequenced and processed by bioinformatic alignment analysis for the Illumina Genome Analyzer, which uses the Efficient Large-Scale Alignment of Nucleotide Databases (ELAND) software. In embodiments of the method that comprise determining the presence or absence of an aneuploidy and fetal fraction using NGS sequencing methods, analysis of sequencing information for the determination of aneuploidy may allow for a small degree of mismatch (0-2 mismatches per sequence tag) to account for minor polymorphisms that may exist between the reference genome and the genomes in the mixed sample. Analysis of sequencing information for the determination of fetal fraction may allow for a small degree of mismatch depending on the polymorphic sequence. For example, a small degree of mismatch may be allowed if the polymorphic sequence is an STR. In cases when the polymorphic sequence is a SNP, all sequence that match exactly to either of the two alleles at the SNP site are counted first and filtered from the remaining reads, for which a small degree of mismatch may be allowed. Quantification of the number of sequence reads aligning to each chromosome for determining chromosomal aneuploidies can be determined as described herein, or using alternative analyses that employ normalizing the median number of sequence tags for a chromosome of interest to the median number of tags for each of the other autosomes (Fan et al., Proc Natl Acad Sci 105:16266-16271 [2008]), or that compare the number of unique reads aligning to each chromosome to the total number of reads aligning to all chromosomes to derive a percent genomic representation for each chromosome. A "z score" is generated to represent the difference between the percent genomic representation of the chromosome of interest and the mean percent representation for the same chromosome between a euploid control group, divided by the standard deviation (Chiu et al., Clin Chem 56:459-463 [2010]). In another embodiment, the sequencing information can be determined as described in U.S. Provisional Patent Application titled "Normalizing Biological Assays," docket no. 32047-768.101, filed Jan. 19, 2010, which is herein incorporated by reference in its entirety.

[0158] Analysis of sequencing information for the determination of fetal fraction may allow for a small degree of mismatch depending on the polymorphic sequence. For example, a small degree of mismatch may be allowed if the polymorphic sequence is an STR. In cases when the polymorphic sequence is a SNP, all sequences that match exactly to either of the two alleles at the SNP site are counted first and filtered from the remaining reads, for which a small degree of mismatch may be allowed. The present method for determining fetal fraction by sequencing of nucleic acids can be used in combination with other methods.

[0159] In step 160, fetal fraction is determined based on the total number of tags that map to the first allele and the total number of tags that map to second allele at an informative polymorphic site e.g. a SNP, contained in a reference genome. For example, the reference genome is an artificial target sequence genome that encompasses the polymorphic sequences that comprise SNPs rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). In one embodiment, the artificial reference genome includes the polymorphic target sequences of SEQ ID NOs:1-56 (see Example-3).

[0160] In another embodiment, the artificial genome is an artificial target sequence genome that encompasses polymorphic sequences that comprise tandem SNPs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427).

[0161] In another embodiment, the artificial target genome encompasses polymorphic sequences that comprise STRs selected from CSF1PO, FGA, TH01, TPOX, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, Penta D, Penta E, D2S1338, D1S1677, D2S441, D4S2364, D10S1248, D14S1434, D22S1045, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. The composition of the artificial target sequences genome will vary depending on the polymorphic sequences that are used for determining the fetal fraction. Accordingly, an artificial target sequences genome is not limited to the SNP, tandem SNP or STR sequences exemplified herein.

[0162] The informative polymorphic site e.g. SNP, is identified by the difference in the allelic sequences and the amount of each of the possible alleles. Fetal cfDNA is present at a concentration that is <10% of the maternal cfDNA. Thus, the presence of a minor contribution of an allele to the mixture of fetal and maternal nucleic acids relative to the major contribution of the maternal allele can be assigned to the fetus. Alleles that are derived from the maternal genome are herein referred to as major alleles, and alleles that are derived from the fetal genome are herein referred to as minor alleles. Alleles that are represented by similar levels of mapped sequence tags represent maternal alleles. The results of an exemplary multiplex amplification of target nucleic acids comprising SNPs and derived from a maternal plasma sample is shown in FIG. 2. Informative SNPs are discerned from the single nucleotide change at a polymorphic site, and fetal alleles are discerned by their relative minor contribution to the mixture of fetal and maternal nucleic acids in the sample when compared to the major contribution to the mixture by the maternal nucleic acids. Accordingly, the relative abundance of fetal cfDNA in the maternal sample is determined as a parameter of the total number of unique sequence tags mapped to the target nucleic acid sequence on a reference genome for each of the two alleles of the predetermined polymorphic site. In one embodiment, the fraction of fetal nucleic acids in the mixture of fetal and maternal nucleic acids is calculated for each of the informative allele (allele.sub.x) as follows:

[0163] % fetal fraction allele.sub.x=((.SIGMA.Fetal sequence tags for allele.sub.x)/(.SIGMA.Maternal sequence tags for allele.sub.x)).times.100 and fetal fraction for the sample is calculated as the average of the fetal fraction of all of the informative alleles. Optionally, the fraction of fetal nucleic acids in the mixture of fetal and maternal nucleic acids is calculated for each of the informative allele (allele.sub.x) as follows:

[0164] % fetal fraction allele.sub.x=((2.times..SIGMA.Fetal sequence tags for allele.sub.x)/(.SIGMA.Maternal sequence tags for allele.sub.x)).times.100,

to compensate for the presence of 2 fetal alleles, one being masked by the maternal background.

[0165] The percent fetal fraction is calculated for at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 11, at least 12, at least 13, at least 14, at least 15, at least 16, at least 17, at least 18, at least 19, at least 20, at least 25, at least 30, at least 40 or more informative alleles. In one embodiment, the fetal fraction is the average fetal fraction determined for at least 3 informative alleles.

[0166] FIG. 3, shows a flowchart of alternate methods whereby fetal fraction can be determined from amplified target nucleic acids that have been combined with unamplified fetal and maternal cIDNA sample to allow for the simultaneous determination of fetal fraction and the presence or absence of fetal aneuploidy by enriching the maternal sample comprising fetal and maternal nucleic acids for polymorphic target nucleic acids. In one embodiment, the sample that is enriched is the plasma fraction of a blood sample (a). For example, a portion of an original maternal plasma sample is used for amplifying target nucleic acid sequences. Subsequently, some or all of the amplified product is combined with the remaining unamplified original plasma sample thereby enriching it (see Example 7). In another embodiment, the sample that is enriched is the sample of purified cfDNA that is extracted from plasma (b). For example, enrichment comprises amplifying the target nucleic acids that are contained in a portion of an original sample of purified mixture of fetal and maternal nucleic acids e.g. cfDNA that has been purified from a maternal plasma sample, and subsequently combining some or all of the amplified product with the remaining unamplified original purified sample (see Example 6). In yet another embodiment, the sample that is enriched is a sequencing library sample prepared from a purified mixture of fetal and maternal nucleic acids (c). For example, enrichment comprises amplifying the target nucleic acids that are contained in a portion of an original sample of purified mixture of fetal and maternal nucleic acids e.g. cfDNA that has been purified from a maternal plasma sample, preparing a first sequencing library of unamplified nucleic acid sequences, preparing a second sequencing library of amplified polymorphic target nucleic acids, and subsequently combining some or all of the second sequencing library with some or all of the first sequencing library (see Example 5). The amount of amplified product that is used to enrich the original sample is selected to obtain sufficient sequencing information for determining both the presence or absence of aneuploidy and the fetal fraction from the same sequencing run. At least about 3%, at least about 5%, at least about 7%, at least about 10%, at least about 15%, at least about 20%, at least about 25%, at least about 30% or more of the total number of sequence tags obtained from sequencing are mapped to determine the fetal fraction. Sequencing of the library generated following any one of the methods depicted in FIG. 3, provides sequence tags derived from the amplified target nucleic acids and tags derived from the original unamplified maternal sample. Fetal fraction is calculated from the number of tags mapped to an artificial reference genome, and the presence or absence of aneuploidy is determined from the number of tags that map to the subject genome e.g. human genome.

[0167] An alternative method for determining fetal fraction from amplified polymorphic target nucleic acids at step 130 of FIG. 1, uses size separation of amplified polymorphic target nucleic acids comprising STRs (step 150 of FIG. 1). As described above, the polymorphic character of a STR locus is due to variation in the number of tandemly repeated units between alleles. Because of the high polymorphism of the STRs most individuals will be heterozygous for STRs. Amplification of an STR will result in one or two PCR products in most samples. In samples obtained from pregnant women e.g. plasma samples, amplification of an STR will result in one or two major PCR products, which correspond to the one or two maternal alleles including one fetal maternally-inherited allele, and a third paternally-inherited fetal allele that is detected at an informative STR.

[0168] The STRs that are targeted for amplification are miniSTRs as described herein that are less than about 300 base pairs and that are amplified in a multiplex PCR reaction, which allows the simultaneous amplification of multiple loci in a single reaction. The primers are labeled with different fluorescent dyes each emitting fluorescence at a different wavelength e.g. 6FAM.TM., VIC.TM., NED.TM., and PET.TM., and the number of repeat units for each fluorescently tagged STR in the resulting PCR products is detected following their separation and accurate sizing that is achieved by slab or capillary electrophoresis. In one embodiment, capillary electrophoresis is used, and it can be performed in microfabricated channels or capillary arrays. Alternatively, methods utilizing mass spectrometry and microarray technology are used. Multiplex STR analysis can be performed to determine fetal fraction using commercially-available kits e.g. AmpF.lamda.STR.RTM. Identifier.RTM. PCR Amplification Kit (FIG. 4) and AmpF.lamda.STR.RTM. MiniFiler.RTM. PCR Amplification Kit (FIG. 5) (Applied Biosystems, Foster City, Calif.). The AmpF.lamda.STR.RTM. MiniFiler.RTM. PCR Amplification Kit was designed to amplify as miniSTRs eight of the largest sized loci in the AmpF.lamda.STR.RTM. Identifier.RTM. PCR Amplification Kit. Together with the gender-identification locus Amelogenin, the nine-locus multiplex enables simultaneous amplification of loci of cfDNA samples (see Example 10).

[0169] In one embodiment, multiplex STR analysis for determining fetal fraction is performed by amplifying polymorphic target nucleic acids present in a maternal plasma sample that each comprise a miniSTR selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. In another embodiment, multiplex STR analysis for determining fetal fraction is performed by amplifying polymorphic target nucleic acids present in a maternal plasma sample for the panel of miniSTRs: CSF1PO, D13S317, D16 S539, D18S51, D21S11, D2S1338, D7S820 and FGA. The miniSTRs can be located on the same or on different chromosomes. The method is a fetal gender-independent method. Therefore, in some embodiments, the miniSTRs are located on chromosomes other than the Y chromosome. In other embodiments, the miniSTRs are located on chromosomes other than chromosomes 13, 18, 21 or X i.e. chromosomes that might be involved in an aneuploidy.

[0170] Samples of maternal plasma often contain less than 100 pg of cfDNA. The low copy number DNA samples can fall below the sensitivity limitations of STR analysis methods. The intractable samples can be made amenable by increasing the number of starting cIDNA available for subsequent STR analysis by a whole genome amplification strategy. In one embodiment, the mixture of fetal and maternal nucleic acids can be preamplified before alleles are detected or quantified. For example, template cell-free DNA can be amplified by PCR. The nucleic acid can be amplified for about 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, or 40 cycles. Nucleic acid can be amplified for about 1-10 cycles, about 1-20 cycles, about 1-30 cycles, about 1-40 cycles, about 5-15 cycles, about 5-20 cycles, about 5-30 cycles, about 5-40 cycles, about 10-15 cycles, about 10-20 cycles, about 10-30 cycles, about 10-40 cycles, about 20-30 cycles, about 20-40 cycles, or about 30-40 cycles. The amount of template nucleic acid that can be amplified can about 10-1000 pg, 25-1000 pg, 50-1000 pg, 100-1000, pg, 200-1000 pg, 300-1000 pg, 400-1000 pg, 500-1000 pg, 600-1000, pg, 700-1000 pg, or 800-1000 pg. Following preamplification, the nucleic acids can be diluted before alleles are detected or quantified. Preamplification can be used to increase the detection sensitivity of alleles in a sample, for example, a maternal sample (Example 11). In another embodiment, genotyping a polymorphism need not require a pre-amplification step. Any PCR-based amplification method can be used to preamplify the cIDNA. Amplification methods include but are not limited to whole genome amplification strategies including methods such as primer extension preamplification, degenerate oligonucleotide-primed PCR (DOP-PCR), low fragments from low quantities of DOP-PCR, improved primer extension preamplification PCR (IPEP PCR), and modified improved primer extension preamplification (mIPEP). Thus, in one embodiment, the method that is used for determining the fetal fraction in a maternal sample e.g. plasma sample, comprises preamplifying the mixture of fetal and maternal nucleic acids present in the plasma cIDNA sample using a whole genome amplification method, amplifying a plurality of polymorphic nucleic acids in said mixture of fetal and maternal nucleic acids, wherein each of said at least one polymorphic nucleic acid comprises an STR; determining the amount of fetal and maternal STR alleles at least one polymorphic nucleic acid; and calculating the fetal fraction from the amount of fetal and maternal STR alleles. Following preamplification, multiplex STR analysis for determining fetal fraction is performed by amplifying polymorphic target nucleic acids present in a maternal plasma sample that each comprise a miniSTR selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113. Alternatively, multiplex STR analysis for determining fetal fraction is performed by amplifying polymorphic target nucleic acids for the panel of miniSTRs: CSF1PO, D13S317, D16 S539, D18S51, D21S11, D2S1338, D7S820 and FGA.

Applications

[0171] Methods described herein are applicable to diagnosis or prognosis of various disease conditions including, but not limited to, cancer, genetic disorders and infection. The fetal fraction of nucleic acid in a maternal sample can be used for determining a chromosomal abnormality. Examples of chromosomal abnormalities include, for example, aneuploidy, monosomy, trisomy, duplication, inversion, deletion, polyploidy, deletion of a part of a chromosome, addition, addition of a part of chromosome, insertion, a fragment of a chromosome, a region of a chromosome, chromosomal rearrangement, and translocation. For example, aneuploidy can refer to the occurrence of one or more extra or missing chromosomes in a sample.

[0172] Examples of fetal conditions that can be determined using the methods of the provided invention include, for example, Angleman syndrome (15q11.2-q13), cri-du-chat syndrome (5p-), DiGeorge syndrome and Velo-cardiofacial syndrome (22q11.2), Miller-Dieker syndrome (17 p13.3), Prader-Willi syndrome (15q11.2-q13), retinoblastoma (13q14), Smith-Magenis syndrome (17 p11.2), trisomy 13, trisomy 16, trisomy 18, trisomy 21 (Down's syndrome), triploidy, Williams syndrome (7q 11.23), and Wolf-Hirschhom syndrome (4p-). Examples of sex chromosome abnormalities that can be detected by methods described herein include, but are not limited to, Kallman syndrome (Xp22.3), steroid sulfate deficiency (STS) (Xp22.3), X-linked ichthyosis (Xp22.3), Klinefelter syndrome (XXY), fragile X syndrome, Turner syndrome metafemales or trisomy X, and monosomy X.

[0173] In one embodiment, fetal fraction information can be used to set thresholds and estimate minimum sample size in aneuploidy detection. Such use is described in Example 7 below. Fetal fraction information can be used in conjunction with sequencing information. For example, nucleic acids from a cell-free sample, for example a maternal plasma or serum sample, can be used to enumerate sequences in a sample. Sequences can be enumerated using any of the sequencing techniques described above. Knowledge of fetal fraction can be used to set "cutoff" thresholds to call "aneuploidy," "normal," or "marginal/no call" (uncertain) states. Then, calculations can be performed to estimate the minimum number of sequences required to achieve adequate sensitivity (i.e. probability of correctly identifying an aneuploidy state).

[0174] The determination of fetal fraction according to the method of the invention can be practiced in combination with any method used to determine the presence of absence of fetal aneuploidy in a maternal plasma sample. In addition to the method described herein for the determination of aneuploidy, the determination of fetal fraction by massively parallel sequencing can be used in conjunction with other methods for determining fetal aneuploidy, for example, according to the methods described in U.S. U.S. Patent Application Publication Nos. US 2007/0202525A1; US2010/0112575A1, US 2009/0087847A1; US2009/0029377A1; US 2008/0220422A1; US2008/0138809A1, US2008/0153090A1, and U.S. Pat. No. 7,645,576. The methods can also be combined with assays for determining other prenatal conditions associated with the mother and/or the fetus. For example, the method can be used in conjunction with prenatal analyses, for example, as described in U.S. Patent Application Publication Nos. US2010/0112590A1, US2009/0162842A1, US2007/0207466A1, and US2001/0051341A1, all of which are incorporated by reference in their entirety.

[0175] The methods described can be applied to determine the fraction of any one population of nucleic acids in a mixture of nucleic acids contributed by different genomes. In addition to determining the fraction contributed to a sample by two individuals e.g. the different genomes are contributed by the fetus and the mother carrying the fetus, the methods can be used to determine the fraction of a genome in a mixture derived from two different cells of from one individual e.g. the genomes are contributed to the sample by aneuploid cancerous cells and normal euploid cells from the same subject.

Compositions and Kits

[0176] The present invention is also directed to compositions and kits or reagent systems useful for practicing the methods described herein.

[0177] The compositions of the invention can be included in kits for massively parallel sequencing mixtures of fetal and maternal nucleic acid molecules e.g. cfDNA, present in a maternal sample e.g. a plasma sample. The kits comprise a composition comprising at least one set of primers for amplifying at least one polymorphic target nucleic acid in said fetal and maternal nucleic acid molecules. Polymorphic target nucleic acids can comprise without limitation single nucleotide polymorphisms (SNPs), tandem SNPs, small-scale multi-base deletions or insertions, called IN-DELS (also called deletion insertion polymorphisms or DIPs), Multi-Nucleotide Polymorphisms (MNPs) Short Tandem Repeats (STRs), restriction fragment length polymorphism (RFLP), or a polymorphism comprising any other change of sequence in a chromosome. Sequencing methods utilizing the compositions of the invention are NGS methods of single nucleic acid molecules or clonally amplified nucleic acid molecules as described herein. The massively parallel sequencing methods of NGS include pyrosequencing, sequencing by synthesis with reversible dye terminators, real-time sequencing, or sequencing by oligonucleotide probe ligation.

[0178] In one embodiment, the compositions includes primers for amplifying polymorphic target nucleic acids that each comprise at least one SNP. In one embodiment, the at least one SNP is selected from SNPs rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56). Exemplary corresponding sets of primers for amplifying the SNPs are provided as SEQ ID NOs:57-112.

[0179] In another embodiment, the composition includes primers for amplifying polymorphic target nucleic acids that each comprise at least one tandem SNP. In one embodiment, the composition includes primers for amplifying tandem SNPs. In one embodiment, the composition includes primers for amplifying the tandem SNPs disclosed herein, and the composition comprises the corresponding exemplary primers of SEQ ID NOS:197-310.

[0180] In another embodiment, the composition includes primers for amplifying polymorphic target nucleic acids that each comprise at least one STR. Exemplary STRs include CSF1PO, FGA, TH01, TPDX, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627 and D1GATA113, which can be amplified by the corresponding sets of primers of SEQ ID NOs:113-196.

[0181] Kits can contain a reagent combination including the elements required to conduct an assay according to the methods disclosed herein. The reagent system is presented in a commercially packaged form, as a composition or admixture where the compatibility of the reagents will allow, in a test device configuration, or more typically as a test kit, i.e., a packaged combination of one or more containers, devices, or the like holding the necessary reagents, and preferably including written instructions for the performance of assays. The kit of the present invention may be adapted for any configuration of assay and may include compositions for performing any of the various assay formats described herein. Kits for determining fetal fraction comprise compositions including primer sets for amplifying polymorphic nucleic acids present in a maternal sample as described and, where applicable, reagents for purifying cIDNA, are within the scope of the invention. In one embodiment, a kit designed to allow quantification of fetal and maternal polymorphic sequences e.g. STRs and/or SNPs and/or tandem SNPs, in a cfDNA plasma sample, includes at least one set of allele specific oligonucleotides specific for a selected SNP and/or region of tandem repeats. Preferably, the kit includes a plurality of primer sets to amplify a panel of polymorphic sequences. A kit can comprise other reagents and/or information for genotyping or quantifying alleles in a sample (e.g., buffers, nucleotides, instructions). The kits also include a plurality of containers of appropriate buffers and reagents.

[0182] The present invention is described in further detail in the following Examples which are not in any way intended to limit the scope of the invention as claimed. The attached Figures are meant to be considered as integral parts of the specification and description of the invention. The following examples are offered to illustrate, but not to limit the claimed invention.

EXPERIMENTAL

Example 1

Determination of Fetal Fraction using Massively Parallel Sequencing: Sample Processing and cfDNA Extraction

[0183] Peripheral blood samples were collected from pregnant women in their first or second trimester of pregnancy and who were deemed at risk for fetal aneuploidy. Informed consent was obtained from each participant prior to the blood draw. Blood was collected before amniocentesis or chorionic villus sampling. Karyotype analysis was performed using the chorionic villus or amniocentesis samples to confirm fetal karyotype.

[0184] Peripheral blood drawn from each subject was collected in ACD tubes. One tube of blood sample (approximately 6-9 mL/tube) was transferred into one 15-mL low speed centrifuge tube. Blood was centrifuged at 2640 rpm, 4.degree. C. for 10 min using Beckman Allegra 6 R centrifuge and rotor model GA 3.8.

[0185] For cell-free plasma extraction, the upper plasma layer was transferred to a 15-ml high speed centrifuge tube and centrifuged at 16000.times.g, 4.degree. C. for 10 min using Beckman Coulter Avanti J-E centrifuge, and JA-14 rotor. The two centrifugation steps were performed within 72 h after blood collection. Cell-free plasma comprising cfDNA was stored at -80.degree. C. and thawed only once before amplification of plasma cIDNA or for purification of cIDNA.

[0186] Purified cell-free DNA (cfDNA) was extracted from cell-free plasma using the QIAamp Blood DNA Mini kit (Qiagen) essentially according to the manufacturer's instruction. One milliliter of buffer AL and 100 .mu.l of Protease solution were added to 1 ml of plasma. The mixture was incubated for 15 minutes at 56.degree. C. One milliliter of 100% ethanol was added to the plasma digest. The resulting mixture was transferred to QIAamp mini columns that were assembled with VacValves and VacConnectors provided in the QIAvac 24 Plus column assembly (Qiagen). Vacuum was applied to the samples, and the cIDNA retained on the column filters was washed under vacuum with 750 .mu.l of buffer AW1, followed by a second wash with 750 .mu.l of buffer AW24. The column was centrifuged at 14,000 RPM for 5 minutes to remove any residual buffer from the filter. The cfDNA was eluted with buffer AE by centrifugation at 14,000 RPM, and the concentration determined using Qubit.TM. Quantitation Platform (Invitrogen).

Example 2

Determination of Fetal Fraction using Massively Parallel Sequencing: Preparation of Sequencing Libraries, Sequencing, and Analysis of Sequencing Data

[0187] a. Preparation of Sequencing Libraries

[0188] All sequencing libraries i.e. target, primary and enriched libraries, were prepared from approximately 2 ng of purified cIDNA that was extracted from maternal plasma. Library preparation was performed using reagents of the NEBNext.TM. DNA Sample Prep DNA Reagent Set 1 (Part No. E6000L; New England Biolabs, Ipswich, Mass.) for Illumina.RTM. as follows. Because cell-free plasma DNA is fragmented in nature, no further fragmentation by nebulization or sonication was done on the plasma DNA samples. The overhangs of approximately 2 ng purified cfDNA fragments contained in 40 .mu.l were converted into phosphorylated blunt ends according to the NEBNext.RTM. End Repair Module by incubating in a 1.5 ml microfuge tube the cIDNA with 5 .mu.l 10.times. phosphorylation buffer, 2 .mu.l deoxynucleotide solution mix (10 mM each dNTP), 1 .mu.l of a 1:5 dilution of DNA Polymerase I, 1 .mu.l T4 DNA Polymerase and 1 .mu.l T4 Polynucleotide Kinase provided in the NEBNext.TM. DNA Sample Prep DNA Reagent Set 1 for 15 minutes at 20.degree. C. The enzymes were then heat inactivated by incubating the reaction mixture at 75.degree. C. for 5 minutes. The mixture was cooled to 4.degree. C., and dA tailing of the blunt-ended DNA was accomplished using 10 .mu.l of the dA-tailing master mix containing the Klenow fragment (3' to 5' exo minus) (NEBNext.TM. DNA Sample Prep DNA Reagent Set 1), and incubating for 15 minutes at 37.degree. C. Subsequently, the Klenow fragment was heat inactivated by incubating the reaction mixture at 75.degree. C. for 5 minutes. Following the inactivation of the Klenow fragment, 1 .mu.l of a 1:5 dilution of Illumina Genomic Adaptor Oligo Mix (Part No. 1000521; Illumina Inc., Hayward, Calif.) was used to ligate the Illumina adaptors (Non-Index Y-Adaptors) to the dA-tailed DNA using 4 .mu.l of the T4 DNA ligase provided in the NEBNext.TM. DNA Sample Prep DNA Reagent Set 1, by incubating the reaction mixture for 15 minutes at 25.degree. C. The mixture was cooled to 4.degree. C., and the adaptor-ligated cIDNA was purified from unligated adaptors, adaptor dimers, and other reagents using magnetic beads provided in the Agencourt AMPure XP PCR purification system (Part No. A63881; Beckman Coulter Genomics, Danvers, Mass.). Eighteen cycles of PCR were performed to selectively enrich adaptor-ligated cIDNA using Phusion.RTM. High-Fidelity Master Mix (Finnzymes, Woburn, Mass.) and Illumina's PCR primers complementary to the adaptors (Part No. 1000537 and 1000537). The adaptor-ligated DNA was subjected to PCR (98.degree. C. for 30 seconds; 18 cycles of 98.degree. C. for 10 seconds, 65.degree. C. for 30 seconds, and 72.degree. C. for 30 seconds; final extension at 72.degree. C. for 5 minutes, and hold at 4.degree. C.) using Illumina Genomic PCR Primers (Part Nos. 100537 and 1000538) and the Phusion HF PCR Master Mix provided in the NEBNext.TM. DNA Sample Prep DNA Reagent Set 1, according to the manufacturer's instructions. The amplified product was purified using the Agencourt AMPure XP PCR purification system (Agencourt Bioscience Corporation, Beverly, Mass.) according to the manufacturer's instructions available at www.beckmangenomics.com/products/AMPureXPProtocol.sub.--000387v001.pdf. The purified amplified product was eluted in 40 .mu.l of Qiagen EB Buffer, and the concentration and size distribution of the amplified libraries was analyzed using the Agilent DNA 1000 Kit for the 2100 Bioanalyzer (Agilent technologies Inc., Santa Clara, Calif.).

b. Sequencing

[0189] Sequencing of library DNA was performed using the Genome Analyzer II (Illumina Inc., San Diego, Calif., USA) according to standard manufacturer protocols. Copies of the protocol for whole genome sequencing using Illumina/Solexa technology may be found at BioTechniques.RTM. Protocol Guide 2007 Published December 2006: p 29, and on the world wide web at biotechniques.com/default.asp?page=protocol&subsection=article_display&id- =112378. The DNA library was diluted to 1 nM and denatured. Library DNA (5 pM) was subjected to cluster amplification according to the procedure described in Illumina's Cluster Station User Guide and Cluster Station Operations Guide, available on the world wide web at illumina.com/systems/genome analyzer/cluster_station.ilmn. The amplified DNA was sequenced using Illumina's Genome Analyzer II to obtain single-end reads of 36 bp. Only about 30 bp of random sequence information are needed to identify a sequence as belonging to a specific human chromosome. Longer sequences can uniquely identify more particular targets. In the present case, a large number of 36 by reads were obtained, covering approximately 10% of the genome.

c. Analysis of Sequencing Data for the Determination of Fetal Fraction

[0190] Upon completion of sequencing of the sample, the Illumina "Sequencer Control Software" transferred image and base call files to a Unix server running the Illumina "Genome Analyzer Pipeline" software version 1.51. the 36 bp reads were aligned to an artificial reference genome e.g. a SNP genome, using the BOWTIE program. The artificial reference genome was identified as the grouping of the polymorphic DNA sequences that encompass the alleles comprised in the polymorphic target sequences. For example, the artificial reference genome is a SNP genome comprising SEQ ID NOs: 1-56. Only reads that mapped uniquely to the artificial genome were used for the analysis of fetal fraction. Reads that matched perfectly to the SNP genome were counted as tags and filtered. Of the remaining reads, only reads having one or two mismatches were counted as tags and included in the analysis. Tags mapped to each of the polymorphic alleles were counted, and the fetal fraction was determined as a percent of the ratio of the number of tags mapped to the major allele i.e. maternal allele, and the number of tags mapped to the minor allele i.e. fetal allele.

Example 3

[0191] Selection of Autosomal SNPs for the Determination of Fetal Fraction

[0192] A set of 28 autosomal SNPs were selected from a list of 92 SNPs (Pakstis et al., Hum Genet 127:315-324 [2010]) and from Applied Biosystems by Life Technologies.RTM. (Carlsbad, Calif.) at world wide web address appliedbiosystems.com, and validated for use in multiplexed PCR amplification. Primers were designed to hybridize to a sequence close to the SNPs site on the cfDNA to ensure that it be included in the 36 by read generated from the massively parallel sequencing on the Illumina Analyzer GII, and to generate amplicons of sufficient length to undergo bridge-amplification during cluster formation. Thus, primers were designed to generate amplicons that were at least 110 bp, which when combined with the universal adaptors (Illumina Inc., San Diego, Calif.) used for cluster amplification, resulted in DNA molecules of at least 200 bp. Primer sequences were identified, and primer sets i.e. forward and reverse primers, were synthesized by Integrated DNA Technologies (San Diego, Calif.), and stored as a 1 .mu.M solution to be used for amplifying polymorphic target sequences as described in Examples 4-7. Table 1 provides the RefSNP (rs) accession ID numbers, the primers used for amplifying the target cIDNA sequence, and the sequences of the amplicons comprising the possible SNP alleles that would be generated using the primers. The SNPs given in Table 1 were used for the simultaneous amplification of 13 target sequences in a multiplexed assay. The panel provided in Table 1 is an exemplary SNP panel. Fewer or more SNPs can be employed to enrich the fetal and maternal DNA for polymorphic target nucleic acids. Additional SNPs that can be used include the SNPs given in Table 2. The SNP alleles are shown in bold and are underlined. Other additional SNPs that can be used to determine fetal fraction according to the present method include rs315791, rs3780962, rs1410059, rs279844, rs38882, rs9951171 (SEQ ID NOS 29 & 30), rs214955, rs6444724, rs2503107, rs1019029, rs1413212, rs1031825, rs891700, rs1005533, rs2831700, rs354439, rs1979255, rs1454361, rs8037429, and rs1490413, which have been analyzed for determining fetal fraction by TaqMan PCR, and are disclosed in U.S. Provisional applications 61/296,358 and 61/360,837.

TABLE-US-00001 TABLE 1 SNP Panel for the Determination of Fetal Fraction Forward Primer Sequence, Reverse Primer Amplicon: Amplicon: name and Sequence, name SNP ID Chr Allele 1 Allele 2 SEQ ID NO: and SEQ ID NO: rs560681 1 CACATGCACAGCCA CACATGCACAGCCA CACATGCA CCCCAAGGTCC GCAACCCTGTCAGC GCAACCCTGTCAGC CAGCCAGC TGTGACCTGAG AGGAGTTCCCACCA AGGAGTTCCCACCA AACCC T GTTTCTTTCTGAGAA GTTTCTTTCTGAGAA (rs560681_C1_ (rs560681_C1_1_R; CATCTGTTCAGGTTT CATCTGTTCAGGTTT 1_F; SEQ ID SEQ ID NO: 58) CTCTCCATCTCTATT CTCTCCATCTCTGTT NO: 57) TACTCAGGTCACAG TACTCAGGTCACAG GACCTTGGGG (SEQ GACCTTGGGG (SEQ ID NO: 1) ID NO: 2) rs1109037 2 TGAGGAAGTGAGGC TGAGGAAGTGAGGC TGAGGAAG TGCCAGTGCGA TCAGAGGGTAAGAA TCAGAGGGTAAGAA TGAGGCTC GATGAAAGTCT ACTTTGTCACAGAGC ACTTTGTCACAGAGC AGAGGGT TT TGGTGGTGAGGGTG TGGTGGTGAGGGTG (rs110937_C2_ (rs110937_C2_1_R; GAGATTTTACACTCC GAGATTTTACACTCC 1_F; SEQ ID SEQ ID NO: 60) CTGCCTCCCACACCA CTGCCTCCCACACCA NO: 59) GTTTCTCCAGAGTGG GTTTCTCCGGAGTGG AAAGACTTTCATCTC AAAGACTTTCATCTC GCACTGGCA (SEQ ID GCACTGGCA (SEQ ID NO: 3) NO: 4) rs9866013 3 GTGCCTTCAGAACCT GTGCCTTCAGAACCT GTGCCTTCA TCCCATCCCAC TTGAGATCTGATTCT TTGAGATCTGATTCT GAACCTTTG CAGCCACCC ATTTTTAAAGCTTCT ATTTTTAAAGCTTCT AGATCTGAT (rs9866013_C3_1_ TAGAAGAGAGATTG TAGAAGAGAGATTG (rs9866013_C3_ R; SEQ ID NO: 62) CAAAGTGGGTTGTTT CAAAGTGGGTTGTTT 1_F; SEQ CTCTAGCCAGACAG CTCTAGCCAGACAG ID NO: 61) GGCAGGCAAATAGG GGCAGGTAAATAGG GGTGGCTGGTGGGA GGTGGCTGGTGGGA TGGGA (SEQ ID NO: 5) TGGGA (SEQ ID NO: 6) rs13182883 5 AGGTGTGTCTCTCTT AGGTGTGTCTCTCTT AGGTGTGTC CCTTTGTCCCAC TTGTGAGGGGAGGG TTGTGAGGGGAGGG TCTCTTTTG CTCCCCACC GTCCCTTCTGGCCTA GTCCCTTCTGGCCTA TGAGGGG (rs13182883_C5_ GTAGAGGGCCTGGC GTAGAGGGCCTGGC (rs13182883_ 1_R; SEQ ID CTGCAGTGAGCATTC CTGCAGTGAGCATTC C5_1_F; SEQ NO: 64) AAATCCTCAAGGAA AAATCCTCGAGGAA ID NO: 63) CAGGGTGGGGAGGT CAGGGTGGGGAGGT GGGACAAAGG (SEQ GGGACAAAGG (SEQ ID NO: 7) ID NO: 8) rs13218440 6 CCTCGCCTACTGTGC CCTCGCCTACTGTGC CCTCGCCTA CCATCCCAGCT TGTTTCTAACCATCA TGTTTCTAACCATCA CTGTGCTGT GAGTATTCCAG TGCTTTTCCCTGAAT TGCTTTTCCCTGAAT TTCTAACC GAG CTCTTGAGTCTTTTT CTCTTGAGTCTTTTT (rs13218440_ (rs13218440_C6_ CTGCTGTGGACTGA CTGCTGTGGACTGA C6_1_F; SEQ 1_R; SEQ ID AACTTGATCCTGAG AACTTGATCCTGAG ID NO: 65) NO: 66) ATTCACCTCTAGTCC ATTCACCTCTAGTCC CTCTGAGCAGCCTCC CTCTGGGCAGCCTCC TGGAATACTCAGCT TGGAATACTCAGCT GGGATGG (SEQ ID GGGATGG (SEQ ID NO: 9) NO: 10) rs7041158 9 AATTGCAATGGTGA AATTGCAATGGTGA AATTGCAAT CCAGTGAGAAG GAGGTTGATGGTAA GAGGTTGATGGTAA GGTGAGAG TGTCTTGGGTT AATCAAACGGAACT AATCAAACGGAACT GTTGATGGT GG (SEQ ID TGTTATTTTGTCATT TGTTATTTTGTCATT (SEQ ID NO: 68) CTGATGGACTGGAA CTGATGGACTGGAA NO: 67) CTGAGGATTTTCAAT CTGAGGATTTTCAAT TTCCTCTCCAACCCA TTCCTTTCCAACCCA AGACACTTCTCACTG AGACACTTCTCACTG G (SEQ ID NO: 11) G (SEQ ID NO: 12) rs740598 10 GAAATGCCTTCTCAG GAAATGCCTTCTCAG GAAATGCC GGTTTGAGCAG GTAATGGAAGGTTA GTAATGGAAGGTTA TTCTCAGGT TTCTGAGAATG TCCAAATATTTTTCG TCCAAATATTTTTCG AATGGAAG TGGCT (SEQ ID TAAGTATTTCAAATA TAAGTATTTCAAATA GT (SEQ ID NO: 70) GCAATGGCTCGTCTA GCAATGGCTCGTCTA NO: 69) TGGTTAGTCTCACAG TGGTTAGTCTCGCAG CCACATTCTCAGAAC CCACATTCTCAGAAC TGCTCAAACC (SEQ TGCTCAAACC (SEQ ID NO: 13) ID NO: 14) rs10773760 12 ACCCAAAACACTGG ACCCAAAACACTGG ACCCAAAA CCCTTATCTGCT AGGGGCCTCTTCTCA AGGGGCCTCTTCTCA CACTGGAG ATGTGGCATAC TTTTCGGTAGACTGC TTTTCGGTAGACTGC GGGCCT TTGG (SEQ ID AAGTGTTAGCCGTC AAGTGTTAGCCGTC (SEQ ID NO: 72) GGGACCAGCTTCTGT GGGACCAGCTTCTGT NO: 71) CTGGAAGTTCGTCA CTGGAAGTTCGTCA AATTGCAGTTAAGTC AATTGCAGTTAGGT CAAGTATGCCACAT CCAAGTATGCCACA AGCAGATAAGGG TAGCAGATAAGGG (SEQ ID NO: 15) (SEQ ID NO: 16) rs4530059 14 GCACCAGAATTTAA GCACCAGAATTTAA GCACCAGA GCACCTGACAG ACAACGCTGACAAT ACAACGCTGACAAT ATTTAAACA GCACATCAGCG AAATATGCAGTCGA AAATATGCAGTCGA ACGCTGAC (SEQ ID NO: 74) TGATGACTTCCCAGA TGATGACTTCCCAGA AA (SEQ ID GCTCCAGAAGCAAC GCTCCAGAAGCAAC NO: 73) TCCAGCACACAGAG TCCAGCACACGGAG AGGCGCTGATGTGC AGGCGCTGATGTGC CTGTCAGGTGC (SEQ CTGTCAGGTGC (SEQ ID NO: 17) ID NO: 18) rs7205345 16 TGACTGTATACCCCA TGACTGTATACCCCA TGACTGTAT GCACTAAGGAT GGTGCACCCTTGGGT GGTGCACCCTTGGGT ACCCCAGG GTGGAAGTCTA CATCTCTATCATAGA CATCTCTATCATAGA TGCACCC GTGTG (SEQ ID ACTTATCTCACAGAG ACTTATCTCACAGAG (SEQ ID NO: 76) TATAAGAGCTGATTT TATAAGAGCTGATTT NO: 75) CTGTGTCTGCCTCTC CTGTGTCTGCCTGTC ACACTAGACTTCCAC ACACTAGACTTCCAC ATCCTTAGTGC (SEQ ATCCTTAGTGC (SEQ ID NO: 19) ID NO: 20) rs8078417 17 TGTACGTGGTCACCA TGTACGTGGTCACCA TGTACGTGG AGTGTGAGAAG GGGGACGCCTGGCG GGGGACGCCTGGCG TCACCAGG AGCCTCAAGGA CTGCGAGGGAGGCC CTGCGAGGGAGGCC GGACG (SEQ CAGC (SEQ ID CCGAGCCTCGTGCCC CCGAGCCTCGTGCCC ID NO: 77) NO: 78) CCGTGAAGCTTCAG CCGTGAAGCTTCAG CTCCCCTCCCCGGCT CTCCCCTCCCTGGCT GTCCTTGAGGCTCTT GTCCTTGAGGCTCTT CTCACACT (SEQ ID CTCACACT (SEQ ID NO: 21) NO: 22) rs576261 19 CAGTGGACCCTGCT CAGTGGACCCTGCT CAGTGGAC GTGGCAAAGGA GCACCTTTCCTCCCC GCACCTTTCCTCCCC CCTGCTGCA GAGAGTTGTGA TCCCATCAACCTCTT TCCCATCAACCTCTT CCTT (SEQ GG (SEQ ID TTGTGCCTCCCCCTC TTGTGCCTCCCCCTC ID NO: 79) NO: 80) CGTGTACCACCTTCT CGTGTACCACCTTCT CTGTCACCAACCCTG CTGTCACCACCCCTG GCCTCACAACTCTCT GCCTCACAACTCTCT CCTTTGCCAC (SEQ CCTTTGCCAC (SEQ ID NO: 23) ID NO: 24) rs2567608 20 CAGTGGCATAGTAG CAGTGGCATAGTAG CAGTGGCA CCTCTCCGACA TCCAGGGGCTCCTCC TCCAGGGGCTCCTCC TAGTAGTCC ACTTCCGCCG TCAGCACCTCCAGC TCAGCACCTCCAGC AGGGGCT (SEQ ID NO: 82) ACCTTCCAGGAGGC ACCTTCCAGGAGGC (SEQ ID AGCAGCGCAGGCAG AGCAGCGCAGGCAG NO: 81) AGAACCCGCTGGAA AGAACCCGCTGGAA GAATCGGCGGAAGT GGATCGGCGGAAGT TGTCGGAGAGG (SEQ TGTCGGAGAGG (SEQ ID NO: 25) ID NO: 26)

TABLE-US-00002 TABLE 2 Additional SNPs for the Determination of Fetal Fraction Forward Primer Sequence, Reverse Primer Amplicon: Amplicon: name and Sequence, name SNP ID Chr Allele 1 Allele 2 SEQ ID NO: and SEQ ID NO: rs430046 16 AGGTCTGGGGGCC AGGTCTGGGGGCCGC AGGTCTGG TCCTCCCATTA GCTGAATGCCAAGC TGAATGCCAAGCTGG GGGCCGCT AACCCAGCACC TGGGAATCTTAAAT GAATCTTAAATGTTA GAAT T GTTAAGGAACAAG AGGAACAAGGTCATA (rs430046_C1_ (rs430046_C1_1_R GTCATACAATGAAT CAATGAATGGTGTGA 1_F; SEQ ID ; SEQ ID NO: 84) GGTGTGATGTAAAA TGTAAAAGCTTGGGA NO: 83) GCTTGGGAGGTGAT GGTGATTTTTGAGGG TTCTGAGGGTAGGT TAGGTGCTGGGTTTA GCTGGGTTTAATGG ATGGGAGGA (SEQ ID GAGGA (SEQ ID NO: 28) NO: 27) rs9951171 18 ACGGTTCTGTCCTG ACGGTTCTGTCCTGT ACGGTTCTG CCTGTTCACTTG TAGGGGAGAAAAG AGGGGAGAAAAGTCC TCCTGTAGG TGGCAGGGCA TCCTCGTTGTTCCT TCGTTGTTCCTCTGGG GGAGA (rs9951171_C1_1_ CTGGGATGCAACAT ATGCAACATGAGAGA (rs9951171_C1_ R; SEQ ID NO: 86) GAGAGAGCAGCAC GCAGCACACTGAGGC 1_F; SEQ ACTGAGGCTTTATG TTTATGGGTTGCCCT ID NO: 85) GATTGCCCTGCCAC GCCACAAGTGAACAG AAGTGAACAGG G (SEQ ID NO: 30) (SEQ ID NO: 29) rs338882 5 GCGCAGTCAGATG GCGCAGTCAGATGGG GCGCAGTC TCCAGCCCTTG GGCGTGCTGGCGTC CGTGCTGGCGTCTGT AGATGGGC TCCCAAACGTG TGTCTTCTCTCTCTC CTTCTCTCTCTCCTGC GTGC T CTGCTCTCTGGCTT TCTCTGGCTTCATTTT (rs338882_C1_ (rs338882_C1_1_R; CATTTTTCTCTCCTT TCTCTCCTTCTGTCTC 1_F; SEQ ID SEQ ID NO: 88) CTGTCTCACCTTCT ACCTTCTTTCGTGTGC NO: 87) TTCGTGTGCCTGTG CTGTGCATACACACG CACACACACGTTTG TTTGGGACAAGGG GGACAAGGG CTGGA (SEQ ID NO: 32) CTGGA (SEQ ID NO: 31) rs10776839 9 GCCGGACCTGCGA GCCGGACCTGCGAAA GCCGGACC CGGGCAACTGG AATCCCAAAATGCC TCCCAAAATGCCAAA TGCGAAAT GGCTCTGATC AAACATTCCCGCCT CATTCCCGCCTCACA CCCAA (rs10776839_C1_1_ CACATGATCCCAGA TGATCCCAGAGAGAG (rs10776839C1_ R; SEQ ID GAGAGGGGACCCA GGGACCCAGTGTTCC 1_F; SEQ NO: 90) GTGTTCCCAGCTTG CAGCTTGCAGCTGAG ID NO: 89) CAGCTGAGGAGCC GAGCCCGAGTTTGCC CGAGGTTGCCGTCA GTCAGATCAGAGCCC GATCAGAGCCCCA CAGTTGCCCG (SEQ ID GTTGCCCG (SEQ ID NO: 34) NO: 33) rs9905977 17 AGCAGCCTCCCTCG AGCAGCCTCCCTCGA AGCAGCCT GGCAGAGGGGA ACTAGCTCACACTA CTAGCTCACACTACG CCCTCGACT AAGACGAAAGG CGATAAGGAAAAT ATAAGGAAAATTCAT AGCT A TCATGAGCTGGTGT GAGCTGGTGTCCAAG (rs9905977_C1_ (rs9905977_C1_1_ CCAAGGAGGGCTG GAGGGCTGGGTGACT 1_F; SEQ R; SEQ ID NO: 92) GGTGACTCGTGGCT CGTGGCTCAGTCAGC ID NO: 91) CAGTCAGCATCAAG GTCAAGATTCCTTTC ATTCCTTTCGTCTTT GTCTTTCCCCTCTGCC CCCCTCTGCC (SEQ (SEQ ID NO: 36) ID NO: 35) rs1277284 4 TGGCATTGCCTGTA TGGCATTGCCTGTAA TGGCATTGC AAGCACCATTC ATATACATAGCCAT TATACATAGCCATGG CTGTAATAT TAATGATTTTG GGTTTTTTATAGGC TTTTTTATAGGCAATT ACATAG G AATTTAAGATGAAT TAAGATGAATAGCTT (rs1277284_C4_ (rs1277284_C4_1_ AGCTTCTAAACTAT CTAAACTATAGATAA 1_F; SEQ R; SEQ ID NO: 94) AGATAAGTTTCATT GTTTCATTACCCCAG ID NO: 93) ACCCCAGGAAGCT GAAGCTGAACTATAG GAACTATAGCTACT CTACTTTCCCCAAAA TTACCCAAAATCAT TCATTAGAATGGTGC TAGAATGGTGCTT TT (SEQ ID NO: 38) (SEQ ID NO: 37) rs258684 7 ATGAAGCCTTCCAC ATGAAGCCTTCCACC ATGAAGCC GATCAGTTGTT CAACTGCCTGTATG AACTGCCTGTATGAC TTCCACCAA GTTTCTATATTT ACTCATCTGGGGAC TCATCTGGGGACTTC CTG CCTT TTCTGCTCTATACT TGCTCTATACTCAAA (rs258684_C7_ (rs258684_C7_1_R; CAAAGTGGCTTAGT GTGGCTTAGTCACTG 1_F; SEQ ID SEQ ID NO: 96) CACTGCCAATGTAT CCAATGTATTTCCAT NO: 95) TTCCATATGAGGGA ATGAGGGACGGTGAT CGATGATTACTAAG TACTAAGGAAATATA GAAATATAGAAAC GAAACAACAACTGAT AACAACTGATC C (SEQ ID NO: 40) (SEQ ID NO: 39) rs1347696 8 ACAACAGAATCAG ACAACAGAATCAGGT ACAACAGA CTGAACTGAAC GTGATTGGAGAAA GATTGGAGAAAAGAT ATCAGGTG AAAGAATTAAG AGATCACAGGCCTA CACAGGCCTAGGCAC ATTGGA GTC GGCACCCAAGGCTT CCAAGGCTTGAAGGA (rs1347696_C8_ (rs1347696_C8_4_ GAAGGATGAAAGA TGAAAGAATGAAAGA 4_F; SEQ F; SEQ ID NO: 98) ATGAAAGATGGAC TGGACGGAAGAAAAT ID NO: 97) GGAACAAAATTAG TAGGACCTTAATTCTT GACCTTAATTCTTT TGTTCAGTTCAG (SEQ GTTCAGTTCAG ID NO: 42) (SEQ ID NO: 41) rs508485 11 TTGGGGTAAATTTT TTGGGGTAAATTTTC TTGGGGTA GGGGTGGGAAT CATTGTCATATGTG ATTGTCATATGTGGA AATTTTCAT TAGACTCTG GAATTTAAATATAC ATTTAAATATACCAT TGTCA (rs508485_C11_1_ CATCATCTACAAAG CATCTACAAAGAATT (rs508485_C11_ R; SEQ ID NO100) AATTCCACAGAGTT CCACAGAGTTAAATA 1_F; SEQ AAATATCTTAAGTT TCTTAAGTTAAACAC ID NO: 99) AAACACTTAAAATA TTAAAATAAGTGTTT AGTGTTTGCGTGAT GCGTGATATTTTGAT ATTTTGATGACAGA GATAGATAAACAGAG TAAACAGAGTCTAA TCTAATTCCCACCCC TTCCCACCCC (SEQ (SEQ ID NO: 44) ID NO: 43) rs9788670 15 TGCAATTCAAATCA TGCAATTCAAATCAG TGCAATTCA GCAACATCGAG GGAAGTATGACCA GAAGTATGACCAAAA AATCAGGA GTTTGTCAG AAAGACAGAGATC GACAGAGATCTTTTT AGTATG (rs9788670_c15_2_ TTTTTTGGATGATC TGGATGATCCCTAGC (rs9788670_ R; SEQ ID CCTAGCCTAGCAAT CTAGCAATGCCTGGC c15_2_F; SEQ NO: 102) GCCTGGCAGCCATG AGCCATGCAGGTGCA ID NO: 101) CAGGTGCAATGTCA ATGTCAACCTTAAAT ACCTTAAATAATGT AATGTATTGCAAATT ATTGCAAACTCAGA CAGAGCTGACAAACC GCTGACAAACCTCG TCGATGTTGC (SEQ ID ATGTTGC (SEQ ID NO: 46) NO: 45) rs8137254 22 CTGTGCTCTGCGAA CTGTGCTCTGCGAAT CTGTGCTCT ACCATGCTCAT TAGCTGCAGAAGTA AGCTGCAGAAGTAAC GCGAATAG GGAGAATCC ACTTGGGGACCCAA TTGGGGACCCAAAAT CTG (rs8137254_c22_2_ AATAAAGCAGAAT AAAGCAGAATGCTAA (rs8137254_ R; SEQ ID GCTAATGTCAAGTC TGTCAAGTCCTGAGA c22_2_F: SEQ NO: 104) CTGAGAACCAAGC ACCAAGCCCTGGGAC ID NO: 103) CCTGGGACTCTGGT TCTGGTGCCATTTTG GCCATTTCGGATTC GATTCTCCATGAGCA TCCATGAGCATGGT TGGT (SEQ ID NO: 48) (SEQ ID NO: 47) rs3143 19 TTTTTCCAGCCAAC TTTTTCCAGCCAACTC TTTTTCCAG CACAGCTTGAG TCAAGGCCAAAAA AAGGCCAAAAAAAAT CCAACTCA GTTTCTTGTG AAATTTCTTAATAT TTCTTAATATAGTTAT AGG (rs3143_c19_2_R; AGTTATTATGCGAG TATGCGAGGGGAGGG (rs3143_c19_2_ SEQ ID NO: 106) GGGAGGGGAAGCA GAAGCAAAGGAGCA F: SEQ ID AAGGAGCACAGGT CAGGTAGTCCACAGA NO: 105) AGTCCACAGAATA ATAGGACACAAGAA AGACACAAGAAAC ACCTCAAGCTGTG CTCAAGCTGTG (SEQ ID NO: 50) (SEQ ID NO: 49) rs2182957 13 TCTTCTCGTCCCCT TCTTCTCGTCCCCTAA TCTTCTCGT TTTCTGGTTTGT AAGCAAACAACAT GCAAACAACATCCGC CCCCTAAGC GCAACAGG CCGCTTGCTTCTGT TTGCTTCTGTCTGTGT AA (rs2182957_c13_1_ CTGTGTAACCACAG AACCACAGTGAATGG (rs2182957_ R; SEQ ID TGAATGGGTGTGCA GTGTGCACGCTTGGT c13_1_F: SEQ NO: 108) CGCTTGATGGGCCT GGGCCTCTGAGCCCC ID NO: 107) CTGAGCCCCTGTTG TGTTGCACAAACCAG CACAAACCAGAAA AAA (SEQ ID NO: 52) (SEQ ID NO: 51) rs3739005 2 CACATGGGGGCATT CACATGGGGGCATTA CACATGGG ACATCGATGAG AAGAATCGCCCAG AGAATCGCCCAGGGA GGCATTAA CACAAAAACAC GGAGGAGGAGGGA GGAGGAGGGAGAAC GAAT (rs3739005_c2_2_ GAACGCGTGCTTTT GCGTGCTTTTCACATT (rs3739005_c2_ R; SEQ ID CACATTTGCATTTG TGCATTTGAATTTTTG 2_F; SEQ ID NO: 110) AATTTTCGAGTTCC AGTTCCCAGGATGTG NO: 109) CAGGATGTGTTTTT TTTTTGTGCTCATCGA GTGCTCATCGATGT TGT (SEQ ID NO: 54) (SEQ ID NO: 53) rs530022 1 GGGCTCTGAGGTGT GGGCTCTGAGGTGTG GGGCTCTG AGATATCCCTG GTGAAATAAAAAC TGAAATAAAAACAAA AGGTGTGT GAACTGTTATT AAATGTCCATGTCT TGTCCATGTCTGTCCT GAAA CC GTCCTTTTATGGCA TTTATGGCATTTTGGG (rs530022_c1_ (rs530022_c1_2_R; TTTTGGGACTTTAC ACTTTACATTTCAAA 2_F; SEQ ID SEQ ID NO: 112) ATTTCAAACATTTC CATTTCAGACATGTA NO: 111) AGACATGTATCACA TCACAACACGAGGGA ACACGAAGGAATA ATAACAGTTCCAGGG ACAGTTCCAGGGAT ATATCT (SEQ ID ATCT (SEQ ID NO: 55) NO: 56)

Example 4

Determination of Fetal Fraction by Massively Parallel Sequencing of a Target Library

[0193] To determine the fraction of fetal cIDNA in a maternal sample, target polymorphic nucleic acid sequences each comprising a SNP were amplified and used for preparing a target library for sequencing in a massively parallel fashion.

[0194] cfDNA was extracted as described in Example 1. A target sequencing library was prepared as follows. cfDNA contained in 5 .mu.l of purified cIDNA was amplified in a reaction volume of 50 .mu.l containing 7.5 .mu.l of a 1 .mu.M primer mix (Table 1), 10 .mu.l of NEB 5.times. Mastermix and 27 .mu.l water. Thermal cycling was performed with the Gene Amp9700 (Applied Biosystems) using the following cycling conditions: incubating at 95.degree. C. for 1 minute, followed by 20-30 cycles at 95.degree. C. for 20 seconds, 68.degree. C. for 1 minute, and 68.degree. C. for 30s, which was followed by a final incubation at 68.degree. C. for 5 minutes. A final hold at 4.degree. C. was added until the samples were removed for combining with the unamplified portion of the purified cIDNA sample. The amplified product was purified using the Agencourt AMPure XP PCR purification system (Part No. A63881; Beckman Coulter Genomics, Danvers, Mass.). A final hold at 4.degree. C. was added until the samples were removed for preparing the target library. The amplified product was analyzed with a 2100 Bioanalyzer (Agilent Technologies, Sunnyvale, Calif.), and the concentration of amplified product determined A sequencing library of amplified target nucleic acids was prepared as described in Example 2, and was sequenced in a massively parallel fashion using sequencing-by-synthesis with reversible dye terminators and according to the Illumina protocol (BioTechniques.RTM. Protocol Guide 2007 Published December 2006: p 29, and on the world wide web at biotechniques.com/default.asp?page=protocol&subsection=article_display&id- =112378). Analysis and counting of tags mapped to a reference genome consisting of 26 sequences (13 pairs each representing two alleles) comprising a SNP i.e. SEQ ID NO:1-26 was performed as described.

[0195] Table 3 provides the tag counts obtained from sequencing the target library, and the calculated fetal fraction derived from sequencing data.

TABLE-US-00003 TABLE 3 Determination of Fetal Fraction by Massively Parallel Sequencing of a Library of Polymorphic Nucleic Acids SNP TAG Fetal SNP COUNTS Fraction (%) rs10773760.1|Chr.12|length = 128|allele = A 236590 1.98 rs10773760.2|Chr.12|length = 128|allele = G 4680 rs13182883.1|Chr.5|length = 111|allele = A 3607 4.99 rs13182883.2|Chr.5|length = 111|allele = G 72347 rs4530059.1|Chr.14|length = 110|allele = A 3698 1.54 rs4530059.1|Chr.14|length = 110|allele = G 239801 rs8078417.1|Chr.17|length = 110|allele = C 1E+06 3.66 rs8078417.2|Chr.17|length = 110|allele = T 50565 Fetal Fraction (Mean .+-. S.D.) = 12.4 .+-. 6.6

[0196] The results show that polymorphic nucleic acid sequences each comprising at least one SNP can be amplified from cfDNA derived from a maternal plasma sample to construct a library that can be sequenced in a massively parallel fashion to determine the fraction of fetal nucleic acids in the maternal sample.

Example 5

Determination of Fetal Fraction Following Enrichment of Fetal and Maternal Nucleic Acids in a cfDNA Sequencing Library Sample

[0197] To enrich the fetal and maternal cfDNA contained in a primary sequencing library constructed using purified fetal and maternal cfDNA, a portion of a purified cfDNA sample was used for amplifying polymorphic target nucleic acid sequences, and for preparing a sequencing library of amplified polymorphic target nucleic acids, which was used to enrich the fetal and maternal nucleic acid sequences comprised in the primary library.

[0198] The method corresponds to workflow 3 diagrammed in FIG. 3. A target sequencing library was prepared from a portion of the purified cfDNA as described in Example 2. A primary sequencing library was prepared using the remaining portion of the purified cfDNA as described in Example 2. Enrichment of the primary library for the amplified polymorphic nucleic acids comprised in the target library was obtained by diluting the primary and the target sequencing libraries to 10 nM, and combining the target library with the primary library at a ratio of 1:9 to provide an enriched sequencing library. Sequencing of the enriched library and analysis of the sequencing data was performed as described in Example 2.

[0199] Table 4 provides the number of sequence tags that mapped to the SNP genome for the informative SNPs identified from sequencing an enriched library derived from plasma samples of pregnant women each carrying a T21, a T13, a T18 and a monosomy X fetus, respectively. Fetal fraction was calculated as follows:

[0200] % fetal fraction allele.sub.x=((.SIGMA.Fetal sequence tags for allele.sub.x)/(.SIGMA.Maternal sequence tags for allele.sub.x)).times.100

[0201] Table 4 also provides the number of the sequence tags mapped to the human reference genome. Tags mapped to the human reference genome were used to determine the presence or absence of aneuploidy using the same plasma sample that was utilized for determining the corresponding fetal fraction. Method for using sequence tags counts for determining aneuploidy are described in U.S. Provisional Applications 61/407,017 and 61/455,849778, which are herein incorporated by reference in their entirety.

TABLE-US-00004 TABLE 4 Determination of Fetal Fraction by Massively Parallel Sequencing of an Enriched Library of Polymorphic Nucleic Acids Sample ID SNP TAG FETAL FRACTION (karyotype) SNP COUNTS (%) 11409 rs13182883.1|Chr.5|length = 111|allele = A 261 4.41 (47, XY + 21) rs13182883.2|Chr.5|length = 111|allele = G 5918 rs740598.1|Chr.10|length = 114|allele = A 5545 7.30 rs740598.2|Chr.10|length = 114|allele = G 405 rs8078417.1|Chr.17|length = 110|allele = C 8189 6.74 rs8078417.2|Chr.17|length = 110|allele = T 121470 rs576261.1|Chr.19|length = 114|allele = A 58342 7.62 rs576261.2|Chr.19|length = 114|allele = C 4443 Fetal Fraction (Mean .+-. S.D.) = 6.5 .+-. 1.5 Sample ID 95133 rs1109037.1|Chr.2|length = 126|allele = A 12229 2.15 (47, XX + 18) rs1109037.2|Chr.2|length = 126|allele = G 263 rs13218440.1|Chr.6|length = 139|allele = A 55949 3.09 rs13218440.2|Chr.6|length = 139|allele = G 1729 rs7041158.1|Chr.9|length = 117|allele = C 7281 4.12 rs7041158.2|Chr.9|length = 117|allele = T 300 rs7205345.1|Chr.16|length = 116|allele = C 53999 2.14 rs7205345.2|Chr.16|length = 116|allele = G 1154 Fetal Fraction (Mean .+-. S.D.) = 2.9 .+-. 0.9 Sample ID 51236 rs13218440.1|Chr.6|length = 139|allele = A 1119 1.65 (46, XY + 13) rs13218440.2|Chr.6|length = 139|allele = G 67756 rs560681.1|Chr.1|length = 111|allele = A 14123 5.18 rs560681.2|Chr.1|length = 111|allele = G 732 rs7205345.1|Chr.16|length = 116|allele = C 18176 1.63 rs7205345.2|Chr.16|length = 116|allele = G 296 rs9866013.1|Chr.3|length = 121|allele = C 117 2.33 rs9866013.2|Chr.3|length = 121|allele = T 5024 Fetal Fraction (Mean .+-. S.D.) = 2.7 .+-. 1.7 Sample ID 54430 rs1109037.1|Chr.2|length = 126|allele = A 19841 1.80 (45, XO) rs1109037.2|Chr.2|length = 126|allele = G 357 rs9866013.1|Chr.3|length = 121|allele = C 12931 3.81 rs9866013.2|Chr.3|length = 121|allele = T 493 rs7041158.1|Chr.9|length = 117|allele = C 2800 4.25 rs7041158.2|Chr.9|length = 117|allele = T 119 rs740598.1|Chr.10|length = 114|allele = A 12903 4.87 rs740598.2|Chr.10|length = 114|allele = G 628 rs10773760.1|Chr.12|length = 128|allele = A 46324 4.65 rsl0773760.2|Chr.12|length = 128|allele = G 2154 Fetal Fraction (Mean .+-. S.D.) = 3.9 .+-. 1.2

Example 6

Determination of Fetal Fraction by Massively Parallel Sequencing Enrichment of Fetal and Maternal Nucleic Acids for Polymorphic Nucleic Acids in a Purified cfDNA Sample

[0202] To enrich the fetal and maternal cfDNA contained in a purified sample of cfDNA extracted from a maternal plasma sample, a portion of the purified cfDNA was used for amplifying polymorphic target nucleic acid sequences each comprising one SNP chosen from the panel of SNPs given in Table 5.

[0203] The method corresponds to workflow 2 diagrammed in FIG. 3. Cell-free plasma was obtained from a maternal blood sample, and cfDNA was purified from the plasma sample as described in Example 1. The final concentration was determined to be 92.8 pg/.mu.l. cfDNA contained in 5 .mu.l of purified cIDNA was amplified in a reaction volume of 50 .mu.l containing 7.5 .mu.l of a 1 uM primer mix (Table 1), 10 .mu.l of NEB 5.times. Mastermix and 27 .mu.l water. Thermal cycling was performed with the Gene Amp9700 (Applied Biosystems). Using the following cycling conditions: incubating at 95.degree. C. for 1 minute, followed by 30 cycles at 95.degree. C. for 20 seconds, 68.degree. C. for 1 minute, and 68.degree. C. for 30s, which was followed by a final incubation at 68.degree. C. for 5 minutes. A final hold at 4.degree. C. was added until the samples were removed for combining with the unamplified portion of the purified cIDNA sample. The amplified product was purified using the Agencourt AMPure XP PCR purification system (Part No. A63881; Beckman Coulter Genomics, Danvers, Mass.), and the concentration quantified using the Nanodrop 2000 (Thermo Scientific, Wilmington, Del.). The purified amplification product was diluted 1:10 in water and 0.9 .mu.l (371 pg) added to 40 .mu.l of purified cfDNA sample to obtain a 10% spike. The enriched fetal and maternal cfDNA present in the purified cfDNA sample was used for preparing a sequencing library, and was sequenced as described in Example 2.

[0204] Table 5 provides the tag counts obtained for each of chromosomes 21, 18, 13, X and Y i.e. sequence tag density, and the tag counts obtained for the informative polymorphic sequences contained in the SNP reference genome . i.e. SNP tag density. The data show that sequencing information can be obtained from sequencing a single library constructed from a purified maternal cfDNA sample that has been enriched for sequences comprising SNPs to simultaneously determine the presence or absence of aneuploidy and the fetal fraction. The presence or absence of aneuploidy was determined using the number of tags mapped to chromosomes as described in U.S. Provisional Applications 61/407,017 and 61/455,849. In the example given, the data show that the fraction of fetal DNA in plasma sample AFR105 was quantifiable from the sequencing results of five informative SNPs and determined to be 3.84%. Sequence tag densities are provided for chromosomes 21, 13, 18, X and Y.

[0205] The example shows that the enrichment protocol provides the requisite tag counts for determining aneuploidy and fetal fraction from a single sequencing process.

TABLE-US-00005 TABLE 5 Determination of Fetal Fraction by Massively Parallel Sequencing: Enrichment of Fetal and Maternal Nucleic Acids for Polymorphic Nucleic Acids in a Purified cfDNA sample Aneuploidy Chromosome Chromosome Chromosome Chromosome Chromosome 21 18 13 X Y Sequence Tag Density 178763 359529 388204 572330 2219 Karyotype Unaffected Unaffected Unaffected Unaffected Unaffected Fetal Fraction SNP SNP TAG DENSITY FETAL FRACTION (%) rs10773760.1|Chr.12|length = 128|allele = A 18903 2.81 rs10773760.2|Chr.12|length = 128|allele = G 532 rs1109037.1|Chr.2|length = 126|allele = A 347 5.43 rs1109037.2|Chr.2|length = 126|allele = G 6394 rs2567608.1|Chr.20|length = 110|allele = A 94503 1.74 rs2567608.2|Chr.20|length = 110|allele = G 1649 rs7041158.1|Chr.9|length = 117|allele = C 107 5.61 rs7041158.2|Chr.9|length = 117|allele = T 6 rs8078417.1|Chr.l7|length = 110|allele = C 162668 3.61 rs8078417.2|Chr.l7|length = 110|allele = T 5877 Fetal Fraction (Mean .+-. S.D.) = 3.8 .+-. 1.7

Example 7

Determination of Fetal Fraction by Massively Parallel Sequencing Enrichment of Fetal and Maternal Nucleic Acids for Polymorphic Nucleic Acids in a Plasma Sample

[0206] To enrich the fetal and maternal cfDNA contained in an original plasma sample derived from a pregnant woman, a portion the original plasma sample was used for amplifying polymorphic target nucleic acid sequences each comprising one SNP chosen from the panel of SNPs given in Table 1, and a portion of the amplified product was combined with the remaining original plasma sample.

[0207] The method corresponds to workflow 2 diagrammed in FIG. 3. cIDNA contained in 15n1 of cell-free plasma was amplified in a reaction volume of 50 .mu.l containing 9 .mu.l of a 1 .mu.M mixture of primers (15 plexTable 1), 1 .mu.l of Phusion blood DNA polymerase, 25 ul of the 2.times. Phusion blood PCR buffer containing deoxynucleotide triphosphates (dNTPs: dATP, dCTP, dGTP and dTTP). Thermal cycling was performed with the Gene Amp9700 (Applied Biosystems) using the following cycling conditions: incubating at 95.degree. C. for 3 minutes, followed by 35 cycles at 95.degree. C. for 20 seconds, 55.degree. C. for 30s, and 70.degree. C. for 1 minute, which was followed by a final incubation at 68.degree. C. for 5 minutes. A final hold at 4.degree. C. was added until the samples were removed for combining with the unamplified portion of the cell-free plasma. The amplified product was diluted 1:2 with water and analyzed using the Bioanalyzer. An additional 3 .mu.l of amplified product was diluted with 11.85 .mu.l of water to obtain a final concentration of 2 ng/.mu.l. 2.2 .mu.l of the diluted amplified product was combined with the remaining plasma sample. The enriched fetal and maternal cIDNA present in the plasma sample was purified as described in Example 1, and used for preparing a sequencing library. Sequencing and analysis of the sequencing data was performed as described in Example 2.

[0208] The results are given in Table 6. In the example given, the data show that the fraction of fetal DNA in plasma sample SAC2517 was quantifiable from the sequencing results of one informative SNP and determined to be 9.5%. In the example given, sample SAC2517 was shown by karyotyping to be unaffected for aneuploidies of chromosomes 21, 13, 18, X and Y. Sequence tag densities are provided for chromosomes 21, 13, 18, X and Y. The presence or absence of aneuploidy was determined using tag counts as described in U.S. Provisional Applications 61/407,017 and 61/455,849, which are herein incorporated by reference in their entirety.

[0209] The example demonstrates that enriching the mixture of fetal and maternal cIDNA present in a plasma sample for nucleic acid sequences that comprise at least one informative SNP can be used to provide the requisite sequence and SNP tag counts for determining aneuploidy and fetal fraction from a single sequencing process by massively parallel sequencing a library prepared from cfDNA contained in a plasma sample that is enriched for polymorphic nucleic acids.

TABLE-US-00006 TABLE 6 Determination of Fetal Fraction by Massively Parallel Sequencing: Enrichment of Fetal and Maternal Nucleic Acids for Polymorphic Nucleic Acids Comprising a SNP in a Plasma Sample Aneuploidy Chromosome Chromosome Chromosome Chromosome Chromosome 21 18 13 X Y Sequence Tag Density 183851 400582 470526 714055 2449 Karyotype Unaffected Unaffected Unaffected Unaffected Unaffected Fetal Fraction SNP TAG COUNTS FETAL FRACTION (%) rs10773760.1|Chr.12|length = 128|allele = A 8536 9.5 rs10773760.2|Chr.12|length = 128|allele = G 89924

Example 8

Determination of Fetal Fraction by Massively Parallel Sequencing of Samples Comprising Amplified Polymorphic Sequences: Tandem SNPs

[0210] To determine the fraction of fetal cIDNA in a maternal sample, target polymorphic nucleic acid sequences each comprising a pair of tandem SNPs are amplified and used for preparing a target library for sequencing in a massively parallel fashion. Pairs of tandem SNPs can be selected from rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427). The primers used for amplifying the target sequences comprising the tandem SNPs are designed to encompass both SNP sites. For example, the forward primer is designed to encompass the first SNP, and the reverse primer is designed to encompass the second of the tandem SNP pair i.e. each of the SNP sites in the tandem pair is encompassed within the 36 by generated by the sequencing method. Paired-end sequencing can be used to identify all sequences encompassing the tandem SNP sites. Exemplary sets of primers that are used to amplify the tandem SNPs disclosed herein are rs7277033-rs2110153_F (SEQ ID NOS 312 & 313): TCCTGGAAACAAAAGTATT (SEQ ID NO:197) and rs7277033-rs2110153_R (SEQ ID NOS 312 & 313): AACCTTACAACAAAGCTAGAA (SEQ ID NO:198), set rs2822654-rs1882882_F (SEQ ID NOS 314 & 315): ACTAAGCCTTGGGGATCCAG (SEQ ID NO:199) and rs2822654-rs1882882_R (SEQ ID NOS 314 & 315): TGCTGTGGAAATACTAAAAGG (SEQ ID NO:200), set rs368657-rs376635_F (SEQ ID NOS 316 & 317):CTCCAGAGGTAATCCTGTGA (SEQ ID NO:201) and rs368657-rs376635_R (SEQ ID NOS 316 & 317):TGGTGTGAGATGGTATCTAGG (SEQ ID NO:202), rs2822731-rs2822732_F (SEQ ID NOS 318 & 319):GTATAATCCATGAATCTTGTTT (SEQ ID NO:203) and rs2822731-rs2822732_R (SEQ ID NOS 318 & 319):TTCAAATTGTATATAAGAGAGT (SEQ ID NO:204), rs1475881-rs7275487_F (SEQ ID NOS 320 & 321):GCAGGAAAGTTATTTTTAAT (SEQ ID NO:205) and rs1475881-rs7275487R (SEQ ID NOS 320 & 321):TGCTTGAGAAAGCTAACACTT (SEQ ID NO:206), rs1735976-rs2827016F (SEQ ID NOS 322 & 323):CAGTGTTTGGAAATTGTCTG (SEQ ID NO:207) and rs1735976-rs2827016R (SEQ ID NOS 322 & 323):GGCACTGGGAGATTATTGTA (SEQ ID NO:208), rs447349-rs2824097_F (SEQ ID NOS 324 & 325):TCCTGTTGTTAAGTACACAT (SEQ ID NO:209) and rs447349-rs2824097_R (SEQ ID NOS 324 & 325):GGGCCGTAATTACTTTTG (SEQ ID NO:210), rs418989-rs13047336_F (SEQ ID NOS 326 & 327):ACTCAGTAGGCACTTTGTGTC (SEQ ID NO:211) and rs418989-rs13047336R (SEQ ID NOS 326 & 327):TCTTCCACCACACCAATC (SEQ ID NO:212), rs987980-rs987981_F (SEQ ID NOS 328 & 329):TGGCTTTTCAAAGGTAAAA (SEQ ID NO:213) and rs987980-rs987981R (SEQ ID NOS 328 & 329): GCAACGTTAACATCTGAATTT (SEQ ID NO:214), rs4143392-rs4143391_F (SEQ ID NOS 330 & 331): rs4143392-rs4143391 (SEQ ID NO:215) and rs4143392-rs4143391_R (SEQ ID NOS 330 & 331):ATTTTATATGTCATGATCTAAG (SEQ ID NO:216), rs1691324-rs13050434_F (SEQ ID NOS 332 & 333): AGAGATTACAGGTGTGAGC (SEQ ID NO:217) and rs1691324-rs13050434R (SEQ ID NOS 332 & 333): ATGATCCTCAACTGCCTCT (SEQ ID NO:218), rs11909758-rs9980111_F (SEQ ID NOS 334 & 335): TGAAACTCAAAAGAGAAAAG (SEQ ID NO:219) and rs11909758-rs9980111R (SEQ ID NOS 334 & 335): ACAGATTTCTACTTAAAATT (SEQ ID NO:220), rs2826842-rs232414_F (SEQ ID NOS 336 & 337): TGAAACTCAAAAGAGAAAAG (SEQ ID NO:221) and rs2826842-rs232414R (SEQ ID NOS 336 & 337): ACAGATTTCTACTTAAAATT (SEQ ID NO:222), rs2826842-rs232414_F (SEQ ID NOS 336 & 337): GCAAAGGGGTACTCTATGTA (SEQ ID NO:223) and rs2826842-rs232414R (SEQ ID NOS 336 & 337): TATCGGGTCATCTTGTTAAA (SEQ ID NO:224), rs1980969-rs1980970_F (SEQ ID NOS 338 & 339): TCTAACAAAGCTCTGTCCAAAA (SEQ ID NO:225) and rs1980969-rs1980970R (SEQ ID NOS 338 & 339): CCACACTGAATAACTGGAACA (SEQ ID NO:226), rs9978999-rs9979175_F (SEQ ID NOS 340 & 341): GCAAGCAAGCTCTCTACCTTC (SEQ ID NO:227) and rs9978999-rs9979175R (SEQ ID NOS 340 & 341): TGTTCTTCCAAAATTCACATGC (SEQ ID NO:228), rs1034346-rs12481852_F (SEQ ID NOS 342 & 343): ATTTCACTATTCCTTCATTTT (SEQ ID NO:229) and rs1034346-rs12481852R (SEQ ID NOS 342 & 343): TAATTGTTGCACACTAAATTAC (SEQ ID NO:230), rs4817013-rs7277036_F: (SEQ ID NOS 346 & 347) AAAAAGCCACAGAAATCAGTC (SEQ ID NO:231) and rs4817013-rs7277036R (SEQ ID NOS 346 & 347): TTCTTATATCTCACTGGGCATT (SEQ ID NO:232), rs9981121-rs2829696_F (SEQ ID NOS 348 & 349): GGATGGTAGAAGAGAAGAAAGG (SEQ ID NO:233) and rs9981121-rs2829696_R (SEQ ID NOS 348 & 349): GGATGGTAGAAGAGAAGAAAGG (SEQ ID NO:234), rs455921-rs2898102_F (SEQ ID NOS 350 & 351): TGCAAAGATGCAGAACCAAC (SEQ ID NO:235) and rs455921-rs2898102R (SEQ ID NOS 350 & 351): TTTTGTTCCTTGTCCTGGCTGA (SEQ ID NO:236), rs2898102-rs458848_F (SEQ ID NOS 352 & 353): TGCAAAGATGCAGAACCAAC (SEQ ID NO:237) and rs2898102-rs458848R (SEQ ID NOS 352 & 353): GCCTCCAGCTCTATCCAAGTT (SEQ ID NO:238), rs961301-rs2830208_F (SEQ ID NOS 354 & 355): CCTTAATATCTTCCCATGTCCA (SEQ ID NO:239) and rs961301-rs2830208R (SEQ ID NOS 354 & 355): ATTGTTAGTGCCTCTTCTGCTT (SEQ ID NO:240), rs2174536-rs458076_F (SEQ ID NOS 356 & 357): GAGAAGTGAGGTCAGCAGCT (SEQ ID NO:241) and rs2174536-rs458076_R (SEQ ID NOS 356 & 357): TTTCTAAATTTCCATTGAACAG (SEQ ID NO:242), rs11088023-rs11088024_F (SEQ ID NOS 358 & 359): GAAATTGGCAATCTGATTCT (SEQ ID NO:243) and rs11088023-rs11088024_R (SEQ ID NOS 358 & 359): CAACTTGTCCTTTATTGATGT (SEQ ID NO:244), rs1011734-rs1011733_F (SEQ ID NOS 360 & 361): CTATGTTGATAAAACATTGAAA (SEQ ID NO:245) and rs1011734-rs1011733_R (SEQ ID NOS 360 & 361): GCCTGTCTGGAATATAGTTT (SEQ ID NO:246), rs2831244-rs9789838_F (SEQ ID NOS 362 & 363): CAGGGCATATAATCTAAGCTGT (SEQ ID NO:247) and rs2831244-rs9789838_R (SEQ ID NOS 362 & 363): CAATGACTCTGAGTTGAGCAC (SEQ ID NO:248), rs8132769-rs2831440_F (SEQ ID NOS 364 & 365): ACTCTCTCCCTCCCCTCT (SEQ ID NO:249) and rs8132769-rs2831440_R (SEQ ID NOS 364 & 365): TATGGCCCCAAAACTATTCT (SEQ ID NO:250), rs8134080-rs2831524_F (SEQ ID NOS 366 & 367): ACAAGTACTGGGCAGATTGA (SEQ ID NO:251) and rs8134080-rs2831524_R (SEQ ID NOS 366 & 367): GCCAGGTTTAGCTTTCAAGT (SEQ ID NO:252), rs4817219-rs4817220_F (SEQ ID NOS 368 & 369): TTTTATATCAGGAGAAACACTG (SEQ ID NO:253) and rs4817219-rs4817220_R (SEQ ID NOS 368 & 369): CCAGAATTTTGGAGGTTTAAT (SEQ ID NO:254), rs2250911-rs2250997_F (SEQ ID NOS 370 & 371): TGTCATTCCTCCTTTATCTCCA (SEQ ID NO:255) and rs2250911-rs2250997_R (SEQ ID NOS 370 & 371): TTCTTTTGCCTCTCCCAAAG (SEQ ID NO:256), rs2831899-rs2831900_F (SEQ ID NOS 372 & 373): ACCCTGGCACAGTGTTGACT (SEQ ID NO:257) and rs2831899-rs2831900_R (SEQ ID NOS 372 & 373): TGGGCCTGAGTTGAGAAGAT (SEQ ID NO:258), rs2831902-rs2831903_F (SEQ ID NOS 374 & 375): AATTTGTAAGTATGTGCAACG (SEQ ID NO:259) and rs2831902-rs2831903_R (SEQ ID NOS 374 & 375): TTTTTCCCATTTCCAACTCT (SEQ ID NO:260), rs11088086-rs2251447_F (SEQ ID NOS 376 & 377): AAAAGATGAGACAGGCAGGT (SEQ ID NO:261) and rs11088086-rs2251447_R (SEQ ID NOS 376 & 377): ACCCCTGTGAATCTCAAAAT (SEQ ID NO:262), rs2832040-rs11088088_F (SEQ ID NOS 378 & 379): GCACTTGCTTCTATTGTTTGT (SEQ ID NO:263) and rs2832040-rs11088088_R (SEQ ID NOS 378 & 379): CCCTTCCTCTCTTCCATTCT (SEQ ID NO:264), rs2832141-rs2246777_F (SEQ ID NOS 380 & 381): AGCACTGCAGGTA (SEQ ID NO:265) and rs2832141-rs2246777_R (SEQ ID NOS 380 & 381): ACAGATACCAAAGAACTGCAA (SEQ ID NO:266), rs2832959-rs9980934_F (SEQ ID NOS 382 & 383): TGGACACCTTTCAACTTAGA (SEQ ID NO:267) and rs2832959-rs9980934_R (SEQ ID NOS 382 & 383): GAACAGTAATGTTGAACTTTTT (SEQ ID NO:268), rs2833734-rs2833735_F (SEQ ID NOS 384 & 385): TCTTGCAAAAAGCTTAGCACA (SEQ ID NO:269) and rs2833734-rs2833735_R (SEQ ID NOS 384 & 385): AAAAAGATCTCAAAGGGTCCA (SEQ ID NO:270), rs933121-rs933122_F (SEQ ID NOS 386 & 387): GCTTTTGCTGAACATCAAGT (SEQ ID NO:271) and rs933121-rs933122_R (SEQ ID NOS 386 & 387): CCTTCCAGCAGCATAGTCT (SEQ ID NO:272), rs2834140-rs12626953_F (SEQ ID NOS 388 & 389): AAATCCAGGATGTGCAGT (SEQ ID NO:273) and rs2834140-rs12626953_R (SEQ ID NOS 388 & 389): ATGATGAGGTCAGTGGTGT (SEQ ID NO:274), rs2834485-rs3453_F (SEQ ID NOS 390 & 391): CATCACAGATCATAGTAAATGG (SEQ ID NO:275) and rs2834485-rs3453_R (SEQ ID NOS 390 & 391): AATTATTATTTTGCAGGCAAT (SEQ ID NO:276), rs9974986-rs2834703_F (SEQ ID NOS 392 & 393): CATGAGGCAAACACCTTTCC (SEQ ID NO:277) and rs9974986-rs2834703_R (SEQ ID NOS 392 & 393): GCTGGACTCAGGATAAAGAACA (SEQ ID NO:278), rs2776266-rs2835001_F (SEQ ID NOS 394 & 395): TGGAAGCCTGAGCTGACTAA (SEQ ID NO:279) and rs2776266-rs2835001_R (SEQ ID NOS 394 & 395):CCTTCTTTTCCCCCAGAATC (SEQ ID NO:280), rs1984014-rs1984015_F (SEQ ID NOS 396 & 397):TAGGAGAACAGAAGATCAGAG (SEQ ID NO:281) and rs1984014-rs1984015_R (SEQ ID NOS 396 & 397):AAAGACTATTGCTAAATGCTTG (SEQ ID NO:282), rs7281674-rs2835316_F (SEQ ID NOS 398 & 399): TAAGCGTAGGGCTGTGTGTG (SEQ ID NO:283) and rs7281674-rs2835316_R (SEQ ID NOS 398 & 399): GGACGGATAGACTCCAGAAGG (SEQ ID NO:284), rs13047304-rs13047322_F (SEQ ID NOS 400 & 401): GAATGACCTTGGCACTTTTATCA (SEQ ID NO:285) and rs13047304-rs13047322_R (SEQ ID NOS 400 & 401): AAGGATAGAGATATACAGATGAATGGA (SEQ ID NO:286), rs2835735-rs2835736_F (SEQ ID NOS 404 & 405): CATGCACCGCGCAAATAC (SEQ ID NO:287) and rs2835735-rs2835736_R (SEQ ID NOS 404 & 405): ATGCCTCACCCACAAACAC (SEQ ID NO:288), rs13047608-rs2835826_F (SEQ ID NOS 406 & 407): TCCAAGCCCTTCTCACTCAC (SEQ ID NO:289) and rs13047608-rs2835826_R (SEQ ID NOS 406 & 407): CTGGGACGGTGACATTTTCT (SEQ ID NO:290), rs2836550-rs2212596_F (SEQ ID NOS 408 & 409): CCCAGGAAGAGTGGAAAGATT (SEQ ID NO:291) and rs2836550-rs2212596_R (SEQ ID NOS 408 & 409): TTAGCTTGCATGTACCTGTGT (SEQ ID NO:292), rs2836660-rs2836661_F (SEQ ID NOS 410 & 411): AGCTAGATGGGGTGAATTTT (SEQ ID NO:293) and _R: TGGGCTGAGGGGAGATTC (SEQ ID NO:294), rs465612-rs8131220_F (SEQ ID NOS 412 & 413): ATCAAGCTAATTAATGTTATCT (SEQ ID NO:295) and rs465612-rs8131220_R (SEQ ID NOS 412 & 413): AATGAATAAGGTCCTCAGAG (SEQ ID NO:296), rs9980072-rs8130031_F (SEQ ID NOS 414 & 415):TTTAATCTGATCATTGCCCTA (SEQ ID NO:297) and rs9980072-rs8130031_R (SEQ ID NOS 414 & 415): AGCTGTGGGTGACCTTGA (SEQ ID NO:298), rs418359-rs2836926_F (SEQ ID NOS 416 & 417): TGTCCCACCATTGTGTATTA (SEQ ID NO:299) and rs418359-rs2836926_R (SEQ ID NOS 416 & 417): TCAGACTTGAAGTCCAGGAT (SEQ ID NO:300), rs7278447-rs7278858_F (SEQ ID NOS 418 & 419): GCTTCAGGGGTGTTAGTTTT (SEQ ID NO:301) and rs7278447-rs7278858_R (SEQ ID NOS 418 & 419): CTTTGTGAAAAGTCGTCCAG (SEQ ID NO:302), rs385787-rs367001_F (SEQ ID NOS 420 & 421):CCATCATGGAAAGCATGG (SEQ ID NO:303) and rs385787-rs367001_R (SEQ ID NOS 420 & 421): TCATCTCCATGACTGCACTA (SEQ ID NO:304), rs367001-rs386095_F (SEQ ID NOS 422 & 423): GAGATGACGGAGTAGCTCAT (SEQ ID NO:305) and rs367001-rs386095_R (SEQ ID NOS 422 & 423): CCCAGCTGCACTGTCTAC (SEQ ID NO:306), rs2837296-rs2837297_F (SEQ ID NOS 424 & 425): TCTTGTTCCAATCACAGGAC (SEQ ID NO:307) and rs2837296-rs2837297_R (SEQ ID NOS 424 & 425): ATGCTGTTAGCTGAAGCTCT (SEQ ID NO:308), and rs2837381-rs4816672_F (SEQ ID NOS 426 & 427): TGAAAGCTCCTAAAGCAGAG (SEQ ID NO:309) and rs2837381-rs4816672_R (SEQ ID NOS 426 & 427):TTGAAGAGATGTGCTATCAT (SEQ ID NO:310). Polynucleotide sequences e.g. GC clamp sequences, can be included to ensure specific hybridization of AT-rich primers (Ghanta et al., PLOS ONE 5(10): doi10.1371/journal.pone.0013184 [2010], available on the world wide web at plosone.org). An example of a GC clamp sequence that can be included either 5' of the forward primer or 3' of the reverse primer is GCCGCCTGCAGCCCGCGCCCCCCGTGCCCCCGCCCCGCCGCCGGCCCGGGCGCC (SEQ ID NO:311). Polymorphic sequences can be used alone or in combination with unamplified cfDNA to determine either fetal fraction or the presence or absence of aneuploidy and fetal fraction in a maternal sample as described for polymorphic SNP sequences. Sample preparation and enrichment of cfDNA sequencing library, a purified cfDNA sample, and a plasma sample is performed according to the method described in Examples 5, 6, and 7, respectively. All sequencing libraries are prepared as described in Example 2a., and sequencing is performed as described in Example 2b. Analysis of the sequencing data for the determination of fetal aneuploidy is performed as described in Example 5. Concomitant to the analysis for determining aneuploidy, the sequencing data is analyzed to determine the fetal fraction as follows. Following the transfer of the image and base call files to the Unix server running the Illumina "Genome Analyzer Pipeline" software version 1.51 as described in Example 3a., the 36 bp reads are aligned to a `tandem SNP genome` using the BOWTIE program. The tandem SNP genome is identified as the grouping of the DNA sequences that encompass the alleles of the 58 tandem SNP pairs disclosed above. Only reads that mapped uniquely to the tandem SNP genome are used for the analysis of fetal fraction. Reads that match perfectly to the tandem SNP genome are counted as tags and filtered. Of the remaining reads, only reads having one or two mismatches are counted as tags and included in the analysis. Tags mapped to each of the tandem SNP alleles are counted, and the fetal fraction is determined essentially as described in Example 6 above but accounting for tags mapped to the two tandem SNP alleles x and y present on each of the amplified polymorphic target nucleic acid sequences that are amplified to enrich the samples i.e.

% fetal fraction allele.sub.x+y=((.SIGMA.Fetal sequence tags for allele.sub.x+y)/(.SIGMA.Maternal sequence tags for allele.sub.x+y)).times.100

Only informative tandem SNPs are used to determine the fetal fraction.

[0211] Optionally, the fraction of fetal nucleic acids in the mixture of fetal and maternal nucleic acids is calculated for each of the informative allele (allele") as follows:

% fetal fraction allele.sub.x+y=((2.times..SIGMA.Fetal sequence tags for allele.sub.x+y)/(.SIGMA.Maternal sequence tags for allele.sub.x+y)).times.100,

to compensate for the presence of 2 sets of tandem fetal alleles, one being masked by the maternal background.

[0212] The percent fetal fraction is calculated for at least 1, at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 9, at least 10, at least 11, at least 12, at least 13, at least 14, at least 15, at least 16, at least 17, at least 18, at least 19, at least 20, or more informative sets of tandem alleles. In one embodiment, the fetal fraction is the average fetal fraction determined for at least 3 informative sets of tandem alleles.

Example 9

Determination of Fetal Fraction by Massively Parallel Sequencing of Samples Comprising Amplified Polymorphic Sequences: STRs

[0213] To determine the fraction of fetal cfDNA in a maternal sample, target polymorphic nucleic acid sequences each comprising an STR are amplified and used for preparing a target library for sequencing in a massively parallel fashion.

[0214] Peripheral blood samples are obtained from pregnant subjects, and cfDNA is purified from the plasma fraction as described in Examples 1 and 2 STRs that are amplified are chosen from the codis and non-codis STRs disclosed in Table 7, and amplification of the polymorphic STR sequences is obtained using the corresponding sets of primers provided. For example, the STRs listed in Table 7 are amplified using the corresponding primers (SEQ ID NOs: 113-197), and the amplified product is used to generate a target sequencing library. The STR target sequencing library is prepared as described for the preparation of the SNP target library as described in Example 8. STRs CSF1PO, D13S317, D16S539, D18S51, D21S11, D2S1338D7S820, and FGA have been analyzed previously for determining fetal fraction, and are disclosed in U.S. Provisional applications 61/296,358 and 61/360,837.

TABLE-US-00007 TABLE 7 CODIS and NON-CODIS miniSTRs STR Locus (Marker Chromosome Size Range GenBank Name) Location (bp) Accession Primer Sequences (Forward/Reverse) Codis miniSTR loci* CSF1P0 5q33.1 89-129 X14720 ACAGTAACTGCCTTCATAGATAG (CSF1PO_F; SEQ ID NO: 113) GTGTCAGACCCTGTTCTAAGTA (CSF1PO_R; SEQ ID NO: 114) FGA 4q31.3 125-281 M64982 AAATAAAATTAGGCATATTTACAAGC (FGA_F; SEQ ID NO: 115) GCTGAGTGATTTGTCTGTAATTG(FGA_R; SEQ ID NO: 116) TH01 11p15.5 51-98 D00269 CCTGTTCCTCCCTTATTTCCC(TH01_F; SEQ ID NO: 117) GGGAACACAGACTCCATGGTG(TH01_R; SEQ ID NO: 118) TPOX 2p25.3 65-101 M68651 CTTAGGGAACCCTCACTGAATG(TPOX_F; SEQ ID NO: 119) GTCCTTGTCAGCGTTTATTTGC(TPOX_R; SEQ ID NO: 120) vWA 12p13.31 88-148 M25858 AATAATCAGTATGTGACTTGGATTGA (vWA_F; SEQ ID NO: 121) ATAGGATGGATGGATAGATGGA(vWA_R; SEQ ID NO: 122) D3S1358 3p21.31 72-120 NT_005997 CAGAGCAAGACCCTGTCTCAT(D3S1358_ F; SEQ ID NO: 123) TCAACAGAGGCTTGCATGTAT(D3S1358_ R; SEQ ID NO: 124) D5S818 5q23.2 81-117 AC008512 GGGTGATTTTCCTCTTTGGT(D5S818_F; SEQ ID NO: 125) AACATTTGTATCTTTATCTGTATCCTTAT TTAT(D5S818_R; SEQ ID NO: 126) D7S820 7q21.11 136-176 AC004848 GAACACTTGTCATAGTTTAGAACGAAC (D7S820_F; SEQ ID NO: 127) TCATTGACAGAATTGCACCA(D7S820_R; SEQ ID NO: 128) D8S1179 8q24.13 86-134 AF216671 TTTGTATTTCATGTGTACATTCGTATC (D7S820_F; SEQ ID NO: 129) ACCTATCCTGTAGATTATTTTCACTGTG (D7S820_R; SEQ ID NO: 130) D13S317 13q31.1 88-132 AL353628 TCTGACCCATCTAACGCCTA(D13S317_F; SEQ ID NO: 131) CAGACAGAAAGATAGATAGATGATTGA (D13S317_R; SEQ ID NO: 132) D16S539 16q24.1 81-121 ACO24591 ATACAGACAGACAGACAGGTG(D16S539 _F; SEQ ID NO: 133) GCATGTATCTATCATCCATCTCT(D16S539_ R; SEQ ID NO: 134) D18S51 18q21.33 113-193 AP001534 TGAGTGACAAATTGAGACCTT(D18S51_F; SEQ ID NO: 135) GTCTTACAATAACAGTTGCTACTATT (D18S51_R; SEQ ID NO: 136) D21S11 21q21.1 153-221 AP000433 ATTCCCCAAGTGAATTGC(D21S11_F; SEQ ID NO: 137) GGTAGATAGACTGGATAGATAGACGA (D21S11_R; SEQ ID NO: 138) D2S1338 2q35 90-142 AC01036 TGGAAACAGAAATGGCTTGG(D2S1338_F; SEQ ID NO: 139) GATTGCAGGAGGGAAGGAAG(D2S1338_ R; SEQ ID NO: 140) Penta D 21q22.3 94-167 AP001752 GAGCAAGACACCATCTCAAGAA(Penta D_F; SEQ ID NO: 141) GAAATTTTACATTTATGTTTATGATTCTC T(Penta D_R; SEQ ID NO: 142) Penta E 15q26.2 80-175 ACO27004 GGCGACTGAGCAAGACTC(Penta E_F; SEQ ID NO: 143) GGTTATTAATTGAGAAAACTCCTTACA (Penta E_R; SEQ ID NO: 144) Non-Codis miniSTR loci* D22S1045 22q12.3 82-115 AL022314 (17) ATTTTCCCCGATGATAGTAGTCT (D22S1045_F; SEQ ID NO: 145) GCGAATGTATGATTGGCAATATTTTT (D22S1045_R; SEQ ID NO: 146) D20S1082 20q13.2 73-101 AL158015 ACATGTATCCCAGAACTTAAAGTAAAC (D2051082_F; SEQ ID NO: 147) GCAGAAGGGAAAATTGAAGCTG (D20S1082_R; SEQ ID NO: 148) D20S482 20p13 85-126 AL121781 (14) CAGAGACACCGAACCAATAAGA (D20S482_F; SEQ ID NO: 149) GCCACATGAATCAATTCCTATAATAAA (D20S482_R; SEQ ID NO: 150) D18S853 18p11.31 82-104 AP005130 (11) GCACATGTACCCTAAAACTTAAAAT (D18S853_F; SEQ ID NO: 151) GTCAACCAAAACTCAACAAGTAGTAA (D185853R; SEQ ID NO: 152) D17S51301 17q25.1 114-139 AC016888 (12) AAGATGAAATTGCCATGTAAAAATA (D17S1301_F; SEQ ID NO: 153) GTGTGTATAACAAAATTCCTATGATGG (D17S1301_R; SEQ ID NO: 154) D17S974 17p13.1 114-139 AC034303 (10) GCACCCAAAACTGAATGTCATA (D17S974_F; SEQ ID NO: 155) GGTGAGAGTGAGACCCTGTC (D17S974_R; SEQ ID NO: 156) D14S1434 14q32.13 70-98 AL121612 (13) TGTAATAACTCTACGACTGTCTGTCTG (D14S1434_F; SEQ ID NO: 157) GAATAGGAGGTGGATGGATGG (D14S1434_R; SEQ ID NO: 158) D12ATA63 12q23.3 76-106 AC009771 (13) GAGCGAGACCCTGTCTCAAG(D12ATA63_ F; SEQ ID NO: 159) GGAAAAGACATAGGATAGCAATTT (D12ATA63_R; SEQ ID NO: 160) D11S4463 11q25 88-116 AP002806 (14) TCTGGATTGATCTGTCTGTCC(D11S4463_ F; SEQ ID NO: 161) GAATTAAATACCATCTGAGCACTGAA (D11S4463R; SEQ ID NO: 162) D10S1435 10p15.3 82-139 AL354747 (11) TGTTATAATGCATTGAGTTTTATTCTG (D10S1435_F; SEQ ID NO: 163) GCCTGTCTCAAAAATAAAGAGATAGAC A(D10S1435_R; SEQ ID NO: 164) D10S1248 10q26.3 79-123 AL391869 (13) TTAATGAATTGAACAAATGAGTGAG (D10S1248_F; SEQ ID NO: 165) GCAACTCTGGTTGTATTGTCTTCAT (D10S1248R; SEQ ID NO: 166) D9S2157 9q34.2 71-107 AL162417 (10) CAAAGCGAGACTCTGTCTCAA(D9S2157_ F; SEQ ID NO: 167) GAAAATGCTATCCTCTTTGGTATAAAT (D9S2157_R; SEQ ID NO: 168) D9S1122 9q21.2 93-125 AL161789 (12) GGGTATTTCAAGATAACTGTAGATAGG (D9S1122_F; SEQ ID NO: 169) GCTTCTGAAAGCTTCTAGTTTACC (D9S1122_R; SEQ ID NO: 170) D8S1115 8p11.21 63-96 AC090739 (9) TCCACATCCTCACCAACAC(D8S1115_F; SEQ ID NO: 171) GCCTAGGAAGGCTACTGTCAA(D8S1115_ R; SEQ ID NO: 172) D6S1017 6p21.1 81-110 AL035588 (10) CCACCCGTCCATTTAGGC(D6S1017_F; SEQ ID NO: 173) GTGAAAAAGTAGATATAATGGTTGGTG (D6S1017_R; SEQ ID NO: 174) D6S474 6q21 107-136 AL357514 (17) GGTTTTCCAAGAGATAGACCAATTA (D6S474_F; SEQ ID NO: 175) GTCCTCTCATAAATCCCTACTCATATC (D6S474R; SEQ ID NO: 176) D5S2500 5q11.2 85-126 AC008791 (17) CTGTTGGTACATAATAGGTAGGTAGGT (D5S2500_F; SEQ ID NO: 177) GTCGTGGGCCCCATAAATC(D5S2500_R; SEQ ID NO: 178) D4S2408 4p15.1 85-109 AC110763 (9) AAGGTACATAACAGTTCAATAGAAAGC (D4S2408_F; SEQ ID NO: 179) GTGAAATGACTGAAAAATAGTAACCA (D4S2408R; SEQ ID NO: 180) D4S2364 4q22.3 67-83 AC022317 (9) CTAGGAGATCATGTGGGTATGATT (D4S2364U_F; SEQ ID NO: 181) GCAGTGAATAAATGAACGAATGGA (D4S2364_R; SEQ ID NO: 182) D3S4529 3p12.1 111-139 AC117452 (13) CCCAAAATTACTTGAGCCAAT(D3S452_F; SEQ ID NO: 183) GAGACAAAATGAAGAAACAGACAG (D3S452R; SEQ ID NO: 184) D3S3053 3g26.31 84-108 AC069259 (9) TCTTTGCTCTCATGAATAGATCAGT (D3S3053_F; SEQ ID NO: 185) GTTTGTGATAATGAACCCACTCAG (D3S3053_R; SEQ ID NO: 186) D2S1776 2q24.3 127-161 AC009475 (11) TGAACACAGATGTTAAGTGTGTATATG (D2S1776_F; SEQ ID NO: 187) GTCTGAGGTGGACAGTTATGAAA (D2S1776_R; SEQ ID NO: 188) D2S441 2p14 78-110 AC079112 (12) CTGTGGCTCATCTATGAAAACTT(D2S441_ F; SEQ ID NO: 189) GAAGTGGCTGTGGTGTTATGAT (D2S441_ R; SEQ ID NO: 190) D1S1677 1q23.3 81-117 AL513307 (15) TTCTGTTGGTATAGAGCAGTGTTT (D1S1677_F; SEQ ID NO: 191) GTGACAGGAAGGACGGAATG(D1S1677_ R; SEQ ID NO: 192) D1S1627 1p21.1 81-100 AC093119 (13) CATGAGGTTTGCAAATACTATCTTAAC (D1S1627_F; SEQ ID NO: 193) GTTTTAATTTTCTCCAAATCTCCA (D1S1627_R; SEQ ID NO: 194) D1GATA113 1p36.23 81-105 Z97987 (11) TCTTAGCCTAGATAGATACTTGCTTCC (D1GATA113_F; SEQ ID NO: 195) GTCAACCTTTGAGGCTATAGGAA (D1GATA113_R; SEQ ID NO: 196) *(Butler et al., J Forensic Sci 5: 1054-1064; Hill et al., Poster #44-17th Internation Symposium on Human Identification-2006)

[0215] Sequencing of the library enriched for polymorphic STR sequences is performed using a NGS technology e.g. sequencing by synthesis. Sequence reads of lengths that encompass the STRs e.g. miniSTRs of at least 100 bp, to a reference STR genome consisting of the polymorphic sequences which were amplified in the sample. Informative STR alleles are identified by differences in the length of the repeats, and the number of STR sequence tags are counted, and used to determine the fetal fraction. Optionally, amplification of the polymorphic STR sequences is performed to enrich a plasma sample, a purified cfDNA sample or a cfDNA sequencing library sample, as described in Examples 5, 6, and 7, respectively.

Example 10

Determination of Fetal Fraction by Capillary Electrophoresis of Polymorphic Sequences Comprising STRs

[0216] To determine fetal fraction in maternal samples comprising fetal and maternal cfDNA, peripheral blood samples were collected from volunteer pregnant women carrying either male or female fetuses. Peripheral blood samples were obtained and processed to provide purified cfDNA as described in Example 1

[0217] Ten microliters of cfDNA samples were analyzed using the AmpF1STR.RTM. MiniFiler.TM. PCR amplification kit (Applied Biosystems, Foster City, Calif.) according to the manufacturer's instructions. Briefly, cfDNA contained in 10 .mu.l was amplified in a reaction volume of 25 .mu.l containing 50_, fluorescently labeled primers (AmpF/STRO MiniFiler.TM. Primer Set), and the AmpF/STR.RTM. MiniFiler.TM. Master Mix, which includes AmpliTaq Gold.RTM. DNA polymerase and associated buffer, salt (1.5 mM MgC12), and 200 .mu.M deoxynucleotide triphosphates (dNTPs: dATP, dCTP, dGTP and dTTP). The fluorescently labeled primers are forward primers that are labeled with 6FAM.TM., VIC.TM., NED.TM., and PET.TM. dyes. Thermal cycling was performed with the Gene Amp9700 (Applied Biosystems) using the following cycling conditions: incubating at 95.degree. C. for 10 minutes, followed by 30 cycles at 94.degree. C. for 20 seconds, 59.degree. C. for 2 minute, and 72.degree. C. for 1 minute, which was followed by a final incubation at 60.degree. C. for 45 minutes. A final hold at 4.degree. C. was added until the samples were removed for analysis. The amplified product was prepared by diluting 1 ul of amplified product in 8.7 ul Hi-Di.TM. formamide (Applied Biosystems) and 0.3 .mu.l GeneScan.TM.-500 LIZ_internal size standard (Applied Biosystems), and analyzed with an ABI PRISM3130x1 Genetic Analyzer (Applied Biosystems) using Data Collection HID_G5_POP4 (Applied Biosystems), and a 36-cm capillary array. All genotyping was performed with GeneMapper_ID v3.2 software (Applied Biosystems) using manufacturer provided allelic ladders and bins and panels.

[0218] All genotyping measurement were performed on the Applied Biosystems 3130x/Genetic Analyzer, using a .+-.0.5-nt "window" around the size obtained for each allele to allow for detection and correct assignment of alleles. Any sample allele whose size was outside the .+-.0.5-nt window was determined to be OL i.e. "Off Ladder". OL alleles are alleles of a size that is not represented in the AmpF/STR.RTM. MiniFiler.TM. Allelic Ladder or an allele that does not correspond to an allelic ladder, but whose size is just outside a window because of measurement error. The minimum peak height threshold of >50 RFU was set based on validation experiments performed to avoid typing when stochastic effects are likely to interfere with accurate interpretation of mixtures. The calculation of fetal fraction is based on averaging all informative markers. Informative markers are identified by the presence of peaks on the electropherogram that fall within the parameters of preset bins for the STRs that are analyzed.

[0219] Calculations of fetal fraction were performed using the average peak height for major and minor alleles at every STR locus determined from triplicate injections. The rules applied to the calculation are:

[0220] 1. off-ladder allele (OL) data for alleles are not included in the calculation; and

[0221] 2. only peak heights derived from >50 RFU (relative fluorescence units) are included in the calculation

[0222] 3. if only one bin is present the marker is deemed non-informative; and

[0223] 4. if a second bin is called but the peaks of the first and second bins are within 50-70% of their relative fluorescence units (RFU) in peak height, the minority fraction is not measured and the marker is deemed not informative.

[0224] The fraction of the minor allele for any given informative marker is calculated by dividing the peak height of the minor component by the sum of the peak height for the major component, and expressed as a percent was first calculated for each informative locus as

fetal fraction=(.SIGMA.peak height of minor allele/.SIGMA. peak height of major allele(s)).times.100,

[0225] The fetal fraction for a sample comprising two or more informative STRs, would be calculated as the average of the fetal fractions calculated for the two or more informative markers.

[0226] Table 8 provides the data obtained from analyzing cIDNA of a subject pregnant with a male fetus.

TABLE-US-00008 TABLE 8 Fetal Fraction Determined in cfDNA of a Pregnant Subject by Analysis of STRs Allele 1 Allele 2 Allele 3 Fetal Fetal Fraction STR Allele 1 Allele 2 Allele 3 Height Height Height Fraction (Mean/STR) AMEL X Y 3599 106 2.9 AMEL X Y 3602 110 3.1 AMEL X Y 3652 109 3.0 3.0 CSF1PO 11 12 2870 2730 CSF1PO 11 12 2924 2762 CSF1PO 11 12 2953 2786 D13S317 11 12 2621 2588 D13S317 11 12 2680 2619 D13S317 11 12 2717 2659 D16S539 9 11 1056 1416 D16S539 9 11 1038 1394 D16S539 9 11 1072 1437 D18S51 13 15 2026 1555 D18S51 13 15 2006 1557 D18S51 13 15 2050 1578 D21S11 28 31.2 2450 61 2.5 D21S11 28 31.2 2472 62 2.5 D21S11 28 31.2 2508 67 2.7 2.6 D2S1338 20 23 3417 3017 D2S1338 20 23 3407 3020 D2S1338 20 23 3493 3055 D7S820 9 12 13 2373 178 1123 5.1 D7S820 9 12 13 2411 181 1140 5.1 D7S820 9 12 13 2441 182 1156 5.1 5.1 FGA 17.2 22 25 68 1140 896 3.3 FGA 17.2 22 25 68 1144 909 3.1 FGA 17.2 22 25 68 1151 925 3.3 3.2 Fetal Fraction = 3.5

[0227] The results show that cIDNA can be used for determining the presence or absence of fetal DNA as indicated by the detection of a minor component at one or more STR alleles, for determining the percent fetal fraction, and for determining fetal gender as indicated by the presence or absence of the Amelogenin allele.

Example 11

Preamplification of cfDNA for Determining Fetal Fraction by Capillary Electrophoresis of Polymorphic Sequences Comprising STRs

[0228] To improve the sensitivity of the STR assay in detecting and quantifying the STR alleles in the minor contributor of the cfDNA sample, the number of starting genomes in the artificial samples was increased by a modified whole genome amplification strategy.

[0229] Peripheral blood samples were collected and processed as described in Example 2. Cell-free DNA was extracted from 1 ml cell-free plasma using the Roche MagNA Pure Compact Nucleic Acid Isolation Kit I--Large Volume (Roche Applied Science, IN) using the MagNA Pure Compact Instrument, and eluted in 50 .mu.l of elution buffer. Ten microliters of the extracted cIDNA were used to quantify the cIDNA, and the remainder was stored (see storage instructions WI0035 Clinical Sample Storage). The concentration of the plasma extracted cfDNA was determined by fluorescence-based quantitation with UV absorbance measurements using the Qubit.TM. Quantitation Platform (Invitrogen).

[0230] The concentration of cfDNA quantified in plasma samples prepared using the MagnaPure Nucleic Acid Isolation Kit I from 16 pregnant subjects was determined to range between 20 and 100 pg/.mu.l. As the fetal component of plasma cfDNA is known to contribute 3-10% of the total plasma cfDNA, artificial plasma samples were created by spiking aliquots of cfDNA derived from plasma of female volunteer subjects with cfDNA extracted from plasma of male volunteer subjects to mimic the ratios of fetal to maternal cIDNA found in the pregnant subjects. Artificial samples were created to contain 200-1000 pg of extracted female cIDNA that was spiked with 45-150 pg of extracted male cIDNA in a total volume of 10 .mu.l. Each artificial sample was spiked to contain 3%, 5% and 10% male cIDNA.

[0231] Artificial samples having concentrations of total cfDNA of less than approximately 50 pg/.mu.l, were pre-amplified using the modified improved primer extension amplification PCR (mIPEP) amplification according to the method of Hanson and Ballantyne, (Hanson and Ballantyne, Analytical Biochem 346:246-257 [2005]) as follows. Ten microliters of spiked plasma cIDNA were amplified in a 25 .mu.l reaction volume containing 1 mM dNTPs, 2.5 mM MgCl.sub.2 (Applied Biosystems), 1.times. Expand High Fidelity Buffer (No.3), 10.5 U Expand High Fidelity Enzyme Mix (Roche Diagnostics), and 40 .mu.M PEP primer (5'-NNNNNNNNNNNNNNN-3', Qiagen). The amplification was performed in a GeneAmp PCR System 9700 Thermocycler under the following conditions: (1) 20 and 30 cycles of 94.degree. C. for 1 minute, 37.degree. C. for 2 minutes, and 0.1.degree. C./s ramp to 55.degree. C. for 4 minutes. The amplification product was purified using a Qiagen column. The concentration of the amplification product was determined using the Qubit.TM. Quantitation Platform as described above. STR analysis was performed as described in Example 9 above, except that only peak heights >100 RFU were included in the calculations.

[0232] The results are shown in Tables 9, 10 and 11. The results provided in Table 9 show that the cIDNA contained in 10 .mu.l cfDNA of artificial samples ART23 and ART24 having a starting concentration of cIDNA of 46.2 and 50.2 pg/.mu.l, respectively, was amplified by approximately 5 and 10 fold following 20 and 30 cycles of PCR amplification, respectively.

[0233] These data indicate that a pre-amplification of cIDNA using the mIPEP method provided enhanced levels of total cIDNA rendering the level of the minor component more amenable to the STR analysis.

TABLE-US-00009 TABLE 9 Preamplification with mIPEP cfDNA with cfDNA with cfDNA without mIPEP: 20 PCR mIPEP: 30 PCR SAMPLE mIPEP (pg/.mu.l) cycles (pg/50 .mu.l) cycles (pg/50 .mu.l) ART23 46.2 2265 4125 ART24 50.2 2085 3875

[0234] Table 10 shows triplicate measurements profiling 9 loci of the cfDNA of spiked samples ART23 and ART24 following the mIPEP procedure with 20 and 30 cycles of amplification, as described above.

[0235] The data in Table 11 indicate that pre-amplification of cfDNA enables the detection and quantification of the minor component at most loci tested in artificially mixed samples having a starting cfDNA concentration that would otherwise not permit an accurate analysis of the minor STR alleles.

TABLE-US-00010 TABLE 10 mIPEP Preamplification and Detection of Minor Component ART23 (453pg) ART23 (825pg) ART23 (462pg) ART24 (417pg) ART24 (775pg) ART24 (502pg) mIPEP mIPEP Extracted mIPEP mIPEP Extracted amplified amplified unamplified amplified amplified unamplified STR 20 cycles 20 cycles cfDNA 30 cycles 30 cycles cfDNA Locus Allele Allele Height Allele Height Allele Height Allele Allele Height Allele Height Allele Height AMEL X/Y 291/95 397/170 535/832 X/Y 695/359 1878/1148 1564/1959 AMEL X/Y 425/147 428/188 675/1048 X/Y 1216/619 1551/954 1573/1943 AMEL X/Y 267/94 455/203 664/1043 X/Y 718/363 1479/924 1621/2024 CSF1PO 10/11 800/979 725/1009 1429/1325 11/12 2029/1317 4159/2317 2990/3083 CSF1PO 10/11 1147/1432 789/1102 1779/1650 11/12 3449/2223 3460/113/1890 2996/3118 CSF1PO 10/11 729/906 831/1162 1783/1657 11/12 2006/1309 3362/1840 3072/3183 D13S317 12 743 515 1229 11 955 1490 3634 D13S317 12 1079 563 1534 11 1631 1198 3631 D13S317 12 668 583 1520 11 968 1170 3795 D16S539 9/10 239/140 370/466 835/676 10/11 513/512 1173/1472 1678/973 D16S539 9/10 347/203 64*(OL)/ 1046/864 10/11 859/870 973/1212 1730/999 391/489 D16S539 9/10 227/134 441/515 1055/860 10/11 530/513 960/1183 1784/1044 D18S51 14/15 359/464 363/220 785/541 12/18 1044/576 1840/786 2559/1507 512/645 391/226 999/672 12/18 1769/994 1511/643 2565/1469 313/402 409/245 994/685 12/18 1033/567 1496/631 2643/1523 D21S11 29/32 103/104 114/173 605/413 31.2 381 661 3276 149/153 130/182 759/523 31.2 650 536 3028 85/86 131/196 760/525 31.2 380 520 3282 D2S1338 18/20 572/383 428/363 1116/1013 19/20 1066/433 2315/1243 2962/2968 827/553 454/386 1428/1279 19/20 1821/757 1901/101 2942/2942 530/351 482/408 1431/1275 19/20 1063/444 1859/1012 3072/3067 D7S820 11/12 262/167 149/270 557/627 11/12 256/138 520/322 1550/1548 62/366/231 162/292 699/775 11/12 448/236 419/258 1484/1466 224/146 169/307 689/779 11/12 253/141 406/250 1579/1573 FGA 21/23 263/146 181/88 596/365 22/24 228/244 375/429 1272/1064 384/215 191/92 762/450 22/24 409/425 303/345 1221/1023 230/136 202/102 749/456 22/24 232/250 297/348 1298/1087 *"OL" means "Off Ladder measurement"

TABLE-US-00011 TABLE 11 Fetal Fraction Determined in a Sample Following Preamplification Using mIPEP Percent minor Percent minor STR Allele 1/ Allele 2/ Allele 3/ Allele 4/ fraction/STR - fraction/STR - marker Height Height Height Height minor >100 RFU minor <100 RFU Amelogenin .sup. X/2799 Y/207 Amelogenin .sup. X/2751 Y/198 Amelogenin .sup. X/3109 Y/232 .sup. X/2886 Y/212 7 CSF1PO 10/2377 11/1869 12/508 CSF1PO 10/2299 11/1814 12/498 CSF1PO 10/2616 11/206 12/562 10/2431 11/1917 12/523 12 D13S317 10/1232 11/1600 13/186 D13S317 10/1208 11/1548 13/182 D13S317 10/1386 11/1758 13/212 10/1275 11/1635 13/193 12 D16S539 11/757 12/933 D16S539 11/729 12/885 D16S539 11/836 12/1031 11/774 12/950 12 D18S51 OL/80.sup. 14/3137 15/371 D18S51 11/73 14/3082 15/362 D18S51 OL/83.sup. 14/3488 15/413 OL 14/3236 15/382 D21S11 29/953 30/941 D21S11 29/921 30/908 D21S11 29/1046 30/1045 29/973 30/965 D2S1338 17/461 18/366 20/2280 24/1760 D2S1338 17/460 18/360 20/2240 24/1712 D2S1338 17/508 18/409 20/2563 24/1971 17/476 18/378 20/2361 24/1814 20 D7S820 8/1409 9/60 12/1059 D7S820 8/1380 9/60 12/1036 D7S820 8/1561 9/69 12/1166 8/1450 9/63 12/1087 2 FGA 19/825 21/850 25/279 FGA 19/807 21/841 25/265 FGA 19/913 21/958 25/306 19/848 21/883 25/283 16 % fetal fraction >100RFU for minor allele .fwdarw.12 12 % fetal fraction including <100RFU for minor allele .fwdarw.11 11

Example 12

Correlation of Fetal Fraction Determined by Analysis of Fetal and Maternal SNPs and STRs

[0236] To verify that the calculated fetal fraction i.e. fraction of minor nucleic acid component, determined using the SNP and STR assay as described in the preceding Examples provided an accurate measurement of the fetal fraction, the percent fetal fraction of cfDNA in the plasma from the same pregnant subjects was compared.

[0237] Peripheral blood samples were obtained from 48 volunteer subjects, 24 of the subjects were pregnant with male fetuses, and 24 were pregnant with female fetuses. cfDNA was prepared as described in Example 1, Fetal fraction using SNPs was determined by massively parallel sequencing by synthesis as described in Example 5, and fetal fraction using STRs was determined using capillary electrophoresis as described in Example 10

[0238] The results shown in FIG. 6 indicate that a positive correlation exists between the fraction determined using the STR assay and the fraction determined using the SNP sequencing. These data further validate the use of polymorphic sequences comprising STRs or SNPs for determining the fraction of fetal cfDNA in a plasma sample.

Example 13

Use of Fetal Fraction to Set Thresholds and Estimate Minimum Sample Size in Aneuploidy Detection

[0239] Counts of sequence matches to different chromosomes are manipulated to generate a score which will vary with chromosomal copy number that can be interpreted to identify chromosomal amplification or deletion. For example, such a score could be generated by comparing the relative amount of a sequence tags on a chromosome undergoing copy number changes to a chromosome known to be a euploid. Examples of scores that can be used to identify amplification or deletion include but are not limited to: counts for the chromosome of interest divided by counts of another chromosome from the same experimental run, the counts for the chromosome of interest divided by the total number of counts from the experimental run, comparison of counts from the sample of interest versus a separate control sample. Without loss of generality, it can be assumed that scores will increase as copy number increases. Knowledge of fetal fraction can be used to set "cutoff" thresholds to call "aneuploidy", "normal", or "marginal" (uncertain) states. Then, calculations are performed to estimate the minimum number of sequences required to achieve adequate sensitivity (i.e. probability of correctly identifying an aneuploidy state).

[0240] FIG. 7 is a plot of two different populations of scores. The x-axis is score and the y-axis is frequency. Scores on samples of chromosomes without aneuploidy can have a distribution shown in FIG. 7A. FIG. 7B illustrates a hypothetical distribution of a population of scores on samples with an amplified chromosome. Without loss of generality, the graphs and equations show the case of a univariate score where the aneuploidy condition represents an amplification of copy number. Multivariate cases and/or reduction/deletion abnormalities are simple extensions or rearrangements of the given descriptions and are intend to fall within the scope of this art.

[0241] The amount of "overlap" between the populations can determine how well normal and aneuploidy cases can be discriminated. In general, increasing fetal fraction, ff, increases discrimination power by separating the two population centers (by moving "C2," the "Center of Aneuploidy Scores", and increasing "d," causing the populations to overlap less. Furthermore, an increase in the absolute value of the magnitude, m, (for example having four copies of the chromosome instead of a trisomy) of the amplification will also increase separation of population centers leading to higher power (i.e. higher probability of correctly identifying aneuploidy states).

[0242] Increasing the number of sequences generated, N, reduces standard deviations "sdevA" and/or "sdevB," the spread of the two populations of scores, which also causes the populations to overlap less.

Setting Thresholds and Estimating Sample Size

[0243] The following procedure can be used to set "c", the critical value for calling "aneuploidy", "normal", or "marginal" (uncertain) states. Without loss of generality, one sided statistical tests are used below.

[0244] First, an acceptable false positive rate, FP (sometimes also called "type I error" or "specificity"), is decided, which is the probability of a false positive or falsely calling aneuploidy. For example, FP can be at least, or about 0.001, 0.002, 0.003, 0.004, 0.005, 0.006, 0.007, 0.008, 0.009, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, or 0.1.

[0245] Second, the value of "c" can be determined by solving the equation: FP=integral from c to infinity of (f1(x)dx).

F P = .intg. c .infin. f 1 ( x ) x ( Equation 1 ) ##EQU00001##

[0246] Once a critical value, c, has been determined, the minimum number sequences required to achieve a certain TP=True positive rate can be estimated. The true positive rate can be, for example, about 0.5, 0.6, 0.7, 0.8, or 0.9. In one embodiment, the true positive rate can be 0.8. In other words, N is the minimum number of sequences required to identify aneuploidy 100*TP percent of the time. N=minimum number such that TP=integral from c to infinity of f2(x,ff)dx>0.8. N is determined by solving

min N s . t . { T B .gtoreq. .intg. c .infin. f 2 ( x , N ) x } ( Equation 2 ) ##EQU00002##

[0247] In classical statistical tests f1 and f2 are often F, non-central F distributions (a special case of t and non-central t distributions) although that is not a necessary condition for this application.

Setting "Levels" of Thresholds to Give More Control of Errors

[0248] Thresholds can also be set in stages using the above methods. For example, a threshold can be set for high confidence calling of "aneuploidy", say ca, using FP 0.001 and a "marginal" threshold, say cb, using FP 0.05. In this case if Score, S: [0249] (S>ca) then call "Trisomy" [0250] (cb>S<=ca) then call "Marginal" [0251] (S<cb) then call "Normal" Some Trivial Generalizations Falling Within Scope of this Art

[0252] Different values for thresholds such as TP, FP, etc can be used. Procedures can be run in any order. For example, one can start with N and solve for c, etc. Distributions can depend on ff so that f1(x,N,ff), f2(x,N,ff), and/or other variables. The above integral equations can be solved by reference to tables or by iterative computer methods. A non-centrality parameter can be estimated and power can be read from standard statistical tables. Statistical power and sample sizes may be derived from calculation or estimation of expected mean squares. Closed form theoretical distributions such as f, t, non-central t, normal, etc. or estimates (kernel or other) can be used to model the distributions f1, f2. Empirical threshold setting and parameter selection using Receiver Operator Characteristic Curves (ROC) can be used and collated with fetal fraction. Various estimates of distribution spread (variance, mean absolute deviation, inter quartile range, etc.) may be used. Various estimates of distribution center (mean, median, etc.) can be used. Two sided as opposed to one sided statistical tests can be used. The simple hypothesis test can be reformulated as linear or non-linear regression. Combinatorial methods, simulation (e.g., Monte Carlo), maximization (e.g., expectation maximization), iterative, or other methods can be used independently or in conjunction with the above to establish statistical power or thresholds.

[0253] While preferred embodiments of the present invention have been shown and described herein, it will be obvious to those skilled in the art that such embodiments are provided by way of example only. Numerous variations, changes, and substitutions will now occur to those skilled in the art without departing from the invention. It should be understood that various alternatives to the embodiments of the invention described herein may be employed in practicing the invention. It is intended that the following claims define the scope of the invention and that methods and structures within the scope of these claims and their equivalents be covered thereby.

Sequence CWU 1 SEQUENCE LISTING <160> NUMBER OF SEQ ID NOS: 427 <210> SEQ ID NO 1 <211> LENGTH: 111 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 1 cacatgcaca gccagcaacc ctgtcagcag gagttcccac cagtttcttt ctgagaacat 60 ctgttcaggt ttctctccat ctctatttac tcaggtcaca ggaccttggg g 111 <210> SEQ ID NO 2 <211> LENGTH: 111 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 2 cacatgcaca gccagcaacc ctgtcagcag gagttcccac cagtttcttt ctgagaacat 60 ctgttcaggt ttctctccat ctctgtttac tcaggtcaca ggaccttggg g 111 <210> SEQ ID NO 3 <211> LENGTH: 126 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 3 tgaggaagtg aggctcagag ggtaagaaac tttgtcacag agctggtggt gagggtggag 60 attttacact ccctgcctcc cacaccagtt tctccagagt ggaaagactt tcatctcgca 120 ctggca 126 <210> SEQ ID NO 4 <211> LENGTH: 126 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 4 tgaggaagtg aggctcagag ggtaagaaac tttgtcacag agctggtggt gagggtggag 60 attttacact ccctgcctcc cacaccagtt tctccggagt ggaaagactt tcatctcgca 120 ctggca 126 <210> SEQ ID NO 5 <211> LENGTH: 121 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 5 gtgccttcag aacctttgag atctgattct atttttaaag cttcttagaa gagagattgc 60 aaagtgggtt gtttctctag ccagacaggg caggcaaata ggggtggctg gtgggatggg 120 a 121 <210> SEQ ID NO 6 <211> LENGTH: 121 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 6 gtgccttcag aacctttgag atctgattct atttttaaag cttcttagaa gagagattgc 60 aaagtgggtt gtttctctag ccagacaggg caggtaaata ggggtggctg gtgggatggg 120 a 121 <210> SEQ ID NO 7 <211> LENGTH: 111 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 7 aggtgtgtct ctcttttgtg aggggagggg tcccttctgg cctagtagag ggcctggcct 60 gcagtgagca ttcaaatcct caaggaacag ggtggggagg tgggacaaag g 111 <210> SEQ ID NO 8 <211> LENGTH: 111 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 8 aggtgtgtct ctcttttgtg aggggagggg tcccttctgg cctagtagag ggcctggcct 60 gcagtgagca ttcaaatcct cgaggaacag ggtggggagg tgggacaaag g 111 <210> SEQ ID NO 9 <211> LENGTH: 139 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 9 cctcgcctac tgtgctgttt ctaaccatca tgcttttccc tgaatctctt gagtcttttt 60 ctgctgtgga ctgaaacttg atcctgagat tcacctctag tccctctgag cagcctcctg 120 gaatactcag ctgggatgg 139 <210> SEQ ID NO 10 <211> LENGTH: 139 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 10 cctcgcctac tgtgctgttt ctaaccatca tgcttttccc tgaatctctt gagtcttttt 60 ctgctgtgga ctgaaacttg atcctgagat tcacctctag tccctctggg cagcctcctg 120 gaatactcag ctgggatgg 139 <210> SEQ ID NO 11 <211> LENGTH: 117 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 11 aattgcaatg gtgagaggtt gatggtaaaa tcaaacggaa cttgttattt tgtcattctg 60 atggactgga actgaggatt ttcaatttcc tctccaaccc aagacacttc tcactgg 117 <210> SEQ ID NO 12 <211> LENGTH: 117 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 12 aattgcaatg gtgagaggtt gatggtaaaa tcaaacggaa cttgttattt tgtcattctg 60 atggactgga actgaggatt ttcaatttcc tttccaaccc aagacacttc tcactgg 117 <210> SEQ ID NO 13 <211> LENGTH: 114 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 13 gaaatgcctt ctcaggtaat ggaaggttat ccaaatattt ttcgtaagta tttcaaatag 60 caatggctcg tctatggtta gtctcacagc cacattctca gaactgctca aacc 114 <210> SEQ ID NO 14 <211> LENGTH: 114 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 14 gaaatgcctt ctcaggtaat ggaaggttat ccaaatattt ttcgtaagta tttcaaatag 60 caatggctcg tctatggtta gtctcgcagc cacattctca gaactgctca aacc 114 <210> SEQ ID NO 15 <211> LENGTH: 128 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 15 acccaaaaca ctggaggggc ctcttctcat tttcggtaga ctgcaagtgt tagccgtcgg 60 gaccagcttc tgtctggaag ttcgtcaaat tgcagttaag tccaagtatg ccacatagca 120 gataaggg 128 <210> SEQ ID NO 16 <211> LENGTH: 128 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 16 acccaaaaca ctggaggggc ctcttctcat tttcggtaga ctgcaagtgt tagccgtcgg 60 gaccagcttc tgtctggaag ttcgtcaaat tgcagttagg tccaagtatg ccacatagca 120 gataaggg 128 <210> SEQ ID NO 17 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 17 gcaccagaat ttaaacaacg ctgacaataa atatgcagtc gatgatgact tcccagagct 60 ccagaagcaa ctccagcaca cagagaggcg ctgatgtgcc tgtcaggtgc 110 <210> SEQ ID NO 18 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 18 gcaccagaat ttaaacaacg ctgacaataa atatgcagtc gatgatgact tcccagagct 60 ccagaagcaa ctccagcaca cggagaggcg ctgatgtgcc tgtcaggtgc 110 <210> SEQ ID NO 19 <211> LENGTH: 116 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 19 tgactgtata ccccaggtgc acccttgggt catctctatc atagaactta tctcacagag 60 tataagagct gatttctgtg tctgcctctc acactagact tccacatcct tagtgc 116 <210> SEQ ID NO 20 <211> LENGTH: 116 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 20 tgactgtata ccccaggtgc acccttgggt catctctatc atagaactta tctcacagag 60 tataagagct gatttctgtg tctgcctgtc acactagact tccacatcct tagtgc 116 <210> SEQ ID NO 21 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 21 tgtacgtggt caccagggga cgcctggcgc tgcgagggag gccccgagcc tcgtgccccc 60 gtgaagcttc agctcccctc cccggctgtc cttgaggctc ttctcacact 110 <210> SEQ ID NO 22 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 22 tgtacgtggt caccagggga cgcctggcgc tgcgagggag gccccgagcc tcgtgccccc 60 gtgaagcttc agctcccctc cctggctgtc cttgaggctc ttctcacact 110 <210> SEQ ID NO 23 <211> LENGTH: 114 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 23 cagtggaccc tgctgcacct ttcctcccct cccatcaacc tcttttgtgc ctccccctcc 60 gtgtaccacc ttctctgtca ccaaccctgg cctcacaact ctctcctttg ccac 114 <210> SEQ ID NO 24 <211> LENGTH: 114 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 24 cagtggaccc tgctgcacct ttcctcccct cccatcaacc tcttttgtgc ctccccctcc 60 gtgtaccacc ttctctgtca ccacccctgg cctcacaact ctctcctttg ccac 114 <210> SEQ ID NO 25 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 25 cagtggcata gtagtccagg ggctcctcct cagcacctcc agcaccttcc aggaggcagc 60 agcgcaggca gagaacccgc tggaagaatc ggcggaagtt gtcggagagg 110 <210> SEQ ID NO 26 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 26 cagtggcata gtagtccagg ggctcctcct cagcacctcc agcaccttcc aggaggcagc 60 agcgcaggca gagaacccgc tggaaggatc ggcggaagtt gtcggagagg 110 <210> SEQ ID NO 27 <211> LENGTH: 129 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 27 aggtctgggg gccgctgaat gccaagctgg gaatcttaaa tgttaaggaa caaggtcata 60 caatgaatgg tgtgatgtaa aagcttggga ggtgatttct gagggtaggt gctgggttta 120 atgggagga 129 <210> SEQ ID NO 28 <211> LENGTH: 129 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 28 aggtctgggg gccgctgaat gccaagctgg gaatcttaaa tgttaaggaa caaggtcata 60 caatgaatgg tgtgatgtaa aagcttggga ggtgattttt gagggtaggt gctgggttta 120 atgggagga 129 <210> SEQ ID NO 29 <211> LENGTH: 107 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 29 acggttctgt cctgtagggg agaaaagtcc tcgttgttcc tctgggatgc aacatgagag 60 agcagcacac tgaggcttta tggattgccc tgccacaagt gaacagg 107 <210> SEQ ID NO 30 <211> LENGTH: 107 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 30 acggttctgt cctgtagggg agaaaagtcc tcgttgttcc tctgggatgc aacatgagag 60 agcagcacac tgaggcttta tgggttgccc tgccacaagt gaacagg 107 <210> SEQ ID NO 31 <211> LENGTH: 127 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 31 gcgcagtcag atgggcgtgc tggcgtctgt cttctctctc tcctgctctc tggcttcatt 60 tttctctcct tctgtctcac cttctttcgt gtgcctgtgc acacacacgt ttgggacaag 120 ggctgga 127 <210> SEQ ID NO 32 <211> LENGTH: 127 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 32 gcgcagtcag atgggcgtgc tggcgtctgt cttctctctc tcctgctctc tggcttcatt 60 tttctctcct tctgtctcac cttctttcgt gtgcctgtgc atacacacgt ttgggacaag 120 ggctgga 127 <210> SEQ ID NO 33 <211> LENGTH: 130 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 33 gccggacctg cgaaatccca aaatgccaaa cattcccgcc tcacatgatc ccagagagag 60 gggacccagt gttcccagct tgcagctgag gagcccgagg ttgccgtcag atcagagccc 120 cagttgcccg 130 <210> SEQ ID NO 34 <211> LENGTH: 130 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 34 gccggacctg cgaaatccca aaatgccaaa cattcccgcc tcacatgatc ccagagagag 60 gggacccagt gttcccagct tgcagctgag gagcccgagt ttgccgtcag atcagagccc 120 cagttgcccg 130 <210> SEQ ID NO 35 <211> LENGTH: 121 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 35 agcagcctcc ctcgactagc tcacactacg ataaggaaaa ttcatgagct ggtgtccaag 60 gagggctggg tgactcgtgg ctcagtcagc atcaagattc ctttcgtctt tcccctctgc 120 c 121 <210> SEQ ID NO 36 <211> LENGTH: 121 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 36 agcagcctcc ctcgactagc tcacactacg ataaggaaaa ttcatgagct ggtgtccaag 60 gagggctggg tgactcgtgg ctcagtcagc gtcaagattc ctttcgtctt tcccctctgc 120 c 121 <210> SEQ ID NO 37 <211> LENGTH: 138 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 37 tggcattgcc tgtaatatac atagccatgg ttttttatag gcaatttaag atgaatagct 60 tctaaactat agataagttt cattacccca ggaagctgaa ctatagctac tttacccaaa 120 atcattagaa tggtgctt 138 <210> SEQ ID NO 38 <211> LENGTH: 138 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 38 tggcattgcc tgtaatatac atagccatgg ttttttatag gcaatttaag atgaatagct 60 tctaaactat agataagttt cattacccca ggaagctgaa ctatagctac tttccccaaa 120 atcattagaa tggtgctt 138 <210> SEQ ID NO 39 <211> LENGTH: 136 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 39 atgaagcctt ccaccaactg cctgtatgac tcatctgggg acttctgctc tatactcaaa 60 gtggcttagt cactgccaat gtatttccat atgagggacg atgattacta aggaaatata 120 gaaacaacaa ctgatc 136 <210> SEQ ID NO 40 <211> LENGTH: 136 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 40 atgaagcctt ccaccaactg cctgtatgac tcatctgggg acttctgctc tatactcaaa 60 gtggcttagt cactgccaat gtatttccat atgagggacg gtgattacta aggaaatata 120 gaaacaacaa ctgatc 136 <210> SEQ ID NO 41 <211> LENGTH: 118 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 41 acaacagaat caggtgattg gagaaaagat cacaggccta ggcacccaag gcttgaagga 60 tgaaagaatg aaagatggac ggaacaaaat taggacctta attctttgtt cagttcag 118 <210> SEQ ID NO 42 <211> LENGTH: 118 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 42 acaacagaat caggtgattg gagaaaagat cacaggccta ggcacccaag gcttgaagga 60 tgaaagaatg aaagatggac ggaagaaaat taggacctta attctttgtt cagttcag 118 <210> SEQ ID NO 43 <211> LENGTH: 150 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 43 ttggggtaaa ttttcattgt catatgtgga atttaaatat accatcatct acaaagaatt 60 ccacagagtt aaatatctta agttaaacac ttaaaataag tgtttgcgtg atattttgat 120 gacagataaa cagagtctaa ttcccacccc 150 <210> SEQ ID NO 44 <211> LENGTH: 150 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 44 ttggggtaaa ttttcattgt catatgtgga atttaaatat accatcatct acaaagaatt 60 ccacagagtt aaatatctta agttaaacac ttaaaataag tgtttgcgtg atattttgat 120 gatagataaa cagagtctaa ttcccacccc 150 <210> SEQ ID NO 45 <211> LENGTH: 145 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 45 tgcaattcaa atcaggaagt atgaccaaaa gacagagatc ttttttggat gatccctagc 60 ctagcaatgc ctggcagcca tgcaggtgca atgtcaacct taaataatgt attgcaaact 120 cagagctgac aaacctcgat gttgc 145 <210> SEQ ID NO 46 <211> LENGTH: 145 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 46 tgcaattcaa atcaggaagt atgaccaaaa gacagagatc ttttttggat gatccctagc 60 ctagcaatgc ctggcagcca tgcaggtgca atgtcaacct taaataatgt attgcaaatt 120 cagagctgac aaacctcgat gttgc 145 <210> SEQ ID NO 47 <211> LENGTH: 124 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 47 ctgtgctctg cgaatagctg cagaagtaac ttggggaccc aaaataaagc agaatgctaa 60 tgtcaagtcc tgagaaccaa gccctgggac tctggtgcca tttcggattc tccatgagca 120 tggt 124 <210> SEQ ID NO 48 <211> LENGTH: 124 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 48 ctgtgctctg cgaatagctg cagaagtaac ttggggaccc aaaataaagc agaatgctaa 60 tgtcaagtcc tgagaaccaa gccctgggac tctggtgcca ttttggattc tccatgagca 120 tggt 124 <210> SEQ ID NO 49 <211> LENGTH: 118 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 49 tttttccagc caactcaagg ccaaaaaaaa tttcttaata tagttattat gcgaggggag 60 gggaagcaaa ggagcacagg tagtccacag aataagacac aagaaacctc aagctgtg 118 <210> SEQ ID NO 50 <211> LENGTH: 118 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 50 tttttccagc caactcaagg ccaaaaaaaa tttcttaata tagttattat gcgaggggag 60 gggaagcaaa ggagcacagg tagtccacag aataggacac aagaaacctc aagctgtg 118 <210> SEQ ID NO 51 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 51 tcttctcgtc ccctaagcaa acaacatccg cttgcttctg tctgtgtaac cacagtgaat 60 gggtgtgcac gcttgatggg cctctgagcc cctgttgcac aaaccagaaa 110 <210> SEQ ID NO 52 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 52 tcttctcgtc ccctaagcaa acaacatccg cttgcttctg tctgtgtaac cacagtgaat 60 gggtgtgcac gcttggtggg cctctgagcc cctgttgcac aaaccagaaa 110 <210> SEQ ID NO 53 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 53 cacatggggg cattaagaat cgcccaggga ggaggaggga gaacgcgtgc ttttcacatt 60 tgcatttgaa ttttcgagtt cccaggatgt gtttttgtgc tcatcgatgt 110 <210> SEQ ID NO 54 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 54 cacatggggg cattaagaat cgcccaggga ggaggaggga gaacgcgtgc ttttcacatt 60 tgcatttgaa tttttgagtt cccaggatgt gtttttgtgc tcatcgatgt 110 <210> SEQ ID NO 55 <211> LENGTH: 128 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 55 gggctctgag gtgtgtgaaa taaaaacaaa tgtccatgtc tgtcctttta tggcattttg 60 ggactttaca tttcaaacat ttcagacatg tatcacaaca cgaaggaata acagttccag 120 ggatatct 128 <210> SEQ ID NO 56 <211> LENGTH: 128 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 56 gggctctgag gtgtgtgaaa taaaaacaaa tgtccatgtc tgtcctttta tggcattttg 60 ggactttaca tttcaaacat ttcagacatg tatcacaaca cgagggaata acagttccag 120 ggatatct 128 <210> SEQ ID NO 57 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 57 cacatgcaca gccagcaacc c 21 <210> SEQ ID NO 58 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 58 ccccaaggtc ctgtgacctg agt 23 <210> SEQ ID NO 59 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 59 tgaggaagtg aggctcagag ggt 23 <210> SEQ ID NO 60 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 60 tgccagtgcg agatgaaagt cttt 24 <210> SEQ ID NO 61 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 61 gtgccttcag aacctttgag atctgat 27 <210> SEQ ID NO 62 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 62 tcccatccca ccagccaccc 20 <210> SEQ ID NO 63 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 63 aggtgtgtct ctcttttgtg agggg 25 <210> SEQ ID NO 64 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 64 cctttgtccc acctccccac c 21 <210> SEQ ID NO 65 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 65 cctcgcctac tgtgctgttt ctaacc 26 <210> SEQ ID NO 66 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 66 ccatcccagc tgagtattcc aggag 25 <210> SEQ ID NO 67 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 67 aattgcaatg gtgagaggtt gatggt 26 <210> SEQ ID NO 68 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 68 ccagtgagaa gtgtcttggg ttgg 24 <210> SEQ ID NO 69 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 69 gaaatgcctt ctcaggtaat ggaaggt 27 <210> SEQ ID NO 70 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 70 ggtttgagca gttctgagaa tgtggct 27 <210> SEQ ID NO 71 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 71 acccaaaaca ctggaggggc ct 22 <210> SEQ ID NO 72 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 72 cccttatctg ctatgtggca tacttgg 27 <210> SEQ ID NO 73 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 73 gcaccagaat ttaaacaacg ctgacaa 27 <210> SEQ ID NO 74 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 74 gcacctgaca ggcacatcag cg 22 <210> SEQ ID NO 75 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 75 tgactgtata ccccaggtgc accc 24 <210> SEQ ID NO 76 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 76 gcactaagga tgtggaagtc tagtgtg 27 <210> SEQ ID NO 77 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 77 tgtacgtggt caccagggga cg 22 <210> SEQ ID NO 78 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 78 agtgtgagaa gagcctcaag gacagc 26 <210> SEQ ID NO 79 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 79 cagtggaccc tgctgcacct t 21 <210> SEQ ID NO 80 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 80 gtggcaaagg agagagttgt gagg 24 <210> SEQ ID NO 81 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 81 cagtggcata gtagtccagg ggct 24 <210> SEQ ID NO 82 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 82 cctctccgac aacttccgcc g 21 <210> SEQ ID NO 83 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 83 aggtctgggg gccgctgaat 20 <210> SEQ ID NO 84 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 84 tcctcccatt aaacccagca cct 23 <210> SEQ ID NO 85 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 85 acggttctgt cctgtagggg aga 23 <210> SEQ ID NO 86 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 86 cctgttcact tgtggcaggg ca 22 <210> SEQ ID NO 87 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 87 gcgcagtcag atgggcgtgc 20 <210> SEQ ID NO 88 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 88 tccagccctt gtcccaaacg tgt 23 <210> SEQ ID NO 89 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 89 gccggacctg cgaaatccca a 21 <210> SEQ ID NO 90 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 90 cgggcaactg gggctctgat c 21 <210> SEQ ID NO 91 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 91 agcagcctcc ctcgactagc t 21 <210> SEQ ID NO 92 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 92 ggcagagggg aaagacgaaa gga 23 <210> SEQ ID NO 93 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 93 tggcattgcc tgtaatatac atag 24 <210> SEQ ID NO 94 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 94 aagcaccatt ctaatgattt tgg 23 <210> SEQ ID NO 95 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 95 atgaagcctt ccaccaactg 20 <210> SEQ ID NO 96 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 96 gatcagttgt tgtttctata tttcctt 27 <210> SEQ ID NO 97 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 97 acaacagaat caggtgattg ga 22 <210> SEQ ID NO 98 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 98 ctgaactgaa caaagaatta aggtc 25 <210> SEQ ID NO 99 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 99 ttggggtaaa ttttcattgt ca 22 <210> SEQ ID NO 100 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 100 ggggtgggaa ttagactctg 20 <210> SEQ ID NO 101 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 101 tgcaattcaa atcaggaagt atg 23 <210> SEQ ID NO 102 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 102 gcaacatcga ggtttgtcag 20 <210> SEQ ID NO 103 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 103 ctgtgctctg cgaatagctg 20 <210> SEQ ID NO 104 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 104 accatgctca tggagaatcc 20 <210> SEQ ID NO 105 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 105 tttttccagc caactcaagg 20 <210> SEQ ID NO 106 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 106 cacagcttga ggtttcttgt g 21 <210> SEQ ID NO 107 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 107 tcttctcgtc ccctaagcaa 20 <210> SEQ ID NO 108 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 108 tttctggttt gtgcaacagg 20 <210> SEQ ID NO 109 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 109 cacatggggg cattaagaat 20 <210> SEQ ID NO 110 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 110 acatcgatga gcacaaaaac ac 22 <210> SEQ ID NO 111 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 111 gggctctgag gtgtgtgaaa 20 <210> SEQ ID NO 112 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 112 agatatccct ggaactgtta ttcc 24 <210> SEQ ID NO 113 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 113 acagtaactg ccttcataga tag 23 <210> SEQ ID NO 114 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 114 gtgtcagacc ctgttctaag ta 22 <210> SEQ ID NO 115 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 115 aaataaaatt aggcatattt acaagc 26 <210> SEQ ID NO 116 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 116 gctgagtgat ttgtctgtaa ttg 23 <210> SEQ ID NO 117 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 117 cctgttcctc ccttatttcc c 21 <210> SEQ ID NO 118 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 118 gggaacacag actccatggt g 21 <210> SEQ ID NO 119 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 119 cttagggaac cctcactgaa tg 22 <210> SEQ ID NO 120 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 120 gtccttgtca gcgtttattt gc 22 <210> SEQ ID NO 121 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 121 aataatcagt atgtgacttg gattga 26 <210> SEQ ID NO 122 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 122 ataggatgga tggatagatg ga 22 <210> SEQ ID NO 123 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 123 cagagcaaga ccctgtctca t 21 <210> SEQ ID NO 124 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 124 tcaacagagg cttgcatgta t 21 <210> SEQ ID NO 125 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 125 gggtgatttt cctctttggt 20 <210> SEQ ID NO 126 <211> LENGTH: 33 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 126 aacatttgta tctttatctg tatccttatt tat 33 <210> SEQ ID NO 127 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 127 gaacacttgt catagtttag aacgaac 27 <210> SEQ ID NO 128 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 128 tcattgacag aattgcacca 20 <210> SEQ ID NO 129 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 129 tttgtatttc atgtgtacat tcgtatc 27 <210> SEQ ID NO 130 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 130 acctatcctg tagattattt tcactgtg 28 <210> SEQ ID NO 131 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 131 tctgacccat ctaacgccta 20 <210> SEQ ID NO 132 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 132 cagacagaaa gatagataga tgattga 27 <210> SEQ ID NO 133 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 133 atacagacag acagacaggt g 21 <210> SEQ ID NO 134 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 134 gcatgtatct atcatccatc tct 23 <210> SEQ ID NO 135 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 135 tgagtgacaa attgagacct t 21 <210> SEQ ID NO 136 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 136 gtcttacaat aacagttgct actatt 26 <210> SEQ ID NO 137 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 137 attccccaag tgaattgc 18 <210> SEQ ID NO 138 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 138 ggtagataga ctggatagat agacga 26 <210> SEQ ID NO 139 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 139 tggaaacaga aatggcttgg 20 <210> SEQ ID NO 140 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 140 gattgcagga gggaaggaag 20 <210> SEQ ID NO 141 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 141 gagcaagaca ccatctcaag aa 22 <210> SEQ ID NO 142 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 142 gaaattttac atttatgttt atgattctct 30 <210> SEQ ID NO 143 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 143 ggcgactgag caagactc 18 <210> SEQ ID NO 144 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 144 ggttattaat tgagaaaact ccttaca 27 <210> SEQ ID NO 145 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 145 attttccccg atgatagtag tct 23 <210> SEQ ID NO 146 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 146 gcgaatgtat gattggcaat attttt 26 <210> SEQ ID NO 147 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 147 acatgtatcc cagaacttaa agtaaac 27 <210> SEQ ID NO 148 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 148 gcagaaggga aaattgaagc tg 22 <210> SEQ ID NO 149 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 149 cagagacacc gaaccaataa ga 22 <210> SEQ ID NO 150 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 150 gccacatgaa tcaattccta taataaa 27 <210> SEQ ID NO 151 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 151 gcacatgtac cctaaaactt aaaat 25 <210> SEQ ID NO 152 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 152 gtcaaccaaa actcaacaag tagtaa 26 <210> SEQ ID NO 153 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 153 aagatgaaat tgccatgtaa aaata 25 <210> SEQ ID NO 154 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 154 gtgtgtataa caaaattcct atgatgg 27 <210> SEQ ID NO 155 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 155 gcacccaaaa ctgaatgtca ta 22 <210> SEQ ID NO 156 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 156 ggtgagagtg agaccctgtc 20 <210> SEQ ID NO 157 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 157 tgtaataact ctacgactgt ctgtctg 27 <210> SEQ ID NO 158 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 158 gaataggagg tggatggatg g 21 <210> SEQ ID NO 159 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 159 gagcgagacc ctgtctcaag 20 <210> SEQ ID NO 160 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 160 ggaaaagaca taggatagca attt 24 <210> SEQ ID NO 161 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 161 tctggattga tctgtctgtc c 21 <210> SEQ ID NO 162 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 162 gaattaaata ccatctgagc actgaa 26 <210> SEQ ID NO 163 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 163 tgttataatg cattgagttt tattctg 27 <210> SEQ ID NO 164 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 164 gcctgtctca aaaataaaga gatagaca 28 <210> SEQ ID NO 165 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 165 ttaatgaatt gaacaaatga gtgag 25 <210> SEQ ID NO 166 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 166 gcaactctgg ttgtattgtc ttcat 25 <210> SEQ ID NO 167 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 167 caaagcgaga ctctgtctca a 21 <210> SEQ ID NO 168 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 168 gaaaatgcta tcctctttgg tataaat 27 <210> SEQ ID NO 169 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 169 gggtatttca agataactgt agatagg 27 <210> SEQ ID NO 170 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 170 gcttctgaaa gcttctagtt tacc 24 <210> SEQ ID NO 171 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 171 tccacatcct caccaacac 19 <210> SEQ ID NO 172 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 172 gcctaggaag gctactgtca a 21 <210> SEQ ID NO 173 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 173 ccacccgtcc atttaggc 18 <210> SEQ ID NO 174 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 174 gtgaaaaagt agatataatg gttggtg 27 <210> SEQ ID NO 175 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 175 ggttttccaa gagatagacc aatta 25 <210> SEQ ID NO 176 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 176 gtcctctcat aaatccctac tcatatc 27 <210> SEQ ID NO 177 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 177 ctgttggtac ataataggta ggtaggt 27 <210> SEQ ID NO 178 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 178 gtcgtgggcc ccataaatc 19 <210> SEQ ID NO 179 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 179 aaggtacata acagttcaat agaaagc 27 <210> SEQ ID NO 180 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 180 gtgaaatgac tgaaaaatag taacca 26 <210> SEQ ID NO 181 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 181 ctaggagatc atgtgggtat gatt 24 <210> SEQ ID NO 182 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 182 gcagtgaata aatgaacgaa tgga 24 <210> SEQ ID NO 183 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 183 cccaaaatta cttgagccaa t 21 <210> SEQ ID NO 184 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 184 gagacaaaat gaagaaacag acag 24 <210> SEQ ID NO 185 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 185 tctttgctct catgaataga tcagt 25 <210> SEQ ID NO 186 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 186 gtttgtgata atgaacccac tcag 24 <210> SEQ ID NO 187 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 187 tgaacacaga tgttaagtgt gtatatg 27 <210> SEQ ID NO 188 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 188 gtctgaggtg gacagttatg aaa 23 <210> SEQ ID NO 189 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 189 ctgtggctca tctatgaaaa ctt 23 <210> SEQ ID NO 190 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 190 gaagtggctg tggtgttatg at 22 <210> SEQ ID NO 191 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 191 ttctgttggt atagagcagt gttt 24 <210> SEQ ID NO 192 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 192 gtgacaggaa ggacggaatg 20 <210> SEQ ID NO 193 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 193 catgaggttt gcaaatacta tcttaac 27 <210> SEQ ID NO 194 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 194 gttttaattt tctccaaatc tcca 24 <210> SEQ ID NO 195 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 195 tcttagccta gatagatact tgcttcc 27 <210> SEQ ID NO 196 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 196 gtcaaccttt gaggctatag gaa 23 <210> SEQ ID NO 197 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 197 tcctggaaac aaaagtatt 19 <210> SEQ ID NO 198 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 198 aaccttacaa caaagctaga a 21 <210> SEQ ID NO 199 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 199 actaagcctt ggggatccag 20 <210> SEQ ID NO 200 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 200 tgctgtggaa atactaaaag g 21 <210> SEQ ID NO 201 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 201 ctccagaggt aatcctgtga 20 <210> SEQ ID NO 202 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 202 tggtgtgaga tggtatctag g 21 <210> SEQ ID NO 203 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 203 gtataatcca tgaatcttgt tt 22 <210> SEQ ID NO 204 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 204 ttcaaattgt atataagaga gt 22 <210> SEQ ID NO 205 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 205 gcaggaaagt tatttttaat 20 <210> SEQ ID NO 206 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 206 tgcttgagaa agctaacact t 21 <210> SEQ ID NO 207 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 207 cagtgtttgg aaattgtctg 20 <210> SEQ ID NO 208 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 208 ggcactggga gattattgta 20 <210> SEQ ID NO 209 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 209 tcctgttgtt aagtacacat 20 <210> SEQ ID NO 210 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 210 gggccgtaat tacttttg 18 <210> SEQ ID NO 211 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 211 actcagtagg cactttgtgt c 21 <210> SEQ ID NO 212 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 212 tcttccacca caccaatc 18 <210> SEQ ID NO 213 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 213 tggcttttca aaggtaaaa 19 <210> SEQ ID NO 214 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 214 gcaacgttaa catctgaatt t 21 <210> SEQ ID NO 215 <400> SEQUENCE: 215 000 <210> SEQ ID NO 216 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 216 attttatatg tcatgatcta ag 22 <210> SEQ ID NO 217 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 217 agagattaca ggtgtgagc 19 <210> SEQ ID NO 218 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 218 atgatcctca actgcctct 19 <210> SEQ ID NO 219 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 219 tgaaactcaa aagagaaaag 20 <210> SEQ ID NO 220 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 220 acagatttct acttaaaatt 20 <210> SEQ ID NO 221 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 221 tgaaactcaa aagagaaaag 20 <210> SEQ ID NO 222 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 222 acagatttct acttaaaatt 20 <210> SEQ ID NO 223 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 223 gcaaaggggt actctatgta 20 <210> SEQ ID NO 224 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 224 tatcgggtca tcttgttaaa 20 <210> SEQ ID NO 225 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 225 tctaacaaag ctctgtccaa aa 22 <210> SEQ ID NO 226 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 226 ccacactgaa taactggaac a 21 <210> SEQ ID NO 227 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 227 gcaagcaagc tctctacctt c 21 <210> SEQ ID NO 228 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 228 tgttcttcca aaattcacat gc 22 <210> SEQ ID NO 229 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 229 atttcactat tccttcattt t 21 <210> SEQ ID NO 230 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 230 taattgttgc acactaaatt ac 22 <210> SEQ ID NO 231 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 231 aaaaagccac agaaatcagt c 21 <210> SEQ ID NO 232 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 232 ttcttatatc tcactgggca tt 22 <210> SEQ ID NO 233 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 233 ggatggtaga agagaagaaa gg 22 <210> SEQ ID NO 234 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 234 ggatggtaga agagaagaaa gg 22 <210> SEQ ID NO 235 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 235 tgcaaagatg cagaaccaac 20 <210> SEQ ID NO 236 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 236 ttttgttcct tgtcctggct ga 22 <210> SEQ ID NO 237 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 237 tgcaaagatg cagaaccaac 20 <210> SEQ ID NO 238 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 238 gcctccagct ctatccaagt t 21 <210> SEQ ID NO 239 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 239 ccttaatatc ttcccatgtc ca 22 <210> SEQ ID NO 240 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 240 attgttagtg cctcttctgc tt 22 <210> SEQ ID NO 241 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 241 gagaagtgag gtcagcagct 20 <210> SEQ ID NO 242 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 242 tttctaaatt tccattgaac ag 22 <210> SEQ ID NO 243 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 243 gaaattggca atctgattct 20 <210> SEQ ID NO 244 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 244 caacttgtcc tttattgatg t 21 <210> SEQ ID NO 245 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 245 ctatgttgat aaaacattga aa 22 <210> SEQ ID NO 246 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 246 gcctgtctgg aatatagttt 20 <210> SEQ ID NO 247 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 247 cagggcatat aatctaagct gt 22 <210> SEQ ID NO 248 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 248 caatgactct gagttgagca c 21 <210> SEQ ID NO 249 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 249 actctctccc tcccctct 18 <210> SEQ ID NO 250 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 250 tatggcccca aaactattct 20 <210> SEQ ID NO 251 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 251 acaagtactg ggcagattga 20 <210> SEQ ID NO 252 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 252 gccaggttta gctttcaagt 20 <210> SEQ ID NO 253 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 253 ttttatatca ggagaaacac tg 22 <210> SEQ ID NO 254 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 254 ccagaatttt ggaggtttaa t 21 <210> SEQ ID NO 255 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 255 tgtcattcct cctttatctc ca 22 <210> SEQ ID NO 256 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 256 ttcttttgcc tctcccaaag 20 <210> SEQ ID NO 257 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 257 accctggcac agtgttgact 20 <210> SEQ ID NO 258 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 258 tgggcctgag ttgagaagat 20 <210> SEQ ID NO 259 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 259 aatttgtaag tatgtgcaac g 21 <210> SEQ ID NO 260 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 260 tttttcccat ttccaactct 20 <210> SEQ ID NO 261 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 261 aaaagatgag acaggcaggt 20 <210> SEQ ID NO 262 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 262 acccctgtga atctcaaaat 20 <210> SEQ ID NO 263 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 263 gcacttgctt ctattgtttg t 21 <210> SEQ ID NO 264 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 264 cccttcctct cttccattct 20 <210> SEQ ID NO 265 <211> LENGTH: 13 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 265 agcactgcag gta 13 <210> SEQ ID NO 266 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 266 acagatacca aagaactgca a 21 <210> SEQ ID NO 267 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 267 tggacacctt tcaacttaga 20 <210> SEQ ID NO 268 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 268 gaacagtaat gttgaacttt tt 22 <210> SEQ ID NO 269 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 269 tcttgcaaaa agcttagcac a 21 <210> SEQ ID NO 270 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 270 aaaaagatct caaagggtcc a 21 <210> SEQ ID NO 271 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 271 gcttttgctg aacatcaagt 20 <210> SEQ ID NO 272 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 272 ccttccagca gcatagtct 19 <210> SEQ ID NO 273 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 273 aaatccagga tgtgcagt 18 <210> SEQ ID NO 274 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 274 atgatgaggt cagtggtgt 19 <210> SEQ ID NO 275 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 275 catcacagat catagtaaat gg 22 <210> SEQ ID NO 276 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 276 aattattatt ttgcaggcaa t 21 <210> SEQ ID NO 277 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 277 catgaggcaa acacctttcc 20 <210> SEQ ID NO 278 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 278 gctggactca ggataaagaa ca 22 <210> SEQ ID NO 279 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 279 tggaagcctg agctgactaa 20 <210> SEQ ID NO 280 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 280 ccttcttttc ccccagaatc 20 <210> SEQ ID NO 281 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 281 taggagaaca gaagatcaga g 21 <210> SEQ ID NO 282 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 282 aaagactatt gctaaatgct tg 22 <210> SEQ ID NO 283 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 283 taagcgtagg gctgtgtgtg 20 <210> SEQ ID NO 284 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 284 ggacggatag actccagaag g 21 <210> SEQ ID NO 285 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 285 gaatgacctt ggcactttta tca 23 <210> SEQ ID NO 286 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 286 aaggatagag atatacagat gaatgga 27 <210> SEQ ID NO 287 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 287 catgcaccgc gcaaatac 18 <210> SEQ ID NO 288 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 288 atgcctcacc cacaaacac 19 <210> SEQ ID NO 289 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 289 tccaagccct tctcactcac 20 <210> SEQ ID NO 290 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 290 ctgggacggt gacattttct 20 <210> SEQ ID NO 291 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 291 cccaggaaga gtggaaagat t 21 <210> SEQ ID NO 292 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 292 ttagcttgca tgtacctgtg t 21 <210> SEQ ID NO 293 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 293 agctagatgg ggtgaatttt 20 <210> SEQ ID NO 294 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 294 tgggctgagg ggagattc 18 <210> SEQ ID NO 295 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 295 atcaagctaa ttaatgttat ct 22 <210> SEQ ID NO 296 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 296 aatgaataag gtcctcagag 20 <210> SEQ ID NO 297 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 297 tttaatctga tcattgccct a 21 <210> SEQ ID NO 298 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 298 agctgtgggt gaccttga 18 <210> SEQ ID NO 299 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 299 tgtcccacca ttgtgtatta 20 <210> SEQ ID NO 300 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 300 tcagacttga agtccaggat 20 <210> SEQ ID NO 301 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 301 gcttcagggg tgttagtttt 20 <210> SEQ ID NO 302 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 302 ctttgtgaaa agtcgtccag 20 <210> SEQ ID NO 303 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 303 ccatcatgga aagcatgg 18 <210> SEQ ID NO 304 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 304 tcatctccat gactgcacta 20 <210> SEQ ID NO 305 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 305 gagatgacgg agtagctcat 20 <210> SEQ ID NO 306 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 306 cccagctgca ctgtctac 18 <210> SEQ ID NO 307 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 307 tcttgttcca atcacaggac 20 <210> SEQ ID NO 308 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 308 atgctgttag ctgaagctct 20 <210> SEQ ID NO 309 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 309 tgaaagctcc taaagcagag 20 <210> SEQ ID NO 310 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 310 ttgaagagat gtgctatcat 20 <210> SEQ ID NO 311 <211> LENGTH: 54 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 311 gccgcctgca gcccgcgccc cccgtgcccc cgccccgccg ccggcccggg cgcc 54 <210> SEQ ID NO 312 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 312 catagtgaca ggtatatgcc caactaactg tggaaaacag ttctttcttt caaccttact 60 catcaccctc acggtctgtt tatgaggctc tcctccacca gccagaaagg atgacgtgcc 120 atacctgcaa aacttataca gcatcaacag aatgaatctt tccaacaagc cgaaacattg 180 agtattgtgg cacagaatat gccccaccca ttactcaatc tagatatcct tttattccac 240 cgtctcatga ttttcttttt cctggaaaac aaaagtattt ctttcatagc ccagctagca 300 ygataaatca gcgagtcaga attctagctt tgttgtaagg ttttgcgaat atctgatcct 360 cttattttgt acttttctat ttcctaggca aatctgagta tttcacccag ttttccttaa 420 ctaggcattg aaaactcagt ttttttctta caaaccttca tgtcttcctg ctcatttgca 480 cagtcttatc ttgcacctcc tataaaatgg agaaacttga cattaaaacg taatttttat 540 tacattttga gggattccca gagaattttt ccccaatctc cttaggtagg gacttcttta 600 c 601 <210> SEQ ID NO 313 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 313 gtgggaacta tagtaaagaa gtccctacct aaggagattg gggaaaaatt ctctgggaat 60 ccctcaaaat gtaataaaaa ttacgtttta atgtcaagtt tctccatttt ataggaggtg 120 caagataaga ctgtgcaaat gagcaggaag acatgaaggt ttgtaagaaa aaaactgagt 180 tttcaatgcc tagttaagga aaactgggtg aaatactcag atttgcctag gaaatagaaa 240 agtacaaaat aagaggatca gatattcgca aaaccttaca acaaagctag aattctgact 300 ygctgattta tcgtgctagc tgggctatga aagaaatact tttgttttcc aggaaaaaga 360 aaatcatgag acggtggaat aaaaggatat ctagattgag taatgggtgg ggcatattct 420 gtgccacaat actcaatgtt tcggcttgtt ggaaagattc attctgttga tgctgtataa 480 gttttgcagg tatggcacgt catcctttct ggctggtgga ggagagcctc ataaacagac 540 cgtgagggtg atgagtaagg ttgaaagaaa gaactgtttt ccacagttag ttgggcatat 600 a 601 <210> SEQ ID NO 314 <211> LENGTH: 650 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 314 tttattggtc ctgactggta caaatactga taaaaaggat tttaagatca tattcatact 60 tttggggaat gagagccaca attaattaac aatgtctgcc atgagattgg atgcaagagt 120 atggcactca tactattcct acttctgtct aattacacta tttgtttctg tgtgcaaaaa 180 tctttggtag gtggtggatg tgcccaagac acagggaaga aaaagaagta aacagggaag 240 tacaacacag actctgaaat ggggcatcat ggaagacgga gctttgtcgt cttggtcttt 300 gctgtatatt cacttcctac aacagtgcta aataccttgt ggatgcttaa atatattaaa 360 tgaatgcata aatgaaaaga gtaaataaag agtgtatatg aaagtatgta gataaaattc 420 ttcactaagc cttggggatc cagctgcttm aggactaaga ccgtatctag ctccttttag 480 tatttccaca gcatgccatg gagatacatg tttctgatta tatatgatac atggaaatta 540 tatgttgttg aatgagtgat tgagtaaatg tgtactaggg cagctaatca taaatatttc 600 tactattgct aaaatgactg gatttatcca ttccttctga gagtttatac 650 <210> SEQ ID NO 315 <211> LENGTH: 626 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 315 ctgcttaagg actaagaccr tatctagctc cttttagtat ttccacagca tgccatggag 60 atacatgttt ctgattatat atgatacatg gaaattatat gttgttgaat gagtgattga 120 gtaaatgtgt actagggcag ctaatcataa atatttctac tattgctaaa atgactggat 180 ttatccattc cttctgagag tttatactga ttgcttatat tgtatcaaat accgtaactg 240 agggcaatgt ttactcaaac taatagcacc attcaaattt atgcaaacaa taacactata 300 tctttaaaat gttttcacta aaagctgcat aaagagtgta ttcaacaaca atagaataat 360 tttacaatct tttttcttgc ttaatggcca tttgtgcctt ctgacatgct gctagccatt 420 caaaggtcac actaccttga agttgaagat caagacaaat gattagactc ataaaagaca 480 aatcacgtct ttctggacag gtgattatta ataattaatt agcatttaaa catgtattat 540 ttaagttctt tttaagttat aaagtctttg atttgctaaa cagtttaaat aatgaataaa 600 acataaaata ataatagtta ccattt 626 <210> SEQ ID NO 316 <211> LENGTH: 1113 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 316 caagagctgc atctcactcc aatttttctt ctccctataa ccttatctag attcccagtt 60 gagggaaccg atgacctaat tcctctcagt ttaaatgcaa cacaggagca aattccaaat 120 atctatgctg gtcttgctgg gattgcagaa ccccagggtg gttatcctcc tccagaggta 180 atcctgtgat cagcactaac rccacatacc agccctttca tcagcttgtt ggagaagcat 240 ctttacttcc caccaagcag tgacctagat accatctcac accagttaga atcaggatca 300 ttaaaaagtc aagaaaaaac agatgctgaa gaggatgtgg agaaatagga atgcttttac 360 actgttagtg ggaatgtaaa ttagttcaac cattgtcaaa gacagtgtgg cgatccctca 420 cagatctaga accagaaata ccatttgacc cagcaatccc attactgggt ctatacccaa 480 aggattataa attactctac tataaagaca catgcacaca tatgtttatt gcagcaccat 540 tcacaatagc aaagaattgc aaccaaccct aatgcccatc aatgacagac tggataaaga 600 aaatctggca catatacacc atggaatact acgcagccat aaaaaaggat gagtttatgt 660 cctttacagg gacatggatg aagctggaaa ccatcattct cagcaaacta acacaggaac 720 agaaaaccaa acacatgttc tcactcacaa gtgggagttg aacaatgaga acacatggac 780 acagggaggg gaacatcaca caccactgct tgtcaggggg tggggggcta ggggaaggat 840 agcattagga gaaataccta atgtagatga agggttgatg ggtgcagcaa accaccatgg 900 catgtgtata cctgtgtaac aaacctccat gttctgcacg tgtatcccag aacttaaagt 960 acaatacaaa aaaaaaaaaa agtgtaatcc agtttacatt ttcaaggtca aagtgggtac 1020 aatgctatct atcttgggct aagaagagaa aaggaaaaat tcttgcttta aatcttagaa 1080 gtctggtttt tttccctgtt ttgtacccca tcc 1113 <210> SEQ ID NO 317 <211> LENGTH: 1113 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 317 ttcccagttg agggaaccga tgacctaatt cctctcagtt taaatgcaac acaggagcaa 60 attccaaata tctatgctgg tcttgctggg attgcagaac cccagggtgg ttatcctcct 120 ccagaggtaa tcctgtgatc agcactaacg ccacatacca gccctttcat cagcttgttg 180 gagaagcatc tttacttccc rccaagcagt gacctagata ccatctcaca ccagttagaa 240 tcaggatcat taaaaagtca agaaaaaaca gatgctgaag aggatgtgga gaaataggaa 300 tgcttttaca ctgttagtgg gaatgtaaat tagttcaacc attgtcaaag acagtgtggc 360 gatccctcac agatctagaa ccagaaatac catttgaccc agcaatccca ttactgggtc 420 tatacccaaa ggattataaa ttactctact ataaagacac atgcacacat atgtttattg 480 cagcaccatt cacaatagca aagaattgca accaacccta atgcccatca atgacagact 540 ggataaagaa aatctggcac atatacacca tggaatacta cgcagccata aaaaaggatg 600 agtttatgtc ctttacaggg acatggatga agctggaaac catcattctc agcaaactaa 660 cacaggaaca gaaaaccaaa cacatgttct cactcacaag tgggagttga acaatgagaa 720 cacatggaca cagggagggg aacatcacac accactgctt gtcagggggt ggggggctag 780 gggaaggata gcattaggag aaatacctaa tgtagatgaa gggttgatgg gtgcagcaaa 840 ccaccatggc atgtgtatac ctgtgtaaca aacctccatg ttctgcacgt gtatcccaga 900 acttaaagta caatacaaaa aaaaaaaaaa gtgtaatcca gtttacattt tcaaggtcaa 960 agtgggtaca atgctatcta tcttgggcta agaagagaaa aggaaaaatt cttgctttaa 1020 atcttagaag tctggttttt ttccctgttt tgtaccccat cctcttggtc tctctagata 1080 tatttaagac tcacatagga cttgtctttt cta 1113 <210> SEQ ID NO 318 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 318 tcatcaacta aatagttgat gaggggaaat tgttctgtat atgttcatac ttcagctaat 60 caattaaaaa tgatgaaata ataagattac cattttgcaa acccctaatg caatgttgga 120 tccaggcaat gatcatcaat ggccactaaa atcacacaaa aggagataac cagaatatgt 180 gctttgtgat ggaagcatta aatacaacta atgagatatt gtttataaga aagaaaggaa 240 gcaagaaagc aatcacacca agctctgtat ctagctacca catttaagga aaaaaagaga 300 cagaagagca tgttaaatgt taccaagaag atacagtcag tcggaaaaaa tacagacaag 360 aaaatacaga gcaaaacaac ccagcttctt cagcaaatca atataaaaaa attttaagaa 420 agagttaaag tataaactga gagacttcag aaacatatta tccaagtata atccatgaat 480 cttgtttaaa tatagatcaa rtaaaccact ataccaaaaa catcaaaaga caactgggta 540 aattttttaa atgactagct atttgatgtt aaggaagtaa tgttactctc ttatatacaa 600 tttgaaataa tctagcgagg agcagcaaat gtgcggctat gaggaagaaa cacaattggc 660 cattcttgaa tcattagctg gatggtggct atatgggggt agattttact actctctaat 720 tttacatata tttaaaatgt tccataataa attgttgagt tatcaaaaga aatatttcta 780 tataatagct aaaattattt ataaaagtta gtggtctcat aactttattt atttatttac 840 ttattttgag accgagtctc cctctgttat gcaggctgga gtgcagtggc tccatctcgg 900 ctcactgcaa acttcacctc ctggattgaa gcgattctcc tgcctcagcc cccccgagta 960 gctgggatta caggcttgca cccccacgcc cagctaattt t 1001 <210> SEQ ID NO 319 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 319 agctaccaca tttaaggaaa aaaagagaca gaagagcatg ttaaatgtta ccaagaagat 60 acagtcagtc ggaaaaaata cagacaagaa aatacagagc aaaacaaccc agcttcttca 120 gcaaatcaat ataaaaaaat tttaagaaag agttaaagta taaactgaga gacttcagaa 180 acatattatc caagtataat ccatgaatct tgtttaaata tagatcaaat aaaccactat 240 accaaaaaca tcaaaagaca actgggtaaa ttttttaaat gactagctat ttgatgttaa 300 rgaagtaatg ttactctctt atatacaatt tgaaataatc tagcgaggag cagcaaatgt 360 gcggctatga ggaagaaaca caattggcca ttcttgaatc attagctgga tggtggctat 420 atgggggtag attttactac tctctaattt tacatatatt taaaatgttc cataataaat 480 tgttgagtta tcaaaagaaa tatttctata taatagctaa aattatttat aaaagttagt 540 ggtctcataa ctttatttat ttatttactt attttgagac cgagtctccc tctgttatgc 600 a 601 <210> SEQ ID NO 320 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 320 ccaactgatc taattagata aacttagtca atatatttga atcccacatt ccagcagcta 60 ttttctccat ttgcttttat tgctgtttgt ggtgagtttg atatataatt ttaaggtgtt 120 aacatcccta acttatgtat gggtacagct cataaatacg aacctgtgtc atgcaactca 180 tatatgactg tgttcaaaat aatgtgtatt agactgtaaa acgattttaa tattttaaat 240 aactttcctg catttgtcgg tttcagcagg aaagttattt ttaataactt ccctgtattt 300 sttggtttca gtattaatta atctcattaa tgctaaactt tgtgatccta ggttaaaaaa 360 catattcaag atagcttcag aatgtttggt atacaaatag gtctggctaa atataagtgt 420 tagctttctc aagcatctaa atgctggcgg gcttttaaaa aaccagggct ttaaggagaa 480 aacacctgct ctgtggtttt gtagcagata tgaagtattc aaatttctta ataaatagaa 540 aaagaaatat ataacagaaa caggttgcac ttgtctttct cattaagcag gtggttagta 600 c 601 <210> SEQ ID NO 321 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 321 agctcataaa tacgaacctg tgtcatgcaa ctcatatatg actgtgttca aaataatgtg 60 tattagactg taaaacgatt ttaatatttt aaataacttt cctgcatttg tcggtttcag 120 caggaaagtt atttttaata acttccctgt atttgttggt ttcagtatta attaatctca 180 ttaatgctaa actttgtgat cctaggttaa aaaacatatt caagatagct tcagaatgtt 240 tggtatacaa rtaggtctgg ctaaatataa gtgttagctt tctcaagcat ctaaatgctg 300 gcgggctttt aaaaaaccag ggctttaagg agaaaacacc tgctctgtgg ttttgtagca 360 gatatgaagt attcaaattt cttaataaat agaaaaagaa atatataaca gaaacaggtt 420 gcacttgtct ttctcattaa gcaggtggtt agtaccatta tttgcattct catagcctta 480 atatacattt tccttctcta g 501 <210> SEQ ID NO 322 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 322 ttttgagttt ctactttagt gtcttagtgc tttctcgata tgggagaatt catgtcctcc 60 attcagaagt atgcactaag taagaggtat catgtctggt tcttgattag gtactaatct 120 tgaaatatta tcctacaata ggttagagca cgtatatctc ctgataatat attgaatatg 180 atagatttaa ataattggtt aactaaatac taaagcaaat tgctgcacgt atcatttatt 240 attcattgtg tagaaagtgc ctgactcagt gtttggaaat tgtctgactt ttcctcatat 300 rtagtgtggt ttcatgttat tgtatataag acctgacatg aactctgttt acaataatct 360 cccagtgcca taaagaccat aataaataat ataaccaatt ggtttcttta tgctgtcatt 420 tattagggca tatggcatta gtggaggatt accttgtatt acccatagtg cttagagtat 480 gaatcacaca tgcaccttga aggaaaagag gtgcaatgta ataagaaacc agatattgaa 540 aatgcaagtt ttgttatgtt attctgggta tgttaacctt tattcctgcc ctccatatgc 600 a 601 <210> SEQ ID NO 323 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 323 aagaggtatc atgtctggtt cttgattagg tactaatctt gaaatactat cctacagtag 60 gttagagcac gtatatctcc tgataatata ttgaatatga tagatttaaa taattggtta 120 actaaatact aaagcaaatt gctgcacgta tcatttatta ttcattgtgt agaaagtgcc 180 tgactcagtg tttggaaatt gtctgacttt tcctcatata tagtgtggtt tcatgttatt 240 gtatataaga mctgacatga accctgttta caataatctc ccagtgccat aaagaccata 300 ataaataata taaccaattg gtttctttat gctgtcattt attagggcat atggcattag 360 tggaggatta ccttgtatta cccatagtgc ttagagtatg aatcacacat gcaccttgaa 420 ggaaaagagg tgcaatgtaa taagaaacca gatattgaaa atgcaagttt tgttatgtta 480 ttctgggtat gttaaccttt a 501 <210> SEQ ID NO 324 <211> LENGTH: 854 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 324 tttcagcact gagagccaga gtggaattgt ctccttcatt gccactgcct tcacgttttg 60 tgtgtcgtat ctgttttgtg atcactgaga cccaagaacc cccgacttgc cgacatacta 120 tgtggccccg agagaggact tgagctctct gggtttcatc attaccatca attaaataaa 180 caggacagta gcttcttcct tggattgtta atttaaggct ctggataata catgtaaccg 240 ccttatgata gagcagaatt gtaagtaggc tcatggtaga atcgttcaat gacatttccc 300 tttcctttgg gagaaacaga aattcacagg tctaattctt ttcctattaa tagttcctgr 360 ccattattcc agaactgtcc taaaggaatt ctttctcctt aaggacacca cctcccagga 420 gggtatttaa agatttgcac aggccgggca cggtggctca tgcttgtaat cccagcagtt 480 tgggaggcca aggcgggtgg atcacttgtg ctcaggggtt caagaccggc ctggccaaca 540 tggtgaaacc ctatctctac taaaaacaca aaagttagct gggcctggct atgcatgcct 600 gtaattccag ctactcggga ggctgaggct ggagaatagc ttgaaccagg gaggtggaga 660 taacagtgag ctgagatgcc actatgacac tccagcctgg gtgacagagc aagactctct 720 ctcaaaaaaa aaaaaagatt tttatagtcc agtattcaac gttcatagta cacctttctt 780 atcctagtaa atcttctttt atcaaggtat atgatcccat atagtagtta actcttactc 840 ttactttatg acaa 854 <210> SEQ ID NO 325 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 325 aaatacttac tattaaatat gagaaactgt ggtgtttatc ggtaagatcc acgaaggaag 60 aagttttaaa gaaaaatact ttaaccgtgg aaaaaaaaaa ctttaatgtc tattatcgaa 120 taggggccgt aattactttt gcaaaataaa aaaacaaaca agactagcta tagtgtaaat 180 gtaatctgta tgctttttaa tgaaacaatt aagtaggttg cccatttaca attagcctga 240 ttttctcctg ygtggtatta tgtgtactta acaacaggac ccagtggaaa ttcactcatt 300 taacaaagtc tgcctacatg gtttcaaata tgggcctaac ttgaaaattc agtcataatt 360 aaatctaagg actaaaacaa atctgtataa aaagattctg ctaaataagg gaaaattcaa 420 gtctagggct acattctgaa agatattgaa gtagaacctc tgcagcaaga ctaggcttgg 480 aaagtgcggg gaggagggaa a 501 <210> SEQ ID NO 326 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 326 ccacatcaga aacatgagga aattctacat ggtaaaaaca gcaacaacca aaaaatactt 60 aaagtcaaca aaccaggaaa agacatctct gaatatagga atgccaaacc tttaacacaa 120 taaaacacag attatatttc agaaggctat attatatgtg tataccaaca tcaatatgtc 180 cagagtagct gcacagagtt ccatatttta gtctttataa gttcccctcc tcaccctact 240 cagtaggcac tttgtgtcta gaaacttctg tgtcaacagt tttccctctc tctggaattc 300 mtcaggacag aagtgattgg tgtggtggaa gagggttgtg ctaagagtga agttatatga 360 aagtaggatg gaggttagca agtagttaaa gtccagaaag gcaataaggt gttaaggaag 420 aacttttcca ttttacaggt ctgagcaagc aggaaatcaa ctctacaaac tttgaaactt 480 ggtaaatatg aaaacattct caataccatt tgtcatttaa taaatacaaa ttatactatt 540 ttactgcttg catctagaag tttgtcaaag atctcgtctt aattattcat tgtgtcggcg 600 a 601 <210> SEQ ID NO 327 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 327 gacgagatct ttgacaaact tctagatgca agcagtaaaa tagtataatt tgtatttatt 60 aaatgacaaa tggtattgag aatgttttca tatttaccaa gtttcaaagt ttgtagagtt 120 gatttcctgc ttgctcagac ctgtaaaatg gaaaagttct tccttaacac cttattgcct 180 ttctggactt taactacttg ctaacctcca tcctactttc atataacttc actcttagca 240 caaccctctt ccaccacacc aatcacttct gtcctgatga attccagaga gagggaaaac 300 ygttgacaca gaagtttcta gacacaaagt gcctactgag tagggtgagg aggggaactt 360 ataaagacta aaatatggaa ctctgtgcag ctactctgga catattgatg ttggtataca 420 catataatat agccttctga aatataatct gtgttttatt gtgttaaagg tttggcattc 480 ctatattcag agatgtcttt tcctggtttg ttgactttaa gtattttttg gttgttgctg 540 tttttaccat gtagaatttc ctcatgtttc tgatgtggaa agtataagaa tatcagccag 600 a 601 <210> SEQ ID NO 328 <211> LENGTH: 811 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 328 taaataatct ctaattagta taatgggtgt tcttagtgca gtgggtactt ttaaagtgct 60 ttgtggcttt tgatgaaaat tgtcttagta tttaaaactt tttcttaccc aattttttgt 120 tcccatcgaa ttagcaatgc tgtaaagaaa ggcatcttat tccatttttt gttgctataa 180 aggaatactt gaggctgggt aatttataaa gatgaaaagt ttatttggct cgcaattctg 240 gatggctgga aggttaagta ctgggccaca gcatctggtg ggggcctcga gctgcttcta 300 gtcataatgg aaggtgaagg gtgtaaagat catgtgacaa gggaggaaag aagagaagga 360 aggaggtgct ggttctttct atcaaccaat tcgcaagaga actaatagag aaagaactca 420 cttagccctg tgggaacaca ttaatctatt cataagggat ctggctgtat gatacaaaca 480 cctcccatta ggccccacct ccaaattgta tcccattggg gatcaaattt caaaaagaga 540 tttggaagga acaaacaaac catatctaag ccatagtaaa aggaatggct tttcaaaggt 600 aaaatttact ragtgtatta atattttacc aatttccagc caggagagta tgaatgttgc 660 attattacat tgctttgaaa caaagcatta gtcttaattc agaagtttaa attcagatgt 720 taacgttgca tatttaataa tgcacaacca gtactaaaat cctcattgaa atgacaaata 780 attttatttc gaatccctta tagaggttca c 811 <210> SEQ ID NO 329 <211> LENGTH: 811 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 329 tgtcttagta tttaaaactt tttcttaccc aattttttgt tcccatcgaa ttagcaatgc 60 tgtaaagaaa ggcatcttat tccatttttt gttgctataa aggaatactt gaggctgggt 120 aatttataaa gatgaaaagt ttatttggct cgcaattctg gatggctgga aggttaagta 180 ctgggccaca gcatctggtg ggggcctcga gctgcttcta gtcataatgg aaggtgaagg 240 gtgtaaagat catgtgacaa gggaggaaag aagagaagga aggaggtgct ggttctttct 300 atcaaccaat tcgcaagaga actaatagag aaagaactca cttagccctg tgggaacaca 360 ttaatctatt cataagggat ctggctgtat gatacaaaca cctcccatta ggccccacct 420 ccaaattgta tcccattggg gatcaaattt caaaaagaga tttggaagga acaaacaaac 480 catatctaag ccatagtaaa aggaatggct tttcaaaggt aaaatttact aagtgtatta 540 atattttacc aatttccagc caggagagta tgaatgttgc attattacat tgctttgaaa 600 caaagcatta ktcttaattc agaagtttaa attcagatgt taacgttgca tatttaataa 660 tgcacaacca gtactaaaat cctcattgaa atgacaaata attttatttc gaatccctta 720 tagaggttca caatgtttta acaatgtagt tttgactaaa tagaagtagt caaaacctgt 780 cagattggaa atagtattta taaaacataa a 811 <210> SEQ ID NO 330 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 330 gctcatcaat tttgacttaa gaaaattcta gcaacattta tagattttgc caaaattcag 60 cttcttccca aatcaatcta taagaaggct cttccttaaa cataattttt atatctatga 120 actgcactag catttactat atatttttat cactctcacc attactggat aataaataaa 180 agctcattaa aagagttaac aaaacatatt tattttaggc atcctgaaaa aaagattcaa 240 ttttattatc atttctacaa taagtattga agaaaggaga atttaaatta cttcatatac 300 stgataaagg aaaacatatg caaggcaaat aaacatctta gatcatgaca tataaaataa 360 tagattatta ctaaagatta aaatactttc ttaagaatta aagcaattct aaaagcaata 420 gtaaataaca ttctttctag tgatcagaca ctggatacta tgtttgagat agacagtgaa 480 ttgggaatgt tgttttacag aagctcctac cttgcaagga caggcaagtt taaatgtcag 540 ctagaaaact atcttgagtt ttcagtaatg taagattttc ctattcaatt tcacacttta 600 a 601 <210> SEQ ID NO 331 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 331 agaaaattct agcaacattt atagattttg ccaaaattca gcttcttccc aaatcaatct 60 ataagaaggc tcttccttaa acataatttt tatatctatg aactgcacta gcatttacta 120 tatattttta tcactctcac cattactgga taataaataa aagctcatta aaagagttaa 180 caaaacatat ttattttagg catcctgaaa aaaagattca attttattat catttctaca 240 ataagtattg aagaaaggag aatttaaatt acttcatata cctgataaag gaaaacatat 300 rcaaggcaaa taaacatctt agatcatgac atataaaata atagattatt actaaagatt 360 aaaatacttt cttaagaatt aaagcaattc taaaagcaat agtaaataac attctttcta 420 gtgatcagac actggatact atgtttgaga tagacagtga attgggaatg ttgttttaca 480 gaagctccta ccttgcaagg acaggcaagt ttaaatgtca gctagaaaac tatcttgagt 540 tttcagtaat gtaagatttt cctattcaat ttcacacttt aaattttata tatatataaa 600 a 601 <210> SEQ ID NO 332 <211> LENGTH: 1110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 332 tgtagaagtt cttatcactt cctggccttt tggctaagat caagtgtgaa atgtagaagt 60 tcctctaagc tttacttccc tcaaaaacta gttttatctt gtcagcagga ttcacttaaa 120 aagacaaatt cagattatga atttttttct tttttacagg gtctgctctg ttgcccaggc 180 tggagtgcag aggcacaatc tcggctcact gcagcctccg cctcctgggt tcaagcaatt 240 ctcttgcctc agcctcccga gtaactggga ttacaggcat gtgccaccac ccagctaatt 300 tttgtatttt tagtagagat ggggtttcac cacattggtc aggctggtct cgaactgctg 360 gcctcaagtg atccacttgc ctcggcctcc caaagtgcag agattacagg tgtgagccac 420 cgtgcccagc ctcataaccg tttcaactac tttttcactt gacaagcaga tgtgaagtta 480 acaaagtcac ccatatttga aataaagata gtatattcct ggggyaggca gaggcagttg 540 aggatcatga aataactatg ttggcatagt tatttaggtg ttgatactgt tattatgcca 600 ttgaaagtta aacagagaac cctctgggta catgttttat accaatgcac actatcttat 660 tagtccctct cataatgtgc agtcatcatt actgttacgg gttgaggtgt ccccatcctc 720 tatgggacac ctctatgttg aagtctcaga ttccctagaa tctcagaatg tgaccttgtt 780 tggaaacaga tttgctacag acgcaattag ttgagatgcg cttatatggg taggtcctaa 840 ttcagtgact ggtgtcctta aaaaaatgga aatgtacaca cggtggtaga catgcataga 900 gggaagagag atggagaaaa tggtcaccta caagccaaag acaggggtct ggagcagatc 960 cttccctcac agccctcaga aggaaccaat cttgccaata ccttgatttt ggacttccac 1020 ctccagaact ataacacatt tctgttcttc aagcaatttg tagccatttg ttacagctaa 1080 tacaatcaca catagaaatg acttgtaaat 1110 <210> SEQ ID NO 333 <211> LENGTH: 691 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 333 taaaacatgt acccagaggg ttctctgttt aactttcaat ggcataataa cagtatcaac 60 acctaaataa ctatgccaac atagttattt catgatcctc aactgcctct gcctacccca 120 ggaatatact atctttattt caaatatggg tgactttgtt aacttcacat ctgcttgtca 180 agtgaaaaag tagttgaaac rgttatgagg ctgggcacgg tggctcacac ctgtaatctc 240 tgcactttgg gaggccgagg caagtggatc acttgaggcc agcagttcga gaccagcctg 300 accaatgtgg tgaaacccca tctctactaa aaatacaaaa attagctggg tggtggcaca 360 tgcctgtaat cccagttact cgggaggctg aggcaagaga attgcttgaa cccaggaggc 420 ggaggctgca gtgagccgag attgtgcctc tgcactccag cctgggcaac agagcagacc 480 ctgtaaaaaa gaaaaaaatt cataatctga atttgtcttt ttaagtgaat cctgctgaca 540 agataaaact agtttttgag ggaagtaaag cttagaggaa cttctacatt tcacacttga 600 tcttagccaa aaggccagga agtgataaga acttctacat tttaagttat tcacaagata 660 actattaatg aacctgaaat agtttgtaaa g 691 <210> SEQ ID NO 334 <211> LENGTH: 640 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 334 aaaccttttt cctgttttac tattactaaa ggtggcacaa cagcaacctc aacaactttg 60 caccatgcca acactgatgt ttacacccag cacagcattt ttggtctcta tttttattct 120 cctctgaatg taatgaggat tcctagatgg ctagccaatt cgaatattta aggcaactga 180 aagttagaat gtttctgaaa catagtgttg ttgccagaga gtacgaaagt tttcaagaat 240 atcgggcaat tctgaaagta caaagaagcc agattaaatg aaataacact ggcgaagttt 300 tagcaaggtg actctcatat aatgatcatt atcattacca cagttaaaag aaaagagttg 360 tttatgaaag gccatgtgtc tgcaatgaaa ctcaaaagag aaaagttaac aggtgcaara 420 ggtagtttta ttataaaagg agggtaggca acaagaatat gtttaatttt tcttcctttt 480 catgagtaag gacaagagtt tcatatatgt gaatattttt atttaatttt aagtagaaat 540 ctgtttttaa aatatgggta tatgcttatt tgtgtaagtg taagaaacag aagtaagtac 600 agcaaaccag aaataggcca aacactcctg agcataattt 640 <210> SEQ ID NO 335 <211> LENGTH: 919 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 335 tacacccagc acagcatttt tggtctctat ttttattctc ctctgaatgt aatgaggatt 60 cctagatggc tagccaattc gaatatttaa ggcaactgaa agttagaatg tttctgaaac 120 atagtgttgt tgccagagag tacgaaagtt ttcaagaata tcgggcaatt ctgaaagtac 180 aaagaagcca gattaaatga aataacactg gcgaagtttt agcaaggtga ctctcatata 240 atgatcatta tcattaccac agttaaaaga aaagagttgt ttatgaaagg ccatgtgtct 300 gcaatgaaac tcaaaagaga aaagttaaca ggtgcaaaag gtagttttat tataaaagga 360 gggtaggcaa caagaatatg tttaattttt cttccttttc atgagtaagg acaagagtkt 420 catatatgtg aatattttta tttaatttta agtagaaatc tgtttttaaa atatgggtat 480 atgcttattt gtgtaagtgt aagaaacaga agtaagtaca gcaaaccaga aataggccaa 540 acactcctga gcataatttt acttggtaga ttattcctga aacttaagga atcatctttg 600 aactcttttc ctcacttgac ttccaggatt caccatgcac ttgtgatttt cctttcattt 660 cactctccgt tcctcctcag tctttttttc tcccccaggt cttttttgtt catcttaaac 720 tctaaatttt agaatatccc aggggtctgc cttcggcctt ctcttttata tctacactgg 780 cctcatacat aatcttaacc aagtcattat tttaaatacc tacaatatac tgaaaacttc 840 taaatttgta ttttaattct tgacttcttc catacagtct agatttgtat gtccataggc 900 tgacatcatt ggctgatac 919 <210> SEQ ID NO 336 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 336 ttactaaata ttctccaaca aatatatact tagtatatac tattagtgat gcatgctttc 60 aaatatttgg actatatcaa tgaatgaaac aaaaaattat ttgcccttaa ggagcttaga 120 ttctaacaga tggattcaga tgatttttat gccttatttc gtaggtttaa aagagcaatg 180 gggaaaaggg aagaagagag ggattgaaaa tattgagaag gttgggagac ttagcaattt 240 taagtaaggt agtgagggta ggttttattg gcaaagtgat ttttcagcag agactgggaa 300 agatgaacgt ggtatcctgg aggaaagcct cccaggcaga gttaagctgc taacaaaagt 360 gcccttaggc tggagtgggc ttgtttgatt aaggaacaaa gaggtcagca tggttgcact 420 agagagaaaa aatcagatgg cgtaaggaga tgaaatcaga aagatacgag gctaggcaaa 480 ggggtactct atgtaatgaa yatgacctgg cagtactgac atctcctgag ggactgttag 540 aagtgcagac tcttgtatct tttctcaagt ctatgaaatc tagacttcat tttaacaaga 600 tgacccgata tttacataca cattaaagtt ccagaagcac tgatataaca cattgtaaga 660 tcgcacagga cttcaattct ttttctggtt tttagaggca gtcctttggg gtgttttgtg 720 tagagtataa tgacctgaaa tatctaggat cactctagct actatcttga ggaaagagtg 780 caataaggcg gaacagttca gaggcaatgg tggtcttcta aatgaaagac acacagcact 840 caaaccaggc agttgaggag ggatgggaag aagttgtcaa attctagaca tattttaaag 900 gtagtgtcca gagaatttcc ttagatgcgt aggaacatgg aggataggac atagggtgga 960 aataaacgaa ataaagaaac tgaagctgat tctgacattt t 1001 <210> SEQ ID NO 337 <211> LENGTH: 1576 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 337 atacctttta agtgacatcc tagtgaatct ccatttgtca cgagacctca agctttccag 60 ttctggcaca aagtgattac tcataccatc acttcaaaat gatgattatc ttcatttatt 120 ttagttatat tgaacaaaat atacatttaa aaaatctaat tactaaatat tctccaacaa 180 atatatactt agtatatact attagtgatg catgctttca aatatttgga ctatatcaat 240 gaatgaaaca aaaaattatt tgcccttaag gagcttagat tctaacagat ggattcagat 300 gatttttatg ccttatttcg taggtttaaa agagcaatgg ggaaaaggga agaagagagg 360 gattgaaaat attgagaagg ttgggagact tagcaatttt aagtaaggta gtgagggtag 420 gttttattgg caaagtgatt tttcagcaga gactgggaaa gatgaacgtg gtatcctgga 480 ggaaagcctc ccaggcagag ttaagctgct aacaaaagtg cccttaggct ggagtgggct 540 tgtttgatta aggaacaaag aggtcagcat ggttgcacta gagagaaaaa atcagatggc 600 gtaaggagat gaaatcagaa agatacgagg ctaggcaaag gggtactcta tgtaatgaac 660 atgacctggc agtactgaca tctcctgagg gactgttaga agtgcagact cttgtatctt 720 ttctcaartc tatgaaatct agacttcatt ttaacaagat gacccgatat ttacatacac 780 attaaagttc cagaagcact gatataacac attgtaagat cgcacaggac ttcaattctt 840 tttctggttt ttagaggcag tcctttgggg tgttttgtgt agagtataat gacctgaaat 900 atctaggatc actctagcta ctatcttgag gaaagagtgc aataaggcgg aacagttcag 960 aggcaatggt ggtcttctaa atgaaagaca cacagcactc aaaccaggca gttgaggagg 1020 gatgggaaga agttgtcaaa ttctagacat attttaaagg tagtgtccag agaatttcct 1080 tagatgcgta ggaacatgga ggataggaca tagggtggaa ataaacgaaa taaagaaact 1140 gaagctgatt ctgacatttt agacctaaaa tctcaactaa aagttgccaa gatgggaaaa 1200 actaggtgca tcttgtttgg tgagtggaaa tcagccttgt gaattaagac ttaaactgat 1260 gtctttaatc ccgtagaaat accatgaagg cagtagaaga tggctaaaga gaggtctaga 1320 ctgtaggtac aaatttaaaa gtcacttgca tttggatgct taaagtcagg atattgtgaa 1380 gtcaacagag gaataaataa atgcagagag gggaaagaaa aggcccatag actgagccat 1440 tgtctggttt atttacatat tagtatatat tttcttaaag atgtttgcta tataataatg 1500 agttacctaa agtgtgactt ttctaaattt atggggaatt ttctacattg tgttatggca 1560 ctactaaaaa taataa 1576 <210> SEQ ID NO 338 <211> LENGTH: 1275 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 338 gtaaaactaa ttataattaa aatcaaaata tttactgaac ctacttactc ctataatttg 60 cgttgctggt taaaacccag ctataaaaat tttgatcaaa aatttttatt ttgtaaatga 120 tctgacacag cataaatgtt aatcacattt ctttatttta tttgcagatt aatttgagta 180 atttgaaaaa ttattaatgt tacttaatta ctctcaacac cttacagtgt ctcctgtaag 240 cactattggt gatactgaat ttaagttaca tttaacaact atcagaaaat agtttttaaa 300 gtaaaaatta tgatttggag tttaccaact aaatcttgtt agctttcact gcctctattg 360 agaagagcag cagttcttat cttcctcctt tttcttcttt aattaacaag agattatttg 420 tatcatagcc ataaaatcag ttcaggtatt acatgaacga cacccctgac tgcaatggtg 480 tagtttattg tattagtcca ttttcatgct gctgataaag acatacataa gactgggtaa 540 tttataaaga aatagaagtt taacggactc acagttccat gtggctgggg aagcctcaca 600 atcatgatcg aaggcaaaag gcacatctta catggcaaca ggcaagagag aatgagagcc 660 aagtgaaagg agaaacccct tataaaacct tcagacctca tgagacttat tcactaccac 720 aagaacagta tgtgagaaac agtcccatga tccagttatc tcccactggg tccctcccac 780 cacacaaggg aattatggga actgcaattc aagatgaaat gtgggtggaa gcacaacgga 840 actatatcat gatcaaagca ttattgtttt ctctgataag ctgatctaga aagtgctgct 900 tgtgatcagc tttggtgacc atgatcagtg aaatggttaa ggaaatctac agattttgta 960 ggtttgtgcc ttgacagacg accggtatct gtttctcttt tcatgatgaa gtatctaaca 1020 aagctctgtc caaaattttg aatttctcgt taaawgcatc atgattatag aacagaggtt 1080 acaatcaatt attcagtcac acaatcactc tcatcagtca ttaaggtgca tacctggtgt 1140 tccagttatt cagtgtggta taacaaacta cctggaactt aatggcttga aatagtcacc 1200 attacattat gattgtccat tctctgcatc aataattagg atttggcaaa gagggaatgg 1260 tttgtttaca gacag 1275 <210> SEQ ID NO 339 <211> LENGTH: 1275 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 339 gtaaaactaa ttataattaa aatcaaaata tttactgaac ctacttactc ctataatttg 60 cgttgctggt taaaacccag ctataaaaat tttgatcaaa aatttttatt ttgtaaatga 120 tctgacacag cataaatgtt aatcacattt ctttatttta tttgcagatt aatttgagta 180 atttgaaaaa ttattaatgt tacttaatta ctctcaacac cttacagtgt ctcctgtaag 240 cactattggt gatactgaat ttaagttaca tttaacaact atcagaaaat agtttttaaa 300 gtaaaaatta tgatttggag tttaccaact aaatcttgtt agctttcact gcctctattg 360 agaagagcag cagttcttat cttcctcctt tttcttcttt aattaacaag agattatttg 420 tatcatagcc ataaaatcag ttcaggtatt acatgaacga cacccctgac tgcaatggtg 480 tagtttattg tattagtcca ttttcatgct gctgataaag acatacataa gactgggtaa 540 tttataaaga aatagaagtt taacggactc acagttccat gtggctgggg aagcctcaca 600 atcatgatcg aaggcaaaag gcacatctta catggcaaca ggcaagagag aatgagagcc 660 aagtgaaagg agaaacccct tataaaacct tcagacctca tgagacttat tcactaccac 720 aagaacagta tgtgagaaac agtcccatga tccagttatc tcccactggg tccctcccac 780 cacacaaggg aattatggga actgcaattc aagatgaaat gtgggtggaa gcacaacgga 840 actatatcat gatcaaagca ttattgtttt ctctgataag ctgatctaga aagtgctgct 900 tgtgatcagc tttggtgacc atgatcagtg aaatggttaa ggaaatctac agattttgta 960 ggtttgtgcc ttgacagacg accggtatct gtttctcttt tcatgatgaa gtatctaaca 1020 aagctctgtc caaaattttg aatttctcgt taaatgcatc atgattatag aacagaggtt 1080 acaatcaatt attcagtcac acaatcactc tcatcagtca ttaaggtgcr tacctggtgt 1140 tccagttatt cagtgtggta taacaaacta cctggaactt aatggcttga aatagtcacc 1200 attacattat gattgtccat tctctgcatc aataattagg atttggcaaa gagggaatgg 1260 tttgtttaca gacag 1275 <210> SEQ ID NO 340 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 340 gaaacaaaaa attgcttttt atatattgat atttttgcac ggatttctta ggattttcta 60 tgtacatgac catgtcatct gcaaatgaaa tagttttatt tctttatcaa tccggatgaa 120 tttattaaaa ttatcttgcc taatttccca aatagggcct ccatgttgaa cataagtggt 180 ggcaagggtg atctgttgct aatctcagtg gatgatattc agtgttttac aatgatcttc 240 gacagctctg gctgttaaat tatcatagtc tgtatggcct aaacaaacaa aatacttatg 300 attatggggg aggctgggat atccaagatc aagttgctgg caggtctagc aacctgccac 360 tgggaagccc tgcttcccag ttttcagatg gccaccttct tatagtatct tcaccaaaga 420 tagggcagag agagcaagca agctctctac cttctcatat aagggcacta atcccaccat 480 gaaggcgcca ctgtcatgac stgattatgt cacaaagacc ccggggcaaa tattaccact 540 gtgaggagta cagttttagc atgtgaattt tggaagaaca caaacattta gtacagagtg 600 actattaagt atgttattaa ctatggagtt tttgtaggca ttttttaaca cattgagaaa 660 gtttcctcta ttcctacttt tgttgagaag tttttatgat gacaaggcat tacattttat 720 ccaatgactt ttctgtgtgt attgagatga ctgatttgtt ctgccaattt aaatccattg 780 ttgattctct ctaggatttt ttttatttca gttattaaat ttttcaacag gagaattact 840 gtcttgttct tttttttgta atttctgtcc ccttactggt attccatatt taataaggca 900 tcataatagt actcttcttt agtttcttaa agatggtttt ctttagtttt taacatattt 960 atgtctattt agaagtcttt gttaagtctg acatctgagc t 1001 <210> SEQ ID NO 341 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 341 ggatttctta ggattttcta tgtacatgac catgtcatct gcaaatgaaa tagttttatt 60 tctttatcaa tccggatgaa tttattaaaa ttatcttgcc taatttccca aatagggcct 120 ccatgttgaa cataagtggt ggcaagggtg atctgttgct aatctcagtg gatgatattc 180 agtgttttac aatgatcttc gacagctctg gctgttaaat tatcatagtc tgtatggcct 240 aaacaaacaa aatacttatg attatggggg aggctgggat atccaagatc aagttgctgg 300 caggtctagc aacctgccac tgggaagccc tgcttcccag ttttcagatg gccaccttct 360 tatagtatct tcaccaaaga tagggcagag agagcaagca agctctctac cttctcatat 420 aagggcacta atcccaccat gaaggcgcca ctgtcatgac ctgattatgt cacaaagacc 480 ccggggcaaa tattaccact stgaggagta cagttttagc atgtgaattt tggaagaaca 540 caaacattta gtacagagtg actattaagt atgttattaa ctatggagtt tttgtaggca 600 ttttttaaca cattgagaaa gtttcctcta ttcctacttt tgttgagaag tttttatgat 660 gacaaggcat tacattttat ccaatgactt ttctgtgtgt attgagatga ctgatttgtt 720 ctgccaattt aaatccattg ttgattctct ctaggatttt ttttatttca gttattaaat 780 ttttcaacag gagaattact gtcttgttct tttttttgta atttctgtcc ccttactggt 840 attccatatt taataaggca tcataatagt actcttcttt agtttcttaa agatggtttt 900 ctttagtttt taacatattt atgtctattt agaagtcttt gttaagtctg acatctgagc 960 tctctcaaag tttctgctga tttttttttt cctatgtttg g 1001 <210> SEQ ID NO 342 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 342 ggaaaccctg gcctcttgat cacactttcc tggagtttag tcccctctgc aatatgtacc 60 tgggagtcat aagaaatgcc agttacaaaa acttcctgta cagatatcct agcactcaac 120 tggaaaccgg ggagagtcac aattctgtct ttccagccat atgtaactga aatggagatc 180 ttttcaccct gagccagggg tgatgggaaa gggagctggt catggctcaa tgtttagcct 240 tttcttggtc ttcaagattt catagacatt cttaaataca tgtttctttc aatgaagttt 300 gcccttagga caattcacag ctacattagg tactttttaa ataatacttt tgaccatccg 360 tggttatttc attgaagaaa atctatagag cacctcagcc atcattccag aagtgactat 420 cctcctcagt aatggttctt attctaattt taaatatcat tgatgtagaa cattctattt 480 cactattcct tcattttatt rttatgggaa attatataca gttctccaga tttttaaagc 540 cttgctaaca tgttttaagt cacacaaata ttcttctgtg ggaaaatgac agtaatttag 600 tgtgcaacaa ttatatagaa ctatttttca aacttataaa cgaagtgaaa ttctaaataa 660 aatcatttat caaacacaaa aatttgagcc agaataagga a 701 <210> SEQ ID NO 343 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 343 aatgccagtt acaaaaactt cctgtacaga tatcctagca ctcaactgga aaccggggag 60 agtcacaatt ctgtctttcc agccatatgt aactgaaatg gagatctttt caccctgagc 120 caggggtgat gggaaaggga gctggtcatg gctcaatgtt tagccttttc ttggtcttca 180 agatttcata gacattctta aatacatgtt tctttcaatg aagtttgccc ttaggacaat 240 tcacagctac attaggtact ttttaaataa tacttttgac catccgtggt tatttcattg 300 aagaaaatct atagagcacc tcagccatca ttccagaagt gactatcctc ctcagtaatg 360 gttcttattc taattttaaa tatcattgat gtagaacatt ctatttcact attccttcat 420 tttattatta tgggaaatta tatacagttc tccagatttt taaagccttg ctaacatgtt 480 ttaagtcaca caaatattct yctgtgggaa aatgacagta atttagtgtg caacaattat 540 atagaactat ttttcaaact tataaacgaa gtgaaattct aaataaaatc atttatcaaa 600 cacaaaaatt tgagccagaa taaggaatgt aaattacaat ttaaacacag attataaact 660 atcttacttt taaaatgtta aaattcctaa cttgtttgaa a 701 <210> SEQ ID NO 344 <211> LENGTH: 768 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 344 ctaaaatcta ccattatatg atatccttcc caatacataa attaaaaaaa aaaacactgt 60 agaggaaaaa gcaatatttt gaaatgatat gcttttcttt gtttgtcttc aaacaattac 120 atcttcatca taatggttgt attagtctgt ttttacactg ctataaagaa ttgcctgaga 180 ctgagtaaca tataaagaaa aaagttttaa ttgaccacag tttcacaggc ttaataggaa 240 gcatgactgg gaaacttaga atcatggcag aagaggaagg ggaagcaagg atcttcttca 300 catggtagca ggagagagag cacaaagggg gacacgctac acactttcaa acaacgagat 360 ctcctgagaa ctctatcggg agaacagcaa gagggaagtt cacccctatg attcaatcag 420 ctcccaccgg gcttctcccc tgacacatga ggaattacaa ttggatgaga gatttgggtg 480 gggacacaca gacaaaccat atcaactgtc atggacttaa acaattgtct ttgaattgtc 540 ttttttcata cttttatttg catctttyca ctaaaaagat gacacaaagt aatcctagtt 600 tacatttttt accatgtaat tccatattac tttttcctga aagttactta tttttaaatc 660 tcaaagctct tcatacttat ggtttgatct gcacttacaa ctggatctca gaaagattga 720 attctcccat cataccaagt tcatgtctct cactcttaat atttgttc 768 <210> SEQ ID NO 345 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 345 aaatgatatg cttttctttg tttgtcttca aacaattaca tcttcatcat aatggttgta 60 ttagtctgtt tttacactgc tataaagaat tgcctgagac tgagtaacat ataaagaaaa 120 aagttttaat tgaccacagt ttcacaggct taataggaag catgactggg aaacttagaa 180 tcatggcaga agaggaaggg gaagcaagga tcttcttcac atggtagcag gagagagagc 240 acaaaggggg acacgctaca cactttcaaa caacgagatc tcctgagaac tctatcggga 300 gaacagcaag agggaagttc acccctatga ttcaatcagc tcccaccggg cttctcccct 360 gacacatgag gaattacaat tggatgagag atttgggtgg ggacacacag acaaaccata 420 tcaactgtca tggacttaaa caattgtctt tgaattgtct tttttcatac ttttatttgc 480 atcttttcac taaaaagatg rcacaaagta atcctagttt acatttttta ccatgtaatt 540 ccatattact ttttcctgaa agttacttat ttttaaatct caaagctctt catacttatg 600 gtttgatctg cacttacaac tggatctcag aaagattgaa ttctcccatc ataccaagtt 660 catgtctctc actcttaata tttgttccca agacaacaat t 701 <210> SEQ ID NO 346 <211> LENGTH: 6758 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 346 agagtgggcc attgttctga ctagtctggg gctccccaaa gaactggtat ctgtctcacc 60 tgactcagaa caatgataag gctgtagatc tttttggaag tctatgaaaa caggcacaat 120 gaaggcagca tgttagagat ataattccac aggaagatgc caggtaaaac aaaagagaaa 180 aagcaggaac aagctgatta ggaaatttgt gatgactaaa agtatataca caagcccaaa 240 taagatactc caaagatgtt tgataggttc tagatctcta gatatactgc tcaatgaaag 300 tgtccccctg aacaaagcca gtctgcaaag actgggtgag atgatttttt ttaaatgtca 360 agtctcagca acaacaaaaa tgacaagaca tgcacagaag caagaaaata taacacaatc 420 aaagaaaaaa aagccacaga aatcagtcct agagaaaacy gatctatgag ctgcctgaca 480 ataattataa aataactatc ataaaaatgc ccagtgagat ataagaaaac acagacaact 540 aaatgaatca ggaaaatgat gcatgaacaa aatgggcata tcaacagaga tggaaatgac 600 aaagataaac aaacagaaat tttggagctt aaaaatacag taagtaaagt gaataattca 660 ctaaaaatat tcaatagcag actagatcag gcagaagaaa atatcaatga acttgaagac 720 agatcatcaa gtcagaggaa caacagcaac aaaaaagaat gaaaaaagtg aagacagcct 780 aagggactta ggagtcagta ccaaggaaat caatatatac gttatagatg tatcagaaga 840 aaaagggaga aaaatgaaaa gaaagcatat ttgaaaaaat aatagctgaa gaattctcaa 900 tttcaaagag agaaattgat atacaaattc aagaagttca aaagactcta gccataataa 960 atctaaagag actcacacta agacatatta tcatcaaact gtcaaaatca aagacaaaga 1020 attgtgaaat ctgccaagga aaagtgactc atcacacata agagatataa cataagattg 1080 tcacaggatt tctgaacaga cactttgcag gtcagaggga agtagggtga catattccag 1140 gtgctgaaag aagaaaacac cctgccaacc aagaatatgg catccagaaa aactttccta 1200 gaagaatgaa ggagaaattt agactttccc aaataaacaa aagctgaggg agttcattac 1260 taccagacct gctctgcaaa atgctaaaga gaaaccttca ggtgaaacaa aaagatgcta 1320 gacagtaaca caaaaccact cataaataac ttcttcagta aaaataatac atcgacaaat 1380 atggtaacct gtattaatac tggtgcacaa attcactttc aaattttata aataagaatt 1440 taaaggatga aaacatctaa aactaactat aaatctatat aatgaatata caatatataa 1500 aaaaatttgt gatcacaata acataaaatg ggggaggtag agctgtatag gggtagagct 1560 tttgtatgca attgaaatta ccatcagttt aaactgaact gttataacat taagatgttt 1620 tatgtaattg caatggtaac tatattctat agaatatatt aaaaagaaaa agaaaatagg 1680 aagggaatca aagcatgtcc ttgtaaaaaa gtcaatgaaa gcaaaagaaa ggcagaaaga 1740 gtgaaaagga ggaataaaaa gttataagac ataaaaaaaa tgaaaatagt aatagtcctg 1800 ccatatcagt aattacatta aatataaatg gattaaactc cctaatcaaa tcatagattg 1860 gtttgcaaga actaacttta caattaaaga cacacagctg acggtgaagg gagaaaaaaa 1920 acttccatgc agtgaccaaa atagaggagg gtggctgtat tactgtcaga caaaataaaa 1980 tttaagtcaa aaactgttac aagagtaaaa gaagggcatt atacagttaa aaaagtaaat 2040 tcgccaggca gacacaacaa ttataaatat caatacataa aaataagagc tcctaaatat 2100 atgcagcaaa cagacataat tgaagaaaga aataaatagc taaaatggta gaagacttta 2160 atacccccac ttacaataat gtataaaata acaagacaga atgtaaataa aaatgtagag 2220 aatttgagca acactgtaga ccaattggac ctaataaata tactcagaat aatccatcca 2280 accaaagcag aaacagaata tacattcttt tcaagtacac atttgacatt ctctgggatt 2340 aactacatgt tatgcaacaa acaagtctca acaatgttta aaagtctgat attacacaaa 2400 gtattgtttc tgatgacgat ggaaagaacc tagaagccaa tagcaaaaag aaaatagaaa 2460 atccacacat atgtggaaat taaactacat gcaattaagc aaagggccaa agaagaagaa 2520 gaaaaaagaa aacaccgtga aacaaataaa aacaaaaata cagcatatga aaatgcatgg 2580 gatgcagcaa aagtgatggt aagagaaatg tttatagtta taaatgcaaa ccttaaaaaa 2640 gaagaaagaa aacaaaaata ctcaaattaa caactttaca agtcaagaag gtagagaaaa 2700 aagaacaaac tataccaaaa gctaacacag aaagaaaaga ataaagatta aaaacaaaaa 2760 caatttaaaa aatagcagaa ctaaaagttg gttctttgaa aagatcaaca gaattgacaa 2820 tttcttagct acattaagaa aaatacaaga ctcaaataac acaaatcagt ggtgaaaggg 2880 ggtattataa ctgatgccac agaaatacaa aaggatcata agggactact acaaattgta 2940 tgacaacaaa ttgagtaacc taggatacct tgataaattc caaaaaatgc acaatatact 3000 gaatcatgaa tacatgaccc ttataaatca agactaaatc ataaagaaat agaaaatatc 3060 aacagaccaa taattagtaa ggagaataaa ctagtaatca gaaacctccc aacaaagaaa 3120 agcttaggac caaatggctt tactggagaa ttctaccaac cattaaaagg ataattaaga 3180 ccaatcttcc tcaaactttt aaaacaaatg ttaaagagga ggaaactctt tcaatctcat 3240 tcataaggtc agcattatcc ttataccaaa accagacaaa gacactatta aaaaaactta 3300 gaccaatatc cctgatgaat ttcgatgcaa gaatcctcag caaaatacta tcaaacaatt 3360 caacagcata cttaaatgat tatatgctgt aatcaagatg catttattct ttgaatgcaa 3420 gtgtaattca acacataaaa ttcaatcaat gtaatacacc acattaacag aatgagagac 3480 aaaaaccaca taattatatc aactgatgca gaaaaaaatc tgacacagtt caacaccttt 3540 tgtgataaaa acactcaaca aactaggaaa agaaggaaac aactttaaca catcatatgc 3600 tcactgatga aaatctacaa gttctttata aaagatcagg aacaagacaa taatctgcat 3660 tgttaccact tctattatac gtagtattgg aagttctaat cagagcaaat taggcaagaa 3720 aaataaataa aaggcatcca aagtggaaag gaagtaaaat aatctctttt tacagatgat 3780 ataaccttag aattagaaaa tcctaaaaat ttcacatacc aagaaaaagc gtgttaaaat 3840 taataagtaa attcagcaag ttgactgata caaaatcaac acagaaagct cagttgtgtg 3900 tctgtgtgtc tcatacacta acaatgaaca atctgaaaag gagattaaga aaacaatttc 3960 atttacaata gcatcaggaa aaaaaataaa tacttaggaa caaacttaac caaggggttg 4020 gaattcctgt atactgaaaa ctacaaatat tgccaaaaga aaataaagga gacacaaata 4080 agtgatatgt ttttaatatg tccacccaaa gtgatcttca gattcaatga aatccctatc 4140 aaagttataa tggcattttt ctgcaggaat gtaaaaattt atcctaaaat tcatatagaa 4200 tctctaggta ccctgagggc caaacaattt tgagaaaaaa aaaagaacaa aattggagga 4260 ctcacacttc cagattacaa gaatatttac aaattacata tttacaaaaa aaattacaaa 4320 gccacaataa tcaaaacaac gtgggatttg cataaaggca gatatataga ccagtggaat 4380 agtattgaga gtccagaaat aaacccttag gtatatcatc aaatgacatt tgacaaagtg 4440 ctggtaccac tcaatgggaa tgggacaatt tgttcaacaa atagagcaaa gaaaactaaa 4500 catccatgtg caaaagaata aatctggacc cttatattac actatagaca aaattaattc 4560 aaaatggatt aaagatctaa atgaaagatc taaaactata aaactcctag gagaaaacag 4620 aggaaaaatt tcatgctaat ttggcaacat tttgtgatgt gacaccaaaa gcagagtcaa 4680 taaaagcaaa aattagacag atggaaatcc atcatagttt ataacttttg gtcattaaag 4740 aacagtcaac agagtgaaaa ggcaatctat aaaatggggg aaaaacagaa aatatgtgca 4800 aatcacagat atctgatagg ggattcatat ccagaataaa taaagaactc ctatatctca 4860 acaacaaaaa atctaatcca atcaaaaaat gggccaaggg agtgaagata catttctcca 4920 aagatgttat acaaatggcc aggaagcata tgaaaagatg ttcaatgtca ctaatcatca 4980 gagaaatgca aatcaaaacc acagtgcaat atcacttcac attcattaga atggcttctg 5040 tcatgaacaa cagaaaataa caagtgttga tgagtgtgta gagaaattga gacctttata 5100 taattttggc agaaattcaa aatggtgcaa ccactataaa aaatgatatg gaggtcctca 5160 aaaaattaaa aatagaacta ccatatgatc cacaatccca cctctgggta catattcaaa 5220 agaattgaaa gcagggtgtt gaagatatat ttgcacactc tttatagcag cactgttcac 5280 aatagccaag agatgaaagt aacccaaagg ttcatgaagc aatgaataaa caaaatatat 5340 tatgtacata gagtaaaata ctgtgcagct ttaaagagaa aggaaatctt atactatgct 5400 acaacatgaa tggaacttta gggcattata gtaagtaaaa taagccagtt ttttttaaag 5460 gacaaataaa cactatacga ttctacttaa gtatttaatg ttgtcaaatt tataaatata 5520 gaatgtagaa tagtggttac cctgagctgg gggaaagggg caaaggggaa ttgttatttt 5580 aatgggtata gtttcagttc tgcaaaatga aaaggttctg gaaatctgtt tcacaatgtt 5640 gtaaatataa ttactctgaa attgtacact taaaaatggt taagatgaca aatagagttg 5700 tgatgtcttc ttttgttatt atatagaaaa actttttcat atgataatag tctttgtttt 5760 taagctgact ttgctgatat taatataatc cttccatttt tctttaaaat gctatatgct 5820 ttcacataat tttgctttac gttgatgtat ttatacataa ggtgggtttc ttatagatac 5880 cacgttgtgt gtctttttta tctaagttga tagacttgcc ttttgttagg gtatttaaat 5940 aatttatatt taatgtaatt attgatatag ttgagtgtgt tgatttttgt tttctatttg 6000 ctccatctgt tgttggttct cattattcct ctgtttctac cttcttttgt actaattatt 6060 atattttatt atttttcatc tcaactgttg gcttattagc cacattgctt ttaaaatttt 6120 taatgattgc tctagggttt ataataaaca aaatgttagc attttctacc atcaaatatt 6180 tttacactat tcatgtatac ttcaatttct ttcttcccat cctttgaact atatcttcat 6240 acattttact ctacatttgt tataactcag tgctttgaaa gtcaattatt tttgtctttg 6300 acagtcaatg atttttaaag agtttaacag tgaaaaaaaa tggctttcat ctttttccat 6360 tagatttcat actccttctg cctgaagaat ttcttttaat agaccttgta ctgcgggtct 6420 caggcaagaa attctctcag cctttgttgg tttgaaaaac tgcttattac acctttgttt 6480 ttgaaagata ttttcactag gtatagaagt ctgggttgac agttctcatt gtttgtcaca 6540 gcatttttaa gatgcccatt caattgtctt gtcttgtata attttggatt agtctggtgt 6600 atttcttacc tttgttcctc tctgtgcaat gcttcaacca tcccacttca ggctgccttt 6660 aagatgtttt cttttccctt aatctttagt ttttagctgg ttgacagtga cgcatctaag 6720 tgtagtgtat gaggttgctt ttattgtcac tgttgttg 6758 <210> SEQ ID NO 347 <211> LENGTH: 6758 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 347 agagtgggcc attgttctga ctagtctggg gctccccaaa gaactggtat ctgtctcacc 60 tgactcagaa caatgataag gctgtagatc tttttggaag tctatgaaaa caggcacaat 120 gaaggcagca tgttagagat ataattccac aggaagatgc caggtaaaac aaaagagaaa 180 aagcaggaac aagctgatta ggaaatttgt gatgactaaa agtatataca caagcccaaa 240 taagatactc caaagatgtt tgataggttc tagatctcta gatatactgc tcaatgaaag 300 tgtccccctg aacaaagcca gtctgcaaag actgggtgag atgatttttt ttaaatgtca 360 agtctcagca acaacaaaaa tgacaagaca tgcacagaag caagaaaata taacacaatc 420 aaagaaaaaa aagccacaga aatcagtcct agagaaaact gatctatgag ctgcctgama 480 ataattataa aataactatc ataaaaatgc ccagtgagat ataagaaaac acagacaact 540 aaatgaatca ggaaaatgat gcatgaacaa aatgggcata tcaacagaga tggaaatgac 600 aaagataaac aaacagaaat tttggagctt aaaaatacag taagtaaagt gaataattca 660 ctaaaaatat tcaatagcag actagatcag gcagaagaaa atatcaatga acttgaagac 720 agatcatcaa gtcagaggaa caacagcaac aaaaaagaat gaaaaaagtg aagacagcct 780 aagggactta ggagtcagta ccaaggaaat caatatatac gttatagatg tatcagaaga 840 aaaagggaga aaaatgaaaa gaaagcatat ttgaaaaaat aatagctgaa gaattctcaa 900 tttcaaagag agaaattgat atacaaattc aagaagttca aaagactcta gccataataa 960 atctaaagag actcacacta agacatatta tcatcaaact gtcaaaatca aagacaaaga 1020 attgtgaaat ctgccaagga aaagtgactc atcacacata agagatataa cataagattg 1080 tcacaggatt tctgaacaga cactttgcag gtcagaggga agtagggtga catattccag 1140 gtgctgaaag aagaaaacac cctgccaacc aagaatatgg catccagaaa aactttccta 1200 gaagaatgaa ggagaaattt agactttccc aaataaacaa aagctgaggg agttcattac 1260 taccagacct gctctgcaaa atgctaaaga gaaaccttca ggtgaaacaa aaagatgcta 1320 gacagtaaca caaaaccact cataaataac ttcttcagta aaaataatac atcgacaaat 1380 atggtaacct gtattaatac tggtgcacaa attcactttc aaattttata aataagaatt 1440 taaaggatga aaacatctaa aactaactat aaatctatat aatgaatata caatatataa 1500 aaaaatttgt gatcacaata acataaaatg ggggaggtag agctgtatag gggtagagct 1560 tttgtatgca attgaaatta ccatcagttt aaactgaact gttataacat taagatgttt 1620 tatgtaattg caatggtaac tatattctat agaatatatt aaaaagaaaa agaaaatagg 1680 aagggaatca aagcatgtcc ttgtaaaaaa gtcaatgaaa gcaaaagaaa ggcagaaaga 1740 gtgaaaagga ggaataaaaa gttataagac ataaaaaaaa tgaaaatagt aatagtcctg 1800 ccatatcagt aattacatta aatataaatg gattaaactc cctaatcaaa tcatagattg 1860 gtttgcaaga actaacttta caattaaaga cacacagctg acggtgaagg gagaaaaaaa 1920 acttccatgc agtgaccaaa atagaggagg gtggctgtat tactgtcaga caaaataaaa 1980 tttaagtcaa aaactgttac aagagtaaaa gaagggcatt atacagttaa aaaagtaaat 2040 tcgccaggca gacacaacaa ttataaatat caatacataa aaataagagc tcctaaatat 2100 atgcagcaaa cagacataat tgaagaaaga aataaatagc taaaatggta gaagacttta 2160 atacccccac ttacaataat gtataaaata acaagacaga atgtaaataa aaatgtagag 2220 aatttgagca acactgtaga ccaattggac ctaataaata tactcagaat aatccatcca 2280 accaaagcag aaacagaata tacattcttt tcaagtacac atttgacatt ctctgggatt 2340 aactacatgt tatgcaacaa acaagtctca acaatgttta aaagtctgat attacacaaa 2400 gtattgtttc tgatgacgat ggaaagaacc tagaagccaa tagcaaaaag aaaatagaaa 2460 atccacacat atgtggaaat taaactacat gcaattaagc aaagggccaa agaagaagaa 2520 gaaaaaagaa aacaccgtga aacaaataaa aacaaaaata cagcatatga aaatgcatgg 2580 gatgcagcaa aagtgatggt aagagaaatg tttatagtta taaatgcaaa ccttaaaaaa 2640 gaagaaagaa aacaaaaata ctcaaattaa caactttaca agtcaagaag gtagagaaaa 2700 aagaacaaac tataccaaaa gctaacacag aaagaaaaga ataaagatta aaaacaaaaa 2760 caatttaaaa aatagcagaa ctaaaagttg gttctttgaa aagatcaaca gaattgacaa 2820 tttcttagct acattaagaa aaatacaaga ctcaaataac acaaatcagt ggtgaaaggg 2880 ggtattataa ctgatgccac agaaatacaa aaggatcata agggactact acaaattgta 2940 tgacaacaaa ttgagtaacc taggatacct tgataaattc caaaaaatgc acaatatact 3000 gaatcatgaa tacatgaccc ttataaatca agactaaatc ataaagaaat agaaaatatc 3060 aacagaccaa taattagtaa ggagaataaa ctagtaatca gaaacctccc aacaaagaaa 3120 agcttaggac caaatggctt tactggagaa ttctaccaac cattaaaagg ataattaaga 3180 ccaatcttcc tcaaactttt aaaacaaatg ttaaagagga ggaaactctt tcaatctcat 3240 tcataaggtc agcattatcc ttataccaaa accagacaaa gacactatta aaaaaactta 3300 gaccaatatc cctgatgaat ttcgatgcaa gaatcctcag caaaatacta tcaaacaatt 3360 caacagcata cttaaatgat tatatgctgt aatcaagatg catttattct ttgaatgcaa 3420 gtgtaattca acacataaaa ttcaatcaat gtaatacacc acattaacag aatgagagac 3480 aaaaaccaca taattatatc aactgatgca gaaaaaaatc tgacacagtt caacaccttt 3540 tgtgataaaa acactcaaca aactaggaaa agaaggaaac aactttaaca catcatatgc 3600 tcactgatga aaatctacaa gttctttata aaagatcagg aacaagacaa taatctgcat 3660 tgttaccact tctattatac gtagtattgg aagttctaat cagagcaaat taggcaagaa 3720 aaataaataa aaggcatcca aagtggaaag gaagtaaaat aatctctttt tacagatgat 3780 ataaccttag aattagaaaa tcctaaaaat ttcacatacc aagaaaaagc gtgttaaaat 3840 taataagtaa attcagcaag ttgactgata caaaatcaac acagaaagct cagttgtgtg 3900 tctgtgtgtc tcatacacta acaatgaaca atctgaaaag gagattaaga aaacaatttc 3960 atttacaata gcatcaggaa aaaaaataaa tacttaggaa caaacttaac caaggggttg 4020 gaattcctgt atactgaaaa ctacaaatat tgccaaaaga aaataaagga gacacaaata 4080 agtgatatgt ttttaatatg tccacccaaa gtgatcttca gattcaatga aatccctatc 4140 aaagttataa tggcattttt ctgcaggaat gtaaaaattt atcctaaaat tcatatagaa 4200 tctctaggta ccctgagggc caaacaattt tgagaaaaaa aaaagaacaa aattggagga 4260 ctcacacttc cagattacaa gaatatttac aaattacata tttacaaaaa aaattacaaa 4320 gccacaataa tcaaaacaac gtgggatttg cataaaggca gatatataga ccagtggaat 4380 agtattgaga gtccagaaat aaacccttag gtatatcatc aaatgacatt tgacaaagtg 4440 ctggtaccac tcaatgggaa tgggacaatt tgttcaacaa atagagcaaa gaaaactaaa 4500 catccatgtg caaaagaata aatctggacc cttatattac actatagaca aaattaattc 4560 aaaatggatt aaagatctaa atgaaagatc taaaactata aaactcctag gagaaaacag 4620 aggaaaaatt tcatgctaat ttggcaacat tttgtgatgt gacaccaaaa gcagagtcaa 4680 taaaagcaaa aattagacag atggaaatcc atcatagttt ataacttttg gtcattaaag 4740 aacagtcaac agagtgaaaa ggcaatctat aaaatggggg aaaaacagaa aatatgtgca 4800 aatcacagat atctgatagg ggattcatat ccagaataaa taaagaactc ctatatctca 4860 acaacaaaaa atctaatcca atcaaaaaat gggccaaggg agtgaagata catttctcca 4920 aagatgttat acaaatggcc aggaagcata tgaaaagatg ttcaatgtca ctaatcatca 4980 gagaaatgca aatcaaaacc acagtgcaat atcacttcac attcattaga atggcttctg 5040 tcatgaacaa cagaaaataa caagtgttga tgagtgtgta gagaaattga gacctttata 5100 taattttggc agaaattcaa aatggtgcaa ccactataaa aaatgatatg gaggtcctca 5160 aaaaattaaa aatagaacta ccatatgatc cacaatccca cctctgggta catattcaaa 5220 agaattgaaa gcagggtgtt gaagatatat ttgcacactc tttatagcag cactgttcac 5280 aatagccaag agatgaaagt aacccaaagg ttcatgaagc aatgaataaa caaaatatat 5340 tatgtacata gagtaaaata ctgtgcagct ttaaagagaa aggaaatctt atactatgct 5400 acaacatgaa tggaacttta gggcattata gtaagtaaaa taagccagtt ttttttaaag 5460 gacaaataaa cactatacga ttctacttaa gtatttaatg ttgtcaaatt tataaatata 5520 gaatgtagaa tagtggttac cctgagctgg gggaaagggg caaaggggaa ttgttatttt 5580 aatgggtata gtttcagttc tgcaaaatga aaaggttctg gaaatctgtt tcacaatgtt 5640 gtaaatataa ttactctgaa attgtacact taaaaatggt taagatgaca aatagagttg 5700 tgatgtcttc ttttgttatt atatagaaaa actttttcat atgataatag tctttgtttt 5760 taagctgact ttgctgatat taatataatc cttccatttt tctttaaaat gctatatgct 5820 ttcacataat tttgctttac gttgatgtat ttatacataa ggtgggtttc ttatagatac 5880 cacgttgtgt gtctttttta tctaagttga tagacttgcc ttttgttagg gtatttaaat 5940 aatttatatt taatgtaatt attgatatag ttgagtgtgt tgatttttgt tttctatttg 6000 ctccatctgt tgttggttct cattattcct ctgtttctac cttcttttgt actaattatt 6060 atattttatt atttttcatc tcaactgttg gcttattagc cacattgctt ttaaaatttt 6120 taatgattgc tctagggttt ataataaaca aaatgttagc attttctacc atcaaatatt 6180 tttacactat tcatgtatac ttcaatttct ttcttcccat cctttgaact atatcttcat 6240 acattttact ctacatttgt tataactcag tgctttgaaa gtcaattatt tttgtctttg 6300 acagtcaatg atttttaaag agtttaacag tgaaaaaaaa tggctttcat ctttttccat 6360 tagatttcat actccttctg cctgaagaat ttcttttaat agaccttgta ctgcgggtct 6420 caggcaagaa attctctcag cctttgttgg tttgaaaaac tgcttattac acctttgttt 6480 ttgaaagata ttttcactag gtatagaagt ctgggttgac agttctcatt gtttgtcaca 6540 gcatttttaa gatgcccatt caattgtctt gtcttgtata attttggatt agtctggtgt 6600 atttcttacc tttgttcctc tctgtgcaat gcttcaacca tcccacttca ggctgccttt 6660 aagatgtttt cttttccctt aatctttagt ttttagctgg ttgacagtga cgcatctaag 6720 tgtagtgtat gaggttgctt ttattgtcac tgttgttg 6758 <210> SEQ ID NO 348 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 348 gaccatgtta tgacatttta gtgcttgcta agcagtaaat actgacttac tttcctgcta 60 cactcttcag agcagaaaga gaaatctaca aaaagggcaa tgtagttggg atccaccaca 120 gccttgagac tgggccatgt ttctacagct tacccacatt ttacccccac tttctctgag 180 aaacaatgca aactggagaa caaggtcaga gaagttatct tggatggtag aagagaagaa 240 aggagaagaa rggataagca gaaaatcaaa aagggcataa aaaaattact ggggaaaata 300 attcttagtc actcaccatt tcttatgttt gtgaaaacag aaacgaggag caagtgttgt 360 tgtaagaatt gttcttgccc ctccccctcc accacccaca tctgtcaagc tatccctgtt 420 tcactgtttc ctctgcactc tctattaact tctttgtcct cctcttttct tttcctacag 480 caaagacttt ttgtcatgtt t 501 <210> SEQ ID NO 349 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 349 tgacttactt tcctgctaca ctcttcagag cagaaagaga aatctacaaa aagggcaatg 60 tagttgggat ccaccacagc cttgagactg ggccatgttt ctacagctta cccacatttt 120 acccccactt tctctgagaa acaatgcaaa ctggagaaca aggtcagaga agttatcttg 180 gatggtagaa gagaagaaag gagaagaaag gataagcaga aaatcaaaaa gggcataaaa 240 aaattactgg rgaaaataat tcttagtcac tcaccatttc ttatgtttgt gaaaacagaa 300 acgaggagca agtgttgttg taagaattgt tcttgcccct ccccctccac cacccacatc 360 tgtcaagcta tccctgtttc actgtttcct ctgcactctc tattaacttc tttgtcctcc 420 tcttttcttt tcctacagca aagacttttt gtcatgtttt gtttcttttt ctattgtttc 480 tttccctttt ctaatccttg a 501 <210> SEQ ID NO 350 <211> LENGTH: 1148 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 350 tatgagattt aatgttaaga aataaaatgt aggatctaaa acgtaatcta tagcataatc 60 tcaaaaatgg tttagaaatg acataataat acagacattt gtgggtggta ggattatgca 120 tatttttata tatttttaaa tatatttttc aaaagcttcc tataaagaat gtaattcttt 180 cccaattcca aatctagctt aaacataatt ttacaaaaat tattctctca gaatgtaaac 240 tagtaccacc tctatggaaa acattatgga gatttcctaa agagttaaaa gtagatctac 300 catttgatcc agcaatctta atactgggta tctacccgga ggaaaagaag tcattgtatg 360 aaaaagacac ttgtacacat atgtttacag gaccacaatt cacaaatgca aagatgcaga 420 accaacctaa gtggccastg actaatgaga ggataaagaa gatgtggcat atatatatca 480 gggactacta ctcagccatt acaaggaaca aaataatgtc ttttgcaaca acttggatag 540 agctggaggc cattattcta agtaaagtaa ttcaggaatt ggaaaaccaa aaaccgtatg 600 ttctctctta taagtgggaa ctaagttagg aataagcaaa ggcacacaga gggacatatt 660 ggactttaga gactcacgag gaggagggta ataggggact agggattaaa agaaaaacta 720 gacattaggt acaaggtacc ctacttaagt gcactaaaat ctcagaattc accactacgt 780 aattcaacta agtaacaaga aaccacttgt accccaaaag ctactgaaat aaaaattatt 840 ctctcaaaaa ttttaagccc taaacttcag ttcctattgt ttatatttac taagaaaaac 900 aacagaaaac actgttttaa aaatggtgga tttttttaag gttaaaggta tataagacag 960 ctgcctaagg aaacgcagat acccctgtac cttgttgttg ttgttgtttt tcactttttt 1020 aaaaaacata gagatgggat ctccttatgc tgcccaggct tgtctcaaac tcctgagctc 1080 aagcaatcct ctgacctcag actctcaaag ttttgggact acaggcgaca gtcaccatgc 1140 cagccaat 1148 <210> SEQ ID NO 351 <211> LENGTH: 1148 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 351 tatgagattt aatgttaaga aataaaatgt aggatctaaa acgtaatcta tagcataatc 60 tcaaaaatgg tttagaaatg acataataat acagacattt gtgggtggta ggattatgca 120 tatttttata tatttttaaa tatatttttc aaaagcttcc tataaagaat gtaattcttt 180 cccaattcca aatctagctt aaacataatt ttacaaaaat tattctctca gaatgtaaac 240 tagtaccacc tctatggaaa acattatgga gatttcctaa agagttaaaa gtagatctac 300 catttgatcc agcaatctta atactgggta tctacccgga ggaaaagaag tcattgtatg 360 aaaaagacac ttgtacacat atgtttacag gaccacaatt cacaaatgca aagatgcaga 420 accaacctaa gtggccactg actaatgaga ggataaagaa gatgtggcat atatayatca 480 gggactacta ctcagccatt acaaggaaca aaataatgtc ttttgcaaca acttggatag 540 agctggaggc cattattcta agtaaagtaa ttcaggaatt ggaaaaccaa aaaccgtatg 600 ttctctctta taagtgggaa ctaagttagg aataagcaaa ggcacacaga gggacatatt 660 ggactttaga gactcacgag gaggagggta ataggggact agggattaaa agaaaaacta 720 gacattaggt acaaggtacc ctacttaagt gcactaaaat ctcagaattc accactacgt 780 aattcaacta agtaacaaga aaccacttgt accccaaaag ctactgaaat aaaaattatt 840 ctctcaaaaa ttttaagccc taaacttcag ttcctattgt ttatatttac taagaaaaac 900 aacagaaaac actgttttaa aaatggtgga tttttttaag gttaaaggta tataagacag 960 ctgcctaagg aaacgcagat acccctgtac cttgttgttg ttgttgtttt tcactttttt 1020 aaaaaacata gagatgggat ctccttatgc tgcccaggct tgtctcaaac tcctgagctc 1080 aagcaatcct ctgacctcag actctcaaag ttttgggact acaggcgaca gtcaccatgc 1140 cagccaat 1148 <210> SEQ ID NO 352 <211> LENGTH: 1148 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 352 tatgagattt aatgttaaga aataaaatgt aggatctaaa acgtaatcta tagcataatc 60 tcaaaaatgg tttagaaatg acataataat acagacattt gtgggtggta ggattatgca 120 tatttttata tatttttaaa tatatttttc aaaagcttcc tataaagaat gtaattcttt 180 cccaattcca aatctagctt aaacataatt ttacaaaaat tattctctca gaatgtaaac 240 tagtaccacc tctatggaaa acattatgga gatttcctaa agagttaaaa gtagatctac 300 catttgatcc agcaatctta atactgggta tctacccgga ggaaaagaag tcattgtatg 360 aaaaagacac ttgtacacat atgtttacag gaccacaatt cacaaatgca aagatgcaga 420 accaacctaa gtggccactg actaatgaga ggataaagaa gatgtggcat atatayatca 480 gggactacta ctcagccatt acaaggaaca aaataatgtc ttttgcaaca acttggatag 540 agctggaggc cattattcta agtaaagtaa ttcaggaatt ggaaaaccaa aaaccgtatg 600 ttctctctta taagtgggaa ctaagttagg aataagcaaa ggcacacaga gggacatatt 660 ggactttaga gactcacgag gaggagggta ataggggact agggattaaa agaaaaacta 720 gacattaggt acaaggtacc ctacttaagt gcactaaaat ctcagaattc accactacgt 780 aattcaacta agtaacaaga aaccacttgt accccaaaag ctactgaaat aaaaattatt 840 ctctcaaaaa ttttaagccc taaacttcag ttcctattgt ttatatttac taagaaaaac 900 aacagaaaac actgttttaa aaatggtgga tttttttaag gttaaaggta tataagacag 960 ctgcctaagg aaacgcagat acccctgtac cttgttgttg ttgttgtttt tcactttttt 1020 aaaaaacata gagatgggat ctccttatgc tgcccaggct tgtctcaaac tcctgagctc 1080 aagcaatcct ctgacctcag actctcaaag ttttgggact acaggcgaca gtcaccatgc 1140 cagccaat 1148 <210> SEQ ID NO 353 <211> LENGTH: 1148 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 353 tatgagattt aatgttaaga aataaaatgt aggatctaaa acgtaatcta tagcataatc 60 tcaaaaatgg tttagaaatg acataataat acagacattt gtgggtggta ggattatgca 120 tatttttata tatttttaaa tatatttttc aaaagcttcc tataaagaat gtaattcttt 180 cccaattcca aatctagctt aaacataatt ttacaaaaat tattctctca gaatgtaaac 240 tagtaccacc tctatggaaa acattatgga gatttcctaa agagttaaaa gtagatctac 300 catttgatcc agcaatctta atactgggta tctacccgga ggaaaagaag tcattgtatg 360 aaaaagacac ttgtacacat atgtttacag gaccacaatt cacaaatgca aagatgcaga 420 accaacctaa gtggccactg actaatgaga ggataaagaa gatgtggcat atatatatca 480 gggactactr ctcagccatt acaaggaaca aaataatgtc ttttgcaaca acttggatag 540 agctggaggc cattattcta agtaaagtaa ttcaggaatt ggaaaaccaa aaaccgtatg 600 ttctctctta taagtgggaa ctaagttagg aataagcaaa ggcacacaga gggacatatt 660 ggactttaga gactcacgag gaggagggta ataggggact agggattaaa agaaaaacta 720 gacattaggt acaaggtacc ctacttaagt gcactaaaat ctcagaattc accactacgt 780 aattcaacta agtaacaaga aaccacttgt accccaaaag ctactgaaat aaaaattatt 840 ctctcaaaaa ttttaagccc taaacttcag ttcctattgt ttatatttac taagaaaaac 900 aacagaaaac actgttttaa aaatggtgga tttttttaag gttaaaggta tataagacag 960 ctgcctaagg aaacgcagat acccctgtac cttgttgttg ttgttgtttt tcactttttt 1020 aaaaaacata gagatgggat ctccttatgc tgcccaggct tgtctcaaac tcctgagctc 1080 aagcaatcct ctgacctcag actctcaaag ttttgggact acaggcgaca gtcaccatgc 1140 cagccaat 1148 <210> SEQ ID NO 354 <211> LENGTH: 611 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 354 caaaacctca accttccaga taagtctaag ggtgagaact tcacacaaga tgaataagaa 60 ccaatttctt ccagggcgat gttgaacctg gaaatgaaag ccaatctctc ttggaaggcc 120 tggtttgtag aaatgtcagt ctttgtttca agctgtggga gaatgagaag caagacttta 180 gggaaagagg aataaaatag atgtgcagaa ataacagagt gagaaagtct tcagggtgtc 240 gctagcccta attgcaggca tccctgaatc ctagaccttg gattgcaaga gactccttaa 300 tatcttccca tgtccacatt tgcttcacat agtttgaatg tggcttctat tatatacaga 360 tacaagattc aaatccaacc tctaygatga ctggtcttgt gaataagcag aagaggcact 420 aacaatatga cgtgagggat tcagggaaga gcactttctt gagcacatat cttccctggt 480 ctgccagctg tagtttatga aattccacaa tgaggatgaa atggaatcac catttacaga 540 gtactctcca gatgtctaac cctaagctag gtaccttcaa aatattatct agtttagata 600 atcaaccctt t 611 <210> SEQ ID NO 355 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 355 ttctctagtc caaagggttg attatctaaa ctagataata ttttgaaggt acctagctta 60 gggttagaca tctggagagt actctgtaaa tggtgattcc atttcatcct cattgtggaa 120 tttcataaac tacagctggc agaccaggga agatatgtgc tcaagaaagt gctcttccct 180 gaatccctca cgtcatattg ttagtgcctc ttctgcttat tcacaagacc agtcatcata 240 gaggttggat ttgaatcttg tatctgtata taatagaagc cacattcaaa ctatgtgaag 300 yaaatgtgga catgggaaga tattaaggag tctcttgcaa tccaaggtct aggattcagg 360 gatgcctgca attagggcta gcgacaccct gaagactttc tcactctgtt atttctgcac 420 atctatttta ttcctctttc cctaaagtct tgcttctcat tctcccacag cttgaaacaa 480 agactgacat ttctacaaac caggccttcc aagagagatt ggctttcatt tccaggttca 540 acatcgccct ggaagaaatt ggttcttatt catcttgtgt gaagttctca cccttagact 600 t 601 <210> SEQ ID NO 356 <211> LENGTH: 527 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 356 gctctagaat atggcattcc agaagtggga tgctacaaat agtctcattg agagtcaact 60 tgcacaatgt atcgtcctac ccttacatca atttctgaaa caacttctct ttgcacttcc 120 cctatagtta catgcataat aaattctgac aactcttatg aagtcatgga ataactttct 180 tcttatgttt cctatcaatg tcattagccc tttatcttgt ttgagtttcc atcagcaatg 240 ttttcaagtc ccaagatcat tcatgtatcc acaagcaatg atacgccaga tttggacaaa 300 taatactgaa tactatctta ttttcactgc catgatcaag gcagtgtgga ttgctgccaa 360 gtccaagaga agtgaggtca gcagctgcaa gccacctccg tcatttagaa aagcttcatg 420 atgtagtgtg tcgtttcgat gtgacactgt ctcacagagt taaaatgatg tgmaaggaac 480 tgttcaatgg aaatttagaa atttctcttt ttctcaattt tagtgta 527 <210> SEQ ID NO 357 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 357 gaacaagatt ttcctgcttt taaaaatact acattaaagc tgaaaattta ggccaaaatt 60 ttcaagtggt aatagttaca ggcaattcat ctttctggtc agaaaagggt gttactgcag 120 ctatttctgc ctgaaactgg gtggcactac tacttttttt tttttttttt taactgagca 180 gacattttcc ttacactaaa attgagaaaa agagaaattt ctaaatttcc attgaacagt 240 tccttgcaca tcattttaac tctgtgagac agtgtcacat cgaaacgaca cactacatca 300 ygaagctttt ctaaatgacg gaggtggctt gcagctgctg acctcacttc tcttggactt 360 ggcagcaatc cacactgcct tgatcatggc agtgaaaata agatagtatt cagtattatt 420 tgtccaaatc tggcgtatca ttgcttgtgg atacatgaat gatcttggga cttgaaaaca 480 ttgctgatgg aaactcaaac aagataaagg gctaatgaca ttgataggaa acataagaag 540 aaagttattc catgacttca taagagttgt cagaatttat tatgcatgta actacagggg 600 a 601 <210> SEQ ID NO 358 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 358 gcttaatacc tgagtgatgg aatattctgt tcaacaaacc cctctgacat aggtttgcct 60 atataataaa cctgttcatg tactcctgaa cctaaaagtt taaaaaagat tatgtagaaa 120 acccaaagga atctataaaa agtctactag agctagagtg attttaacaa gatttcaata 180 cacaaattca aatgtctttc tatatattaa tgacaatcaa caataaaatt ttaaaacatt 240 attaaagtat aatgaaaata tcaactgttt agggagaaat gtaacaagaa tggtgaagga 300 cctatacact aaaaagcttc aatatgttgt tgagattaac tgaagaaggt ctaaatagat 360 ttttttttca tgtctcggaa gacttaatat gtgaagatac caattcttcc ccaaatgatc 420 aacaggtgaa atgcaatccc aatcaaaatc ccagcaatta ttttaagggg gaaattggca 480 atctgattct aaaattcata yggaaaaaaa caatggagtt agaataacta aaacaagtcc 540 gaaaaagaaa aagaaatgga ggactaatgc tacctgattt caagtcttat cgtataaatc 600 tacatcaata aaggacaagt tggtattggg ttaaagatag ataaatacat cagtggaata 660 gaatattgaa tccagaataa atccacacat atatggataa aaataccaga caattcagtg 720 gagatggttt tgtttttaca acaaatgtta ctggaacaaa ttgatatatg tattagtcag 780 atatggctgc cataacaaag aaccacaaac aggtggttta aataatggaa ataaatttcc 840 tcagaattct ggagtatgga agcccaagat caagttgctg ggaggattcg tttcttctga 900 gtgtctcttt ttttgatgac agatgactat cttttaccaa tgtcttcact tggttttccc 960 tctgtgtgtg cctaggtcct attctccaat tcctataagg a 1001 <210> SEQ ID NO 359 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 359 ctaaaagttt aaaaaagatt atgtagaaaa cccaaaggaa tctataaaaa gtctactaga 60 gctagagtga ttttaacaag atttcaatac acaaattcaa atgtctttct atatattaat 120 gacaatcaac aataaaattt taaaacatta ttaaagtata atgaaaatat caactgttta 180 gggagaaatg taacaagaat ggtgaaggac ctatacacta aaaagcttca atatgttgtt 240 gagattaact gaagaaggtc taaatagatt tttttttcat gtctcggaag acttaatatg 300 tgaagatacc aattcttccc caaatgatca acaggtgaaa tgcaatccca atcaaaatcc 360 cagcaattat tttaaggggg aaattggcaa tctgattcta aaattcatat ggaaaaaaac 420 aatggagtta gaataactaa aacaagtccg aaaaagaaaa agaaatggag gactaatgct 480 acctgatttc aagtcttatc rtataaatct acatcaataa aggacaagtt ggtattgggt 540 taaagataga taaatacatc agtggaatag aatattgaat ccagaataaa tccacacata 600 tatggataaa aataccagac aattcagtgg agatggtttt gtttttacaa caaatgttac 660 tggaacaaat tgatatatgt attagtcaga tatggctgcc ataacaaaga accacaaaca 720 ggtggtttaa ataatggaaa taaatttcct cagaattctg gagtatggaa gcccaagatc 780 aagttgctgg gaggattcgt ttcttctgag tgtctctttt tttgatgaca gatgactatc 840 ttttaccaat gtcttcactt ggttttccct ctgtgtgtgc ctaggtccta ttctccaatt 900 cctataagga aaccagtcat attggattag ggcccactct aatggcccca ttttacttgc 960 attatctctt taaagacact atctccagat gtagccacac t 1001 <210> SEQ ID NO 360 <211> LENGTH: 1058 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 360 catgattagc tatgctactt tccactgctc ttagtatact gagaggcagc ataagtaaaa 60 ctaaaatatc tgaagatagc aatagactat ttaaagtaga agaagtatgc tatttttgtt 120 ttgttttcat ttcgaaggaa atatgcaaag gtttattgag tatttcagct tctcttacag 180 taggtttttt ttggattctt tctgtgtttg tctatgttga taaaacattg aaatgccata 240 tagctcaaag gtcattcact taagaaatct aagtactgat aacatcttag ccccgattct 300 tcataggcat tgttaagcct attataattt tggtwcagag agaaggtaaa ctatattcca 360 gacaggcata taaagcaatt tctcctataa ttggagttca cgaaaaattc acatatttct 420 ttttaatagt aactctcaca gcaagaacat atgtttgtaa ataatacatc acagaatctt 480 attggcagac aaggaaattc ctaaaatatt ttttactgcc acatcaatta agatatataa 540 aataccttat atagaagatg tttgcaccca ggccaaacaa atcaaacaag aatagaagca 600 ctgacagtct tatttcaaaa ttggtttaac ttgtatttac aggatattgt agtaccttat 660 aaagttgatt gctgattggc cgtcttttac agaattctgt cagattgtta ttatttcttg 720 taaagattga ttcaaacaaa taaaaattgt caggattgga tatgtcctat agtgaggtgt 780 agttatgtca catgagattt ttaattacaa agaaatggaa aataaaatga gaatagaatt 840 gagactcccc tgtcacctca caaatatgtt gaaatacaat gaaatttcca aagatgttaa 900 agcatataaa gttgaataat tcttattatg tattaaactt acagaaattt aatttcttta 960 ctttataaga ggtagtgaaa atataaaatt aattatgaag acagagtagt cttagtcaga 1020 catggcccta taaagcatat tcccattcgt tacatcaa 1058 <210> SEQ ID NO 361 <211> LENGTH: 1058 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 361 catgattagc tatgctactt tccactgctc ttagtatact gagaggcagc ataagtaaaa 60 ctaaaatatc tgaagatagc aatagactat ttaaagtaga agaagtatgc tatttttgtt 120 ttgttttcat ttcgaaggaa atatgcaaag gtttattgag tatttcagct tctcttacag 180 taggtttttt ttggattctt tctgtgtttg tctatgttga taaaacattg aaatgccaya 240 tagctcaaag gtcattcact taagaaatct aagtactgat aacatcttag ccccgattct 300 tcataggcat tgttaagcct attataattt tggtacagag agaaggtaaa ctatattcca 360 gacaggcata taaagcaatt tctcctataa ttggagttca cgaaaaattc acatatttct 420 ttttaatagt aactctcaca gcaagaacat atgtttgtaa ataatacatc acagaatctt 480 attggcagac aaggaaattc ctaaaatatt ttttactgcc acatcaatta agatatataa 540 aataccttat atagaagatg tttgcaccca ggccaaacaa atcaaacaag aatagaagca 600 ctgacagtct tatttcaaaa ttggtttaac ttgtatttac aggatattgt agtaccttat 660 aaagttgatt gctgattggc cgtcttttac agaattctgt cagattgtta ttatttcttg 720 taaagattga ttcaaacaaa taaaaattgt caggattgga tatgtcctat agtgaggtgt 780 agttatgtca catgagattt ttaattacaa agaaatggaa aataaaatga gaatagaatt 840 gagactcccc tgtcacctca caaatatgtt gaaatacaat gaaatttcca aagatgttaa 900 agcatataaa gttgaataat tcttattatg tattaaactt acagaaattt aatttcttta 960 ctttataaga ggtagtgaaa atataaaatt aattatgaag acagagtagt cttagtcaga 1020 catggcccta taaagcatat tcccattcgt tacatcaa 1058 <210> SEQ ID NO 362 <211> LENGTH: 956 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 362 aaaacaagga acaaacaaac aaaaatgtta caaccgaaca acagactttt gagtcatgtt 60 tcaggccaag aggtgatgag ttactgtagt tgcttgagct ggttggtgaa atattacctg 120 gcaacaaaac tgaaatagaa ggtggcttag taaaatgcag attcagaatg agtgccttaa 180 ggttaaggca tataagacca aactgatttt ctttttcacg aggtcttcag gtaaggccat 240 tgtagaagat accttgtttg cgaacttcag taaattactt cacttgtctc atattttcat 300 tttcaggatg gaggcttgag attgaattgt agtgcaatta ggtaaatttt tacccatttt 360 aaatataata ttaaaatatt aattataaat taccttattt gaatctggaa taatatttat 420 tgcagggcat ataatctaag ctgtaaacgt cctgtyagaa gacaacatat tcatcttgct 480 aaggtataag ctatatgact ggcactgtgc tcaactcaga gtcattgaat gaacagtatt 540 tatttaatct atgaatgaga gcacttcaag tatacagaaa gatatctcaa aagattcagc 600 cttacattgc tcataacttc aatgacttag atgaaaacct cctgaacatt tttatcagtt 660 gtataggtac cccaaatcat aagggaatgt ttatcaatta gatgatgaaa tggggatgca 720 actacatcat ggcaggctaa agcaatagaa tgactttgac aagaggaaat tacatagagg 780 cacctgagtc tcctaaacca atttcaaagg tatgagaggg gggtgatata aataaatagt 840 tgatagatga aaaaactcag aagttatagt tgacagcaat tttaatataa tatgaaaaat 900 gtggttggac ttttagggaa aaaaacctaa taaaatctaa tggaaattag tggtcc 956 <210> SEQ ID NO 363 <211> LENGTH: 956 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 363 caaccgaaca acagactttt gagtcatgtt tcaggccaag aggtgatgag ttactgtagt 60 tgcttgagct ggttggtgaa atattacctg gcaacaaaac tgaaatagaa ggtggcttag 120 taaaatgcag attcagaatg agtgccttaa ggttaaggca tataagacca aactgatttt 180 ctttttcacg aggtcttcag gtaaggccat tgtagaagat accttgtttg cgaacttcag 240 taaattactt cacttgtctc atattttcat tttcaggatg gaggcttgag attgaattgt 300 agtgcaatta ggtaaatttt tacccatttt aaatataata ttaaaatatt aattataaat 360 taccttattt gaatctggaa taatatttat tgcagggcat ataatctaag ctgtaaacgt 420 cctgtcagaa gacaacatat tcatcttgct aaggtrtaag ctatatgact ggcactgtgc 480 tcaactcaga gtcattgaat gaacagtatt tatttaatct atgaatgaga gcacttcaag 540 tatacagaaa gatatctcaa aagattcagc cttacattgc tcataacttc aatgacttag 600 atgaaaacct cctgaacatt tttatcagtt gtataggtac cccaaatcat aagggaatgt 660 ttatcaatta gatgatgaaa tggggatgca actacatcat ggcaggctaa agcaatagaa 720 tgactttgac aagaggaaat tacatagagg cacctgagtc tcctaaacca atttcaaagg 780 tatgagaggg gggtgatata aataaatagt tgatagatga aaaaactcag aagttatagt 840 tgacagcaat tttaatataa tatgaaaaat gtggttggac ttttagggaa aaaaacctaa 900 taaaatctaa tggaaattag tggtccactc atttctccac ctaggatgtt aaaaat 956 <210> SEQ ID NO 364 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 364 gtaaaacaca tagatcgctg tatccttgtt cagtaagcta caacatactc gtatctcctg 60 aaatcctggg cttaaatcga ggtctcaaag gctttgtttt gttttgttgt atggttgtat 120 ggtgagtgtg tgtgtgtgtg tgtgtgtgtg tgtttattct cctgaaattc tcctcctcac 180 ttgacttaag ctaaaagata aacgtcctct tcctttcagc cacagatggt gatggataaa 240 ttgaatgtca ttcacattat tcccttaaaa taaactctct ccctcccctc tcccgtctca 300 wccttgtccc tttctttata taatgggtaa tgcgttaatg tcagcagaat agttttgggg 360 ccataatggc aagtatcacg tggatggttt agcattgttt ttagaatgct gtgaatttgg 420 gtatatgtga gttttgggga aagttttgca actatatgtt tgttaattaa atgaggacta 480 taaagtaata taaaattatg tttctggaac atattttgga agctataaag tcatctgtat 540 ttattatcca cagacataat gtcattgttc aggtcctgca accttcttat aatcaacata 600 c 601 <210> SEQ ID NO 365 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 365 agtaagctac aacatactcg tatctcctga aatcctgggc ttaaatcgag gtctcaaagg 60 ctttgttttg ttttgttgta tggttgtatg gtgagtgtgt gtgtgtgtgt gtgtgtgtgt 120 gtttattctc ctgaaattct cctcctcact tgacttaagc taaaagataa acgtcctctt 180 cctttcagcc acagatggtg atggataaat tgaatgtcat tcacattatt cccttaaaat 240 aaactctctc cctcccctct cccgtctcat ccttgtccct ttctttatat aatgggtaat 300 kcgttaatgt cagcagaata gttttggggc cataatggca agtatcacgt ggatggttta 360 gcattgtttt tagaatgctg tgaatttggg tatatgtgag ttttggggaa agttttgcaa 420 ctatatgttt gttaattaaa tgaggactat aaagtaatat aaaattatgt ttctggaaca 480 tattttggaa gctataaagt catctgtatt tattatccac agacataatg tcattgttca 540 ggtcctgcaa ccttcttata atcaacatac gtgggcccag ggattttatg tatcttcgcc 600 t 601 <210> SEQ ID NO 366 <211> LENGTH: 1079 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 366 gaatttatgg tctgatggag aagggaatca ttaaagttct atgtagtgag atatccccaa 60 ggggtgtatt aggcttacca ccactggaat ctggatagat gaagacagag tggcagggaa 120 gtcgtattaa ggttctgttt ctgctgggag ccacaggtcc tcaggaagca acaagtactg 180 ggcagattga tactgtagct rggctctagc tctatacctc tagaataaag gttacaaact 240 agcaacttga aagctaaacc tggcccacag atatgtttta tttggctctt acactgtttt 300 aaaaaatatt accaacattt aaaactggga agttttatga aaaaacccag acttctggat 360 tctgttgaaa aaaaaaatca gaagatctgg caatactgag ctgacattcc tatatgacaa 420 caattggctg gatctatgca gcttctctcc aaaaagcaaa gaatgtgttc ttgcttaaca 480 cagtccccac cactccctca tattctccaa tcctggacct gagcgtcatt tgctatgtat 540 cgccatttgc catgaagttt tacactctac agaaatataa tttttttgta gaagactatg 600 ctttaatcaa gatcaggata atataaagtg agatctgaaa gtggaaaaaa gataaatgtc 660 caacaatgat agactggatt aagaaaatgt ggcacatata caccgtggag tactatgcag 720 ccaaaaaaaa cgatgagttc atgtcctttg tagggacatg gatgaagctg gaaaccacca 780 ttctcagcaa actatcgcaa ggacaaaaaa ccaaacgccg catgttctca ctcataggtg 840 ggaattgaac aatgagaaca cttgggcaca ggaaggggaa catcacacac cgggccctgt 900 tgtggggtgg ggggaggagg gagggatagc atttggagat atacctaatg ttaaatgact 960 agtttctggg tgcagcacac catcatggca catgtataca tatgtaacta acctgcacat 1020 tgtgcacatg taccctaaaa cttaaagtat aatttttaaa aaaagatatt ttcttatct 1079 <210> SEQ ID NO 367 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 367 ataaattttc tcttccctca agaatttatg gtctgatgga gaagggaatc attaaagttc 60 tatgtagtga gatatcccca aggggtgtat taggcttacc accactggaa tctggataga 120 tgaagacaga gtggcaggga agtcgtatta aggttctgtt tctgctggga gccacaggtc 180 ctcaggaagc aacaagtact gggcagattg atactgtagc tgggctctag ctctatacct 240 ctagaataaa kgttacaaac tagcaacttg aaagctaaac ctggcccaca gatatgtttt 300 atttggctct tacactgttt taaaaaatat taccaacatt taaaactggg aagttttatg 360 aaaaaaccca gacttctgga ttctgttgaa aaaaaaaatc agaagatctg gcaatactga 420 gctgacattc ctatatgaca acaattggct ggatctatgc agcttctctc caaaaagcaa 480 agaatgtgtt cttgcttaac a 501 <210> SEQ ID NO 368 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 368 tgaagaagcc gcctggcttc ttgtttcttc tcatagcaaa atgcaatgag aaagagataa 60 tttgagaaaa gaaccgttta aacaaaaaga aaccaagaca taatgatttt ggaaattctc 120 agtttattca gactgcaaaa gatattaaaa taaagaaact cagtaacagg gatagataat 180 ctaaagaaaa agcctaggac acggctgtag taaccttctg tttttatacc tcagcaattt 240 gctaatgcct caaaaagatc aaaagtactc aaatataaag ggctctttga agagattaga 300 tttcctcaat caaaccaaag agcatcgagg aagcttaagg ttactgtccc tcacatatct 360 cagcagaagg caaaaataga agactgatta tctaagaaag atctctgaaa gagtctcata 420 ttatggagtg aacccctgtg gcatacatgg gagacccact tggttcttga gaattttata 480 tcaggagaaa cactgtcagt ytgtattgaa aggaacagag aaaatacgaa attaaagaag 540 actattaaac ctccaaaatt ctggcaggaa agaagcttac acagctactc agttgcaaag 600 atctgccact tttcatatac atgaaaggac tcagaggagg aagccacagg tttagaagga 660 aaagctaaaa gcaacatcgt attagtcttg gatctaggaa cctaatttct ctagcagaat 720 ctagaaatgg cttgggacaa gtgattgttt ttttacctag gattttctcc ctcttgaaaa 780 caggactgtc tgtaactatt atcctatgcc tgccctacca tcatatttca gaaacaggta 840 acttatgttt tcactttcaa agattcacaa taaagagaaa ttgtacctca gaatggatta 900 taccagagct ttcctcatgc ataaattaaa taatttaggt tatgtgattt gaagcttttg 960 agtgggtgag gtgacatttt ggatgctgag ttggtgccgt a 1001 <210> SEQ ID NO 369 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 369 tcttctcata gcaaaatgca atgagaaaga gataatttga gaaaagaacc gtttaaacaa 60 aaagaaacca agacataatg attttggaaa ttctcagttt attcagactg caaaagatat 120 taaaataaag aaactcagta acagggatag ataatctaaa gaaaaagcct aggacacggc 180 tgtagtaacc ttctgttttt atacctcagc aatttgctaa tgcctcaaaa agatcaaaag 240 tactcaaata taaagggctc tttgaagaga ttagatttcc tcaatcaaac caaagagcat 300 cgaggaagct taaggttact gtccctcaca tatctcagca gaaggcaaaa atagaagact 360 gattatctaa gaaagatctc tgaaagagtc tcatattatg gagtgaaccc ctgtggcata 420 catgggagac ccacttggtt cttgagaatt ttatatcagg agaaacactg tcagtctgta 480 ttgaaaggaa cagagaaaat rcgaaattaa agaagactat taaacctcca aaattctggc 540 aggaaagaag cttacacagc tactcagttg caaagatctg ccacttttca tatacatgaa 600 aggactcaga ggaggaagcc acaggtttag aaggaaaagc taaaagcaac atcgtattag 660 tcttggatct aggaacctaa tttctctagc agaatctaga aatggcttgg gacaagtgat 720 tgttttttta cctaggattt tctccctctt gaaaacagga ctgtctgtaa ctattatcct 780 atgcctgccc taccatcata tttcagaaac aggtaactta tgttttcact ttcaaagatt 840 cacaataaag agaaattgta cctcagaatg gattatacca gagctttcct catgcataaa 900 ttaaataatt taggttatgt gatttgaagc ttttgagtgg gtgaggtgac attttggatg 960 ctgagttggt gccgtagtga gtccagaatt ctgcggaact t 1001 <210> SEQ ID NO 370 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 370 ctctagactc ctcctgtatt ttaatttagc cactttttta gggcctacaa ttttagatct 60 ccacagggct cttgaaactt cttgaacctc atcagtaaca tgtccattag tggcatgacc 120 caagagttct agaacatcta ttcagcaagt gtgtatctgg taagtgaata ttccttctat 180 gtgttccctt ttgcatcaaa ctacacactg tcattcctcc tttatctcca aaagcttgaa 240 aattcctcac ttgtatctca ttctttctct cttagaaaac tgatcacctc tgatgaatta 300 raacggaatg accaagcttt gggagaggca aaagaatctc ggtgttaaag actcagagtt 360 taagaagcaa caaaaagatt atacagatgt gaatatgtga ccttcctcca ccagggcatg 420 ttgccttgga gtaagataat ctaagcacac acttcatagc ctgagaacaa ttttggaagt 480 ctttgcttta tggatattta cataaagcaa atatggatat ttacctaaag gctggaccaa 540 ggcctaattc ctctagagcc ccttgatcat gaacaccatt cctgtcatga ttcttaaggt 600 c 601 <210> SEQ ID NO 371 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 371 acaagctcca gccatggacg caattccttc tagaagcaaa atttatctct agactcctcc 60 tgtattttaa tttagccact tttttagggc ctacaatttt agatctccac agggctcttg 120 aaacttcttg aacctcatca gtaacatgtc cattagtggc atgacccaag agttctagaa 180 catctattca gcaagtgtgt atctggtaag tgaatattcc ttctatgtgt tcccttttgc 240 atcaaactac acactgtcat tcctccttta tctccaaaag cttgaaaatt cctcacttgt 300 rtctcattct ttctctctta gaaaactgat cacctctgat gaattagaac ggaatgacca 360 agctttggga gaggcaaaag aatctcggtg ttaaagactc agagtttaag aagcaacaaa 420 aagattatac agatgtgaat atgtgacctt cctccaccag ggcatgttgc cttggagtaa 480 gataatctaa gcacacactt catagcctga gaacaatttt ggaagtcttt gctttatgga 540 tatttacata aagcaaatat ggatatttac ctaaaggctg gaccaaggcc taattcctct 600 a 601 <210> SEQ ID NO 372 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 372 gaagatgcac tctaatgttt tttcccagaa gctctgtagg tttagctttt acctttctgg 60 gtttgttttg ttttgttttt tgagatggag tcccactcgt gtcacccagg ctggagtaca 120 atggtgcaat ctcggttcac tgcaacctcc acctcccggg ttcaagcaat tcccctgtct 180 ccacctctcg agtagctggg atgggaggcg cctgccacca tacctggcta attttcatat 240 ttttagtaaa gatagggttt caccatgtta gccaggctgg tctcgaactc ctgacctcaa 300 gtgatccacc cgcctcagct tcccaaagtg ctgggattac aggcgtgagc cactgcgccc 360 agccctagct ttttggtcta tgattcctcc caaattaatt tctgtgaacc attaccttaa 420 gatgttgaga tttaatgtcc agaatctcat ttgttcacct ttgaaaatta agaaaccctg 480 gcacagtgtt gactggagcc wcttacctta atagaaaata aagctcacat atatccataa 540 tgaaaagcag agaccagcac aaccatagtc acctgacagt tttaaaatcc aaggccagga 600 tcttctcaac tcaggcccac tcacttactc cacaacatac ttcttctttc ctcagcatct 660 actacttgtg ctgggacctt ggtcttccca ttgttcatgt c 701 <210> SEQ ID NO 373 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 373 agatggagtc ccactcgtgt cacccaggct ggagtacaat ggtgcaatct cggttcactg 60 caacctccac ctcccgggtt caagcaattc ccctgtctcc acctctcgag tagctgggat 120 gggaggcgcc tgccaccata cctggctaat tttcatattt ttagtaaaga tagggtttca 180 ccatgttagc caggctggtc tcgaactcct gacctcaagt gatccacccg cctcagcttc 240 ccaaagtgct gggattacag gcgtgagcca ctgcgcccag ccctagcttt ttggtctatg 300 attcctccca aattaatttc tgtgaaccat taccttaaga tgttgagatt taatgtccag 360 aatctcattt gttcaccttt gaaaattaag aaaccctggc acagtgttga ctggagccac 420 ttaccttaat agaaaataaa gctcacatat atccataatg aaaagcagag accagcacaa 480 ccatagtcac ctgacagttt waaaatccaa ggccaggatc ttctcaactc aggcccactc 540 acttactcca caacatactt cttctttcct cagcatctac tacttgtgct gggaccttgg 600 tcttcccatt gttcatgtca ttcttttcct cacagttccc attcttttct ccctgaaata 660 aagaaatttc aaaatatacc atgtttcatg aaaaagacaa a 701 <210> SEQ ID NO 374 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 374 gatttccacc ctcaggtgat ggggatggtt gaacatccaa cacctgaaac aggacagacg 60 atattgacag tacttgttag ttgcatataa tcacagacca gtggaaacag atgaaccaca 120 cagggccaca gcggggtttc actggggaac agagtgaaca atcaggaggt gtgggaggca 180 ggtttagtag tttaaagagg ttgaggtgtc cccctggatc ccatgggagg atcacattgg 240 ctcatttgaa ttatcatacg gactggcagg gaactgaaat cttctactca gggataagca 300 gaaactgtcc ctggtttcct tgataaaaag ggttgtttga taggggacct tatccatggg 360 aggaaagtga ggagggaaat ttgtggctaa gccattcaag gccctcccag ttttactaga 420 tgtcaaggca gcacacgtaa tattgggact taattttagc cacataacta ataaatttgt 480 aagtatgtgc aacggctcac rcttgcttcc agaatggcac ctaaaaaaca gatttacctc 540 tccccaaatt cagatatgga attaaatgta atgtcaggaa aattgtctaa gagttggaaa 600 tgggaaaaaa atgttctttt ggtggagtta tggactccag aggttatcag attctattga 660 ataacgtact tttgattgta tttgtaacaa ttaggctatt t 701 <210> SEQ ID NO 375 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 375 gcatataatc acagaccagt ggaaacagat gaaccacaca gggccacagc ggggtttcac 60 tggggaacag agtgaacaat caggaggtgt gggaggcagg tttagtagtt taaagaggtt 120 gaggtgtccc cctggatccc atgggaggat cacattggct catttgaatt atcatacgga 180 ctggcaggga actgaaatct tctactcagg gataagcaga aactgtccct ggtttccttg 240 ataaaaaggg ttgtttgata ggggacctta tccatgggag gaaagtgagg agggaaattt 300 gtggctaagc cattcaaggc cctcccagtt ttactagatg tcaaggcagc acacgtaata 360 ttgggactta attttagcca cataactaat aaatttgtaa gtatgtgcaa cggctcacac 420 ttgcttccag aatggcacct aaaaaacaga tttacctctc cccaaattca gatatggaat 480 taaatgtaat gtcaggaaaa ytgtctaaga gttggaaatg ggaaaaaaat gttcttttgg 540 tggagttatg gactccagag gttatcagat tctattgaat aacgtacttt tgattgtatt 600 tgtaacaatt aggctatttg tgaactcggt aggggtagaa atcgagttgt agaaaatgga 660 tggtaatgca agtgattttt gaccatatca atgcaaatga attctgttgg tagaaatatt 720 catttccaca ctgtagatga ccctaaacat atgtcattac attatatttt attgccttat 780 agactattaa ccaattttga atcatacagt agcaaattta tttcagcatt cttgtgtgta 840 tgtgtttata tatacacgtg catatgtatt taagatatat aattgtatat tcttcaaatt 900 cttctttgaa caggtttgaa cctcttatta gtttcctcat taaggaattt aataagacct 960 ttaatgcatg tttgtatttt catgagagtc attattttac c 1001 <210> SEQ ID NO 376 <211> LENGTH: 695 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 376 tgctccttca ttagtgcaat ggaacagcaa atcaggatac tttcacagtt ctcttaagtg 60 agcctagaag tggggagctg cttgttcaca aacttgaagc ctgaatatgt taatattctt 120 tcagtggccg gacgcggtgg ctcatgcctg taatcccaac actttgggag gccgaggtag 180 gcagatcaac ctgaagtcag gagttcgagg ccagcctggc caacatggtg aaaccccacc 240 tgttggtctg tactaaaaat agaaaaatta gctgggcatg gtggcgcatg cctgtaatcc 300 cagctactca ggaggctgtg gcagaagaat cgcctgcacc tgggaggcag aggttgcttt 360 gagttgatat cgtgtcactg cactccagcc tgggcaacag agtgagatcc tttcagaaac 420 ctgctgtctg tatttggata caattaaaaa aaaaaaaaag atgagacagg caggtgcgaa 480 agaaataaaa gtcamaactg atccagttgg gaaactcaga attgacagtt acgtgtcctt 540 tcatttattg atattttgag attcacaggg gtttaaactt tatttttcca agactgaata 600 gttcccacct cccttccata tataaaattt gagtagctgg ggagatttaa aagaggctcc 660 ccataaactc agaagttaaa agagacaagg gtccc 695 <210> SEQ ID NO 377 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 377 aaccccacct gttggtctgt actaaaaata gaaaaattag ctgggcatgg tggcgcatgc 60 ctgtaatccc agctactcag gaggctgtgg cagaagaatc gcctgcacct gggaggcaga 120 ggttgctttg agttgatatc gtgtcactgc actccagcct gggcaacaga gtgagatcct 180 ttcagaaacc tgctgtctgt atttggatac aattaaaaaa aaaaaaaaga tgagacaggc 240 aggtgcgaaa gaaataaaag tcacaactga tccagttggg aaactcagaa ttgacagtta 300 sgtgtccttt catttattga tattttgaga ttcacagggg tttaaacttt attcttccaa 360 gactgaatag ttcccacctc ccttccatat ataaaatttg agtagctggg gagatttaaa 420 agaggctccc cataaactca gaagttaaaa gagacaaggg tcccagtaaa tacaaaatga 480 ttggggttga ggaggcagat tttctgtcct cagtgaagtt tgttggttgg ttggttggtt 540 ggttggttaa ttggttggtt tttgagtcag ggtctcactt tgtcacccaa gctggagtgc 600 a 601 <210> SEQ ID NO 378 <211> LENGTH: 663 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 378 tgtagcaaca ggagggatga gacccaaagg tctgaaaagc cagtatttta agaagtcttg 60 gaaaatgtgg aggttgaaaa atctaacagg agtgcttgct tcagcagcaa tttagagtag 120 attagcatgg cctctgcgcc aggatgacat gcacattcct aaaagtgttc cgtgttttaa 180 aaaaaagaga gagacagaat ctaaggggat gtgtacattt gctagagcta ctataacaaa 240 gtaccagagg cagggtcact tcaacaacag aaatttattt ctcacagttc tggaggctag 300 acgtccaaga ttaaggtgtt gactgggttg aattcagccc ataacaggaa ataaggagtt 360 aaataaagca cttgcttcta ttgtttgtac ctaaacttaa cagaayacag taagtaacaa 420 gtcattggga tgcagaaaag aaaaaagaga gtgaaggaag gagagaaggt gaagggagaa 480 tggaagagag gaagggaggg aggaaagaaa agtttgatga atgattgcag tctaaactgg 540 ttcaaacaag agatcttgtt taattaagga attcatccca tctctgccta ttaggaggag 600 gaaaaagtct aaaatagaag atggtgaaag ttggatgacc ccaggcatta aggccattca 660 tct 663 <210> SEQ ID NO 379 <211> LENGTH: 662 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 379 ttaagaagtc ttggaaaatg tggaggttga aaaatctaac aggagtgctt gcttcagcag 60 caatttagag tagattagca tggcctctgc gccaggatga catgcacatt cctaaaagtg 120 ttccgtgttt taaaaaaaag agagagacag aatctaaggg gatgtgtaca tttgctagag 180 ctactataac aaagtaccag aggcagggtc acttcaacaa cagaaattta tttctcacag 240 ttctggaggc tagacgtcca agattaaggt gttgactggg ttgaattcag cccataacag 300 gaaataagga gttaaataaa gcacttgctt ctattgtttg tacctaaact taacagaaca 360 cagtaagtaa caagtcattg ggatgcagaa aagaaaaaag agagtgaagg aaggagaraa 420 ggtgaaggga gaatggaaga gaggaaggga gggaggaaag aaaagtttga tgaatgattg 480 cagtctaaac tggttcaaac aagagatctt gtttaattaa ggaattcatc ccatctctgc 540 ctattaggag gaggaaaaag tctaaaatag aagatggtga aagttggatg accccaggca 600 ttaaggccat tcatctttaa ctgttatgct tggatcatgc aaatgtgtct ggtagctaca 660 ag 662 <210> SEQ ID NO 380 <211> LENGTH: 615 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 380 ttccatacat tccttccaca ccattgccct taacctttca aattcctgct taaaactaat 60 cccattttta tggctgacct caccctgtat caaaaactcc gacatccctt tacgacagag 120 agcacaaact agtggtccaa aatgtcatgg gggtcttctc agagttgttt tttcaatcag 180 gaaatttcac ataaaaatat ggatttctga tttctctttt aaaaacagaa aaacgagcca 240 ccagtgggag cactgcaggt atctgtgtga gaccygtact tcacaactcc tgctttccct 300 ccataaagta gcttgcattt tccacattga ctttgcagtt ctttggtatc tgtattggtt 360 ttaagataat ttctactata tcacatatct cctcacagta caaagatatc attttctttc 420 ccttttcttt ttaaaaaatt tgtattttta atttttgtgg gtacacagta gatatttatg 480 gggcatatga ggtattttat aggcatataa tatgtactag ggtaagtggg gtattcatca 540 cctcaagcat ttatcctttc tttgtgtaaa atatagcatt ttctgaacac tatgaatact 600 taagtacaag gatca 615 <210> SEQ ID NO 381 <211> LENGTH: 994 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 381 tcaaagtgta acaaatttcc tttcctcata aactagcaga cattctatcc cctcattatt 60 gtaacacatt tctaatatct ttctcaaatt gtcttcctgt attacaatgc actcaccttg 120 gcttagaatg tctgagacaa gaaaatctat tcaccattcc cacagatgac tccctcactc 180 tcctcccaag tcttccatac attccttcca caccattgcc cttaaccttt caaattcctg 240 cttaaaacta atcccatttt tatggctgac ctcaccctgt atcaaaaact ccgacatccc 300 tttacgacag agagcacaaa ctagtggtcc aaaatgtcat gggggtcttc tcagagttgt 360 tttttcaatc aggaaatttc acataaaaat atggatttct gatttctctt ttaaaaacag 420 aaaaacgagc caccagtggg agcactgcag gtatctgtgt gagacctgta cttcacaact 480 cctgctttcc ctccataaag yagcttgcat tttccacatt gactttgcag ttctttggta 540 tctgtattgg ttttaagata atttctacta tatcacatat ctcctcacag tacaaagata 600 tcattttctt tcccttttct ttttaaaaaa tttgtatttt taatttttgt gggtacacag 660 tagatattta tggggcatat gaggtatttt ataggcatat aatatgtact agggtaagtg 720 gggtattcat cacctcaagc atttatcctt tctttgtgta aaatatagca ttttctgaac 780 actatgaata cttaagtaca aggatcaagt cataggattt ggaattgatt tttaaaatat 840 gttgaccaaa gtgctcttat catcaaactt aacatcacta atgaaggatg aacatcccaa 900 atctgaaaat ccaaaatcca aaatgctcca taatctaaaa cttgttgagc accaacatga 960 tgcttaaagg aaatgctcct ggagcatttc agat 994 <210> SEQ ID NO 382 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 382 ctatgagaaa tatttttaaa gtggttagga acaattcata gcactgacat gttatcagta 60 aaaatagaag aaaataaatt aatattatga aatattaatt atatttcatt aattatgtaa 120 tatgaattat gttttagctc aaatatttcc caagggacaa ttaagtaaat gaaaaataca 180 cacagattaa aataataaat agagaaggag atattaatga ggtacaaaaa gaaaaaatac 240 atgtaatcac atgaaatgct attatttgaa agattaacaa aacttgtaaa ctacctgcta 300 acttgatcaa agaaaaaaat cgagaaacca tatgcgcaat taatagtaag agggaaataa 360 acattgaaac agaagacatt tgaaatacca tataagactg ggtttcagag ctctatgtac 420 gtaaattgat aatgtcctgg agaagtgcag atgaccaaaa tggacacctt tcaacttaga 480 aatcataaac agattcattt ycttaaagtt aatgaaaaga attaacagac cctcctcaaa 540 aaagacatat atgcggccta caatcatatg aaaaaaagtt caacattact gttcattaga 600 gaaatgcaaa tcaaaaccac aatgagatac catctcacac cagtcagaat ggctattatt 660 aagaagtcaa aaaataaaag atgctggcga ggttgtggag aaaaaagaat gcttttatac 720 acttggtggg aatgtaaatt agttcagtca ttgtggaaga ctttgatgat tcctagaaga 780 cctaaataca gaactactat ttgacccaac aatcccatta ctgggtatat actcaaatga 840 ctataaatca ttctattata aagacacatg catggatatg ttcattacag cactatgcac 900 aatagcaaag acttggaatc aacatgaatg tccatcaatg atagactaga taaagaaaat 960 gtggtacaca tataccatgg aatactatgc agccataaaa a 1001 <210> SEQ ID NO 383 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 383 tcagtaaaaa tagaagaaaa taaattaata ttatgaaata ttaattatat ttcattaatt 60 atgtaatatg aattatgttt tagctcaaat atttcccaag ggacaattaa gtaaatgaaa 120 aatacacaca gattaaaata ataaatagag aaggagatat taatgaggta caaaaagaaa 180 aaatacatgt aatcacatga aatgctatta tttgaaagat taacaaaact tgtaaactac 240 ctgctaactt gatcaaagaa aaaaatcgag aaaccatatg cgcaattaat agtaagaggg 300 aaataaacat tgaaacagaa gacatttgaa ataccatata agactgggtt tcagagctct 360 atgtacgtaa attgataatg tcctggagaa gtgcagatga ccaaaatgga cacctttcaa 420 cttagaaatc ataaacagat tcatttcctt aaagttaatg aaaagaatta acagaccctc 480 ctcaaaaaag acatatatgc rgcctacaat catatgaaaa aaagttcaac attactgttc 540 attagagaaa tgcaaatcaa aaccacaatg agataccatc tcacaccagt cagaatggct 600 attattaaga agtcaaaaaa taaaagatgc tggcgaggtt gtggagaaaa aagaatgctt 660 ttatacactt ggtgggaatg taaattagtt cagtcattgt ggaagacttt gatgattcct 720 agaagaccta aatacagaac tactatttga cccaacaatc ccattactgg gtatatactc 780 aaatgactat aaatcattct attataaaga cacatgcatg gatatgttca ttacagcact 840 atgcacaata gcaaagactt ggaatcaaca tgaatgtcca tcaatgatag actagataaa 900 gaaaatgtgg tacacatata ccatggaata ctatgcagcc ataaaaatga aggagatcat 960 gccctttgca gggacacgaa tagaggtgga ggccattatc c 1001 <210> SEQ ID NO 384 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 384 agttgcttga aagcaaagtt ctcgcagtag ctctctatct agaaggaggc attttattta 60 tgtaaggaag tcacctaaaa gaaaattcat ttgttatggt gtggctttaa gagttactta 120 cttttaatgg aatcccccag ataataataa attctgaaaa aaaaaaatca gaatcatggc 180 atgttaaaac tggatacatt cctagaaata gatggaaact gctcttgcaa aaagcttagc 240 acatgttaaa rcattttaga aacaatttgc caaagtttat ttagtctagt gatttcgaca 300 ggttaaatgg accctttgag atcttttttc ctcaagtaca aaggctcact tgcttaatga 360 acacagtccc agaaaagcag ggggctgaac cttggctcta ccatcttacc taagattcta 420 gagttagcaa agggtttcca caagcccaaa ttattatgtt taatcttttc aattatctgt 480 gaagcattag gttggtgcaa a 501 <210> SEQ ID NO 385 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 385 gaggcatttt atttatgtaa ggaagtcacc taaaagaaaa ttcatttgtt atggtgtggc 60 tttaagagtt acttactttt aatggaatcc cccagataat aataaattct gaaaaaaaaa 120 aatcagaatc atggcatgtt aaaactggat acattcctag aaatagatgg aaactgctct 180 tgcaaaaagc ttagcacatg ttaaagcatt ttagaaacaa tttgccaaag tttatttagt 240 ctagtgattt ygacaggtta aatggaccct ttgagatctt ttttcctcaa gtacaaaggc 300 tcacttgctt aatgaacaca gtcccagaaa agcagggggc tgaaccttgg ctctaccatc 360 ttacctaaga ttctagagtt agcaaagggt ttccacaagc ccaaattatt atgtttaatc 420 ttttcaatta tctgtgaagc attaggttgg tgcaaaagta actgcaggtt ttgacattaa 480 aactggcaaa aactgcaata a 501 <210> SEQ ID NO 386 <211> LENGTH: 703 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 386 gacaccagtt agcatattgt cgcgggggag aggggtggga aaggcgagag aacagcatgt 60 ggtccagagg ccatacccag atggaggctg cagtcagctc cccagtcaaa ggcaaagccc 120 aagtcaaagc catgcttccc tcttgcccac ctgctccaat gccacccaca gagagtgcgc 180 cacagctcac aggatgcagg tctggttgaa tcttaacaat aactttgtaa gggaggtgtc 240 attagctcca ttctcctggc aggaggatga ggctcaaggc agctaaaggc ttttgctgaa 300 catcaagtgg tgagccagga ctcaawgcca gatcttcttg tttccctgtt aggtgtatgt 360 agcacaactg gtatctgcag actatgctgc tggaagggct agccgtcact gttatcacag 420 cgactgctgc ctgagatatg ccaggtactg ctgcaagaag tttacaaata taagctcact 480 tgatcttcat aacatactac ctaggtacaa tcattatatt tatttgacag atacagagac 540 agaggggaca cagaaaggat tagtaacttg ccccaaacca cacagccagc aaggtgtaag 600 tgagcacctg cagtctagat gagacaccac tcaaaacgtc atttttctgg cagccccgtg 660 cagttaccac agtggtcacc ccagtggtca gctaaaggcc aag 703 <210> SEQ ID NO 387 <211> LENGTH: 704 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 387 gcatattgtc gcgggggaga ggggtgggaa aggcgagaga acagcatgtg gtccagaggc 60 catacccaga tggaggctgc agtcagctcc ccagtcaaag gcaaagccca agtcaaagcc 120 atgcttccct cttgcccacc tgctccaatg ccacccacag agagtgcgcc acagctcaca 180 ggatgcaggt ctggttgaat cttaacaata actttgtaag ggaggtgtca ttagctccat 240 tctcctggca ggaggatgag gctcaaggca gctaaaggct tttgctgaac atcaagtggt 300 gagccaggac tcaatgccag atcttcttgt ttccctgtta ggtgtwtgta gcacaactgg 360 tatctgcaga ctatgctgct ggaagggcta gccgtcactg ttatcacagc gactgctgcc 420 tgagatatgc caggtactgc tgcaagaagt ttacaaatat aagctcactt gatcttcata 480 acatactacc taggtacaat cattatattt atttgacaga tacagagaca gaggggacac 540 agaaaggatt agtaacttgc cccaaaccac acagccagca aggtgtaagt gagcacctgc 600 agtctagatg agacaccact caaaacgtca tttttctggc agccccgtgc agttaccaca 660 gtggtcaccc cagtggtcag ctaaaggcca agcccaccgt ttct 704 <210> SEQ ID NO 388 <211> LENGTH: 975 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 388 gacttaagac aagggggtct taatttgatt atttttttct gttttatatg atttctatga 60 aaactacaac aaaataaagt taattctatt taagtgactt tttaatgaat tgcctttgtt 120 agaaaaaaaa ttaagtgttt ttgtctcact ctgtcaccca ggctggagca cagtggtgtg 180 atcatggctt actgcagcca tgacctcccg ggctcaggtg atcctcccac ctcagcttcc 240 caaatagatg ggactacagt tgtgtgccac aacgcctggc taatttttgt atttttttgt 300 agagacaggg tctcaccagg ttgcccaggc tgatcttgaa ctccttggct caagcgatcc 360 acccacctca gcctccctga gtgctgggat tacaggcatg agccagcgca cccagccaga 420 attacatttt tttaaatggt actgtcctag aaaatccagg atgtgcagtg atcaygtatg 480 aatgcatgga cctgcacaca caggagtgaa caaaagaccc acccctgcca ggtcaccact 540 catatctcac cccagcccac gctagctcac actcctcccc acacaccact gacctcatca 600 ttgctaggta cccacttgac ttctcaacag gttcaagaca attggccttc ctcgtctctt 660 ctagaaacac cctcttttct gggctttgtg taacacctgg tctttctccc ctctctggcc 720 acttctcagc ttttcttttt ctttctttct tttttttttt tttttttttg ccacttcctc 780 ttcctctaca tcaagcttgt ccaacccaca gcccaggaca gctttgaatg cagcctaaca 840 caaattcgta agctttctta aaacattatg agatgtgtgt gtgtgtgtgt gtgtgtgtgt 900 gtgtgtgtgt gtgtgtgtgt gtttagctca tcagctatcg ttattgttag tgtattttat 960 gtgtggccca agaca 975 <210> SEQ ID NO 389 <211> LENGTH: 976 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 389 gactttttaa tgaattgcct ttgttagaaa aaaaattaag tgtttttgtc tcactctgtc 60 acccaggctg gagcacagtg gtgtgatcat ggcttactgc agccatgacc tcccgggctc 120 aggtgatcct cccacctcag cttcccaaat agatgggact acagttgtgt gccacaacgc 180 ctggctaatt tttgtatttt tttgtagaga cagggtctca ccaggttgcc caggctgatc 240 ttgaactcct tggctcaagc gatccaccca cctcagcctc cctgagtgct gggattacag 300 gcatgagcca gcgcacccag ccagaattac atttttttaa atggtactgt cctagaaaat 360 ccaggatgtg cagtgatcac gtatgaatgc atggacctgc acacacagga gtgaacaaaa 420 gacccacccc tgccaggtca ccactcatat ctcaccccag cccacgctag ctcacrctcc 480 tccccacaca ccactgacct catcattgct aggtacccac ttgacttctc aacaggttca 540 agacaattgg ccttcctcgt ctcttctaga aacaccctct tttctgggct ttgtgtaaca 600 cctggtcttt ctcccctctc tggccacttc tcagcttttc tttttctttc tttctttttt 660 tttttttttt ttttgccact tcctcttcct ctacatcaag cttgtccaac ccacagccca 720 ggacagcttt gaatgcagcc taacacaaat tcgtaagctt tcttaaaaca ttatgagatg 780 tgtgtgtgtg tgtgtgtgtg tgtgtgtgtg tgtgtgtgtg tgtgtgttta gctcatcagc 840 tatcgttatt gttagtgtat tttatgtgtg gcccaagaca tttcttcttc cagtgtggcc 900 cagggaagcc aaaagattgg acacccctgc tctacaacat ctcaatatag gcctttttca 960 tgtttcattc tagatt 976 <210> SEQ ID NO 390 <211> LENGTH: 801 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 390 atccagacgg tgcccatact ccctgctctg tctagatggt gtccacattc cctgctccgt 60 ctagactgtg cccatattcg ctgctggctg caaatgcgag gagttgacag cagcctcccc 120 tttacaaggc aggaggtgcc actgttcgcc attgtctcca cctagggctt cacttgcttt 180 ctatctgcag acatcagagg gacccacatc tctctgttct gacacgctgt gtgttgatgg 240 cagagtttaa ttatccacat gcaatcttac tttccttatt cccaagtccg tggggctgcc 300 tcatcaaagc attgtaagaa ctgataacca tcttctagaa gtatcatagt gatattaaga 360 acacacatca cagatcatag taaatggctt taatttttta rcgaaatctc actactgcaa 420 atgcattgtt gtcctagcta atgaatgcat agagtattgc ctgcaaaata ataattgaga 480 ttctattttt aagaagctta gaacagtaca tggtgcatag caaagactct gtgtatgtga 540 agccagattt taaaatatgg taacaagtgt ctgaaaatat gtggctcaat ttgtctcccg 600 gttacttttc cctctccccc tttaaaatgt agaggaagga gaagaagaga taagaggttt 660 gtgagtgaag acaagggccc tttaaggcct gggaagacta acgccatagg gatctccctc 720 tgccttaaaa ggcacaggaa tcttagtggg gaaaaagaag tggtgataaa tagccagtcc 780 gtgtgcctgg aatatcaaag t 801 <210> SEQ ID NO 391 <211> LENGTH: 801 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 391 ccctgctccg tctagactgt gcccatattc gctgctggct gcaaatgcga ggagttgaca 60 gcagcctccc ctttacaagg caggaggtgc cactgttcgc cattgtctcc acctagggct 120 tcacttgctt tctatctgca gacatcagag ggacccacat ctctctgttc tgacacgctg 180 tgtgttgatg gcagagttta attatccaca tgcaatctta ctttccttat tcccaagtcc 240 gtggggctgc ctcatcaaag cattgtaaga actgataacc atcttctaga agtatcatag 300 tgatattaag aacacacatc acagatcata gtaaatggct ttaatttttt agcgaaatct 360 cactactgca aatgcattgt tgtcctagct aatgaatgca yagagtattg cctgcaaaat 420 aataattgag attctatttt taagaagctt agaacagtac atggtgcata gcaaagactc 480 tgtgtatgtg aagccagatt ttaaaatatg gtaacaagtg tctgaaaata tgtggctcaa 540 tttgtctccc ggttactttt ccctctcccc ctttaaaatg tagaggaagg agaagaagag 600 ataagaggtt tgtgagtgaa gacaagggcc ctttaaggcc tgggaagact aacgccatag 660 ggatctccct ctgccttaaa aggcacagga atcttagtgg ggaaaaagaa gtggtgataa 720 atagccagtc cgtgtgcctg gaatatcaaa gtcagtgcgt gccagggatc acactgcggg 780 tcacgtgcac tctgggtctc t 801 <210> SEQ ID NO 392 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 392 ttggcctggg gctgattcct ccaaagcaat gtgtctcttc gcagagtctc ttagagctgc 60 aaggcagtat gggatcatca gagaggatgc taggaagctt cagaaatgga ggtcctggta 120 gaaagggtcc tttggcgtgg cctctgaaga gtccaaatgt gggacaagac cctccgaaag 180 cggtggcctg gggagccaca ggtggggcag ccagcacgga agagggtggc tttgctacca 240 ttgggaaaac ttatcctcca catcctcatg aggcaaacac ctttcctacc ttaccgctcc 300 ycagtggcct ccctgttgcc ttcttattca agactaagac cctctagaat gttctttatc 360 ctgagtccag ctgattgtct atactaatat cagtacgggg tgtagatgag gacaaccagt 420 gtgcctggct gccaggcacc ccctccccaa accccaggag tttctggaac attccaactc 480 tgcttgaggg tatccatgca gcatctacta ctgtgagcag gtggtctgat ctgtggaaaa 540 cttctatgat tcacctgagg gtaactgccc tttgtgattt gaaagaatga tgctaacaga 600 a 601 <210> SEQ ID NO 393 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 393 gcagagtctc ttagagctgc aaggcagtat gggatcatca gagaggatgc taggaagctt 60 cagaaatgga ggtcctggta gaaagggtcc tttggcgtgg cctctgaaga gtccaaatgt 120 gggacaagac cctccgaaag cggtggcctg gggagccaca ggtggggcag ccagcacgga 180 agagggtggc tttgctacca ttgggaaaac ttatcctcca catcctcatg aggcaaacac 240 ctttcctacc ttaccgctcc tcagtggcct ccctgttgcc ttcttattca agactaagac 300 yctctagaat gttctttatc ctgagtccag ctgattgtct atactaatat cagtacgggg 360 tgtagatgag gacaaccagt gtgcctggct gccaggcacc ccctccccaa accccaggag 420 tttctggaac attccaactc tgcttgaggg tatccatgca gcatctacta ctgtgagcag 480 gtggtctgat ctgtggaaaa cttctatgat tcacctgagg gtaactgccc tttgtgattt 540 gaaagaatga tgctaacaga aagtgttgtc atttctgaac ttttctgaac tctgcagcga 600 g 601 <210> SEQ ID NO 394 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 394 agatttggat ggggacacaa aaccaaacca tatcataggt taaattgtgt ctcccacccc 60 aaaaatgtgt atgttgaagt cctaaccttc agtactcaga atgtgacatt atttggaaat 120 agggtcattg cagatggagt tagttaagat gaggtcatta ggatgagtcc ctaatccaat 180 atgactggtg ctcttacaaa aaggggaagt ttggacacag agccatgcac atgggtggga 240 agaatcccaa atgaacggat aggcagaggg ttggagagat gcatcaacaa ggaacaccaa 300 agattgccag caacccccag aagctggggg agaggcctgg aacagattct ccctcacagc 360 ctgagaggaa ccaagctggc tgacaccttg atctcaggtt accggccttg agaactgaga 420 gaccctgggt ttctgttgtt taagcctctc agggtgcagc actttattat ggaagcctga 480 gctgactaat acaggtgtct ytatatctca ctgagggaaa gtgacaggaa agtaagaacc 540 atttatgtcc aagagtccag aggagtcaac cagattctgg gggaaaagaa ggtacaatgc 600 tggcctctcc atgcagccta gtccccaaca cttgtagggc ccagggcaag atctaaagca 660 ctctctcacc tatgcatcta tatgctgtaa ctcagataaa caaactatta aataatatat 720 gtgtcttgcc tctcaatctg acaattacac ctttataata gcaacatagg aaaataacta 780 aaactatggt ttttaggcaa ccaaatacca gcaaaatgta ataattccta ttattagata 840 tgtttaagtg ttctgctggt gggtcagcat ctttggtaga gtcataaaat taaaatgtac 900 ataattaatt aaatattata tgtttattcc ctaacattta tttctgtcat ttcttttttc 960 tttttttcag acagtctcac tcttttgccc aggccggagt g 1001 <210> SEQ ID NO 395 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 395 ttgtgtctcc caccccaaaa atgtgtatgt tgaagtccta accttcagta ctcagaatgt 60 gacattattt ggaaataggg tcattgcaga tggagttagt taagatgagg tcattaggat 120 gagtccctaa tccaatatga ctggtgctct tacaaaaagg ggaagtttgg acacagagcc 180 atgcacatgg gtgggaagaa tcccaaatga acggataggc agagggttgg agagatgcat 240 caacaaggaa caccaaagat tgccagcaac ccccagaagc tgggggagag gcctggaaca 300 gattctccct cacagcctga gaggaaccaa gctggctgac accttgatct caggttaccg 360 gccttgagaa ctgagagacc ctgggtttct gttgtttaag cctctcaggg tgcagcactt 420 tattatggaa gcctgagctg actaatacag gtgtctctat atctcactga gggaaagtga 480 caggaaagta agaaccattt rtgtccaaga gtccagagga gtcaaccaga ttctggggga 540 aaagaaggta caatgctggc ctctccatgc agcctagtcc ccaacacttg tagggcccag 600 ggcaagatct aaagcactct ctcacctatg catctatatg ctgtaactca gataaacaaa 660 ctattaaata atatatgtgt cttgcctctc aatctgacaa ttacaccttt ataatagcaa 720 cataggaaaa taactaaaac tatggttttt aggcaaccaa ataccagcaa aatgtaataa 780 ttcctattat tagatatgtt taagtgttct gctggtgggt cagcatcttt ggtagagtca 840 taaaattaaa atgtacataa ttaattaaat attatatgtt tattccctaa catttatttc 900 tgtcatttct tttttctttt tttcagacag tctcactctt ttgcccaggc cggagtgcag 960 tggcgtgatc tcagctcact gcaacctccg cctcccaggt t 1001 <210> SEQ ID NO 396 <211> LENGTH: 1218 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 396 gataaagaaa ggtcatcctc aatttcaatt tactttatat attctttgag aggtaaccgt 60 gtcttatctc cccccaaaat tccttttaaa aggaaatttc caaagatgct ctattctgtg 120 aataaagcat tgtgccacag ccgagaggat ccagcaatga acatgagatt gcccttgatt 180 cataaggtct acaagctagt aaggatagag aacactttaa aataaaaaaa aatagttttt 240 ggtatattta tattgtgtat ttggtataat tgagttttct acattctcat atatgtattt 300 catattttga agaatatgca gaaaataatc aagcttccaa ataaacattt ttttttaaga 360 actgcacaag tgagaattta ggagaacaga agatcagagg gctgcacrgg ctaaactaga 420 caatgagccc atgcaagtaa gttaagagga gaagcgggta agtatgcacc tgctttgtct 480 aggtgaccag caagcattta gcaatagtct tttcaaaaca acagctcctt atattgtcaa 540 atctcaagaa gtaatattta tggttaaaaa aatctcagac ccaacagaaa atccatgagg 600 gagatggttt tggaaacgca gaattttcag ctatgatatc cttttataaa caagcagata 660 ctttccccaa atataattca atgcctcagt ctacctcctg ctgaaaccac taacaccacc 720 actaaagctc gactatatgg gaaaatttag gtgtcacttt caaaatatgt cctagcataa 780 aggcaattaa aaaatgtaaa gcaccaaaga tgcaagagag acataaatga ataaaatatc 840 tggcacgaaa gttttcaaaa gcttgggaat ctgattcaaa aaaaaataaa atcagccaag 900 cagtgttagt aagttagcca atcaggtttc aagaaggcag aaagacaaaa tcaacatcac 960 cagcatttga caccgctact gggggaaaaa agggggatgg agttcgttta tggccttttt 1020 aaaaatgcca ttacttggac aagagtcata acagagaagc actgcttatt tcagttctgt 1080 taactgtaaa tatcagagcc aacacccaga aaaagttcac cattagccaa ttggttttgc 1140 ctggccaatt ggagatggta ataggcctgc tatggatgac attctttctg atataagttg 1200 tttcttgctt tttctccc 1218 <210> SEQ ID NO 397 <211> LENGTH: 1218 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 397 gataaagaaa ggtcatcctc aatttcaatt tactttatat attctttgag aggtaaccgt 60 gtcttatctc cccccaaaat tccttttaaa aggaaatttc caaagatgct ctattctgtg 120 aataaagcat tgtgccacag ccgagaggat ccagcaatga acatgagatt gcccttgatt 180 cataaggtct acaagctagt aaggatagag aacactttaa aataaaaaaa aatagttttt 240 ggtatattta tattgtgtat ttggtataat tgagttttct acattctcat atatgtattt 300 catattttga agaatatgca gaaaataatc aagcttccaa ataaacattt ttttttaaga 360 actgcacaag tgagaattta ggagaacaga agatcagagg gctgcacggg ctaaactaga 420 caatgagccc atgcaagtaa gttaagagga gaagcgggta agtatgcacc tgctttgtct 480 aggwgaccag caagcattta gcaatagtct tttcaaaaca acagctcctt atattgtcaa 540 atctcaagaa gtaatattta tggttaaaaa aatctcagac ccaacagaaa atccatgagg 600 gagatggttt tggaaacgca gaattttcag ctatgatatc cttttataaa caagcagata 660 ctttccccaa atataattca atgcctcagt ctacctcctg ctgaaaccac taacaccacc 720 actaaagctc gactatatgg gaaaatttag gtgtcacttt caaaatatgt cctagcataa 780 aggcaattaa aaaatgtaaa gcaccaaaga tgcaagagag acataaatga ataaaatatc 840 tggcacgaaa gttttcaaaa gcttgggaat ctgattcaaa aaaaaataaa atcagccaag 900 cagtgttagt aagttagcca atcaggtttc aagaaggcag aaagacaaaa tcaacatcac 960 cagcatttga caccgctact gggggaaaaa agggggatgg agttcgttta tggccttttt 1020 aaaaatgcca ttacttggac aagagtcata acagagaagc actgcttatt tcagttctgt 1080 taactgtaaa tatcagagcc aacacccaga aaaagttcac cattagccaa ttggttttgc 1140 ctggccaatt ggagatggta ataggcctgc tatggatgac attctttctg atataagttg 1200 tttcttgctt tttctccc 1218 <210> SEQ ID NO 398 <211> LENGTH: 1072 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 398 cacttaaaag ctctggaaac ctacgagatt atctttaaaa tcgtggggac caaatggctg 60 gccaaggact tgtttctgta caggtgcgat tgcttctctg ctgtgttcct ttttattacc 120 caagtaaccg gtatttcagc tcacaagatg agaaaatgac aaacaggcaa aataagcgta 180 gggctgtgtg tgcaacagtt watcataaag ccatcaccag gagacgtcac tgggcgcctt 240 ctggagtcta tccgtcctaa ctttgctttc tttctttttt tttttaaatt taagttctag 300 ggtacatatg cacaacgtgc aggtttgtca cacatgtata catgtgccat gttggtgtgc 360 tgcacccatt aactcgtcat ttacattagg tgtatctcct agtgctatcc ctccccactc 420 ccccgacccc atgacaggcc ccagtgtgtg atgttcccct tcctgtgtcc aagtgttctc 480 attgttcaat ccccacctat gagtgagaac atgccatgtt tggttttttg tccttgcgat 540 agtttgctga gaatgatggt ttccagcttc atccatgtcc ctacaaagga catgaactca 600 tcctttttta tggctacata gtattccatg gtgtatatgt gccacatttt cttaatccag 660 tctatcatcg atggacattt gggttggttc caagtctttg ctattgtgac tagtgttgca 720 ataaatatac gtgtggatgt gtctttatag cagtttgatt tataatcctt tgggtatata 780 cccagtaacg ggatggctgg gtcaaatggt atttctagtt ctagatcctt gaggaatcgc 840 cacactgact tccacaatgg ttgaactagt taacagtccc accaacagtg tgaaagtgtt 900 cctatttctc cacatcctct ccagcacccc attttgactt tgctataagg gaactttagc 960 atctgaacgt gcggacagct tcattgctgg cttgttacgt aacagtgttt tgtgaccatc 1020 tcatgtcata cccacacatc gaaaccagca gtttaaatgg ccagctgttt gc 1072 <210> SEQ ID NO 399 <211> LENGTH: 1072 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 399 agattatctt taaaatcgtg gggaccaaat ggctggccaa ggacttgttt ctgtacaggt 60 gcgattgctt ctctgctgtg ttccttttta ttacccaagt aaccggtatt tcagctcaca 120 agatgagaaa atgacaaaca ggcaaaataa gcgtagggct gtgtgtgcaa cagtttatca 180 taaagccatc accaggagac rtcactgggc gccttctgga gtctatccgt cctaactttg 240 ctttctttct tttttttttt aaatttaagt tctagggtac atatgcacaa cgtgcaggtt 300 tgtcacacat gtatacatgt gccatgttgg tgtgctgcac ccattaactc gtcatttaca 360 ttaggtgtat ctcctagtgc tatccctccc cactcccccg accccatgac aggccccagt 420 gtgtgatgtt ccccttcctg tgtccaagtg ttctcattgt tcaatcccca cctatgagtg 480 agaacatgcc atgtttggtt ttttgtcctt gcgatagttt gctgagaatg atggtttcca 540 gcttcatcca tgtccctaca aaggacatga actcatcctt ttttatggct acatagtatt 600 ccatggtgta tatgtgccac attttcttaa tccagtctat catcgatgga catttgggtt 660 ggttccaagt ctttgctatt gtgactagtg ttgcaataaa tatacgtgtg gatgtgtctt 720 tatagcagtt tgatttataa tcctttgggt atatacccag taacgggatg gctgggtcaa 780 atggtatttc tagttctaga tccttgagga atcgccacac tgacttccac aatggttgaa 840 ctagttaaca gtcccaccaa cagtgtgaaa gtgttcctat ttctccacat cctctccagc 900 accccatttt gactttgcta taagggaact ttagcatctg aacgtgcgga cagcttcatt 960 gctggcttgt tacgtaacag tgttttgtga ccatctcatg tcatacccac acatcgaaac 1020 cagcagttta aatggccagc tgtttgcttg tgaaaactcc cctcggctgg ct 1072 <210> SEQ ID NO 400 <211> LENGTH: 948 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 400 aaattttctt tgctgaagtg tcttttcaaa tttttgcctt ttaaaaaaat tgagttgtct 60 taatattgag tcgtaaggtt ctttatatat tctggctata tgtcctttgt cagatatatg 120 tcttgcaaat attttctccc agtctgtggc ttaccttttc catttttaaa ctgtgtttta 180 taaaaaaaag aagttttttt agatcaaagt ccattttaat cattttttct tttatagttc 240 atgctttttg tgtctcattt aagaaatctt tccctactcc aatgtcacaa atatattctc 300 tgagaagctt aacagttttt gcaactaaat ttaggtctat gatccgtttt gacttaattt 360 ttccatatgg tgtcatgtaa cagttgagat ttttttccta tgcaggcaga tattcaatgg 420 ttcaagtacc atttattgaa atggctatct tttctccact gaatgacctt ggcactttta 480 tcaaacatca actggccaca yacaggtgag tctacttctg gacacttacc ctgttccatt 540 catctgtata tctctatcct tacaccaaca cgcatagtct tgaatactag ggcaagttaa 600 ttttaagatg tctcctggat atgtaaaaat tatatctgag ttgaactaca gtttatttat 660 atatccaggc agcaaataaa tgtgagaatc tggaggtgag ggaagagatc agagatacca 720 ccttggaaac catcaattta gagatgattc ttaaggcagg ggactaaggg acactctgta 780 ggacacagac atagagaagg gaaggggctg cggcctgaac accccacctg catgctcact 840 cacatacttt cgtcggcctg tgttaacgaa gtgctgggtc tccccagcct ctctcatctg 900 taagcagtgc caacaacgtc caacacagtt ccatccaatt tggatctg 948 <210> SEQ ID NO 401 <211> LENGTH: 920 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 401 aatttttgcc ttttaaaaaa attgagttgt cttaatattg agtcgtaagg ttctttatat 60 attctggcta tatgtccttt gtcagatata tgtcttgcaa atattttctc ccagtctgtg 120 gcttaccttt tccattttta aactgtgttt tataaaaaaa agaagttttt ttagatcaaa 180 gtccatttta atcatttttt cttttatagt tcatgctttt tgtgtctcat ttaagaaatc 240 tttccctact ccaatgtcac aaatatattc tctgagaagc ttaacagttt ttgcaactaa 300 atttaggtct atgatccgtt ttgacttaat ttttccatat ggtgtcatgt aacagttgag 360 atttttttcc tatgcaggca gatattcaat ggttcaagta ccatttattg aaatggctat 420 cttttctcca ctgaatgacc ttggcacttt tatcaaacat caactggcca cacacaggtg 480 agtctacttc tggacactta ycctgttcca ttcatctgta tatctctatc cttacaccaa 540 cacgcatagt cttgaatact agggcaagtt aattttaaga tgtctcctgg atatgtaaaa 600 attatatctg agttgaacta cagtttattt atatatccag gcagcaaata aatgtgagaa 660 tctggaggtg agggaagaga tcagagatac caccttggaa accatcaatt tagagatgat 720 tcttaaggca ggggactaag ggacactctg taggacacag acatagagaa gggaaggggc 780 tgcggcctga acaccccacc tgcatgctca ctcacatact ttcgtcggcc tgtgttaacg 840 aagtgctggg tctccccagc ctctctcatc tgtaagcagt gccaacaacg tccaacacag 900 ttccatccaa tttggatctg 920 <210> SEQ ID NO 402 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 402 tgtgctgctt ccattccata ggcacctgat cctaagtgtt aaccaatccc agaactctcc 60 ccttatttct tgctgcatgt tttgaattga tgtgataaac aatgtgattc gagcgtctta 120 actcagccta tgagcctctc tattctgtga ctgctggaat aggctgcttg gccatgttct 180 tggaagctac caccatatca rggtaatttc ccacacaaca ttccagcccc tgctttcccc 240 tctggcctta tctagggcca ttccccaact caggtgaatg cagactccaa atgtactgag 300 ctgtgtgcag gggccaggtg caaatgcttt ctgtgcatct gcacatgctg ttctacctgg 360 gaagtccttt cctcctttca cctattttta ccttaaacct cagacatcat ctaccctgga 420 aagtccttcc tgacctcacg catctaagta ggtccccccc ataatcccta tccatgcctt 480 ctatagtact taacatggtg acctttaatt gttcatttac ttagctctct gctctcccac 540 actgtgaact ccttacaaac agggaatgtc atctctgaat gaatctttca tctccatgta 600 acacatgcct ccaaccctac ctagcacaca atctggcata taacaggcac tcaataaacc 660 ttcaatgaat gccttgatca agtacaagga acataagcaa a 701 <210> SEQ ID NO 403 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 403 ttaaccaatc ccagaactct ccccttattt cttgctgcat gttttgaatt gatgtgataa 60 acaatgtgat tcgagcgtct taactcagcc tatgagcctc tctattctgt gactgctgga 120 ataggctgct tggccatgtt cttggaagct accaccatat cagggtaatt tcccacacaa 180 cattccagcc cctgctttcc yctctggcct tatctagggc cattccccaa ctcaggtgaa 240 tgcagactcc aaatgtactg agctgtgtgc aggggccagg tgcaaatgct ttctgtgcat 300 ctgcacatgc tgttctacct gggaagtcct ttcctccttt cacctatttt taccttaaac 360 ctcagacatc atctaccctg gaaagtcctt cctgacctca cgcatctaag taggtccccc 420 ccataatccc tatccatgcc ttctatagta cttaacatgg tgacctttaa ttgttcattt 480 acttagctct ctgctctccc acactgtgaa ctccttacaa acagggaatg tcatctctga 540 atgaatcttt catctccatg taacacatgc ctccaaccct acctagcaca caatctggca 600 tataacaggc actcaataaa ccttcaatga atgccttgat caagtacaag gaacataagc 660 aaatttcctg tggaaaaaaa gaattgtatt aagttctttg g 701 <210> SEQ ID NO 404 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 404 atgttcactt acacatcttt ctttcactta attgaatcct ttatttttgt cttagaatct 60 tctgaatatt gaaaacagag aactatactg gaagaacata gtgtattaag actcatggag 120 agggagatgt gatactgtgt cactgaggtc gttccagtca taggagaaat gttaccactg 180 gattgaggtc tggtacattt taaaagatga tttaattcta tgatatgtgt tcaacttgca 240 ctaggatagt ttttactttc acctttgttc catgcaccgc gcaaatacct gggaaccctt 300 rttgcccaac tcaagagcca gagtcctctg tcatcatttt gcctctctcc taagtgacag 360 gactgagtgc agacttggtg tttgtgggtg aggcatgtgg actgacaggc aggcttcagt 420 ttatttagcg agtgtgagcc ctggcaggaa gattctcttt ctctgcttgc caggttgagg 480 aggcctcatt aagcagtttg aacttgtggt tttggcgtgt ctagtcctgg tgcaggtggc 540 ttggtatcct cacaggcatt tctttggcct cacccttggg gtgactgttc acttgtgttt 600 g 601 <210> SEQ ID NO 405 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 405 tcttctgaat attgaaaaca gagaactata ctggaagaac atagtgtatt aagactcatg 60 gagagggaga tgtgatactg tgtcactgag gtcgttccag tcataggaga aatgttacca 120 ctggattgag gtctggtaca ttttaaaaga tgatttaatt ctatgatatg tgttcaactt 180 gcactaggat agtttttact ttcacctttg ttccatgcac cgcgcaaata cctgggaacc 240 cttgttgccc aactcaagag ccagagtcct ctgtcatcat tttgcctctc tcctaagtga 300 saggactgag tgcagacttg gtgtttgtgg gtgaggcatg tggactgaca ggcaggcttc 360 agtttattta gcgagtgtga gccctggcag gaagattctc tttctctgct tgccaggttg 420 aggaggcctc attaagcagt ttgaacttgt ggttttggcg tgtctagtcc tggtgcaggt 480 ggcttggtat cctcacaggc atttctttgg cctcaccctt ggggtgactg ttcacttgtg 540 tttgagcggc tgggactcag taggttcact ggagtaggta tttctttaga gccactggcg 600 g 601 <210> SEQ ID NO 406 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 406 cagctccttg gcaagcctgc tccttcccca gcaaatggaa acaccattct gaacacctgg 60 gcattgtctc tgatgtccct tttcatctcc ctactctcac acaatccagc tgcctctctg 120 ccttccacgg atattaagaa cgtccaccat ctcctgagtc caagcccttc tcactcacct 180 ctttcttgaa ctaatttctt yctgtttttt tccagtcctc ccttctgttc atgtctctcc 240 tctgcacact tccattttct ggttcagaaa atgtcaccgt cccagtcaca cttgccttat 300 ggctgttgtg tcataaatac agttgacact tgaacaacat gggtttgaac tgcatggatt 360 cacttataca catatttttt caatacaaat atatttaaaa attttggaga tttgcaacaa 420 tttgaaaaaa cttgcagatg aacagcatag catagaaata ttgaaaaatt aagaaaaagg 480 tatgtcatga atgcataaaa catatgcaga tactagtcta ttttaacctt tactgccata 540 aaatatacac aaatctatta taaaaggtta aagtttatca aagcttatgc acacaaacac 600 ttatagacca tatagggagc cattcagtag agagaaatgt aagcgaacgt aaaggtgtgc 660 tatttaatca caactgcata cacactgtac cactgcacta a 701 <210> SEQ ID NO 407 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 407 gggcattgtc tctgatgtcc cttttcatct ccctactctc acacaatcca gctgcctctc 60 tgccttccac ggatattaag aacgtccacc atctcctgag tccaagccct tctcactcac 120 ctctttcttg aactaatttc tttctgtttt tttccagtcc tcccttctgt tcatgtctct 180 cctctgcaca cttccatttt stggttcaga aaatgtcacc gtcccagtca cacttgcctt 240 atggctgttg tgtcataaat acagttgaca cttgaacaac atgggtttga actgcatgga 300 ttcacttata cacatatttt ttcaatacaa atatatttaa aaattttgga gatttgcaac 360 aatttgaaaa aacttgcaga tgaacagcat agcatagaaa tattgaaaaa ttaagaaaaa 420 ggtatgtcat gaatgcataa aacatatgca gatactagtc tattttaacc tttactgcca 480 taaaatatac acaaatctat tataaaaggt taaagtttat caaagcttat gcacacaaac 540 acttatagac catataggga gccattcagt agagagaaat gtaagcgaac gtaaaggtgt 600 gctatttaat cacaactgca tacacactgt accactgcac taatttcaga gccacctcct 660 gttgtgattg tggtgagccc aagtgttgtg aggatctgct t 701 <210> SEQ ID NO 408 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 408 caggtagggt aagcaaatga acacaaattc aaactcggaa ttcaaaacca gcctctgtgt 60 attcctgagg accatactgt ctgctaagtg tagagaaagg cacatcctgg ttcaacagca 120 gagaaagcaa acaggaggca ctttctgtga gtcatctcca ccacagggcc ctctcttttg 180 tgatccagcg atacttgttc acagtcaaag cccaggaaga gtggaaagat taacctttgt 240 gagccaaacc rtgtgacact tgattacttg acagaactaa tccttctgtc ctgatgacag 300 aaattcaact acacaggtac atgcaagcta atatctgttg taatgcctcc cagtttctct 360 ggagaattcc ttagtttcct ggacatctct gaaatgcaaa gttttggcaa cgagtctctg 420 aattaacctc tgaaaatctc acccagccaa gatggccttc ttgagaagac tgaagaacat 480 ggttggtttc aggctgagct g 501 <210> SEQ ID NO 409 <211> LENGTH: 604 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 409 cactttctgt gagtcatctc caccacaggg ccctctcttt tgtgatccag cgatacttgt 60 tcacagtcaa agcccaggaa gagtggaaag attaaccttt gtgagccaaa ccgtgtgaca 120 cttgattact tgacagaact aatccttctg tcctgatgac agaamttcaa ctacacaggt 180 acatgcaagc taatatctgt tgtaatgcct cccagtttct ctggagaatt ccttagtttc 240 ctggacatct ctgaaatgca aagttttggc aacgagtctc tgaattaacc tctgaaaatc 300 tcacccagcc aagatggcct tcttgagaag actgaagaac atggttggtt tcaggctgag 360 ctggaagtgg tttacctccc aggagaggtt ccccacagtg gtgtttaagg catggggtgg 420 accaacacca ggaagactca gacatcacac cacccacctt caactcagtc acatccacct 480 acattttctg aaaacaaaag gcagtctccc caaaaagcac tgagactctt gtgtaggtaa 540 tctgagcaga caccaacttc ccagggcttc cttttatcca ggagagcttg gctgttcttt 600 ttaa 604 <210> SEQ ID NO 410 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 410 ctccttccgc catggttgta agtttcctga cgcctcccag tcatgcttcc cgtacagcct 60 gcagaactgc gagtcaatga aatccctttt ctccacaaat tacccagtct caggtagttc 120 cttacagcag cgtgggaaca gactcaagag ctgaagcaag caaggccgtt agcaaggagc 180 gggctgggga gagcactcca ggcagaggga acagccaggg ccagggcctt gagacagacg 240 tgagccagga tatctgagga acagcagaga agccagtgtg gccgcagcta aatgaggaac 300 aatgtgtgag ttccctgggg cggccaaaac aaacaccacg gacgggggcc ttcaaccaca 360 gacaccgatt tcctcacagc tctggaggcg aaaagtccaa gaaaactgca cggagtatct 420 atgaggccct gatggagacc tgacctggtc cacacccatg gcctggcaag ctagatgggg 480 tgaattttca cctgccacag ycgcaagtca aagccaccgg cttctctctt ctccctccca 540 ttgctcctga cagccagggt taatattttg cctcatgtaa acagggaggc atccacccga 600 gaatctcccc tcagcccaca taagctctgc agagagggct gtgttgctcc agttcccacc 660 tggacatgag cactttgaag ggcagcttcc ctcccggggt c 701 <210> SEQ ID NO 411 <211> LENGTH: 612 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 411 gggctgggga gagcactcca ggcagaggga acagccaggg ccagggcctt gagacagacg 60 tgagccagga tatctgagga acagcagaga agccagtgtg gccgcagcta aatgaggaac 120 aatgtgtgag ttccctgggg cggccaaaac aaacaccacg gacgggggcc ttcaaccaca 180 gacaccgatt tcctcacagc tctggaggcg aaaagtccaa gaaaactgca cggagtatct 240 atgaggccct gatggagacc tgacctggtc cacacccatg gcctggcaag ctagatgggg 300 tgaattttca cctgccacag tcgcaagtca aagccaccgg cttctctctt ctccctccca 360 ttgctcctga cagccagggt taatattttg cctcatgtaa acagggaggc ayccacccga 420 gaatctcccc tcagcccaca taagctctgc agagagggct gtgttgctcc agttcccacc 480 tggacatgag cactttgaag ggcagcttcc ctcccggggt ctggctgagc tcagggtagg 540 cgtcagtctg catggattgg atggaggaag gctgtgcgtg gcaggagatg acactgccct 600 tgggctgtgt gg 612 <210> SEQ ID NO 412 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 412 ttggggaagg aagcactggg gggaaggaag cactgggctt gggacagggc tgggcgctgc 60 ctcttcactg gaccatgaca aggttgttac ctcaccaagg agaggtgcaa aaagcttagg 120 ggcttggatt tctagatttc agtgccaact atgccactta ctggctttat ccttggggaa 180 tttatctact ctgtgaccct cagttttttt atcttaatta ttaatacata cctcataatg 240 tgactgtgag gattcactta ataatatatg gaaaaccata gaatagtgcc cagcatctag 300 gaagtgccac agcccccttc agaagctagt gaaacctgca gaccactttt cagagtgata 360 ttattatttt tttctaggtt tactgagtta taattgaaaa aataaaaatg gaatatagat 420 gtacaacatg aagctctgat gcatatatcc attgtgaaat gatgaccaca atcaagctaa 480 ttaatgttat ctatcacttc wcatagttca accttttttt gtggtgagag tactgaagat 540 ctactctctt agcaattttc aaatctaaaa tacattatta ttaacacagt cactgtgccg 600 tacgttagct ctgaggacct tattcatttt atacctaaaa gtctgtatcc tttaaccaac 660 ctctcctaat ttcccactgt catccctact gccacctctg gtaaccagcc ttctgctctg 720 tttctgagtc caaccttctt agattccaca tatgagtgag atcatgctgt gcagtgtttg 780 tttttctgtg tctggcttgc tttcacttag cataatgtcc tccaggtcca cccatgttgt 840 tgcaaatggc agaatcttct tcttgttaaa gactgaataa tatccctgtg tgtgcgtgca 900 tgtgtgtgtg tgtttgtgtg tgtgtgtgta tcacattttc ttcatccatt catccatcaa 960 tggacactaa gcactaaggt tgattccgta tcttggctat t 1001 <210> SEQ ID NO 413 <211> LENGTH: 2480 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 413 aacattactt ggggaaggaa gcactggggg gaaggaagca ctgggcttgg gacagggctg 60 ggcgctgcct cttcactgga ccatgacaag gttgttacct caccaaggag aggtgcaaaa 120 agcttagggg cttggatttc tagatttcag tgccaactat gccacttact ggctttatcc 180 ttggggaatt tatctactct gtgaccctca gtttttttat cttaattatt aatacatacc 240 tcataatgtg actgtgagga ttcacttaat aatatatgga aaaccataga atagtgccca 300 gcatctagga agtgccacag cccccttcag aagctagtga aacctgcaga ccacttttca 360 gagtgatatt attatttttt tctaggttta ctgagttata attgaaaaaa taaaaatgga 420 atatagatgt acaacatgaa gctctgatgc atatatccat tgtgaaatga tgaccacaat 480 caagctaatt aatgttatct atcacttcac atagttcaac ctttttttgt ggtgagagta 540 ctgaagatct actctcttag caattttcaa atctaaaata cattattatt aacacagtca 600 ctgtgccrta cgttagctct gaggacctta ttcattttat acctaaaagt ctgtatcctt 660 taaccaacct ctcctaattt cccactgtca tccctactgc cacctctggt aaccagcctt 720 ctgctctgtt tctgagtcca accttcttag attccacata tgagtgagat catgctgtgc 780 agtgtttgtt tttctgtgtc tggcttgctt tcacttagca taatgtcctc caggtccacc 840 catgttgttg caaatggcag aatcttcttc ttgttaaaga ctgaataata tccctgtgtg 900 tgcgtgcatg tgtgtgtgtg tttgtgtgtg tgtgtgtatc acattttctt catccattca 960 tccatcaatg gacactaagc actaaggttg attccgtatc ttggctattg tgaataatgc 1020 tgcaataaac atatgagtcc agatacctct tcaagatact gatttcattt cctttaaata 1080 tatgcccaga agtgggattg ctggatcata tggtagttct atatttagta tcttgaggaa 1140 tttccatact gtttttcata atgattgtag caatctatat tcccatcaac agtgtacaag 1200 ggttccattt tctacatggc cttaccaacg tttgttatca cttatctttt tgataataga 1260 tattctagca ggtgtgaggt ggtatctcat tgtggtttta atttgcattt tcctgatgat 1320 tagtggtgta gagcatcttt tcatattccc attggtaatt cgtatatctt cctttgagaa 1380 atatttattc agatcttttg cccattgtta gctgagttat atgtgagttg gttttggttt 1440 gttgttgttt tttgtttttg ctattgagct gagttccttg tatattttgg atattaaatc 1500 cttctcagct gtatggttga cagatacatt cttgcattct gtaagttgca tctgtaggtt 1560 gcaacagagt ctctttactc tgttgattgc ttgctttact gtgtgaaagc ttttttagct 1620 tgatgtaatt gtgtttgtct atttttgctt ttgttgcttg tacttttagt gtcatatcca 1680 aaaagttatt gcccagacca gtgtcatccc ctatgttttc ttctagtaat tttaaagttt 1740 caggtcttat gtctatgtct ttaatccatt ttgagttaat ttttgtgtag ggtttaagat 1800 aagaatccaa ttttattttt attttttgta tatggatatc caatttcccc aacaccattt 1860 attgaaaatt ctatcctttc tttgttgtgt attaacatca gaataatatt tttaaataca 1920 taaaattcag aagatgacaa aggaaaccaa ttacattgaa atgcatacag agttataatt 1980 ctgaaagagc aatatatgtg cctctttgta aacacatcat atatcaaact gcagtgaccg 2040 ttctaacaac tattgcaatt tcaaagtcat gttgagtagg aggagtactt tgagattctg 2100 aaacaacgtt cttgtgctat gaaatatcca tgattttgat tggtgatggt atcccaggtc 2160 ttgttaatgc tgctgtaatc tgttgcttcc attccatagt tgaataaaat gcttgatatc 2220 tgttggaaat tagtaaaaat aaaaacgtat ttttttccat ccaagttcat tctcagaccc 2280 tgaagagtca cttctctgga ttctgcagca aagttcccag ctggggcagc aagatttagg 2340 caattgaaaa gaacatacac cttgttctca gtggcaaacc acatggaaag ctttaaatgt 2400 cagagaagaa ttctgccatt ttgctgactt ttttgtagtt ctcctaataa acaagtgtta 2460 agtgacaagc ttttcagagg 2480 <210> SEQ ID NO 414 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 414 cccccccccc ccccgcagat ctcaggtggg catttttgaa cttaactaga taacaaaaca 60 cagctaagac aagtcctttt ctccagcaaa gatggcaatg ctctaataac tctgagcata 120 ttaaagattc tccaagactc tagcctctgc tgcaaaaaca catacaaata cctactacta 180 ctgctgctgt gatgatgatg atgacagcaa tagtgagaat attttaaata tgccaggcac 240 ggtggcaact gctttccaaa tattatcata tttaatctga tcattgccct atgaggtagg 300 ragtattctg attcccattt tataaataag gaacccgagg cttagagagc atcggtgact 360 tgttcaaggt cacccacagc tgtcaagtga cagaacttcg ataaaaatcc agactccttt 420 aatggagtat ggagggaggt cagaaaacat aggaagtaag ggattgtgat tgacaatgtg 480 tccttgcaaa gggacaggtt aagagacaca agggcagctg tctgaggtgt gccattcacc 540 agcttcagga gagaagtggc aggctacctc cagctatcca gccctatcca gccaaggaag 600 c 601 <210> SEQ ID NO 415 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 415 caaaacacag ctaagacaag tccttttctc cagcaaagat ggcaatgctc taataactct 60 gagcatatta aagattctcc aagactctag cctctgctgc aaaaacacat acaaatacct 120 actactactg ctgctgtgat gatgatgatg acagcaatag tgagaatatt ttaaatatgc 180 caggcacggt ggcaactgct ttccaaatat tatcatattt aatctgatca ttgccctatg 240 aggtagggag tattctgatt cccattttat aaataaggaa cccgaggctt agagagcatc 300 rgtgacttgt tcaaggtcac ccacagctgt caagtgacag aacttcgata aaaatccaga 360 ctcctttaat ggagtatgga gggaggtcag aaaacatagg aagtaaggga ttgtgattga 420 caatgtgtcc ttgcaaaggg acaggttaag agacacaagg gcagctgtct gaggtgtgcc 480 attcaccagc ttcaggagag aagtggcagg ctacctccag ctatccagcc ctatccagcc 540 aaggaagctt gggagacatg ttagttcccg ccttcatttc catcagcaac ctcaaagcca 600 c 601 <210> SEQ ID NO 416 <211> LENGTH: 5823 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 416 tatttcaggc tttcttcttt ctatggataa gaaagctcct caggtggcaa caaaggccat 60 ttctttggaa gcaggcatgg catgtgacga aaaaaagaca tctcagaaaa gagccaagaa 120 taagactgga gagccactgt cagagaacag aaactgggct taatcaagga acatctcttg 180 ttcccagagt aggaggctgg caatattttc tcactgaaat ttcagaattg ttatggacca 240 gtgactgctc tatgtgttca atttgttccc ttttcaaatg gaagcattta ttgcagacga 300 cctgcctctg tcccaccatt gtgtattagg tttgtagagy gtagacaact tgccttttta 360 gtttgtaggt ttctgtatca agagaagatg tgtgtgggcc taacctagat tacaggatcc 420 tggacttcaa gtctgatata atgactggat gagactttga ctgtcctaga attgggatga 480 acatattttg ccggtgggag ggcgtgagta attgcggtta gagggcagac tgtccctcac 540 acctattcct tttcatggtg ccttcccaaa ctgcctctgg aggtggccac acaaatggct 600 ttggccattg tgaccatggg aaacttgatg cagaggctgg aaaaagcact tgcatgtttc 660 tgtctcctct cttgttcctc tacaatcaca agaaatgtct aggcaggtct gagcaggccc 720 aggctcatct gccatggaag aagaatggca catggaagag ggtcacattg tcccaaccaa 780 gacgatccta gaccagccag gccccagttc atggttcaag acacatgaac atagttgcac 840 gaaccaagat tagttgtgta tggcccagac tagcagcagc acccatccaa cctacagact 900 ctgagaaata aatactagtt gtcttaagct tccaagtttc agtgtgagca ttaggtagta 960 acagttaatg aataagacag ataatcattt tatctgtctg gatacttata caatgatttc 1020 tattttttat tgatacataa tattttacat attgctgggg tacatgtgac attttgctac 1080 atacatagaa tgtgtaatga tccagtcagg atatctgagg tgtccatcac tttgagaatt 1140 tctcacttct gtgtgttggg aacaattcaa gtcgtctctt ctagttattt taaaatatac 1200 aatacattgt taactgtagt cttttttatt gaatgacagg acttgtacct tttatctaac 1260 tgtatgtttg tatctattaa gctagttctc tttatccctg ccccctccta cccactcact 1320 cttcccaacc tctaacatgt atcatcctat tctatatctc catgagatca acttctttag 1380 ctcccacata tgagcaaaaa catatgatgt ttgtctttct gtgcccggtt tatttcactt 1440 atgacctcca tttccatcca tgttactata aatgacagga tttcattctt tttgtggcca 1500 aacagtattt cattgtgtat atatactaca ttttctttat ccattcatcc attgatgaac 1560 acttacgttg attccatatc tttgctattg tgaatggtgc tgcaataaac atgcacgtgc 1620 agttatccct ttgatacact gatttatttt cctttggata aatacccagt agtgagattg 1680 ctggatcata cggtagttct acttttagtt tttgagacat ttccatactt ttccagtgtt 1740 tgtattaatt tacattccca tcaacaatgt ataagatttc cctttcctcc acatcctcac 1800 cagcatctgc tattttttgt ctttttaata atagtcattc taactggggt gagaggatat 1860 ctcgctatgg ttttgatttg catttccctg atatttaatg atattgagca tttcttcata 1920 taacctattg gccatttgtg tgtctttttt tttttttttt ttttttttga gaattgtcta 1980 ctcatttttg gctttttaaa agatttattt tttgttgttg ttgagtttag tgcatatcct 2040 ggatattagt ctcttatctg atgaagagtt tgccaatatt ttctcccatt caacaggttg 2100 tctcttcatt ctgttgactg tttcctttgc tgtgcagaag cactttatat acagtcccat 2160 ttgtctattt tttagtagtc tatgcattta aggtctcagc cacaaaatct ttgcctagac 2220 cagtcctaaa gtgtttcccc tatattttct tctagtagtt ttattgtttc atgtcttata 2280 tttaagtcta taatccattg tgagttgatt tttgtatatg gtgagatagg ggccttgttt 2340 cattcctctg catatagata tttaattttc tcagcaccat ttattgaagg tgtccttccc 2400 tattgtatgt tcttggtgcc tttgtcaaaa ttcagttggc tataaatatg tgaatttatt 2460 tctgggttct ctatgtggtt ccattagtct atgtgtctat ttttatacca atatcatgct 2520 gttttgatta ccatagcctt gtaatatatt ttgaagtcag gtagtgtgat gcctccagct 2580 ttgttctttt tgctcaggat tgctgtgcat actctggctt tttggttaca tacaaatttc 2640 aggatttttg tatttctgtg aaaaatggca ttagtatttt gataggaatt gcactggatc 2700 tgtatattgt cctggacaac atggtcattt taacaatatt aattcttcta atctatgagt 2760 atgagacgtc ttcccacttg tttgtgtcct cttcaatttc tttcattggt gtttcataat 2820 ctcccttcta caggcctttc acctccttgg ttaaattaat tcctaggtat ttttttgtag 2880 ctactgtaaa tgggactgcc ttctttctca gctagttcat ttttggtgca tagaaaccct 2940 atttttgtat gttcattttc tatcctgcaa cattaccaaa tttgcttatc agctttaagt 3000 gtgtattttg ctttgcttgt agagtcttct ggtttctcta aatgtaagac gatgtcatct 3060 gcaaacgggg acaatttgac ttcctcttaa aaatctgtat gccttttatt cctttctctt 3120 gcctgattgc tctggctcta cctccagtac tatactgaat aaaagtggta aaagtgagca 3180 tccttccttg tcttgctcta gttcttagag gaaatacttt cagtttttcc ccactcagta 3240 tgatgttagc tgtgggtcat atatagcctt tattatgtta agatatgttt cttctgtacc 3300 tggtttgttg acagcttttt atcataaaag gatgtagaat tttatcaaat gttttttctg 3360 catctgttga gataatcata tggtttttgt cattccttct actgttgtga tgtatcatgt 3420 ttattgattt gtgtatgtta aaccatcctt gtgtccttgg tataaattat acttggtcat 3480 ggtgtattat ctttttggca tcctgtcgaa ttgtttgcta gctttttgtt ttgttctttt 3540 tgagaatttt tatgtctagg ttccttagaa acactggcct gtagttctct ttttgtgtgt 3600 gtgtccttgt ctagtttggt gtcagggaaa tggtggtctt gtagaatgag ttgttttttc 3660 tttgattttt ttgcaagagt ttgaggagaa tgggtattag ttcttcttta tgtggttggt 3720 caaattggca gtgaattcat tcagtcatga gcttttcttt ttttgggagg gttctcatta 3780 ctgagttaat cacactgctc attactgatc tgttcagatt ttctatttct tctggaatct 3840 cagtagttgt atgtttccag caatttatcc atttcctcta ggttttctag tttggtagta 3900 tatagctatt cataatagtc tctgatgatc ttttgtattt ctgtgatatc agttgtaatg 3960 tctttttcat ttcctatttt atttgggtct tttcttgttt agtctagcaa ggggtttatc 4020 tattttatct ttttgaagaa ccaacttttt gtttcattga ccctttctac gtctttagtc 4080 tttatttcat ttagatttgc tctgaacttt actatgtctt tccttctaat tttgggtttg 4140 gtttgttctt ttctagttcc ttgaggtgca tcattgaatt gtttctttga tatctatcta 4200 ctcatttgat gtaggtgttt attgctatac actctcccct cctagagctc cttttgttgt 4260 gtcccatagg tcttggtatg ttgtttctat tttcatttgt ttcaaacatt ttatttccat 4320 attaattttt atcattcagg aggagcatat tatttaattc ccatgtattt gtatagtttc 4380 caaagttcct cttatttcta tttttactcc attgtggtct gagaagatac ttcatatgat 4440 ttcaattttt aaaaatttgt caagacttgt tttttgtcct aacatatggt ctatcctgga 4500 gaatgttcca tgtgctgatg agaaaaatgt gtactcagca gttgttgagt aacatgttct 4560 acaaatatct gttagatcca tttggtctaa agtctagttt aaatccaatg agtttttgtt 4620 aattttgtct agatgatcat gatctgagac tgaggtgaag tccccaacaa ttatcgtgtt 4680 ggagtctacc tctcttttta aatctagaaa tatttgcttt ataaatccgg gtggtctagt 4740 gttgggtgca tatatttagt tgttatttcc tcattagatt gatctcttta ctattatata 4800 ataactgttt actgcttctg gcataaagtc tgttttatgt aagtacagcc attcctgctt 4860 gagtttagta ccatgttgac aaagggatgc atagagagtt ggtaaagcat gatttctggg 4920 tgtctgtgtg aaggtgtttt gagaagagtt tagcatgagt ctgtggagtg agtgggaaga 4980 ttctccctca atgtcagcag gaaccatcca tccactgggg gcccaggtag aaaaagatga 5040 agaaatggtg aattctctct ctctcctgga gctgggtcac ccttcttctg cccttgaaca 5100 ggacatcaca actccaggct ctccagcctt tggactccaa gactgacacc agtgcccctc 5160 cccaattacc ccaggccctc aggcctttgg cctaggattg agacttacac catcagcttc 5220 cctggttctg aggcttctgg acttgcactg ggccatacta ccagcatccc agggtctcca 5280 gcttgcagag agcctgttgt gggacttttc agcctccata atcaagtaag ccaatttccc 5340 tggtatctat atagatatac aatcatgttt tgcttaccag cctgaaaaat gtatcgctag 5400 atgagtctgt cattgcataa acatcatagt gtacttacac aaacctagat tctatagcct 5460 actacacacc tagtctataa acatgtacag catgttactg tactgaatat tgtaggcaac 5520 tgtaacacaa tggtgaatat ttgcatattt aaacatatct tatcattaaa aagatacagt 5580 aaacataagg tataaaagac aaaaaccggc acacctatat agggcactta ccataaatgc 5640 agcttgcagg actagaagtc actcagggtg agtcagtgag cgaacgtgaa ggcctaggtt 5700 attactgtcc actacggtag actttatcaa cactgtacac aggctacact aaatttattt 5760 tttaaaaatt tgctctccaa taataaatta atcttcgcat cctttttttg ttgttcactg 5820 tgg 5823 <210> SEQ ID NO 417 <211> LENGTH: 5823 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 417 tatttcaggc tttcttcttt ctatggataa gaaagctcct caggtggcaa caaaggccat 60 ttctttggaa gcaggcatgg catgtgacga aaaaaagaca tctcagaaaa gagccaagaa 120 taagactgga gagccactgt cagagaacag aaactgggct taatcaagga acatctcttg 180 ttcccagagt aggaggctgg caatattttc tcactgaaat ttcagaattg ttatggacca 240 gtgactgctc tatgtgttca atttgttccc ttttcaaatg gaagcattta ttgcagacga 300 cctgcctctg tcccaccatt gtgtattagg tttgtagagt gtagacaact tgccttttta 360 gtttgtaggt ttctgtatca agagaagatg tgtgtrggcc taacctagat tacaggatcc 420 tggacttcaa gtctgatata atgactggat gagactttga ctgtcctaga attgggatga 480 acatattttg ccggtgggag ggcgtgagta attgcggtta gagggcagac tgtccctcac 540 acctattcct tttcatggtg ccttcccaaa ctgcctctgg aggtggccac acaaatggct 600 ttggccattg tgaccatggg aaacttgatg cagaggctgg aaaaagcact tgcatgtttc 660 tgtctcctct cttgttcctc tacaatcaca agaaatgtct aggcaggtct gagcaggccc 720 aggctcatct gccatggaag aagaatggca catggaagag ggtcacattg tcccaaccaa 780 gacgatccta gaccagccag gccccagttc atggttcaag acacatgaac atagttgcac 840 gaaccaagat tagttgtgta tggcccagac tagcagcagc acccatccaa cctacagact 900 ctgagaaata aatactagtt gtcttaagct tccaagtttc agtgtgagca ttaggtagta 960 acagttaatg aataagacag ataatcattt tatctgtctg gatacttata caatgatttc 1020 tattttttat tgatacataa tattttacat attgctgggg tacatgtgac attttgctac 1080 atacatagaa tgtgtaatga tccagtcagg atatctgagg tgtccatcac tttgagaatt 1140 tctcacttct gtgtgttggg aacaattcaa gtcgtctctt ctagttattt taaaatatac 1200 aatacattgt taactgtagt cttttttatt gaatgacagg acttgtacct tttatctaac 1260 tgtatgtttg tatctattaa gctagttctc tttatccctg ccccctccta cccactcact 1320 cttcccaacc tctaacatgt atcatcctat tctatatctc catgagatca acttctttag 1380 ctcccacata tgagcaaaaa catatgatgt ttgtctttct gtgcccggtt tatttcactt 1440 atgacctcca tttccatcca tgttactata aatgacagga tttcattctt tttgtggcca 1500 aacagtattt cattgtgtat atatactaca ttttctttat ccattcatcc attgatgaac 1560 acttacgttg attccatatc tttgctattg tgaatggtgc tgcaataaac atgcacgtgc 1620 agttatccct ttgatacact gatttatttt cctttggata aatacccagt agtgagattg 1680 ctggatcata cggtagttct acttttagtt tttgagacat ttccatactt ttccagtgtt 1740 tgtattaatt tacattccca tcaacaatgt ataagatttc cctttcctcc acatcctcac 1800 cagcatctgc tattttttgt ctttttaata atagtcattc taactggggt gagaggatat 1860 ctcgctatgg ttttgatttg catttccctg atatttaatg atattgagca tttcttcata 1920 taacctattg gccatttgtg tgtctttttt tttttttttt ttttttttga gaattgtcta 1980 ctcatttttg gctttttaaa agatttattt tttgttgttg ttgagtttag tgcatatcct 2040 ggatattagt ctcttatctg atgaagagtt tgccaatatt ttctcccatt caacaggttg 2100 tctcttcatt ctgttgactg tttcctttgc tgtgcagaag cactttatat acagtcccat 2160 ttgtctattt tttagtagtc tatgcattta aggtctcagc cacaaaatct ttgcctagac 2220 cagtcctaaa gtgtttcccc tatattttct tctagtagtt ttattgtttc atgtcttata 2280 tttaagtcta taatccattg tgagttgatt tttgtatatg gtgagatagg ggccttgttt 2340 cattcctctg catatagata tttaattttc tcagcaccat ttattgaagg tgtccttccc 2400 tattgtatgt tcttggtgcc tttgtcaaaa ttcagttggc tataaatatg tgaatttatt 2460 tctgggttct ctatgtggtt ccattagtct atgtgtctat ttttatacca atatcatgct 2520 gttttgatta ccatagcctt gtaatatatt ttgaagtcag gtagtgtgat gcctccagct 2580 ttgttctttt tgctcaggat tgctgtgcat actctggctt tttggttaca tacaaatttc 2640 aggatttttg tatttctgtg aaaaatggca ttagtatttt gataggaatt gcactggatc 2700 tgtatattgt cctggacaac atggtcattt taacaatatt aattcttcta atctatgagt 2760 atgagacgtc ttcccacttg tttgtgtcct cttcaatttc tttcattggt gtttcataat 2820 ctcccttcta caggcctttc acctccttgg ttaaattaat tcctaggtat ttttttgtag 2880 ctactgtaaa tgggactgcc ttctttctca gctagttcat ttttggtgca tagaaaccct 2940 atttttgtat gttcattttc tatcctgcaa cattaccaaa tttgcttatc agctttaagt 3000 gtgtattttg ctttgcttgt agagtcttct ggtttctcta aatgtaagac gatgtcatct 3060 gcaaacgggg acaatttgac ttcctcttaa aaatctgtat gccttttatt cctttctctt 3120 gcctgattgc tctggctcta cctccagtac tatactgaat aaaagtggta aaagtgagca 3180 tccttccttg tcttgctcta gttcttagag gaaatacttt cagtttttcc ccactcagta 3240 tgatgttagc tgtgggtcat atatagcctt tattatgtta agatatgttt cttctgtacc 3300 tggtttgttg acagcttttt atcataaaag gatgtagaat tttatcaaat gttttttctg 3360 catctgttga gataatcata tggtttttgt cattccttct actgttgtga tgtatcatgt 3420 ttattgattt gtgtatgtta aaccatcctt gtgtccttgg tataaattat acttggtcat 3480 ggtgtattat ctttttggca tcctgtcgaa ttgtttgcta gctttttgtt ttgttctttt 3540 tgagaatttt tatgtctagg ttccttagaa acactggcct gtagttctct ttttgtgtgt 3600 gtgtccttgt ctagtttggt gtcagggaaa tggtggtctt gtagaatgag ttgttttttc 3660 tttgattttt ttgcaagagt ttgaggagaa tgggtattag ttcttcttta tgtggttggt 3720 caaattggca gtgaattcat tcagtcatga gcttttcttt ttttgggagg gttctcatta 3780 ctgagttaat cacactgctc attactgatc tgttcagatt ttctatttct tctggaatct 3840 cagtagttgt atgtttccag caatttatcc atttcctcta ggttttctag tttggtagta 3900 tatagctatt cataatagtc tctgatgatc ttttgtattt ctgtgatatc agttgtaatg 3960 tctttttcat ttcctatttt atttgggtct tttcttgttt agtctagcaa ggggtttatc 4020 tattttatct ttttgaagaa ccaacttttt gtttcattga ccctttctac gtctttagtc 4080 tttatttcat ttagatttgc tctgaacttt actatgtctt tccttctaat tttgggtttg 4140 gtttgttctt ttctagttcc ttgaggtgca tcattgaatt gtttctttga tatctatcta 4200 ctcatttgat gtaggtgttt attgctatac actctcccct cctagagctc cttttgttgt 4260 gtcccatagg tcttggtatg ttgtttctat tttcatttgt ttcaaacatt ttatttccat 4320 attaattttt atcattcagg aggagcatat tatttaattc ccatgtattt gtatagtttc 4380 caaagttcct cttatttcta tttttactcc attgtggtct gagaagatac ttcatatgat 4440 ttcaattttt aaaaatttgt caagacttgt tttttgtcct aacatatggt ctatcctgga 4500 gaatgttcca tgtgctgatg agaaaaatgt gtactcagca gttgttgagt aacatgttct 4560 acaaatatct gttagatcca tttggtctaa agtctagttt aaatccaatg agtttttgtt 4620 aattttgtct agatgatcat gatctgagac tgaggtgaag tccccaacaa ttatcgtgtt 4680 ggagtctacc tctcttttta aatctagaaa tatttgcttt ataaatccgg gtggtctagt 4740 gttgggtgca tatatttagt tgttatttcc tcattagatt gatctcttta ctattatata 4800 ataactgttt actgcttctg gcataaagtc tgttttatgt aagtacagcc attcctgctt 4860 gagtttagta ccatgttgac aaagggatgc atagagagtt ggtaaagcat gatttctggg 4920 tgtctgtgtg aaggtgtttt gagaagagtt tagcatgagt ctgtggagtg agtgggaaga 4980 ttctccctca atgtcagcag gaaccatcca tccactgggg gcccaggtag aaaaagatga 5040 agaaatggtg aattctctct ctctcctgga gctgggtcac ccttcttctg cccttgaaca 5100 ggacatcaca actccaggct ctccagcctt tggactccaa gactgacacc agtgcccctc 5160 cccaattacc ccaggccctc aggcctttgg cctaggattg agacttacac catcagcttc 5220 cctggttctg aggcttctgg acttgcactg ggccatacta ccagcatccc agggtctcca 5280 gcttgcagag agcctgttgt gggacttttc agcctccata atcaagtaag ccaatttccc 5340 tggtatctat atagatatac aatcatgttt tgcttaccag cctgaaaaat gtatcgctag 5400 atgagtctgt cattgcataa acatcatagt gtacttacac aaacctagat tctatagcct 5460 actacacacc tagtctataa acatgtacag catgttactg tactgaatat tgtaggcaac 5520 tgtaacacaa tggtgaatat ttgcatattt aaacatatct tatcattaaa aagatacagt 5580 aaacataagg tataaaagac aaaaaccggc acacctatat agggcactta ccataaatgc 5640 agcttgcagg actagaagtc actcagggtg agtcagtgag cgaacgtgaa ggcctaggtt 5700 attactgtcc actacggtag actttatcaa cactgtacac aggctacact aaatttattt 5760 tttaaaaatt tgctctccaa taataaatta atcttcgcat cctttttttg ttgttcactg 5820 tgg 5823 <210> SEQ ID NO 418 <211> LENGTH: 707 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 418 aacggtgtca gctggagtga actcctgtgt gtgcaaggcc tgggtctcct ggtcagacta 60 ctttctatgg gaaaggcata gtgtatagtc tatatactat acataggggt gctgggagga 120 actggggttt tcacagccag ctttggtttt cattaggttt gtttagtttc cattgcttca 180 ggggtgttag ttttgtgttc mcaactagat tataaactcc tcttgcattc ctgatggcag 240 tgacttgaag gcatttattt gaagaataat agacatacag aaaggggcgc atgtcataaa 300 ggtacagctg gacgactttt cacaaagtga gcacatttgt atgatcgatg ttgagaccaa 360 gagcattcag tggacaactc ctttccagtt actccacccc actcccagtg accatcattc 420 tgacttctaa ctgtgtagac atgttttgct tgttttgtac tttacaaaca tatctactct 480 attttaggtg gctagacaat gtgttttaca atgctggcca tgacagtgtt tgaaagaata 540 aaatggaatc aaatagaatg ggcagtatca gagtgtgttg cctgcctaag aaatgttttg 600 tgacattttg gctttgggtc tatttacaca ttaaatctaa gagcaccaga atgtggtgtc 660 aaaatgtgtt tggggatgaa gatattctaa agtcctgtag taagcaa 707 <210> SEQ ID NO 419 <211> LENGTH: 712 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 419 cagactactt tctatgggaa aggcatagtg tatagtctat atactataca taggggtgct 60 gggaggaact ggggttttca cagccagctt tggttttcat taggtttgtt tagtttccat 120 tgcttcaggg gtgttagttt tgtgttccca actagattat aaactcctct tgcattcctg 180 atggcagtga cttgaaggca tttatttgaa gaataataga catacagaaa ggggcrcatg 240 tcataaaggt acagctggac gacttttcac aaagtgagca catttgtatg atcgatgttg 300 agaccaagag cattcagtgg acaactcctt tccagttact ccaccccact cccagtgacc 360 atcattctga cttctaactg tgtagacatg ttttgcttgt tttgtacttt acaaacatat 420 ctactctatt ttaggtggct agacaatgtg ttttacaatg ctggccatga cagtgtttga 480 aagaataaaa tggaatcaaa tagaatgggc agtatcagag tgtgttgcct gcctaagaaa 540 tgttttgtga cattttggct ttgggtctat ttacacatta aatctaagag caccagaatg 600 tggtgtcaaa atgtgtttgg ggatgaagat attctaaagt cctgtagtaa gcaatgcaaa 660 acgttctgga ggtgtttatt aaacatttgt ttgtagaatg gagaggaaga ca 712 <210> SEQ ID NO 420 <211> LENGTH: 1210 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 420 aaagcagcac tgctctgcat tcagccttgc tacgtctcct tcagatgggc gcactagata 60 ctgagtgatg atcatgcctt gtctaggatc tcaccaagac agttcatgaa agagacagtg 120 cagctcatgg aggagatggt gcagctcaca gagaggatgg tgccatcatg gaaagcatgg 180 ggcagtcatg gagatgacgg rgtagctcat ggagaatata atgccatcat ggaaggcata 240 gtgcagtcat ggagatgatg gtgcagctca tggagaagat ggtgccatca tggaaggcat 300 ggtgcaatca tggagtagac agtgcagctg ggccaagatt ctccctgact aagctcttct 360 caggcacctc tgagccgtcg tcttaactag gcctccagct tggcttgtga aaactgcaga 420 ctctcagcac aaatgatttg cctcctacat taagagactt aaataaacac ttgcatggct 480 gtgtttattt aaacagctca aggctgtgtc cctgggatga caatgactcc agcccctaaa 540 attcctgctt gtgaaagctc attgctgaca gaaggatcta ccatttgttc cagccaacac 600 ctggtggcag gcagataggc cctgagcccc atttaagagc agttccttta gaaagcttgc 660 aattgtaaat cttttctctg cccatttgag atgtaaatct tctaccacct agaactgtct 720 tctcaaggac ctgtgagctg actcactgaa atgcaaacat tcagggagat aactccactc 780 ctgtccccat gcgacggcga ggccctgact ttggtgggca ccttgctctt atttgcacca 840 ccacctcctg tcctaaagac atgagacgtt tgtctctcct ctggataagt gcctattaac 900 caacccaggt gtcctggtca catgaaccag tccagcctag cacctggcac tgcctttccc 960 tcagcacact ccagtctgta aaagtctcct tatggttgtt ttggcaaagt tgagcttagt 1020 taatgctaga ccccttctct actgcaatag ttactgctga ataaagtcta tccttaccac 1080 tttaactagt gttgggcttt gtttctcttt cataagctca tggagaagac aatgcagttc 1140 catcaagttt ctggctctta cactgctaac agtcagctct ggggtccctg agagggacag 1200 actcacacca 1210 <210> SEQ ID NO 421 <211> LENGTH: 1194 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 421 gcattcagcc ttgctacgtc tccttcagat gggcgcacta gatactgagt gatgatcatg 60 ccttgtctag gatctcacca agacagttca tgaaagagac agtgcagctc atggaggaga 120 tggtgcagct cacagagagg atggtgccat catggaaagc atggggcagt catggagatg 180 acggagtagc tcatggagaa kataatgcca tcatggaagg catagtgcag tcatggagat 240 gatggtgcag ctcatggaga agatggtgcc atcatggaag gcatggtgca atcatggagt 300 agacagtgca gctgggccaa gattctccct gactaagctc ttctcaggca cctctgagcc 360 gtcgtcttaa ctaggcctcc agcttggctt gtgaaaactg cagactctca gcacaaatga 420 tttgcctcct acattaagag acttaaataa acacttgcat ggctgtgttt atttaaacag 480 ctcaaggctg tgtccctggg atgacaatga ctccagcccc taaaattcct gcttgtgaaa 540 gctcattgct gacagaagga tctaccattt gttccagcca acacctggtg gcaggcagat 600 aggccctgag ccccatttaa gagcagttcc tttagaaagc ttgcaattgt aaatcttttc 660 tctgcccatt tgagatgtaa atcttctacc acctagaact gtcttctcaa ggacctgtga 720 gctgactcac tgaaatgcaa acattcaggg agataactcc actcctgtcc ccatgcgacg 780 gcgaggccct gactttggtg ggcaccttgc tcttatttgc accaccacct cctgtcctaa 840 agacatgaga cgtttgtctc tcctctggat aagtgcctat taaccaaccc aggtgtcctg 900 gtcacatgaa ccagtccagc ctagcacctg gcactgcctt tccctcagca cactccagtc 960 tgtaaaagtc tccttatggt tgttttggca aagttgagct tagttaatgc tagacccctt 1020 ctctactgca atagttactg ctgaataaag tctatcctta ccactttaac tagtgttggg 1080 ctttgtttct ctttcataag ctcatggaga agacaatgca gttccatcaa gtttctggct 1140 cttacactgc taacagtcag ctctggggtc cctgagaggg acagactcac acca 1194 <210> SEQ ID NO 422 <211> LENGTH: 1194 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 422 gcattcagcc ttgctacgtc tccttcagat gggcgcacta gatactgagt gatgatcatg 60 ccttgtctag gatctcacca agacagttca tgaaagagac agtgcagctc atggaggaga 120 tggtgcagct cacagagagg atggtgccat catggaaagc atggggcagt catggagatg 180 acggagtagc tcatggagaa kataatgcca tcatggaagg catagtgcag tcatggagat 240 gatggtgcag ctcatggaga agatggtgcc atcatggaag gcatggtgca atcatggagt 300 agacagtgca gctgggccaa gattctccct gactaagctc ttctcaggca cctctgagcc 360 gtcgtcttaa ctaggcctcc agcttggctt gtgaaaactg cagactctca gcacaaatga 420 tttgcctcct acattaagag acttaaataa acacttgcat ggctgtgttt atttaaacag 480 ctcaaggctg tgtccctggg atgacaatga ctccagcccc taaaattcct gcttgtgaaa 540 gctcattgct gacagaagga tctaccattt gttccagcca acacctggtg gcaggcagat 600 aggccctgag ccccatttaa gagcagttcc tttagaaagc ttgcaattgt aaatcttttc 660 tctgcccatt tgagatgtaa atcttctacc acctagaact gtcttctcaa ggacctgtga 720 gctgactcac tgaaatgcaa acattcaggg agataactcc actcctgtcc ccatgcgacg 780 gcgaggccct gactttggtg ggcaccttgc tcttatttgc accaccacct cctgtcctaa 840 agacatgaga cgtttgtctc tcctctggat aagtgcctat taaccaaccc aggtgtcctg 900 gtcacatgaa ccagtccagc ctagcacctg gcactgcctt tccctcagca cactccagtc 960 tgtaaaagtc tccttatggt tgttttggca aagttgagct tagttaatgc tagacccctt 1020 ctctactgca atagttactg ctgaataaag tctatcctta ccactttaac tagtgttggg 1080 ctttgtttct ctttcataag ctcatggaga agacaatgca gttccatcaa gtttctggct 1140 cttacactgc taacagtcag ctctggggtc cctgagaggg acagactcac acca 1194 <210> SEQ ID NO 423 <211> LENGTH: 1118 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 423 accaagacag ttcatgaaag agacagtgca gctcatggag gagatggtgc agctcacaga 60 gaggatggtg ccatcatgga aagcatgggg cagtcatgga gatgacggag tagctcatgg 120 agaagataat gccatcatgg aaggcatagt gcagtcatgg agatgatggt gcagctcatg 180 gagaagatgg tgccatcatg raaggcatgg tgcaatcatg gagtagacag tgcagctggg 240 ccaagattct ccctgactaa gctcttctca ggcacctctg agccgtcgtc ttaactaggc 300 ctccagcttg gcttgtgaaa actgcagact ctcagcacaa atgatttgcc tcctacatta 360 agagacttaa ataaacactt gcatggctgt gtttatttaa acagctcaag gctgtgtccc 420 tgggatgaca atgactccag cccctaaaat tcctgcttgt gaaagctcat tgctgacaga 480 aggatctacc atttgttcca gccaacacct ggtggcaggc agataggccc tgagccccat 540 ttaagagcag ttcctttaga aagcttgcaa ttgtaaatct tttctctgcc catttgagat 600 gtaaatcttc taccacctag aactgtcttc tcaaggacct gtgagctgac tcactgaaat 660 gcaaacattc agggagataa ctccactcct gtccccatgc gacggcgagg ccctgacttt 720 ggtgggcacc ttgctcttat ttgcaccacc acctcctgtc ctaaagacat gagacgtttg 780 tctctcctct ggataagtgc ctattaacca acccaggtgt cctggtcaca tgaaccagtc 840 cagcctagca cctggcactg cctttccctc agcacactcc agtctgtaaa agtctcctta 900 tggttgtttt ggcaaagttg agcttagtta atgctagacc ccttctctac tgcaatagtt 960 actgctgaat aaagtctatc cttaccactt taactagtgt tgggctttgt ttctctttca 1020 taagctcatg gagaagacaa tgcagttcca tcaagtttct ggctcttaca ctgctaacag 1080 tcagctctgg ggtccctgag agggacagac tcacacca 1118 <210> SEQ ID NO 424 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 424 gtaggggcac tgtctatact ggctgcactc tggccagtgc tgtcccaacg ctgacccctc 60 tggaagctaa tctggcttat aatgaggatg ctttctttag aggggactct ccatgcacag 120 cagaaaatcc caatggagtg gttcttccct atgtccccaa gggactggga atattctttc 180 agtaacaatg gcccattggg ggaagaagga tgaaagtggg gtgagagacg tgaaatttgg 240 agaggtccct caaagattgt gatgtgcctc tcttgttcca atcacaggac aggggtataa 300 yggctttcct ttgaaacacg gggatgaatt taactattca cttcccaggt agattcatca 360 gggtctagag cttcagctaa cagcatgagg aagattccaa atgtgccccc atcagcatag 420 gaactgggta tgttgagtct atggtctcat aaaaccagaa gaaggacaag ggattgtggc 480 tccaggcttg ggagcacctt ttccttacca tgggctacag tatttattta gggtaaagga 540 aggaaactcc tgaggtgcta tggggtgcca gcaatttgga gcatcagtaa ttcaatgtcc 600 c 601 <210> SEQ ID NO 425 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 425 acgctgaccc ctctggaagc taatctggct tataatgagg atgctttctt tagaggggac 60 tctccatgca cagcagaaaa tcccaatgga gtggttcttc cctatgtccc caagggactg 120 ggaatattct ttcagtaaca atggcccatt gggggaagaa ggatgaaagt ggggtgagag 180 acgtgaaatt tggagaggtc cctcaaagat tgtgatgtgc ctctcttgtt ccaatcacag 240 gacaggggta taacggcttt cctttgaaac acggggatga atttaactat tcacttccca 300 rgtagattca tcagggtcta gagcttcagc taacagcatg aggaagattc caaatgtgcc 360 cccatcagca taggaactgg gtatgttgag tctatggtct cataaaacca gaagaaggac 420 aagggattgt ggctccaggc ttgggagcac cttttcctta ccatgggcta cagtatttat 480 ttagggtaaa ggaaggaaac tcctgaggtg ctatggggtg ccagcaattt ggagcatcag 540 taattcaatg tcccttcagc catgtgtatt caactcctgc tgtgggtgtg gacttggtgc 600 a 601 <210> SEQ ID NO 426 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 426 ttcctgggca tcgtcatatt ctgtaaaaca aggaagctca gcccagtgtg ttctaacatg 60 acctcctttc tacatcctta ggtgttgtta tgcgtgaatc acgtcccccc aaaagacatg 120 ttcatgtcct aacccccagg acctcagaat gtgtgatctg gtttggaaat aaggtcatca 180 cagatgaaat tagctaagac aaggtcatat tggaataggg ttggccctta atccactgtg 240 actggtgtcc ttttaagaag aggacacaga cacaggaggg gagagggcca tgggatgatg 300 caggtggaga ctggagtgct acagctgcaa gcaaatacat ttctgtgctg tgaagccacc 360 catttggtgg tactacgtta aaacagctct aggaaattaa tacagatgtt gcctgtattt 420 ttgtttctca tattactact cattgtttta atgatgactg ttttattcat taagttgaaa 480 gctcctaaag cagagggacc rtatttttat gtcccaactc tccttaaggc cttgcctatg 540 atagcacatc tcttcaatag aattgtccta actttaacag agacaacttg ggttatttaa 600 tatggagaac aaagggttaa gctggtgcca gatgggtttc attttctcta aatctggaac 660 caaaggcagc aagtctatgg ggtggacgga gttcttagct c 701 <210> SEQ ID NO 427 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 427 caaggaagct cagcccagtg tgttctaaca tgacctcctt tctacatcct taggtgttgt 60 tatgcgtgaa tcacgtcccc ccaaaagaca tgttcatgtc ctaaccccca ggacctcaga 120 atgtgtgatc tggtttggaa ataaggtcat cacagatgaa attagctaag acaaggtcat 180 attggaatag ggttggccct taatccactg tgactggtgt ccttttaaga agaggacaca 240 gacacaggag gggagagggc catgggatga tgcaggtgga gactggagtg ctacagctgc 300 aagcaaatac atttctgtgc tgtgaagcca cccatttggt ggtactacgt taaaacagct 360 ctaggaaatt aatacagatg ttgcctgtat ttttgtttct catattacta ctcattgttt 420 taatgatgac tgttttattc attaagttga aagctcctaa agcagaggga ccatattttt 480 atgtcccaac tctccttaag sccttgccta tgatagcaca tctcttcaat agaattgtcc 540 taactttaac agagacaact tgggttattt aatatggaga acaaagggtt aagctggtgc 600 cagatgggtt tcattttctc taaatctgga accaaaggca gcaagtctat ggggtggacg 660 gagttcttag ctcaaccctt tggtgaggta agaagaagga t 701

1 SEQUENCE LISTING <160> NUMBER OF SEQ ID NOS: 427 <210> SEQ ID NO 1 <211> LENGTH: 111 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 1 cacatgcaca gccagcaacc ctgtcagcag gagttcccac cagtttcttt ctgagaacat 60 ctgttcaggt ttctctccat ctctatttac tcaggtcaca ggaccttggg g 111 <210> SEQ ID NO 2 <211> LENGTH: 111 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 2 cacatgcaca gccagcaacc ctgtcagcag gagttcccac cagtttcttt ctgagaacat 60 ctgttcaggt ttctctccat ctctgtttac tcaggtcaca ggaccttggg g 111 <210> SEQ ID NO 3 <211> LENGTH: 126 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 3 tgaggaagtg aggctcagag ggtaagaaac tttgtcacag agctggtggt gagggtggag 60 attttacact ccctgcctcc cacaccagtt tctccagagt ggaaagactt tcatctcgca 120 ctggca 126 <210> SEQ ID NO 4 <211> LENGTH: 126 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 4 tgaggaagtg aggctcagag ggtaagaaac tttgtcacag agctggtggt gagggtggag 60 attttacact ccctgcctcc cacaccagtt tctccggagt ggaaagactt tcatctcgca 120 ctggca 126 <210> SEQ ID NO 5 <211> LENGTH: 121 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 5 gtgccttcag aacctttgag atctgattct atttttaaag cttcttagaa gagagattgc 60 aaagtgggtt gtttctctag ccagacaggg caggcaaata ggggtggctg gtgggatggg 120 a 121 <210> SEQ ID NO 6 <211> LENGTH: 121 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 6 gtgccttcag aacctttgag atctgattct atttttaaag cttcttagaa gagagattgc 60 aaagtgggtt gtttctctag ccagacaggg caggtaaata ggggtggctg gtgggatggg 120 a 121 <210> SEQ ID NO 7 <211> LENGTH: 111 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 7 aggtgtgtct ctcttttgtg aggggagggg tcccttctgg cctagtagag ggcctggcct 60 gcagtgagca ttcaaatcct caaggaacag ggtggggagg tgggacaaag g 111 <210> SEQ ID NO 8 <211> LENGTH: 111 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 8 aggtgtgtct ctcttttgtg aggggagggg tcccttctgg cctagtagag ggcctggcct 60 gcagtgagca ttcaaatcct cgaggaacag ggtggggagg tgggacaaag g 111 <210> SEQ ID NO 9 <211> LENGTH: 139 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 9 cctcgcctac tgtgctgttt ctaaccatca tgcttttccc tgaatctctt gagtcttttt 60 ctgctgtgga ctgaaacttg atcctgagat tcacctctag tccctctgag cagcctcctg 120 gaatactcag ctgggatgg 139 <210> SEQ ID NO 10 <211> LENGTH: 139 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 10 cctcgcctac tgtgctgttt ctaaccatca tgcttttccc tgaatctctt gagtcttttt 60 ctgctgtgga ctgaaacttg atcctgagat tcacctctag tccctctggg cagcctcctg 120 gaatactcag ctgggatgg 139 <210> SEQ ID NO 11 <211> LENGTH: 117 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 11 aattgcaatg gtgagaggtt gatggtaaaa tcaaacggaa cttgttattt tgtcattctg 60 atggactgga actgaggatt ttcaatttcc tctccaaccc aagacacttc tcactgg 117 <210> SEQ ID NO 12 <211> LENGTH: 117 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 12 aattgcaatg gtgagaggtt gatggtaaaa tcaaacggaa cttgttattt tgtcattctg 60 atggactgga actgaggatt ttcaatttcc tttccaaccc aagacacttc tcactgg 117 <210> SEQ ID NO 13 <211> LENGTH: 114 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 13 gaaatgcctt ctcaggtaat ggaaggttat ccaaatattt ttcgtaagta tttcaaatag 60 caatggctcg tctatggtta gtctcacagc cacattctca gaactgctca aacc 114 <210> SEQ ID NO 14 <211> LENGTH: 114 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 14 gaaatgcctt ctcaggtaat ggaaggttat ccaaatattt ttcgtaagta tttcaaatag 60 caatggctcg tctatggtta gtctcgcagc cacattctca gaactgctca aacc 114 <210> SEQ ID NO 15 <211> LENGTH: 128 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 15 acccaaaaca ctggaggggc ctcttctcat tttcggtaga ctgcaagtgt tagccgtcgg 60 gaccagcttc tgtctggaag ttcgtcaaat tgcagttaag tccaagtatg ccacatagca 120 gataaggg 128 <210> SEQ ID NO 16 <211> LENGTH: 128 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 16 acccaaaaca ctggaggggc ctcttctcat tttcggtaga ctgcaagtgt tagccgtcgg 60 gaccagcttc tgtctggaag ttcgtcaaat tgcagttagg tccaagtatg ccacatagca 120 gataaggg 128 <210> SEQ ID NO 17 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 17 gcaccagaat ttaaacaacg ctgacaataa atatgcagtc gatgatgact tcccagagct 60 ccagaagcaa ctccagcaca cagagaggcg ctgatgtgcc tgtcaggtgc 110 <210> SEQ ID NO 18 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 18 gcaccagaat ttaaacaacg ctgacaataa atatgcagtc gatgatgact tcccagagct 60 ccagaagcaa ctccagcaca cggagaggcg ctgatgtgcc tgtcaggtgc 110 <210> SEQ ID NO 19 <211> LENGTH: 116 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 19 tgactgtata ccccaggtgc acccttgggt catctctatc atagaactta tctcacagag 60 tataagagct gatttctgtg tctgcctctc acactagact tccacatcct tagtgc 116

<210> SEQ ID NO 20 <211> LENGTH: 116 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 20 tgactgtata ccccaggtgc acccttgggt catctctatc atagaactta tctcacagag 60 tataagagct gatttctgtg tctgcctgtc acactagact tccacatcct tagtgc 116 <210> SEQ ID NO 21 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 21 tgtacgtggt caccagggga cgcctggcgc tgcgagggag gccccgagcc tcgtgccccc 60 gtgaagcttc agctcccctc cccggctgtc cttgaggctc ttctcacact 110 <210> SEQ ID NO 22 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 22 tgtacgtggt caccagggga cgcctggcgc tgcgagggag gccccgagcc tcgtgccccc 60 gtgaagcttc agctcccctc cctggctgtc cttgaggctc ttctcacact 110 <210> SEQ ID NO 23 <211> LENGTH: 114 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 23 cagtggaccc tgctgcacct ttcctcccct cccatcaacc tcttttgtgc ctccccctcc 60 gtgtaccacc ttctctgtca ccaaccctgg cctcacaact ctctcctttg ccac 114 <210> SEQ ID NO 24 <211> LENGTH: 114 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 24 cagtggaccc tgctgcacct ttcctcccct cccatcaacc tcttttgtgc ctccccctcc 60 gtgtaccacc ttctctgtca ccacccctgg cctcacaact ctctcctttg ccac 114 <210> SEQ ID NO 25 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 25 cagtggcata gtagtccagg ggctcctcct cagcacctcc agcaccttcc aggaggcagc 60 agcgcaggca gagaacccgc tggaagaatc ggcggaagtt gtcggagagg 110 <210> SEQ ID NO 26 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 26 cagtggcata gtagtccagg ggctcctcct cagcacctcc agcaccttcc aggaggcagc 60 agcgcaggca gagaacccgc tggaaggatc ggcggaagtt gtcggagagg 110 <210> SEQ ID NO 27 <211> LENGTH: 129 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 27 aggtctgggg gccgctgaat gccaagctgg gaatcttaaa tgttaaggaa caaggtcata 60 caatgaatgg tgtgatgtaa aagcttggga ggtgatttct gagggtaggt gctgggttta 120 atgggagga 129 <210> SEQ ID NO 28 <211> LENGTH: 129 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 28 aggtctgggg gccgctgaat gccaagctgg gaatcttaaa tgttaaggaa caaggtcata 60 caatgaatgg tgtgatgtaa aagcttggga ggtgattttt gagggtaggt gctgggttta 120 atgggagga 129 <210> SEQ ID NO 29 <211> LENGTH: 107 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 29 acggttctgt cctgtagggg agaaaagtcc tcgttgttcc tctgggatgc aacatgagag 60 agcagcacac tgaggcttta tggattgccc tgccacaagt gaacagg 107 <210> SEQ ID NO 30 <211> LENGTH: 107 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 30 acggttctgt cctgtagggg agaaaagtcc tcgttgttcc tctgggatgc aacatgagag 60 agcagcacac tgaggcttta tgggttgccc tgccacaagt gaacagg 107 <210> SEQ ID NO 31 <211> LENGTH: 127 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 31 gcgcagtcag atgggcgtgc tggcgtctgt cttctctctc tcctgctctc tggcttcatt 60 tttctctcct tctgtctcac cttctttcgt gtgcctgtgc acacacacgt ttgggacaag 120 ggctgga 127 <210> SEQ ID NO 32 <211> LENGTH: 127 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 32 gcgcagtcag atgggcgtgc tggcgtctgt cttctctctc tcctgctctc tggcttcatt 60 tttctctcct tctgtctcac cttctttcgt gtgcctgtgc atacacacgt ttgggacaag 120 ggctgga 127 <210> SEQ ID NO 33 <211> LENGTH: 130 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 33 gccggacctg cgaaatccca aaatgccaaa cattcccgcc tcacatgatc ccagagagag 60 gggacccagt gttcccagct tgcagctgag gagcccgagg ttgccgtcag atcagagccc 120 cagttgcccg 130 <210> SEQ ID NO 34 <211> LENGTH: 130 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 34 gccggacctg cgaaatccca aaatgccaaa cattcccgcc tcacatgatc ccagagagag 60 gggacccagt gttcccagct tgcagctgag gagcccgagt ttgccgtcag atcagagccc 120 cagttgcccg 130 <210> SEQ ID NO 35 <211> LENGTH: 121 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 35 agcagcctcc ctcgactagc tcacactacg ataaggaaaa ttcatgagct ggtgtccaag 60 gagggctggg tgactcgtgg ctcagtcagc atcaagattc ctttcgtctt tcccctctgc 120 c 121 <210> SEQ ID NO 36 <211> LENGTH: 121 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 36 agcagcctcc ctcgactagc tcacactacg ataaggaaaa ttcatgagct ggtgtccaag 60 gagggctggg tgactcgtgg ctcagtcagc gtcaagattc ctttcgtctt tcccctctgc 120 c 121 <210> SEQ ID NO 37 <211> LENGTH: 138 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 37 tggcattgcc tgtaatatac atagccatgg ttttttatag gcaatttaag atgaatagct 60 tctaaactat agataagttt cattacccca ggaagctgaa ctatagctac tttacccaaa 120 atcattagaa tggtgctt 138 <210> SEQ ID NO 38 <211> LENGTH: 138 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 38 tggcattgcc tgtaatatac atagccatgg ttttttatag gcaatttaag atgaatagct 60 tctaaactat agataagttt cattacccca ggaagctgaa ctatagctac tttccccaaa 120 atcattagaa tggtgctt 138 <210> SEQ ID NO 39 <211> LENGTH: 136 <212> TYPE: DNA

<213> ORGANISM: Homo sapiens <400> SEQUENCE: 39 atgaagcctt ccaccaactg cctgtatgac tcatctgggg acttctgctc tatactcaaa 60 gtggcttagt cactgccaat gtatttccat atgagggacg atgattacta aggaaatata 120 gaaacaacaa ctgatc 136 <210> SEQ ID NO 40 <211> LENGTH: 136 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 40 atgaagcctt ccaccaactg cctgtatgac tcatctgggg acttctgctc tatactcaaa 60 gtggcttagt cactgccaat gtatttccat atgagggacg gtgattacta aggaaatata 120 gaaacaacaa ctgatc 136 <210> SEQ ID NO 41 <211> LENGTH: 118 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 41 acaacagaat caggtgattg gagaaaagat cacaggccta ggcacccaag gcttgaagga 60 tgaaagaatg aaagatggac ggaacaaaat taggacctta attctttgtt cagttcag 118 <210> SEQ ID NO 42 <211> LENGTH: 118 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 42 acaacagaat caggtgattg gagaaaagat cacaggccta ggcacccaag gcttgaagga 60 tgaaagaatg aaagatggac ggaagaaaat taggacctta attctttgtt cagttcag 118 <210> SEQ ID NO 43 <211> LENGTH: 150 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 43 ttggggtaaa ttttcattgt catatgtgga atttaaatat accatcatct acaaagaatt 60 ccacagagtt aaatatctta agttaaacac ttaaaataag tgtttgcgtg atattttgat 120 gacagataaa cagagtctaa ttcccacccc 150 <210> SEQ ID NO 44 <211> LENGTH: 150 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 44 ttggggtaaa ttttcattgt catatgtgga atttaaatat accatcatct acaaagaatt 60 ccacagagtt aaatatctta agttaaacac ttaaaataag tgtttgcgtg atattttgat 120 gatagataaa cagagtctaa ttcccacccc 150 <210> SEQ ID NO 45 <211> LENGTH: 145 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 45 tgcaattcaa atcaggaagt atgaccaaaa gacagagatc ttttttggat gatccctagc 60 ctagcaatgc ctggcagcca tgcaggtgca atgtcaacct taaataatgt attgcaaact 120 cagagctgac aaacctcgat gttgc 145 <210> SEQ ID NO 46 <211> LENGTH: 145 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 46 tgcaattcaa atcaggaagt atgaccaaaa gacagagatc ttttttggat gatccctagc 60 ctagcaatgc ctggcagcca tgcaggtgca atgtcaacct taaataatgt attgcaaatt 120 cagagctgac aaacctcgat gttgc 145 <210> SEQ ID NO 47 <211> LENGTH: 124 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 47 ctgtgctctg cgaatagctg cagaagtaac ttggggaccc aaaataaagc agaatgctaa 60 tgtcaagtcc tgagaaccaa gccctgggac tctggtgcca tttcggattc tccatgagca 120 tggt 124 <210> SEQ ID NO 48 <211> LENGTH: 124 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 48 ctgtgctctg cgaatagctg cagaagtaac ttggggaccc aaaataaagc agaatgctaa 60 tgtcaagtcc tgagaaccaa gccctgggac tctggtgcca ttttggattc tccatgagca 120 tggt 124 <210> SEQ ID NO 49 <211> LENGTH: 118 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 49 tttttccagc caactcaagg ccaaaaaaaa tttcttaata tagttattat gcgaggggag 60 gggaagcaaa ggagcacagg tagtccacag aataagacac aagaaacctc aagctgtg 118 <210> SEQ ID NO 50 <211> LENGTH: 118 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 50 tttttccagc caactcaagg ccaaaaaaaa tttcttaata tagttattat gcgaggggag 60 gggaagcaaa ggagcacagg tagtccacag aataggacac aagaaacctc aagctgtg 118 <210> SEQ ID NO 51 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 51 tcttctcgtc ccctaagcaa acaacatccg cttgcttctg tctgtgtaac cacagtgaat 60 gggtgtgcac gcttgatggg cctctgagcc cctgttgcac aaaccagaaa 110 <210> SEQ ID NO 52 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 52 tcttctcgtc ccctaagcaa acaacatccg cttgcttctg tctgtgtaac cacagtgaat 60 gggtgtgcac gcttggtggg cctctgagcc cctgttgcac aaaccagaaa 110 <210> SEQ ID NO 53 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 53 cacatggggg cattaagaat cgcccaggga ggaggaggga gaacgcgtgc ttttcacatt 60 tgcatttgaa ttttcgagtt cccaggatgt gtttttgtgc tcatcgatgt 110 <210> SEQ ID NO 54 <211> LENGTH: 110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 54 cacatggggg cattaagaat cgcccaggga ggaggaggga gaacgcgtgc ttttcacatt 60 tgcatttgaa tttttgagtt cccaggatgt gtttttgtgc tcatcgatgt 110 <210> SEQ ID NO 55 <211> LENGTH: 128 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 55 gggctctgag gtgtgtgaaa taaaaacaaa tgtccatgtc tgtcctttta tggcattttg 60 ggactttaca tttcaaacat ttcagacatg tatcacaaca cgaaggaata acagttccag 120 ggatatct 128 <210> SEQ ID NO 56 <211> LENGTH: 128 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 56 gggctctgag gtgtgtgaaa taaaaacaaa tgtccatgtc tgtcctttta tggcattttg 60 ggactttaca tttcaaacat ttcagacatg tatcacaaca cgagggaata acagttccag 120 ggatatct 128 <210> SEQ ID NO 57 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 57 cacatgcaca gccagcaacc c 21 <210> SEQ ID NO 58 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence

<220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 58 ccccaaggtc ctgtgacctg agt 23 <210> SEQ ID NO 59 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 59 tgaggaagtg aggctcagag ggt 23 <210> SEQ ID NO 60 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 60 tgccagtgcg agatgaaagt cttt 24 <210> SEQ ID NO 61 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 61 gtgccttcag aacctttgag atctgat 27 <210> SEQ ID NO 62 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 62 tcccatccca ccagccaccc 20 <210> SEQ ID NO 63 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 63 aggtgtgtct ctcttttgtg agggg 25 <210> SEQ ID NO 64 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 64 cctttgtccc acctccccac c 21 <210> SEQ ID NO 65 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 65 cctcgcctac tgtgctgttt ctaacc 26 <210> SEQ ID NO 66 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 66 ccatcccagc tgagtattcc aggag 25 <210> SEQ ID NO 67 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 67 aattgcaatg gtgagaggtt gatggt 26 <210> SEQ ID NO 68 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 68 ccagtgagaa gtgtcttggg ttgg 24 <210> SEQ ID NO 69 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 69 gaaatgcctt ctcaggtaat ggaaggt 27 <210> SEQ ID NO 70 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 70 ggtttgagca gttctgagaa tgtggct 27 <210> SEQ ID NO 71 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 71 acccaaaaca ctggaggggc ct 22 <210> SEQ ID NO 72 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 72 cccttatctg ctatgtggca tacttgg 27 <210> SEQ ID NO 73 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 73 gcaccagaat ttaaacaacg ctgacaa 27 <210> SEQ ID NO 74 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 74 gcacctgaca ggcacatcag cg 22 <210> SEQ ID NO 75 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 75 tgactgtata ccccaggtgc accc 24 <210> SEQ ID NO 76 <211> LENGTH: 27 <212> TYPE: DNA

<213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 76 gcactaagga tgtggaagtc tagtgtg 27 <210> SEQ ID NO 77 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 77 tgtacgtggt caccagggga cg 22 <210> SEQ ID NO 78 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 78 agtgtgagaa gagcctcaag gacagc 26 <210> SEQ ID NO 79 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 79 cagtggaccc tgctgcacct t 21 <210> SEQ ID NO 80 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 80 gtggcaaagg agagagttgt gagg 24 <210> SEQ ID NO 81 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 81 cagtggcata gtagtccagg ggct 24 <210> SEQ ID NO 82 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 82 cctctccgac aacttccgcc g 21 <210> SEQ ID NO 83 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 83 aggtctgggg gccgctgaat 20 <210> SEQ ID NO 84 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 84 tcctcccatt aaacccagca cct 23 <210> SEQ ID NO 85 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 85 acggttctgt cctgtagggg aga 23 <210> SEQ ID NO 86 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 86 cctgttcact tgtggcaggg ca 22 <210> SEQ ID NO 87 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 87 gcgcagtcag atgggcgtgc 20 <210> SEQ ID NO 88 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 88 tccagccctt gtcccaaacg tgt 23 <210> SEQ ID NO 89 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 89 gccggacctg cgaaatccca a 21 <210> SEQ ID NO 90 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 90 cgggcaactg gggctctgat c 21 <210> SEQ ID NO 91 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 91 agcagcctcc ctcgactagc t 21 <210> SEQ ID NO 92 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 92 ggcagagggg aaagacgaaa gga 23 <210> SEQ ID NO 93 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 93 tggcattgcc tgtaatatac atag 24 <210> SEQ ID NO 94 <211> LENGTH: 23

<212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 94 aagcaccatt ctaatgattt tgg 23 <210> SEQ ID NO 95 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 95 atgaagcctt ccaccaactg 20 <210> SEQ ID NO 96 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 96 gatcagttgt tgtttctata tttcctt 27 <210> SEQ ID NO 97 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 97 acaacagaat caggtgattg ga 22 <210> SEQ ID NO 98 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 98 ctgaactgaa caaagaatta aggtc 25 <210> SEQ ID NO 99 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 99 ttggggtaaa ttttcattgt ca 22 <210> SEQ ID NO 100 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 100 ggggtgggaa ttagactctg 20 <210> SEQ ID NO 101 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 101 tgcaattcaa atcaggaagt atg 23 <210> SEQ ID NO 102 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 102 gcaacatcga ggtttgtcag 20 <210> SEQ ID NO 103 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 103 ctgtgctctg cgaatagctg 20 <210> SEQ ID NO 104 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 104 accatgctca tggagaatcc 20 <210> SEQ ID NO 105 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 105 tttttccagc caactcaagg 20 <210> SEQ ID NO 106 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 106 cacagcttga ggtttcttgt g 21 <210> SEQ ID NO 107 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 107 tcttctcgtc ccctaagcaa 20 <210> SEQ ID NO 108 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 108 tttctggttt gtgcaacagg 20 <210> SEQ ID NO 109 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 109 cacatggggg cattaagaat 20 <210> SEQ ID NO 110 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 110 acatcgatga gcacaaaaac ac 22 <210> SEQ ID NO 111 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 111 gggctctgag gtgtgtgaaa 20 <210> SEQ ID NO 112

<211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 112 agatatccct ggaactgtta ttcc 24 <210> SEQ ID NO 113 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 113 acagtaactg ccttcataga tag 23 <210> SEQ ID NO 114 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 114 gtgtcagacc ctgttctaag ta 22 <210> SEQ ID NO 115 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 115 aaataaaatt aggcatattt acaagc 26 <210> SEQ ID NO 116 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 116 gctgagtgat ttgtctgtaa ttg 23 <210> SEQ ID NO 117 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 117 cctgttcctc ccttatttcc c 21 <210> SEQ ID NO 118 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 118 gggaacacag actccatggt g 21 <210> SEQ ID NO 119 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 119 cttagggaac cctcactgaa tg 22 <210> SEQ ID NO 120 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 120 gtccttgtca gcgtttattt gc 22 <210> SEQ ID NO 121 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 121 aataatcagt atgtgacttg gattga 26 <210> SEQ ID NO 122 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 122 ataggatgga tggatagatg ga 22 <210> SEQ ID NO 123 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 123 cagagcaaga ccctgtctca t 21 <210> SEQ ID NO 124 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 124 tcaacagagg cttgcatgta t 21 <210> SEQ ID NO 125 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 125 gggtgatttt cctctttggt 20 <210> SEQ ID NO 126 <211> LENGTH: 33 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 126 aacatttgta tctttatctg tatccttatt tat 33 <210> SEQ ID NO 127 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 127 gaacacttgt catagtttag aacgaac 27 <210> SEQ ID NO 128 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 128 tcattgacag aattgcacca 20 <210> SEQ ID NO 129 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 129 tttgtatttc atgtgtacat tcgtatc 27

<210> SEQ ID NO 130 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 130 acctatcctg tagattattt tcactgtg 28 <210> SEQ ID NO 131 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 131 tctgacccat ctaacgccta 20 <210> SEQ ID NO 132 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 132 cagacagaaa gatagataga tgattga 27 <210> SEQ ID NO 133 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 133 atacagacag acagacaggt g 21 <210> SEQ ID NO 134 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 134 gcatgtatct atcatccatc tct 23 <210> SEQ ID NO 135 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 135 tgagtgacaa attgagacct t 21 <210> SEQ ID NO 136 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 136 gtcttacaat aacagttgct actatt 26 <210> SEQ ID NO 137 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 137 attccccaag tgaattgc 18 <210> SEQ ID NO 138 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 138 ggtagataga ctggatagat agacga 26 <210> SEQ ID NO 139 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 139 tggaaacaga aatggcttgg 20 <210> SEQ ID NO 140 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 140 gattgcagga gggaaggaag 20 <210> SEQ ID NO 141 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 141 gagcaagaca ccatctcaag aa 22 <210> SEQ ID NO 142 <211> LENGTH: 30 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 142 gaaattttac atttatgttt atgattctct 30 <210> SEQ ID NO 143 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 143 ggcgactgag caagactc 18 <210> SEQ ID NO 144 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 144 ggttattaat tgagaaaact ccttaca 27 <210> SEQ ID NO 145 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 145 attttccccg atgatagtag tct 23 <210> SEQ ID NO 146 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 146 gcgaatgtat gattggcaat attttt 26 <210> SEQ ID NO 147 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 147 acatgtatcc cagaacttaa agtaaac 27

<210> SEQ ID NO 148 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 148 gcagaaggga aaattgaagc tg 22 <210> SEQ ID NO 149 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 149 cagagacacc gaaccaataa ga 22 <210> SEQ ID NO 150 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 150 gccacatgaa tcaattccta taataaa 27 <210> SEQ ID NO 151 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 151 gcacatgtac cctaaaactt aaaat 25 <210> SEQ ID NO 152 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 152 gtcaaccaaa actcaacaag tagtaa 26 <210> SEQ ID NO 153 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 153 aagatgaaat tgccatgtaa aaata 25 <210> SEQ ID NO 154 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 154 gtgtgtataa caaaattcct atgatgg 27 <210> SEQ ID NO 155 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 155 gcacccaaaa ctgaatgtca ta 22 <210> SEQ ID NO 156 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 156 ggtgagagtg agaccctgtc 20 <210> SEQ ID NO 157 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 157 tgtaataact ctacgactgt ctgtctg 27 <210> SEQ ID NO 158 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 158 gaataggagg tggatggatg g 21 <210> SEQ ID NO 159 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 159 gagcgagacc ctgtctcaag 20 <210> SEQ ID NO 160 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 160 ggaaaagaca taggatagca attt 24 <210> SEQ ID NO 161 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 161 tctggattga tctgtctgtc c 21 <210> SEQ ID NO 162 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 162 gaattaaata ccatctgagc actgaa 26 <210> SEQ ID NO 163 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 163 tgttataatg cattgagttt tattctg 27 <210> SEQ ID NO 164 <211> LENGTH: 28 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 164 gcctgtctca aaaataaaga gatagaca 28 <210> SEQ ID NO 165 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 165 ttaatgaatt gaacaaatga gtgag 25

<210> SEQ ID NO 166 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 166 gcaactctgg ttgtattgtc ttcat 25 <210> SEQ ID NO 167 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 167 caaagcgaga ctctgtctca a 21 <210> SEQ ID NO 168 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 168 gaaaatgcta tcctctttgg tataaat 27 <210> SEQ ID NO 169 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 169 gggtatttca agataactgt agatagg 27 <210> SEQ ID NO 170 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 170 gcttctgaaa gcttctagtt tacc 24 <210> SEQ ID NO 171 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 171 tccacatcct caccaacac 19 <210> SEQ ID NO 172 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 172 gcctaggaag gctactgtca a 21 <210> SEQ ID NO 173 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 173 ccacccgtcc atttaggc 18 <210> SEQ ID NO 174 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 174 gtgaaaaagt agatataatg gttggtg 27 <210> SEQ ID NO 175 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 175 ggttttccaa gagatagacc aatta 25 <210> SEQ ID NO 176 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 176 gtcctctcat aaatccctac tcatatc 27 <210> SEQ ID NO 177 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 177 ctgttggtac ataataggta ggtaggt 27 <210> SEQ ID NO 178 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 178 gtcgtgggcc ccataaatc 19 <210> SEQ ID NO 179 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 179 aaggtacata acagttcaat agaaagc 27 <210> SEQ ID NO 180 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 180 gtgaaatgac tgaaaaatag taacca 26 <210> SEQ ID NO 181 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 181 ctaggagatc atgtgggtat gatt 24 <210> SEQ ID NO 182 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 182 gcagtgaata aatgaacgaa tgga 24 <210> SEQ ID NO 183 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 183

cccaaaatta cttgagccaa t 21 <210> SEQ ID NO 184 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 184 gagacaaaat gaagaaacag acag 24 <210> SEQ ID NO 185 <211> LENGTH: 25 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 185 tctttgctct catgaataga tcagt 25 <210> SEQ ID NO 186 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 186 gtttgtgata atgaacccac tcag 24 <210> SEQ ID NO 187 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 187 tgaacacaga tgttaagtgt gtatatg 27 <210> SEQ ID NO 188 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 188 gtctgaggtg gacagttatg aaa 23 <210> SEQ ID NO 189 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 189 ctgtggctca tctatgaaaa ctt 23 <210> SEQ ID NO 190 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 190 gaagtggctg tggtgttatg at 22 <210> SEQ ID NO 191 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 191 ttctgttggt atagagcagt gttt 24 <210> SEQ ID NO 192 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 192 gtgacaggaa ggacggaatg 20 <210> SEQ ID NO 193 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 193 catgaggttt gcaaatacta tcttaac 27 <210> SEQ ID NO 194 <211> LENGTH: 24 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 194 gttttaattt tctccaaatc tcca 24 <210> SEQ ID NO 195 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 195 tcttagccta gatagatact tgcttcc 27 <210> SEQ ID NO 196 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 196 gtcaaccttt gaggctatag gaa 23 <210> SEQ ID NO 197 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 197 tcctggaaac aaaagtatt 19 <210> SEQ ID NO 198 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 198 aaccttacaa caaagctaga a 21 <210> SEQ ID NO 199 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 199 actaagcctt ggggatccag 20 <210> SEQ ID NO 200 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 200 tgctgtggaa atactaaaag g 21 <210> SEQ ID NO 201 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 201

ctccagaggt aatcctgtga 20 <210> SEQ ID NO 202 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 202 tggtgtgaga tggtatctag g 21 <210> SEQ ID NO 203 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 203 gtataatcca tgaatcttgt tt 22 <210> SEQ ID NO 204 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 204 ttcaaattgt atataagaga gt 22 <210> SEQ ID NO 205 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 205 gcaggaaagt tatttttaat 20 <210> SEQ ID NO 206 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 206 tgcttgagaa agctaacact t 21 <210> SEQ ID NO 207 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 207 cagtgtttgg aaattgtctg 20 <210> SEQ ID NO 208 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 208 ggcactggga gattattgta 20 <210> SEQ ID NO 209 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 209 tcctgttgtt aagtacacat 20 <210> SEQ ID NO 210 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 210 gggccgtaat tacttttg 18 <210> SEQ ID NO 211 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 211 actcagtagg cactttgtgt c 21 <210> SEQ ID NO 212 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 212 tcttccacca caccaatc 18 <210> SEQ ID NO 213 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 213 tggcttttca aaggtaaaa 19 <210> SEQ ID NO 214 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 214 gcaacgttaa catctgaatt t 21 <210> SEQ ID NO 215 <400> SEQUENCE: 215 000 <210> SEQ ID NO 216 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 216 attttatatg tcatgatcta ag 22 <210> SEQ ID NO 217 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 217 agagattaca ggtgtgagc 19 <210> SEQ ID NO 218 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 218 atgatcctca actgcctct 19 <210> SEQ ID NO 219 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 219 tgaaactcaa aagagaaaag 20 <210> SEQ ID NO 220 <211> LENGTH: 20

<212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 220 acagatttct acttaaaatt 20 <210> SEQ ID NO 221 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 221 tgaaactcaa aagagaaaag 20 <210> SEQ ID NO 222 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 222 acagatttct acttaaaatt 20 <210> SEQ ID NO 223 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 223 gcaaaggggt actctatgta 20 <210> SEQ ID NO 224 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 224 tatcgggtca tcttgttaaa 20 <210> SEQ ID NO 225 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 225 tctaacaaag ctctgtccaa aa 22 <210> SEQ ID NO 226 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 226 ccacactgaa taactggaac a 21 <210> SEQ ID NO 227 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 227 gcaagcaagc tctctacctt c 21 <210> SEQ ID NO 228 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 228 tgttcttcca aaattcacat gc 22 <210> SEQ ID NO 229 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 229 atttcactat tccttcattt t 21 <210> SEQ ID NO 230 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 230 taattgttgc acactaaatt ac 22 <210> SEQ ID NO 231 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 231 aaaaagccac agaaatcagt c 21 <210> SEQ ID NO 232 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 232 ttcttatatc tcactgggca tt 22 <210> SEQ ID NO 233 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 233 ggatggtaga agagaagaaa gg 22 <210> SEQ ID NO 234 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 234 ggatggtaga agagaagaaa gg 22 <210> SEQ ID NO 235 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 235 tgcaaagatg cagaaccaac 20 <210> SEQ ID NO 236 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 236 ttttgttcct tgtcctggct ga 22 <210> SEQ ID NO 237 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 237 tgcaaagatg cagaaccaac 20 <210> SEQ ID NO 238

<211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 238 gcctccagct ctatccaagt t 21 <210> SEQ ID NO 239 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 239 ccttaatatc ttcccatgtc ca 22 <210> SEQ ID NO 240 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 240 attgttagtg cctcttctgc tt 22 <210> SEQ ID NO 241 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 241 gagaagtgag gtcagcagct 20 <210> SEQ ID NO 242 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 242 tttctaaatt tccattgaac ag 22 <210> SEQ ID NO 243 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 243 gaaattggca atctgattct 20 <210> SEQ ID NO 244 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 244 caacttgtcc tttattgatg t 21 <210> SEQ ID NO 245 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 245 ctatgttgat aaaacattga aa 22 <210> SEQ ID NO 246 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 246 gcctgtctgg aatatagttt 20 <210> SEQ ID NO 247 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 247 cagggcatat aatctaagct gt 22 <210> SEQ ID NO 248 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 248 caatgactct gagttgagca c 21 <210> SEQ ID NO 249 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 249 actctctccc tcccctct 18 <210> SEQ ID NO 250 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 250 tatggcccca aaactattct 20 <210> SEQ ID NO 251 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 251 acaagtactg ggcagattga 20 <210> SEQ ID NO 252 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 252 gccaggttta gctttcaagt 20 <210> SEQ ID NO 253 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 253 ttttatatca ggagaaacac tg 22 <210> SEQ ID NO 254 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 254 ccagaatttt ggaggtttaa t 21 <210> SEQ ID NO 255 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 255 tgtcattcct cctttatctc ca 22

<210> SEQ ID NO 256 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 256 ttcttttgcc tctcccaaag 20 <210> SEQ ID NO 257 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 257 accctggcac agtgttgact 20 <210> SEQ ID NO 258 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 258 tgggcctgag ttgagaagat 20 <210> SEQ ID NO 259 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 259 aatttgtaag tatgtgcaac g 21 <210> SEQ ID NO 260 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 260 tttttcccat ttccaactct 20 <210> SEQ ID NO 261 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 261 aaaagatgag acaggcaggt 20 <210> SEQ ID NO 262 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 262 acccctgtga atctcaaaat 20 <210> SEQ ID NO 263 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 263 gcacttgctt ctattgtttg t 21 <210> SEQ ID NO 264 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 264 cccttcctct cttccattct 20 <210> SEQ ID NO 265 <211> LENGTH: 13 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 265 agcactgcag gta 13 <210> SEQ ID NO 266 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 266 acagatacca aagaactgca a 21 <210> SEQ ID NO 267 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 267 tggacacctt tcaacttaga 20 <210> SEQ ID NO 268 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 268 gaacagtaat gttgaacttt tt 22 <210> SEQ ID NO 269 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 269 tcttgcaaaa agcttagcac a 21 <210> SEQ ID NO 270 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 270 aaaaagatct caaagggtcc a 21 <210> SEQ ID NO 271 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 271 gcttttgctg aacatcaagt 20 <210> SEQ ID NO 272 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 272 ccttccagca gcatagtct 19 <210> SEQ ID NO 273 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 273 aaatccagga tgtgcagt 18

<210> SEQ ID NO 274 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 274 atgatgaggt cagtggtgt 19 <210> SEQ ID NO 275 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 275 catcacagat catagtaaat gg 22 <210> SEQ ID NO 276 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 276 aattattatt ttgcaggcaa t 21 <210> SEQ ID NO 277 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 277 catgaggcaa acacctttcc 20 <210> SEQ ID NO 278 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 278 gctggactca ggataaagaa ca 22 <210> SEQ ID NO 279 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 279 tggaagcctg agctgactaa 20 <210> SEQ ID NO 280 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 280 ccttcttttc ccccagaatc 20 <210> SEQ ID NO 281 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 281 taggagaaca gaagatcaga g 21 <210> SEQ ID NO 282 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 282 aaagactatt gctaaatgct tg 22 <210> SEQ ID NO 283 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 283 taagcgtagg gctgtgtgtg 20 <210> SEQ ID NO 284 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 284 ggacggatag actccagaag g 21 <210> SEQ ID NO 285 <211> LENGTH: 23 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 285 gaatgacctt ggcactttta tca 23 <210> SEQ ID NO 286 <211> LENGTH: 27 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 286 aaggatagag atatacagat gaatgga 27 <210> SEQ ID NO 287 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 287 catgcaccgc gcaaatac 18 <210> SEQ ID NO 288 <211> LENGTH: 19 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 288 atgcctcacc cacaaacac 19 <210> SEQ ID NO 289 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 289 tccaagccct tctcactcac 20 <210> SEQ ID NO 290 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 290 ctgggacggt gacattttct 20 <210> SEQ ID NO 291 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 291 cccaggaaga gtggaaagat t 21

<210> SEQ ID NO 292 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 292 ttagcttgca tgtacctgtg t 21 <210> SEQ ID NO 293 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 293 agctagatgg ggtgaatttt 20 <210> SEQ ID NO 294 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 294 tgggctgagg ggagattc 18 <210> SEQ ID NO 295 <211> LENGTH: 22 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 295 atcaagctaa ttaatgttat ct 22 <210> SEQ ID NO 296 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 296 aatgaataag gtcctcagag 20 <210> SEQ ID NO 297 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 297 tttaatctga tcattgccct a 21 <210> SEQ ID NO 298 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 298 agctgtgggt gaccttga 18 <210> SEQ ID NO 299 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 299 tgtcccacca ttgtgtatta 20 <210> SEQ ID NO 300 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 300 tcagacttga agtccaggat 20 <210> SEQ ID NO 301 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 301 gcttcagggg tgttagtttt 20 <210> SEQ ID NO 302 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 302 ctttgtgaaa agtcgtccag 20 <210> SEQ ID NO 303 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 303 ccatcatgga aagcatgg 18 <210> SEQ ID NO 304 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 304 tcatctccat gactgcacta 20 <210> SEQ ID NO 305 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 305 gagatgacgg agtagctcat 20 <210> SEQ ID NO 306 <211> LENGTH: 18 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 306 cccagctgca ctgtctac 18 <210> SEQ ID NO 307 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 307 tcttgttcca atcacaggac 20 <210> SEQ ID NO 308 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 308 atgctgttag ctgaagctct 20 <210> SEQ ID NO 309 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 309

tgaaagctcc taaagcagag 20 <210> SEQ ID NO 310 <211> LENGTH: 20 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 310 ttgaagagat gtgctatcat 20 <210> SEQ ID NO 311 <211> LENGTH: 54 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: Description of Artificial Sequence: Synthetic primer <400> SEQUENCE: 311 gccgcctgca gcccgcgccc cccgtgcccc cgccccgccg ccggcccggg cgcc 54 <210> SEQ ID NO 312 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 312 catagtgaca ggtatatgcc caactaactg tggaaaacag ttctttcttt caaccttact 60 catcaccctc acggtctgtt tatgaggctc tcctccacca gccagaaagg atgacgtgcc 120 atacctgcaa aacttataca gcatcaacag aatgaatctt tccaacaagc cgaaacattg 180 agtattgtgg cacagaatat gccccaccca ttactcaatc tagatatcct tttattccac 240 cgtctcatga ttttcttttt cctggaaaac aaaagtattt ctttcatagc ccagctagca 300 ygataaatca gcgagtcaga attctagctt tgttgtaagg ttttgcgaat atctgatcct 360 cttattttgt acttttctat ttcctaggca aatctgagta tttcacccag ttttccttaa 420 ctaggcattg aaaactcagt ttttttctta caaaccttca tgtcttcctg ctcatttgca 480 cagtcttatc ttgcacctcc tataaaatgg agaaacttga cattaaaacg taatttttat 540 tacattttga gggattccca gagaattttt ccccaatctc cttaggtagg gacttcttta 600 c 601 <210> SEQ ID NO 313 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 313 gtgggaacta tagtaaagaa gtccctacct aaggagattg gggaaaaatt ctctgggaat 60 ccctcaaaat gtaataaaaa ttacgtttta atgtcaagtt tctccatttt ataggaggtg 120 caagataaga ctgtgcaaat gagcaggaag acatgaaggt ttgtaagaaa aaaactgagt 180 tttcaatgcc tagttaagga aaactgggtg aaatactcag atttgcctag gaaatagaaa 240 agtacaaaat aagaggatca gatattcgca aaaccttaca acaaagctag aattctgact 300 ygctgattta tcgtgctagc tgggctatga aagaaatact tttgttttcc aggaaaaaga 360 aaatcatgag acggtggaat aaaaggatat ctagattgag taatgggtgg ggcatattct 420 gtgccacaat actcaatgtt tcggcttgtt ggaaagattc attctgttga tgctgtataa 480 gttttgcagg tatggcacgt catcctttct ggctggtgga ggagagcctc ataaacagac 540 cgtgagggtg atgagtaagg ttgaaagaaa gaactgtttt ccacagttag ttgggcatat 600 a 601 <210> SEQ ID NO 314 <211> LENGTH: 650 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 314 tttattggtc ctgactggta caaatactga taaaaaggat tttaagatca tattcatact 60 tttggggaat gagagccaca attaattaac aatgtctgcc atgagattgg atgcaagagt 120 atggcactca tactattcct acttctgtct aattacacta tttgtttctg tgtgcaaaaa 180 tctttggtag gtggtggatg tgcccaagac acagggaaga aaaagaagta aacagggaag 240 tacaacacag actctgaaat ggggcatcat ggaagacgga gctttgtcgt cttggtcttt 300 gctgtatatt cacttcctac aacagtgcta aataccttgt ggatgcttaa atatattaaa 360 tgaatgcata aatgaaaaga gtaaataaag agtgtatatg aaagtatgta gataaaattc 420 ttcactaagc cttggggatc cagctgcttm aggactaaga ccgtatctag ctccttttag 480 tatttccaca gcatgccatg gagatacatg tttctgatta tatatgatac atggaaatta 540 tatgttgttg aatgagtgat tgagtaaatg tgtactaggg cagctaatca taaatatttc 600 tactattgct aaaatgactg gatttatcca ttccttctga gagtttatac 650 <210> SEQ ID NO 315 <211> LENGTH: 626 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 315 ctgcttaagg actaagaccr tatctagctc cttttagtat ttccacagca tgccatggag 60 atacatgttt ctgattatat atgatacatg gaaattatat gttgttgaat gagtgattga 120 gtaaatgtgt actagggcag ctaatcataa atatttctac tattgctaaa atgactggat 180 ttatccattc cttctgagag tttatactga ttgcttatat tgtatcaaat accgtaactg 240 agggcaatgt ttactcaaac taatagcacc attcaaattt atgcaaacaa taacactata 300 tctttaaaat gttttcacta aaagctgcat aaagagtgta ttcaacaaca atagaataat 360 tttacaatct tttttcttgc ttaatggcca tttgtgcctt ctgacatgct gctagccatt 420 caaaggtcac actaccttga agttgaagat caagacaaat gattagactc ataaaagaca 480 aatcacgtct ttctggacag gtgattatta ataattaatt agcatttaaa catgtattat 540 ttaagttctt tttaagttat aaagtctttg atttgctaaa cagtttaaat aatgaataaa 600 acataaaata ataatagtta ccattt 626 <210> SEQ ID NO 316 <211> LENGTH: 1113 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 316 caagagctgc atctcactcc aatttttctt ctccctataa ccttatctag attcccagtt 60 gagggaaccg atgacctaat tcctctcagt ttaaatgcaa cacaggagca aattccaaat 120 atctatgctg gtcttgctgg gattgcagaa ccccagggtg gttatcctcc tccagaggta 180 atcctgtgat cagcactaac rccacatacc agccctttca tcagcttgtt ggagaagcat 240 ctttacttcc caccaagcag tgacctagat accatctcac accagttaga atcaggatca 300 ttaaaaagtc aagaaaaaac agatgctgaa gaggatgtgg agaaatagga atgcttttac 360 actgttagtg ggaatgtaaa ttagttcaac cattgtcaaa gacagtgtgg cgatccctca 420 cagatctaga accagaaata ccatttgacc cagcaatccc attactgggt ctatacccaa 480 aggattataa attactctac tataaagaca catgcacaca tatgtttatt gcagcaccat 540 tcacaatagc aaagaattgc aaccaaccct aatgcccatc aatgacagac tggataaaga 600 aaatctggca catatacacc atggaatact acgcagccat aaaaaaggat gagtttatgt 660 cctttacagg gacatggatg aagctggaaa ccatcattct cagcaaacta acacaggaac 720 agaaaaccaa acacatgttc tcactcacaa gtgggagttg aacaatgaga acacatggac 780 acagggaggg gaacatcaca caccactgct tgtcaggggg tggggggcta ggggaaggat 840 agcattagga gaaataccta atgtagatga agggttgatg ggtgcagcaa accaccatgg 900 catgtgtata cctgtgtaac aaacctccat gttctgcacg tgtatcccag aacttaaagt 960 acaatacaaa aaaaaaaaaa agtgtaatcc agtttacatt ttcaaggtca aagtgggtac 1020 aatgctatct atcttgggct aagaagagaa aaggaaaaat tcttgcttta aatcttagaa 1080 gtctggtttt tttccctgtt ttgtacccca tcc 1113 <210> SEQ ID NO 317 <211> LENGTH: 1113 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 317 ttcccagttg agggaaccga tgacctaatt cctctcagtt taaatgcaac acaggagcaa 60 attccaaata tctatgctgg tcttgctggg attgcagaac cccagggtgg ttatcctcct 120 ccagaggtaa tcctgtgatc agcactaacg ccacatacca gccctttcat cagcttgttg 180 gagaagcatc tttacttccc rccaagcagt gacctagata ccatctcaca ccagttagaa 240 tcaggatcat taaaaagtca agaaaaaaca gatgctgaag aggatgtgga gaaataggaa 300 tgcttttaca ctgttagtgg gaatgtaaat tagttcaacc attgtcaaag acagtgtggc 360 gatccctcac agatctagaa ccagaaatac catttgaccc agcaatccca ttactgggtc 420 tatacccaaa ggattataaa ttactctact ataaagacac atgcacacat atgtttattg 480 cagcaccatt cacaatagca aagaattgca accaacccta atgcccatca atgacagact 540 ggataaagaa aatctggcac atatacacca tggaatacta cgcagccata aaaaaggatg 600 agtttatgtc ctttacaggg acatggatga agctggaaac catcattctc agcaaactaa 660 cacaggaaca gaaaaccaaa cacatgttct cactcacaag tgggagttga acaatgagaa 720 cacatggaca cagggagggg aacatcacac accactgctt gtcagggggt ggggggctag 780 gggaaggata gcattaggag aaatacctaa tgtagatgaa gggttgatgg gtgcagcaaa 840 ccaccatggc atgtgtatac ctgtgtaaca aacctccatg ttctgcacgt gtatcccaga 900 acttaaagta caatacaaaa aaaaaaaaaa gtgtaatcca gtttacattt tcaaggtcaa 960 agtgggtaca atgctatcta tcttgggcta agaagagaaa aggaaaaatt cttgctttaa 1020 atcttagaag tctggttttt ttccctgttt tgtaccccat cctcttggtc tctctagata 1080 tatttaagac tcacatagga cttgtctttt cta 1113 <210> SEQ ID NO 318 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 318 tcatcaacta aatagttgat gaggggaaat tgttctgtat atgttcatac ttcagctaat 60

caattaaaaa tgatgaaata ataagattac cattttgcaa acccctaatg caatgttgga 120 tccaggcaat gatcatcaat ggccactaaa atcacacaaa aggagataac cagaatatgt 180 gctttgtgat ggaagcatta aatacaacta atgagatatt gtttataaga aagaaaggaa 240 gcaagaaagc aatcacacca agctctgtat ctagctacca catttaagga aaaaaagaga 300 cagaagagca tgttaaatgt taccaagaag atacagtcag tcggaaaaaa tacagacaag 360 aaaatacaga gcaaaacaac ccagcttctt cagcaaatca atataaaaaa attttaagaa 420 agagttaaag tataaactga gagacttcag aaacatatta tccaagtata atccatgaat 480 cttgtttaaa tatagatcaa rtaaaccact ataccaaaaa catcaaaaga caactgggta 540 aattttttaa atgactagct atttgatgtt aaggaagtaa tgttactctc ttatatacaa 600 tttgaaataa tctagcgagg agcagcaaat gtgcggctat gaggaagaaa cacaattggc 660 cattcttgaa tcattagctg gatggtggct atatgggggt agattttact actctctaat 720 tttacatata tttaaaatgt tccataataa attgttgagt tatcaaaaga aatatttcta 780 tataatagct aaaattattt ataaaagtta gtggtctcat aactttattt atttatttac 840 ttattttgag accgagtctc cctctgttat gcaggctgga gtgcagtggc tccatctcgg 900 ctcactgcaa acttcacctc ctggattgaa gcgattctcc tgcctcagcc cccccgagta 960 gctgggatta caggcttgca cccccacgcc cagctaattt t 1001 <210> SEQ ID NO 319 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 319 agctaccaca tttaaggaaa aaaagagaca gaagagcatg ttaaatgtta ccaagaagat 60 acagtcagtc ggaaaaaata cagacaagaa aatacagagc aaaacaaccc agcttcttca 120 gcaaatcaat ataaaaaaat tttaagaaag agttaaagta taaactgaga gacttcagaa 180 acatattatc caagtataat ccatgaatct tgtttaaata tagatcaaat aaaccactat 240 accaaaaaca tcaaaagaca actgggtaaa ttttttaaat gactagctat ttgatgttaa 300 rgaagtaatg ttactctctt atatacaatt tgaaataatc tagcgaggag cagcaaatgt 360 gcggctatga ggaagaaaca caattggcca ttcttgaatc attagctgga tggtggctat 420 atgggggtag attttactac tctctaattt tacatatatt taaaatgttc cataataaat 480 tgttgagtta tcaaaagaaa tatttctata taatagctaa aattatttat aaaagttagt 540 ggtctcataa ctttatttat ttatttactt attttgagac cgagtctccc tctgttatgc 600 a 601 <210> SEQ ID NO 320 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 320 ccaactgatc taattagata aacttagtca atatatttga atcccacatt ccagcagcta 60 ttttctccat ttgcttttat tgctgtttgt ggtgagtttg atatataatt ttaaggtgtt 120 aacatcccta acttatgtat gggtacagct cataaatacg aacctgtgtc atgcaactca 180 tatatgactg tgttcaaaat aatgtgtatt agactgtaaa acgattttaa tattttaaat 240 aactttcctg catttgtcgg tttcagcagg aaagttattt ttaataactt ccctgtattt 300 sttggtttca gtattaatta atctcattaa tgctaaactt tgtgatccta ggttaaaaaa 360 catattcaag atagcttcag aatgtttggt atacaaatag gtctggctaa atataagtgt 420 tagctttctc aagcatctaa atgctggcgg gcttttaaaa aaccagggct ttaaggagaa 480 aacacctgct ctgtggtttt gtagcagata tgaagtattc aaatttctta ataaatagaa 540 aaagaaatat ataacagaaa caggttgcac ttgtctttct cattaagcag gtggttagta 600 c 601 <210> SEQ ID NO 321 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 321 agctcataaa tacgaacctg tgtcatgcaa ctcatatatg actgtgttca aaataatgtg 60 tattagactg taaaacgatt ttaatatttt aaataacttt cctgcatttg tcggtttcag 120 caggaaagtt atttttaata acttccctgt atttgttggt ttcagtatta attaatctca 180 ttaatgctaa actttgtgat cctaggttaa aaaacatatt caagatagct tcagaatgtt 240 tggtatacaa rtaggtctgg ctaaatataa gtgttagctt tctcaagcat ctaaatgctg 300 gcgggctttt aaaaaaccag ggctttaagg agaaaacacc tgctctgtgg ttttgtagca 360 gatatgaagt attcaaattt cttaataaat agaaaaagaa atatataaca gaaacaggtt 420 gcacttgtct ttctcattaa gcaggtggtt agtaccatta tttgcattct catagcctta 480 atatacattt tccttctcta g 501 <210> SEQ ID NO 322 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 322 ttttgagttt ctactttagt gtcttagtgc tttctcgata tgggagaatt catgtcctcc 60 attcagaagt atgcactaag taagaggtat catgtctggt tcttgattag gtactaatct 120 tgaaatatta tcctacaata ggttagagca cgtatatctc ctgataatat attgaatatg 180 atagatttaa ataattggtt aactaaatac taaagcaaat tgctgcacgt atcatttatt 240 attcattgtg tagaaagtgc ctgactcagt gtttggaaat tgtctgactt ttcctcatat 300 rtagtgtggt ttcatgttat tgtatataag acctgacatg aactctgttt acaataatct 360 cccagtgcca taaagaccat aataaataat ataaccaatt ggtttcttta tgctgtcatt 420 tattagggca tatggcatta gtggaggatt accttgtatt acccatagtg cttagagtat 480 gaatcacaca tgcaccttga aggaaaagag gtgcaatgta ataagaaacc agatattgaa 540 aatgcaagtt ttgttatgtt attctgggta tgttaacctt tattcctgcc ctccatatgc 600 a 601 <210> SEQ ID NO 323 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 323 aagaggtatc atgtctggtt cttgattagg tactaatctt gaaatactat cctacagtag 60 gttagagcac gtatatctcc tgataatata ttgaatatga tagatttaaa taattggtta 120 actaaatact aaagcaaatt gctgcacgta tcatttatta ttcattgtgt agaaagtgcc 180 tgactcagtg tttggaaatt gtctgacttt tcctcatata tagtgtggtt tcatgttatt 240 gtatataaga mctgacatga accctgttta caataatctc ccagtgccat aaagaccata 300 ataaataata taaccaattg gtttctttat gctgtcattt attagggcat atggcattag 360 tggaggatta ccttgtatta cccatagtgc ttagagtatg aatcacacat gcaccttgaa 420 ggaaaagagg tgcaatgtaa taagaaacca gatattgaaa atgcaagttt tgttatgtta 480 ttctgggtat gttaaccttt a 501 <210> SEQ ID NO 324 <211> LENGTH: 854 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 324 tttcagcact gagagccaga gtggaattgt ctccttcatt gccactgcct tcacgttttg 60 tgtgtcgtat ctgttttgtg atcactgaga cccaagaacc cccgacttgc cgacatacta 120 tgtggccccg agagaggact tgagctctct gggtttcatc attaccatca attaaataaa 180 caggacagta gcttcttcct tggattgtta atttaaggct ctggataata catgtaaccg 240 ccttatgata gagcagaatt gtaagtaggc tcatggtaga atcgttcaat gacatttccc 300 tttcctttgg gagaaacaga aattcacagg tctaattctt ttcctattaa tagttcctgr 360 ccattattcc agaactgtcc taaaggaatt ctttctcctt aaggacacca cctcccagga 420 gggtatttaa agatttgcac aggccgggca cggtggctca tgcttgtaat cccagcagtt 480 tgggaggcca aggcgggtgg atcacttgtg ctcaggggtt caagaccggc ctggccaaca 540 tggtgaaacc ctatctctac taaaaacaca aaagttagct gggcctggct atgcatgcct 600 gtaattccag ctactcggga ggctgaggct ggagaatagc ttgaaccagg gaggtggaga 660 taacagtgag ctgagatgcc actatgacac tccagcctgg gtgacagagc aagactctct 720 ctcaaaaaaa aaaaaagatt tttatagtcc agtattcaac gttcatagta cacctttctt 780 atcctagtaa atcttctttt atcaaggtat atgatcccat atagtagtta actcttactc 840 ttactttatg acaa 854 <210> SEQ ID NO 325 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 325 aaatacttac tattaaatat gagaaactgt ggtgtttatc ggtaagatcc acgaaggaag 60 aagttttaaa gaaaaatact ttaaccgtgg aaaaaaaaaa ctttaatgtc tattatcgaa 120 taggggccgt aattactttt gcaaaataaa aaaacaaaca agactagcta tagtgtaaat 180 gtaatctgta tgctttttaa tgaaacaatt aagtaggttg cccatttaca attagcctga 240 ttttctcctg ygtggtatta tgtgtactta acaacaggac ccagtggaaa ttcactcatt 300 taacaaagtc tgcctacatg gtttcaaata tgggcctaac ttgaaaattc agtcataatt 360 aaatctaagg actaaaacaa atctgtataa aaagattctg ctaaataagg gaaaattcaa 420 gtctagggct acattctgaa agatattgaa gtagaacctc tgcagcaaga ctaggcttgg 480 aaagtgcggg gaggagggaa a 501 <210> SEQ ID NO 326 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 326 ccacatcaga aacatgagga aattctacat ggtaaaaaca gcaacaacca aaaaatactt 60 aaagtcaaca aaccaggaaa agacatctct gaatatagga atgccaaacc tttaacacaa 120

taaaacacag attatatttc agaaggctat attatatgtg tataccaaca tcaatatgtc 180 cagagtagct gcacagagtt ccatatttta gtctttataa gttcccctcc tcaccctact 240 cagtaggcac tttgtgtcta gaaacttctg tgtcaacagt tttccctctc tctggaattc 300 mtcaggacag aagtgattgg tgtggtggaa gagggttgtg ctaagagtga agttatatga 360 aagtaggatg gaggttagca agtagttaaa gtccagaaag gcaataaggt gttaaggaag 420 aacttttcca ttttacaggt ctgagcaagc aggaaatcaa ctctacaaac tttgaaactt 480 ggtaaatatg aaaacattct caataccatt tgtcatttaa taaatacaaa ttatactatt 540 ttactgcttg catctagaag tttgtcaaag atctcgtctt aattattcat tgtgtcggcg 600 a 601 <210> SEQ ID NO 327 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 327 gacgagatct ttgacaaact tctagatgca agcagtaaaa tagtataatt tgtatttatt 60 aaatgacaaa tggtattgag aatgttttca tatttaccaa gtttcaaagt ttgtagagtt 120 gatttcctgc ttgctcagac ctgtaaaatg gaaaagttct tccttaacac cttattgcct 180 ttctggactt taactacttg ctaacctcca tcctactttc atataacttc actcttagca 240 caaccctctt ccaccacacc aatcacttct gtcctgatga attccagaga gagggaaaac 300 ygttgacaca gaagtttcta gacacaaagt gcctactgag tagggtgagg aggggaactt 360 ataaagacta aaatatggaa ctctgtgcag ctactctgga catattgatg ttggtataca 420 catataatat agccttctga aatataatct gtgttttatt gtgttaaagg tttggcattc 480 ctatattcag agatgtcttt tcctggtttg ttgactttaa gtattttttg gttgttgctg 540 tttttaccat gtagaatttc ctcatgtttc tgatgtggaa agtataagaa tatcagccag 600 a 601 <210> SEQ ID NO 328 <211> LENGTH: 811 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 328 taaataatct ctaattagta taatgggtgt tcttagtgca gtgggtactt ttaaagtgct 60 ttgtggcttt tgatgaaaat tgtcttagta tttaaaactt tttcttaccc aattttttgt 120 tcccatcgaa ttagcaatgc tgtaaagaaa ggcatcttat tccatttttt gttgctataa 180 aggaatactt gaggctgggt aatttataaa gatgaaaagt ttatttggct cgcaattctg 240 gatggctgga aggttaagta ctgggccaca gcatctggtg ggggcctcga gctgcttcta 300 gtcataatgg aaggtgaagg gtgtaaagat catgtgacaa gggaggaaag aagagaagga 360 aggaggtgct ggttctttct atcaaccaat tcgcaagaga actaatagag aaagaactca 420 cttagccctg tgggaacaca ttaatctatt cataagggat ctggctgtat gatacaaaca 480 cctcccatta ggccccacct ccaaattgta tcccattggg gatcaaattt caaaaagaga 540 tttggaagga acaaacaaac catatctaag ccatagtaaa aggaatggct tttcaaaggt 600 aaaatttact ragtgtatta atattttacc aatttccagc caggagagta tgaatgttgc 660 attattacat tgctttgaaa caaagcatta gtcttaattc agaagtttaa attcagatgt 720 taacgttgca tatttaataa tgcacaacca gtactaaaat cctcattgaa atgacaaata 780 attttatttc gaatccctta tagaggttca c 811 <210> SEQ ID NO 329 <211> LENGTH: 811 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 329 tgtcttagta tttaaaactt tttcttaccc aattttttgt tcccatcgaa ttagcaatgc 60 tgtaaagaaa ggcatcttat tccatttttt gttgctataa aggaatactt gaggctgggt 120 aatttataaa gatgaaaagt ttatttggct cgcaattctg gatggctgga aggttaagta 180 ctgggccaca gcatctggtg ggggcctcga gctgcttcta gtcataatgg aaggtgaagg 240 gtgtaaagat catgtgacaa gggaggaaag aagagaagga aggaggtgct ggttctttct 300 atcaaccaat tcgcaagaga actaatagag aaagaactca cttagccctg tgggaacaca 360 ttaatctatt cataagggat ctggctgtat gatacaaaca cctcccatta ggccccacct 420 ccaaattgta tcccattggg gatcaaattt caaaaagaga tttggaagga acaaacaaac 480 catatctaag ccatagtaaa aggaatggct tttcaaaggt aaaatttact aagtgtatta 540 atattttacc aatttccagc caggagagta tgaatgttgc attattacat tgctttgaaa 600 caaagcatta ktcttaattc agaagtttaa attcagatgt taacgttgca tatttaataa 660 tgcacaacca gtactaaaat cctcattgaa atgacaaata attttatttc gaatccctta 720 tagaggttca caatgtttta acaatgtagt tttgactaaa tagaagtagt caaaacctgt 780 cagattggaa atagtattta taaaacataa a 811 <210> SEQ ID NO 330 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 330 gctcatcaat tttgacttaa gaaaattcta gcaacattta tagattttgc caaaattcag 60 cttcttccca aatcaatcta taagaaggct cttccttaaa cataattttt atatctatga 120 actgcactag catttactat atatttttat cactctcacc attactggat aataaataaa 180 agctcattaa aagagttaac aaaacatatt tattttaggc atcctgaaaa aaagattcaa 240 ttttattatc atttctacaa taagtattga agaaaggaga atttaaatta cttcatatac 300 stgataaagg aaaacatatg caaggcaaat aaacatctta gatcatgaca tataaaataa 360 tagattatta ctaaagatta aaatactttc ttaagaatta aagcaattct aaaagcaata 420 gtaaataaca ttctttctag tgatcagaca ctggatacta tgtttgagat agacagtgaa 480 ttgggaatgt tgttttacag aagctcctac cttgcaagga caggcaagtt taaatgtcag 540 ctagaaaact atcttgagtt ttcagtaatg taagattttc ctattcaatt tcacacttta 600 a 601 <210> SEQ ID NO 331 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 331 agaaaattct agcaacattt atagattttg ccaaaattca gcttcttccc aaatcaatct 60 ataagaaggc tcttccttaa acataatttt tatatctatg aactgcacta gcatttacta 120 tatattttta tcactctcac cattactgga taataaataa aagctcatta aaagagttaa 180 caaaacatat ttattttagg catcctgaaa aaaagattca attttattat catttctaca 240 ataagtattg aagaaaggag aatttaaatt acttcatata cctgataaag gaaaacatat 300 rcaaggcaaa taaacatctt agatcatgac atataaaata atagattatt actaaagatt 360 aaaatacttt cttaagaatt aaagcaattc taaaagcaat agtaaataac attctttcta 420 gtgatcagac actggatact atgtttgaga tagacagtga attgggaatg ttgttttaca 480 gaagctccta ccttgcaagg acaggcaagt ttaaatgtca gctagaaaac tatcttgagt 540 tttcagtaat gtaagatttt cctattcaat ttcacacttt aaattttata tatatataaa 600 a 601 <210> SEQ ID NO 332 <211> LENGTH: 1110 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 332 tgtagaagtt cttatcactt cctggccttt tggctaagat caagtgtgaa atgtagaagt 60 tcctctaagc tttacttccc tcaaaaacta gttttatctt gtcagcagga ttcacttaaa 120 aagacaaatt cagattatga atttttttct tttttacagg gtctgctctg ttgcccaggc 180 tggagtgcag aggcacaatc tcggctcact gcagcctccg cctcctgggt tcaagcaatt 240 ctcttgcctc agcctcccga gtaactggga ttacaggcat gtgccaccac ccagctaatt 300 tttgtatttt tagtagagat ggggtttcac cacattggtc aggctggtct cgaactgctg 360 gcctcaagtg atccacttgc ctcggcctcc caaagtgcag agattacagg tgtgagccac 420 cgtgcccagc ctcataaccg tttcaactac tttttcactt gacaagcaga tgtgaagtta 480 acaaagtcac ccatatttga aataaagata gtatattcct ggggyaggca gaggcagttg 540 aggatcatga aataactatg ttggcatagt tatttaggtg ttgatactgt tattatgcca 600 ttgaaagtta aacagagaac cctctgggta catgttttat accaatgcac actatcttat 660 tagtccctct cataatgtgc agtcatcatt actgttacgg gttgaggtgt ccccatcctc 720 tatgggacac ctctatgttg aagtctcaga ttccctagaa tctcagaatg tgaccttgtt 780 tggaaacaga tttgctacag acgcaattag ttgagatgcg cttatatggg taggtcctaa 840 ttcagtgact ggtgtcctta aaaaaatgga aatgtacaca cggtggtaga catgcataga 900 gggaagagag atggagaaaa tggtcaccta caagccaaag acaggggtct ggagcagatc 960 cttccctcac agccctcaga aggaaccaat cttgccaata ccttgatttt ggacttccac 1020 ctccagaact ataacacatt tctgttcttc aagcaatttg tagccatttg ttacagctaa 1080 tacaatcaca catagaaatg acttgtaaat 1110 <210> SEQ ID NO 333 <211> LENGTH: 691 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 333 taaaacatgt acccagaggg ttctctgttt aactttcaat ggcataataa cagtatcaac 60 acctaaataa ctatgccaac atagttattt catgatcctc aactgcctct gcctacccca 120 ggaatatact atctttattt caaatatggg tgactttgtt aacttcacat ctgcttgtca 180 agtgaaaaag tagttgaaac rgttatgagg ctgggcacgg tggctcacac ctgtaatctc 240 tgcactttgg gaggccgagg caagtggatc acttgaggcc agcagttcga gaccagcctg 300 accaatgtgg tgaaacccca tctctactaa aaatacaaaa attagctggg tggtggcaca 360 tgcctgtaat cccagttact cgggaggctg aggcaagaga attgcttgaa cccaggaggc 420 ggaggctgca gtgagccgag attgtgcctc tgcactccag cctgggcaac agagcagacc 480 ctgtaaaaaa gaaaaaaatt cataatctga atttgtcttt ttaagtgaat cctgctgaca 540

agataaaact agtttttgag ggaagtaaag cttagaggaa cttctacatt tcacacttga 600 tcttagccaa aaggccagga agtgataaga acttctacat tttaagttat tcacaagata 660 actattaatg aacctgaaat agtttgtaaa g 691 <210> SEQ ID NO 334 <211> LENGTH: 640 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 334 aaaccttttt cctgttttac tattactaaa ggtggcacaa cagcaacctc aacaactttg 60 caccatgcca acactgatgt ttacacccag cacagcattt ttggtctcta tttttattct 120 cctctgaatg taatgaggat tcctagatgg ctagccaatt cgaatattta aggcaactga 180 aagttagaat gtttctgaaa catagtgttg ttgccagaga gtacgaaagt tttcaagaat 240 atcgggcaat tctgaaagta caaagaagcc agattaaatg aaataacact ggcgaagttt 300 tagcaaggtg actctcatat aatgatcatt atcattacca cagttaaaag aaaagagttg 360 tttatgaaag gccatgtgtc tgcaatgaaa ctcaaaagag aaaagttaac aggtgcaara 420 ggtagtttta ttataaaagg agggtaggca acaagaatat gtttaatttt tcttcctttt 480 catgagtaag gacaagagtt tcatatatgt gaatattttt atttaatttt aagtagaaat 540 ctgtttttaa aatatgggta tatgcttatt tgtgtaagtg taagaaacag aagtaagtac 600 agcaaaccag aaataggcca aacactcctg agcataattt 640 <210> SEQ ID NO 335 <211> LENGTH: 919 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 335 tacacccagc acagcatttt tggtctctat ttttattctc ctctgaatgt aatgaggatt 60 cctagatggc tagccaattc gaatatttaa ggcaactgaa agttagaatg tttctgaaac 120 atagtgttgt tgccagagag tacgaaagtt ttcaagaata tcgggcaatt ctgaaagtac 180 aaagaagcca gattaaatga aataacactg gcgaagtttt agcaaggtga ctctcatata 240 atgatcatta tcattaccac agttaaaaga aaagagttgt ttatgaaagg ccatgtgtct 300 gcaatgaaac tcaaaagaga aaagttaaca ggtgcaaaag gtagttttat tataaaagga 360 gggtaggcaa caagaatatg tttaattttt cttccttttc atgagtaagg acaagagtkt 420 catatatgtg aatattttta tttaatttta agtagaaatc tgtttttaaa atatgggtat 480 atgcttattt gtgtaagtgt aagaaacaga agtaagtaca gcaaaccaga aataggccaa 540 acactcctga gcataatttt acttggtaga ttattcctga aacttaagga atcatctttg 600 aactcttttc ctcacttgac ttccaggatt caccatgcac ttgtgatttt cctttcattt 660 cactctccgt tcctcctcag tctttttttc tcccccaggt cttttttgtt catcttaaac 720 tctaaatttt agaatatccc aggggtctgc cttcggcctt ctcttttata tctacactgg 780 cctcatacat aatcttaacc aagtcattat tttaaatacc tacaatatac tgaaaacttc 840 taaatttgta ttttaattct tgacttcttc catacagtct agatttgtat gtccataggc 900 tgacatcatt ggctgatac 919 <210> SEQ ID NO 336 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 336 ttactaaata ttctccaaca aatatatact tagtatatac tattagtgat gcatgctttc 60 aaatatttgg actatatcaa tgaatgaaac aaaaaattat ttgcccttaa ggagcttaga 120 ttctaacaga tggattcaga tgatttttat gccttatttc gtaggtttaa aagagcaatg 180 gggaaaaggg aagaagagag ggattgaaaa tattgagaag gttgggagac ttagcaattt 240 taagtaaggt agtgagggta ggttttattg gcaaagtgat ttttcagcag agactgggaa 300 agatgaacgt ggtatcctgg aggaaagcct cccaggcaga gttaagctgc taacaaaagt 360 gcccttaggc tggagtgggc ttgtttgatt aaggaacaaa gaggtcagca tggttgcact 420 agagagaaaa aatcagatgg cgtaaggaga tgaaatcaga aagatacgag gctaggcaaa 480 ggggtactct atgtaatgaa yatgacctgg cagtactgac atctcctgag ggactgttag 540 aagtgcagac tcttgtatct tttctcaagt ctatgaaatc tagacttcat tttaacaaga 600 tgacccgata tttacataca cattaaagtt ccagaagcac tgatataaca cattgtaaga 660 tcgcacagga cttcaattct ttttctggtt tttagaggca gtcctttggg gtgttttgtg 720 tagagtataa tgacctgaaa tatctaggat cactctagct actatcttga ggaaagagtg 780 caataaggcg gaacagttca gaggcaatgg tggtcttcta aatgaaagac acacagcact 840 caaaccaggc agttgaggag ggatgggaag aagttgtcaa attctagaca tattttaaag 900 gtagtgtcca gagaatttcc ttagatgcgt aggaacatgg aggataggac atagggtgga 960 aataaacgaa ataaagaaac tgaagctgat tctgacattt t 1001 <210> SEQ ID NO 337 <211> LENGTH: 1576 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 337 atacctttta agtgacatcc tagtgaatct ccatttgtca cgagacctca agctttccag 60 ttctggcaca aagtgattac tcataccatc acttcaaaat gatgattatc ttcatttatt 120 ttagttatat tgaacaaaat atacatttaa aaaatctaat tactaaatat tctccaacaa 180 atatatactt agtatatact attagtgatg catgctttca aatatttgga ctatatcaat 240 gaatgaaaca aaaaattatt tgcccttaag gagcttagat tctaacagat ggattcagat 300 gatttttatg ccttatttcg taggtttaaa agagcaatgg ggaaaaggga agaagagagg 360 gattgaaaat attgagaagg ttgggagact tagcaatttt aagtaaggta gtgagggtag 420 gttttattgg caaagtgatt tttcagcaga gactgggaaa gatgaacgtg gtatcctgga 480 ggaaagcctc ccaggcagag ttaagctgct aacaaaagtg cccttaggct ggagtgggct 540 tgtttgatta aggaacaaag aggtcagcat ggttgcacta gagagaaaaa atcagatggc 600 gtaaggagat gaaatcagaa agatacgagg ctaggcaaag gggtactcta tgtaatgaac 660 atgacctggc agtactgaca tctcctgagg gactgttaga agtgcagact cttgtatctt 720 ttctcaartc tatgaaatct agacttcatt ttaacaagat gacccgatat ttacatacac 780 attaaagttc cagaagcact gatataacac attgtaagat cgcacaggac ttcaattctt 840 tttctggttt ttagaggcag tcctttgggg tgttttgtgt agagtataat gacctgaaat 900 atctaggatc actctagcta ctatcttgag gaaagagtgc aataaggcgg aacagttcag 960 aggcaatggt ggtcttctaa atgaaagaca cacagcactc aaaccaggca gttgaggagg 1020 gatgggaaga agttgtcaaa ttctagacat attttaaagg tagtgtccag agaatttcct 1080 tagatgcgta ggaacatgga ggataggaca tagggtggaa ataaacgaaa taaagaaact 1140 gaagctgatt ctgacatttt agacctaaaa tctcaactaa aagttgccaa gatgggaaaa 1200 actaggtgca tcttgtttgg tgagtggaaa tcagccttgt gaattaagac ttaaactgat 1260 gtctttaatc ccgtagaaat accatgaagg cagtagaaga tggctaaaga gaggtctaga 1320 ctgtaggtac aaatttaaaa gtcacttgca tttggatgct taaagtcagg atattgtgaa 1380 gtcaacagag gaataaataa atgcagagag gggaaagaaa aggcccatag actgagccat 1440 tgtctggttt atttacatat tagtatatat tttcttaaag atgtttgcta tataataatg 1500 agttacctaa agtgtgactt ttctaaattt atggggaatt ttctacattg tgttatggca 1560 ctactaaaaa taataa 1576 <210> SEQ ID NO 338 <211> LENGTH: 1275 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 338 gtaaaactaa ttataattaa aatcaaaata tttactgaac ctacttactc ctataatttg 60 cgttgctggt taaaacccag ctataaaaat tttgatcaaa aatttttatt ttgtaaatga 120 tctgacacag cataaatgtt aatcacattt ctttatttta tttgcagatt aatttgagta 180 atttgaaaaa ttattaatgt tacttaatta ctctcaacac cttacagtgt ctcctgtaag 240 cactattggt gatactgaat ttaagttaca tttaacaact atcagaaaat agtttttaaa 300 gtaaaaatta tgatttggag tttaccaact aaatcttgtt agctttcact gcctctattg 360 agaagagcag cagttcttat cttcctcctt tttcttcttt aattaacaag agattatttg 420 tatcatagcc ataaaatcag ttcaggtatt acatgaacga cacccctgac tgcaatggtg 480 tagtttattg tattagtcca ttttcatgct gctgataaag acatacataa gactgggtaa 540 tttataaaga aatagaagtt taacggactc acagttccat gtggctgggg aagcctcaca 600 atcatgatcg aaggcaaaag gcacatctta catggcaaca ggcaagagag aatgagagcc 660 aagtgaaagg agaaacccct tataaaacct tcagacctca tgagacttat tcactaccac 720 aagaacagta tgtgagaaac agtcccatga tccagttatc tcccactggg tccctcccac 780 cacacaaggg aattatggga actgcaattc aagatgaaat gtgggtggaa gcacaacgga 840 actatatcat gatcaaagca ttattgtttt ctctgataag ctgatctaga aagtgctgct 900 tgtgatcagc tttggtgacc atgatcagtg aaatggttaa ggaaatctac agattttgta 960 ggtttgtgcc ttgacagacg accggtatct gtttctcttt tcatgatgaa gtatctaaca 1020 aagctctgtc caaaattttg aatttctcgt taaawgcatc atgattatag aacagaggtt 1080 acaatcaatt attcagtcac acaatcactc tcatcagtca ttaaggtgca tacctggtgt 1140 tccagttatt cagtgtggta taacaaacta cctggaactt aatggcttga aatagtcacc 1200 attacattat gattgtccat tctctgcatc aataattagg atttggcaaa gagggaatgg 1260 tttgtttaca gacag 1275 <210> SEQ ID NO 339 <211> LENGTH: 1275 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 339 gtaaaactaa ttataattaa aatcaaaata tttactgaac ctacttactc ctataatttg 60 cgttgctggt taaaacccag ctataaaaat tttgatcaaa aatttttatt ttgtaaatga 120 tctgacacag cataaatgtt aatcacattt ctttatttta tttgcagatt aatttgagta 180 atttgaaaaa ttattaatgt tacttaatta ctctcaacac cttacagtgt ctcctgtaag 240 cactattggt gatactgaat ttaagttaca tttaacaact atcagaaaat agtttttaaa 300

gtaaaaatta tgatttggag tttaccaact aaatcttgtt agctttcact gcctctattg 360 agaagagcag cagttcttat cttcctcctt tttcttcttt aattaacaag agattatttg 420 tatcatagcc ataaaatcag ttcaggtatt acatgaacga cacccctgac tgcaatggtg 480 tagtttattg tattagtcca ttttcatgct gctgataaag acatacataa gactgggtaa 540 tttataaaga aatagaagtt taacggactc acagttccat gtggctgggg aagcctcaca 600 atcatgatcg aaggcaaaag gcacatctta catggcaaca ggcaagagag aatgagagcc 660 aagtgaaagg agaaacccct tataaaacct tcagacctca tgagacttat tcactaccac 720 aagaacagta tgtgagaaac agtcccatga tccagttatc tcccactggg tccctcccac 780 cacacaaggg aattatggga actgcaattc aagatgaaat gtgggtggaa gcacaacgga 840 actatatcat gatcaaagca ttattgtttt ctctgataag ctgatctaga aagtgctgct 900 tgtgatcagc tttggtgacc atgatcagtg aaatggttaa ggaaatctac agattttgta 960 ggtttgtgcc ttgacagacg accggtatct gtttctcttt tcatgatgaa gtatctaaca 1020 aagctctgtc caaaattttg aatttctcgt taaatgcatc atgattatag aacagaggtt 1080 acaatcaatt attcagtcac acaatcactc tcatcagtca ttaaggtgcr tacctggtgt 1140 tccagttatt cagtgtggta taacaaacta cctggaactt aatggcttga aatagtcacc 1200 attacattat gattgtccat tctctgcatc aataattagg atttggcaaa gagggaatgg 1260 tttgtttaca gacag 1275 <210> SEQ ID NO 340 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 340 gaaacaaaaa attgcttttt atatattgat atttttgcac ggatttctta ggattttcta 60 tgtacatgac catgtcatct gcaaatgaaa tagttttatt tctttatcaa tccggatgaa 120 tttattaaaa ttatcttgcc taatttccca aatagggcct ccatgttgaa cataagtggt 180 ggcaagggtg atctgttgct aatctcagtg gatgatattc agtgttttac aatgatcttc 240 gacagctctg gctgttaaat tatcatagtc tgtatggcct aaacaaacaa aatacttatg 300 attatggggg aggctgggat atccaagatc aagttgctgg caggtctagc aacctgccac 360 tgggaagccc tgcttcccag ttttcagatg gccaccttct tatagtatct tcaccaaaga 420 tagggcagag agagcaagca agctctctac cttctcatat aagggcacta atcccaccat 480 gaaggcgcca ctgtcatgac stgattatgt cacaaagacc ccggggcaaa tattaccact 540 gtgaggagta cagttttagc atgtgaattt tggaagaaca caaacattta gtacagagtg 600 actattaagt atgttattaa ctatggagtt tttgtaggca ttttttaaca cattgagaaa 660 gtttcctcta ttcctacttt tgttgagaag tttttatgat gacaaggcat tacattttat 720 ccaatgactt ttctgtgtgt attgagatga ctgatttgtt ctgccaattt aaatccattg 780 ttgattctct ctaggatttt ttttatttca gttattaaat ttttcaacag gagaattact 840 gtcttgttct tttttttgta atttctgtcc ccttactggt attccatatt taataaggca 900 tcataatagt actcttcttt agtttcttaa agatggtttt ctttagtttt taacatattt 960 atgtctattt agaagtcttt gttaagtctg acatctgagc t 1001 <210> SEQ ID NO 341 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 341 ggatttctta ggattttcta tgtacatgac catgtcatct gcaaatgaaa tagttttatt 60 tctttatcaa tccggatgaa tttattaaaa ttatcttgcc taatttccca aatagggcct 120 ccatgttgaa cataagtggt ggcaagggtg atctgttgct aatctcagtg gatgatattc 180 agtgttttac aatgatcttc gacagctctg gctgttaaat tatcatagtc tgtatggcct 240 aaacaaacaa aatacttatg attatggggg aggctgggat atccaagatc aagttgctgg 300 caggtctagc aacctgccac tgggaagccc tgcttcccag ttttcagatg gccaccttct 360 tatagtatct tcaccaaaga tagggcagag agagcaagca agctctctac cttctcatat 420 aagggcacta atcccaccat gaaggcgcca ctgtcatgac ctgattatgt cacaaagacc 480 ccggggcaaa tattaccact stgaggagta cagttttagc atgtgaattt tggaagaaca 540 caaacattta gtacagagtg actattaagt atgttattaa ctatggagtt tttgtaggca 600 ttttttaaca cattgagaaa gtttcctcta ttcctacttt tgttgagaag tttttatgat 660 gacaaggcat tacattttat ccaatgactt ttctgtgtgt attgagatga ctgatttgtt 720 ctgccaattt aaatccattg ttgattctct ctaggatttt ttttatttca gttattaaat 780 ttttcaacag gagaattact gtcttgttct tttttttgta atttctgtcc ccttactggt 840 attccatatt taataaggca tcataatagt actcttcttt agtttcttaa agatggtttt 900 ctttagtttt taacatattt atgtctattt agaagtcttt gttaagtctg acatctgagc 960 tctctcaaag tttctgctga tttttttttt cctatgtttg g 1001 <210> SEQ ID NO 342 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 342 ggaaaccctg gcctcttgat cacactttcc tggagtttag tcccctctgc aatatgtacc 60 tgggagtcat aagaaatgcc agttacaaaa acttcctgta cagatatcct agcactcaac 120 tggaaaccgg ggagagtcac aattctgtct ttccagccat atgtaactga aatggagatc 180 ttttcaccct gagccagggg tgatgggaaa gggagctggt catggctcaa tgtttagcct 240 tttcttggtc ttcaagattt catagacatt cttaaataca tgtttctttc aatgaagttt 300 gcccttagga caattcacag ctacattagg tactttttaa ataatacttt tgaccatccg 360 tggttatttc attgaagaaa atctatagag cacctcagcc atcattccag aagtgactat 420 cctcctcagt aatggttctt attctaattt taaatatcat tgatgtagaa cattctattt 480 cactattcct tcattttatt rttatgggaa attatataca gttctccaga tttttaaagc 540 cttgctaaca tgttttaagt cacacaaata ttcttctgtg ggaaaatgac agtaatttag 600 tgtgcaacaa ttatatagaa ctatttttca aacttataaa cgaagtgaaa ttctaaataa 660 aatcatttat caaacacaaa aatttgagcc agaataagga a 701 <210> SEQ ID NO 343 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 343 aatgccagtt acaaaaactt cctgtacaga tatcctagca ctcaactgga aaccggggag 60 agtcacaatt ctgtctttcc agccatatgt aactgaaatg gagatctttt caccctgagc 120 caggggtgat gggaaaggga gctggtcatg gctcaatgtt tagccttttc ttggtcttca 180 agatttcata gacattctta aatacatgtt tctttcaatg aagtttgccc ttaggacaat 240 tcacagctac attaggtact ttttaaataa tacttttgac catccgtggt tatttcattg 300 aagaaaatct atagagcacc tcagccatca ttccagaagt gactatcctc ctcagtaatg 360 gttcttattc taattttaaa tatcattgat gtagaacatt ctatttcact attccttcat 420 tttattatta tgggaaatta tatacagttc tccagatttt taaagccttg ctaacatgtt 480 ttaagtcaca caaatattct yctgtgggaa aatgacagta atttagtgtg caacaattat 540 atagaactat ttttcaaact tataaacgaa gtgaaattct aaataaaatc atttatcaaa 600 cacaaaaatt tgagccagaa taaggaatgt aaattacaat ttaaacacag attataaact 660 atcttacttt taaaatgtta aaattcctaa cttgtttgaa a 701 <210> SEQ ID NO 344 <211> LENGTH: 768 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 344 ctaaaatcta ccattatatg atatccttcc caatacataa attaaaaaaa aaaacactgt 60 agaggaaaaa gcaatatttt gaaatgatat gcttttcttt gtttgtcttc aaacaattac 120 atcttcatca taatggttgt attagtctgt ttttacactg ctataaagaa ttgcctgaga 180 ctgagtaaca tataaagaaa aaagttttaa ttgaccacag tttcacaggc ttaataggaa 240 gcatgactgg gaaacttaga atcatggcag aagaggaagg ggaagcaagg atcttcttca 300 catggtagca ggagagagag cacaaagggg gacacgctac acactttcaa acaacgagat 360 ctcctgagaa ctctatcggg agaacagcaa gagggaagtt cacccctatg attcaatcag 420 ctcccaccgg gcttctcccc tgacacatga ggaattacaa ttggatgaga gatttgggtg 480 gggacacaca gacaaaccat atcaactgtc atggacttaa acaattgtct ttgaattgtc 540 ttttttcata cttttatttg catctttyca ctaaaaagat gacacaaagt aatcctagtt 600 tacatttttt accatgtaat tccatattac tttttcctga aagttactta tttttaaatc 660 tcaaagctct tcatacttat ggtttgatct gcacttacaa ctggatctca gaaagattga 720 attctcccat cataccaagt tcatgtctct cactcttaat atttgttc 768 <210> SEQ ID NO 345 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 345 aaatgatatg cttttctttg tttgtcttca aacaattaca tcttcatcat aatggttgta 60 ttagtctgtt tttacactgc tataaagaat tgcctgagac tgagtaacat ataaagaaaa 120 aagttttaat tgaccacagt ttcacaggct taataggaag catgactggg aaacttagaa 180 tcatggcaga agaggaaggg gaagcaagga tcttcttcac atggtagcag gagagagagc 240 acaaaggggg acacgctaca cactttcaaa caacgagatc tcctgagaac tctatcggga 300 gaacagcaag agggaagttc acccctatga ttcaatcagc tcccaccggg cttctcccct 360 gacacatgag gaattacaat tggatgagag atttgggtgg ggacacacag acaaaccata 420 tcaactgtca tggacttaaa caattgtctt tgaattgtct tttttcatac ttttatttgc 480 atcttttcac taaaaagatg rcacaaagta atcctagttt acatttttta ccatgtaatt 540 ccatattact ttttcctgaa agttacttat ttttaaatct caaagctctt catacttatg 600 gtttgatctg cacttacaac tggatctcag aaagattgaa ttctcccatc ataccaagtt 660 catgtctctc actcttaata tttgttccca agacaacaat t 701 <210> SEQ ID NO 346 <211> LENGTH: 6758

<212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 346 agagtgggcc attgttctga ctagtctggg gctccccaaa gaactggtat ctgtctcacc 60 tgactcagaa caatgataag gctgtagatc tttttggaag tctatgaaaa caggcacaat 120 gaaggcagca tgttagagat ataattccac aggaagatgc caggtaaaac aaaagagaaa 180 aagcaggaac aagctgatta ggaaatttgt gatgactaaa agtatataca caagcccaaa 240 taagatactc caaagatgtt tgataggttc tagatctcta gatatactgc tcaatgaaag 300 tgtccccctg aacaaagcca gtctgcaaag actgggtgag atgatttttt ttaaatgtca 360 agtctcagca acaacaaaaa tgacaagaca tgcacagaag caagaaaata taacacaatc 420 aaagaaaaaa aagccacaga aatcagtcct agagaaaacy gatctatgag ctgcctgaca 480 ataattataa aataactatc ataaaaatgc ccagtgagat ataagaaaac acagacaact 540 aaatgaatca ggaaaatgat gcatgaacaa aatgggcata tcaacagaga tggaaatgac 600 aaagataaac aaacagaaat tttggagctt aaaaatacag taagtaaagt gaataattca 660 ctaaaaatat tcaatagcag actagatcag gcagaagaaa atatcaatga acttgaagac 720 agatcatcaa gtcagaggaa caacagcaac aaaaaagaat gaaaaaagtg aagacagcct 780 aagggactta ggagtcagta ccaaggaaat caatatatac gttatagatg tatcagaaga 840 aaaagggaga aaaatgaaaa gaaagcatat ttgaaaaaat aatagctgaa gaattctcaa 900 tttcaaagag agaaattgat atacaaattc aagaagttca aaagactcta gccataataa 960 atctaaagag actcacacta agacatatta tcatcaaact gtcaaaatca aagacaaaga 1020 attgtgaaat ctgccaagga aaagtgactc atcacacata agagatataa cataagattg 1080 tcacaggatt tctgaacaga cactttgcag gtcagaggga agtagggtga catattccag 1140 gtgctgaaag aagaaaacac cctgccaacc aagaatatgg catccagaaa aactttccta 1200 gaagaatgaa ggagaaattt agactttccc aaataaacaa aagctgaggg agttcattac 1260 taccagacct gctctgcaaa atgctaaaga gaaaccttca ggtgaaacaa aaagatgcta 1320 gacagtaaca caaaaccact cataaataac ttcttcagta aaaataatac atcgacaaat 1380 atggtaacct gtattaatac tggtgcacaa attcactttc aaattttata aataagaatt 1440 taaaggatga aaacatctaa aactaactat aaatctatat aatgaatata caatatataa 1500 aaaaatttgt gatcacaata acataaaatg ggggaggtag agctgtatag gggtagagct 1560 tttgtatgca attgaaatta ccatcagttt aaactgaact gttataacat taagatgttt 1620 tatgtaattg caatggtaac tatattctat agaatatatt aaaaagaaaa agaaaatagg 1680 aagggaatca aagcatgtcc ttgtaaaaaa gtcaatgaaa gcaaaagaaa ggcagaaaga 1740 gtgaaaagga ggaataaaaa gttataagac ataaaaaaaa tgaaaatagt aatagtcctg 1800 ccatatcagt aattacatta aatataaatg gattaaactc cctaatcaaa tcatagattg 1860 gtttgcaaga actaacttta caattaaaga cacacagctg acggtgaagg gagaaaaaaa 1920 acttccatgc agtgaccaaa atagaggagg gtggctgtat tactgtcaga caaaataaaa 1980 tttaagtcaa aaactgttac aagagtaaaa gaagggcatt atacagttaa aaaagtaaat 2040 tcgccaggca gacacaacaa ttataaatat caatacataa aaataagagc tcctaaatat 2100 atgcagcaaa cagacataat tgaagaaaga aataaatagc taaaatggta gaagacttta 2160 atacccccac ttacaataat gtataaaata acaagacaga atgtaaataa aaatgtagag 2220 aatttgagca acactgtaga ccaattggac ctaataaata tactcagaat aatccatcca 2280 accaaagcag aaacagaata tacattcttt tcaagtacac atttgacatt ctctgggatt 2340 aactacatgt tatgcaacaa acaagtctca acaatgttta aaagtctgat attacacaaa 2400 gtattgtttc tgatgacgat ggaaagaacc tagaagccaa tagcaaaaag aaaatagaaa 2460 atccacacat atgtggaaat taaactacat gcaattaagc aaagggccaa agaagaagaa 2520 gaaaaaagaa aacaccgtga aacaaataaa aacaaaaata cagcatatga aaatgcatgg 2580 gatgcagcaa aagtgatggt aagagaaatg tttatagtta taaatgcaaa ccttaaaaaa 2640 gaagaaagaa aacaaaaata ctcaaattaa caactttaca agtcaagaag gtagagaaaa 2700 aagaacaaac tataccaaaa gctaacacag aaagaaaaga ataaagatta aaaacaaaaa 2760 caatttaaaa aatagcagaa ctaaaagttg gttctttgaa aagatcaaca gaattgacaa 2820 tttcttagct acattaagaa aaatacaaga ctcaaataac acaaatcagt ggtgaaaggg 2880 ggtattataa ctgatgccac agaaatacaa aaggatcata agggactact acaaattgta 2940 tgacaacaaa ttgagtaacc taggatacct tgataaattc caaaaaatgc acaatatact 3000 gaatcatgaa tacatgaccc ttataaatca agactaaatc ataaagaaat agaaaatatc 3060 aacagaccaa taattagtaa ggagaataaa ctagtaatca gaaacctccc aacaaagaaa 3120 agcttaggac caaatggctt tactggagaa ttctaccaac cattaaaagg ataattaaga 3180 ccaatcttcc tcaaactttt aaaacaaatg ttaaagagga ggaaactctt tcaatctcat 3240 tcataaggtc agcattatcc ttataccaaa accagacaaa gacactatta aaaaaactta 3300 gaccaatatc cctgatgaat ttcgatgcaa gaatcctcag caaaatacta tcaaacaatt 3360 caacagcata cttaaatgat tatatgctgt aatcaagatg catttattct ttgaatgcaa 3420 gtgtaattca acacataaaa ttcaatcaat gtaatacacc acattaacag aatgagagac 3480 aaaaaccaca taattatatc aactgatgca gaaaaaaatc tgacacagtt caacaccttt 3540 tgtgataaaa acactcaaca aactaggaaa agaaggaaac aactttaaca catcatatgc 3600 tcactgatga aaatctacaa gttctttata aaagatcagg aacaagacaa taatctgcat 3660 tgttaccact tctattatac gtagtattgg aagttctaat cagagcaaat taggcaagaa 3720 aaataaataa aaggcatcca aagtggaaag gaagtaaaat aatctctttt tacagatgat 3780 ataaccttag aattagaaaa tcctaaaaat ttcacatacc aagaaaaagc gtgttaaaat 3840 taataagtaa attcagcaag ttgactgata caaaatcaac acagaaagct cagttgtgtg 3900 tctgtgtgtc tcatacacta acaatgaaca atctgaaaag gagattaaga aaacaatttc 3960 atttacaata gcatcaggaa aaaaaataaa tacttaggaa caaacttaac caaggggttg 4020 gaattcctgt atactgaaaa ctacaaatat tgccaaaaga aaataaagga gacacaaata 4080 agtgatatgt ttttaatatg tccacccaaa gtgatcttca gattcaatga aatccctatc 4140 aaagttataa tggcattttt ctgcaggaat gtaaaaattt atcctaaaat tcatatagaa 4200 tctctaggta ccctgagggc caaacaattt tgagaaaaaa aaaagaacaa aattggagga 4260 ctcacacttc cagattacaa gaatatttac aaattacata tttacaaaaa aaattacaaa 4320 gccacaataa tcaaaacaac gtgggatttg cataaaggca gatatataga ccagtggaat 4380 agtattgaga gtccagaaat aaacccttag gtatatcatc aaatgacatt tgacaaagtg 4440 ctggtaccac tcaatgggaa tgggacaatt tgttcaacaa atagagcaaa gaaaactaaa 4500 catccatgtg caaaagaata aatctggacc cttatattac actatagaca aaattaattc 4560 aaaatggatt aaagatctaa atgaaagatc taaaactata aaactcctag gagaaaacag 4620 aggaaaaatt tcatgctaat ttggcaacat tttgtgatgt gacaccaaaa gcagagtcaa 4680 taaaagcaaa aattagacag atggaaatcc atcatagttt ataacttttg gtcattaaag 4740 aacagtcaac agagtgaaaa ggcaatctat aaaatggggg aaaaacagaa aatatgtgca 4800 aatcacagat atctgatagg ggattcatat ccagaataaa taaagaactc ctatatctca 4860 acaacaaaaa atctaatcca atcaaaaaat gggccaaggg agtgaagata catttctcca 4920 aagatgttat acaaatggcc aggaagcata tgaaaagatg ttcaatgtca ctaatcatca 4980 gagaaatgca aatcaaaacc acagtgcaat atcacttcac attcattaga atggcttctg 5040 tcatgaacaa cagaaaataa caagtgttga tgagtgtgta gagaaattga gacctttata 5100 taattttggc agaaattcaa aatggtgcaa ccactataaa aaatgatatg gaggtcctca 5160 aaaaattaaa aatagaacta ccatatgatc cacaatccca cctctgggta catattcaaa 5220 agaattgaaa gcagggtgtt gaagatatat ttgcacactc tttatagcag cactgttcac 5280 aatagccaag agatgaaagt aacccaaagg ttcatgaagc aatgaataaa caaaatatat 5340 tatgtacata gagtaaaata ctgtgcagct ttaaagagaa aggaaatctt atactatgct 5400 acaacatgaa tggaacttta gggcattata gtaagtaaaa taagccagtt ttttttaaag 5460 gacaaataaa cactatacga ttctacttaa gtatttaatg ttgtcaaatt tataaatata 5520 gaatgtagaa tagtggttac cctgagctgg gggaaagggg caaaggggaa ttgttatttt 5580 aatgggtata gtttcagttc tgcaaaatga aaaggttctg gaaatctgtt tcacaatgtt 5640 gtaaatataa ttactctgaa attgtacact taaaaatggt taagatgaca aatagagttg 5700 tgatgtcttc ttttgttatt atatagaaaa actttttcat atgataatag tctttgtttt 5760 taagctgact ttgctgatat taatataatc cttccatttt tctttaaaat gctatatgct 5820 ttcacataat tttgctttac gttgatgtat ttatacataa ggtgggtttc ttatagatac 5880 cacgttgtgt gtctttttta tctaagttga tagacttgcc ttttgttagg gtatttaaat 5940 aatttatatt taatgtaatt attgatatag ttgagtgtgt tgatttttgt tttctatttg 6000 ctccatctgt tgttggttct cattattcct ctgtttctac cttcttttgt actaattatt 6060 atattttatt atttttcatc tcaactgttg gcttattagc cacattgctt ttaaaatttt 6120 taatgattgc tctagggttt ataataaaca aaatgttagc attttctacc atcaaatatt 6180 tttacactat tcatgtatac ttcaatttct ttcttcccat cctttgaact atatcttcat 6240 acattttact ctacatttgt tataactcag tgctttgaaa gtcaattatt tttgtctttg 6300 acagtcaatg atttttaaag agtttaacag tgaaaaaaaa tggctttcat ctttttccat 6360 tagatttcat actccttctg cctgaagaat ttcttttaat agaccttgta ctgcgggtct 6420 caggcaagaa attctctcag cctttgttgg tttgaaaaac tgcttattac acctttgttt 6480 ttgaaagata ttttcactag gtatagaagt ctgggttgac agttctcatt gtttgtcaca 6540 gcatttttaa gatgcccatt caattgtctt gtcttgtata attttggatt agtctggtgt 6600 atttcttacc tttgttcctc tctgtgcaat gcttcaacca tcccacttca ggctgccttt 6660 aagatgtttt cttttccctt aatctttagt ttttagctgg ttgacagtga cgcatctaag 6720 tgtagtgtat gaggttgctt ttattgtcac tgttgttg 6758 <210> SEQ ID NO 347 <211> LENGTH: 6758 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 347 agagtgggcc attgttctga ctagtctggg gctccccaaa gaactggtat ctgtctcacc 60 tgactcagaa caatgataag gctgtagatc tttttggaag tctatgaaaa caggcacaat 120 gaaggcagca tgttagagat ataattccac aggaagatgc caggtaaaac aaaagagaaa 180 aagcaggaac aagctgatta ggaaatttgt gatgactaaa agtatataca caagcccaaa 240 taagatactc caaagatgtt tgataggttc tagatctcta gatatactgc tcaatgaaag 300 tgtccccctg aacaaagcca gtctgcaaag actgggtgag atgatttttt ttaaatgtca 360

agtctcagca acaacaaaaa tgacaagaca tgcacagaag caagaaaata taacacaatc 420 aaagaaaaaa aagccacaga aatcagtcct agagaaaact gatctatgag ctgcctgama 480 ataattataa aataactatc ataaaaatgc ccagtgagat ataagaaaac acagacaact 540 aaatgaatca ggaaaatgat gcatgaacaa aatgggcata tcaacagaga tggaaatgac 600 aaagataaac aaacagaaat tttggagctt aaaaatacag taagtaaagt gaataattca 660 ctaaaaatat tcaatagcag actagatcag gcagaagaaa atatcaatga acttgaagac 720 agatcatcaa gtcagaggaa caacagcaac aaaaaagaat gaaaaaagtg aagacagcct 780 aagggactta ggagtcagta ccaaggaaat caatatatac gttatagatg tatcagaaga 840 aaaagggaga aaaatgaaaa gaaagcatat ttgaaaaaat aatagctgaa gaattctcaa 900 tttcaaagag agaaattgat atacaaattc aagaagttca aaagactcta gccataataa 960 atctaaagag actcacacta agacatatta tcatcaaact gtcaaaatca aagacaaaga 1020 attgtgaaat ctgccaagga aaagtgactc atcacacata agagatataa cataagattg 1080 tcacaggatt tctgaacaga cactttgcag gtcagaggga agtagggtga catattccag 1140 gtgctgaaag aagaaaacac cctgccaacc aagaatatgg catccagaaa aactttccta 1200 gaagaatgaa ggagaaattt agactttccc aaataaacaa aagctgaggg agttcattac 1260 taccagacct gctctgcaaa atgctaaaga gaaaccttca ggtgaaacaa aaagatgcta 1320 gacagtaaca caaaaccact cataaataac ttcttcagta aaaataatac atcgacaaat 1380 atggtaacct gtattaatac tggtgcacaa attcactttc aaattttata aataagaatt 1440 taaaggatga aaacatctaa aactaactat aaatctatat aatgaatata caatatataa 1500 aaaaatttgt gatcacaata acataaaatg ggggaggtag agctgtatag gggtagagct 1560 tttgtatgca attgaaatta ccatcagttt aaactgaact gttataacat taagatgttt 1620 tatgtaattg caatggtaac tatattctat agaatatatt aaaaagaaaa agaaaatagg 1680 aagggaatca aagcatgtcc ttgtaaaaaa gtcaatgaaa gcaaaagaaa ggcagaaaga 1740 gtgaaaagga ggaataaaaa gttataagac ataaaaaaaa tgaaaatagt aatagtcctg 1800 ccatatcagt aattacatta aatataaatg gattaaactc cctaatcaaa tcatagattg 1860 gtttgcaaga actaacttta caattaaaga cacacagctg acggtgaagg gagaaaaaaa 1920 acttccatgc agtgaccaaa atagaggagg gtggctgtat tactgtcaga caaaataaaa 1980 tttaagtcaa aaactgttac aagagtaaaa gaagggcatt atacagttaa aaaagtaaat 2040 tcgccaggca gacacaacaa ttataaatat caatacataa aaataagagc tcctaaatat 2100 atgcagcaaa cagacataat tgaagaaaga aataaatagc taaaatggta gaagacttta 2160 atacccccac ttacaataat gtataaaata acaagacaga atgtaaataa aaatgtagag 2220 aatttgagca acactgtaga ccaattggac ctaataaata tactcagaat aatccatcca 2280 accaaagcag aaacagaata tacattcttt tcaagtacac atttgacatt ctctgggatt 2340 aactacatgt tatgcaacaa acaagtctca acaatgttta aaagtctgat attacacaaa 2400 gtattgtttc tgatgacgat ggaaagaacc tagaagccaa tagcaaaaag aaaatagaaa 2460 atccacacat atgtggaaat taaactacat gcaattaagc aaagggccaa agaagaagaa 2520 gaaaaaagaa aacaccgtga aacaaataaa aacaaaaata cagcatatga aaatgcatgg 2580 gatgcagcaa aagtgatggt aagagaaatg tttatagtta taaatgcaaa ccttaaaaaa 2640 gaagaaagaa aacaaaaata ctcaaattaa caactttaca agtcaagaag gtagagaaaa 2700 aagaacaaac tataccaaaa gctaacacag aaagaaaaga ataaagatta aaaacaaaaa 2760 caatttaaaa aatagcagaa ctaaaagttg gttctttgaa aagatcaaca gaattgacaa 2820 tttcttagct acattaagaa aaatacaaga ctcaaataac acaaatcagt ggtgaaaggg 2880 ggtattataa ctgatgccac agaaatacaa aaggatcata agggactact acaaattgta 2940 tgacaacaaa ttgagtaacc taggatacct tgataaattc caaaaaatgc acaatatact 3000 gaatcatgaa tacatgaccc ttataaatca agactaaatc ataaagaaat agaaaatatc 3060 aacagaccaa taattagtaa ggagaataaa ctagtaatca gaaacctccc aacaaagaaa 3120 agcttaggac caaatggctt tactggagaa ttctaccaac cattaaaagg ataattaaga 3180 ccaatcttcc tcaaactttt aaaacaaatg ttaaagagga ggaaactctt tcaatctcat 3240 tcataaggtc agcattatcc ttataccaaa accagacaaa gacactatta aaaaaactta 3300 gaccaatatc cctgatgaat ttcgatgcaa gaatcctcag caaaatacta tcaaacaatt 3360 caacagcata cttaaatgat tatatgctgt aatcaagatg catttattct ttgaatgcaa 3420 gtgtaattca acacataaaa ttcaatcaat gtaatacacc acattaacag aatgagagac 3480 aaaaaccaca taattatatc aactgatgca gaaaaaaatc tgacacagtt caacaccttt 3540 tgtgataaaa acactcaaca aactaggaaa agaaggaaac aactttaaca catcatatgc 3600 tcactgatga aaatctacaa gttctttata aaagatcagg aacaagacaa taatctgcat 3660 tgttaccact tctattatac gtagtattgg aagttctaat cagagcaaat taggcaagaa 3720 aaataaataa aaggcatcca aagtggaaag gaagtaaaat aatctctttt tacagatgat 3780 ataaccttag aattagaaaa tcctaaaaat ttcacatacc aagaaaaagc gtgttaaaat 3840 taataagtaa attcagcaag ttgactgata caaaatcaac acagaaagct cagttgtgtg 3900 tctgtgtgtc tcatacacta acaatgaaca atctgaaaag gagattaaga aaacaatttc 3960 atttacaata gcatcaggaa aaaaaataaa tacttaggaa caaacttaac caaggggttg 4020 gaattcctgt atactgaaaa ctacaaatat tgccaaaaga aaataaagga gacacaaata 4080 agtgatatgt ttttaatatg tccacccaaa gtgatcttca gattcaatga aatccctatc 4140 aaagttataa tggcattttt ctgcaggaat gtaaaaattt atcctaaaat tcatatagaa 4200 tctctaggta ccctgagggc caaacaattt tgagaaaaaa aaaagaacaa aattggagga 4260 ctcacacttc cagattacaa gaatatttac aaattacata tttacaaaaa aaattacaaa 4320 gccacaataa tcaaaacaac gtgggatttg cataaaggca gatatataga ccagtggaat 4380 agtattgaga gtccagaaat aaacccttag gtatatcatc aaatgacatt tgacaaagtg 4440 ctggtaccac tcaatgggaa tgggacaatt tgttcaacaa atagagcaaa gaaaactaaa 4500 catccatgtg caaaagaata aatctggacc cttatattac actatagaca aaattaattc 4560 aaaatggatt aaagatctaa atgaaagatc taaaactata aaactcctag gagaaaacag 4620 aggaaaaatt tcatgctaat ttggcaacat tttgtgatgt gacaccaaaa gcagagtcaa 4680 taaaagcaaa aattagacag atggaaatcc atcatagttt ataacttttg gtcattaaag 4740 aacagtcaac agagtgaaaa ggcaatctat aaaatggggg aaaaacagaa aatatgtgca 4800 aatcacagat atctgatagg ggattcatat ccagaataaa taaagaactc ctatatctca 4860 acaacaaaaa atctaatcca atcaaaaaat gggccaaggg agtgaagata catttctcca 4920 aagatgttat acaaatggcc aggaagcata tgaaaagatg ttcaatgtca ctaatcatca 4980 gagaaatgca aatcaaaacc acagtgcaat atcacttcac attcattaga atggcttctg 5040 tcatgaacaa cagaaaataa caagtgttga tgagtgtgta gagaaattga gacctttata 5100 taattttggc agaaattcaa aatggtgcaa ccactataaa aaatgatatg gaggtcctca 5160 aaaaattaaa aatagaacta ccatatgatc cacaatccca cctctgggta catattcaaa 5220 agaattgaaa gcagggtgtt gaagatatat ttgcacactc tttatagcag cactgttcac 5280 aatagccaag agatgaaagt aacccaaagg ttcatgaagc aatgaataaa caaaatatat 5340 tatgtacata gagtaaaata ctgtgcagct ttaaagagaa aggaaatctt atactatgct 5400 acaacatgaa tggaacttta gggcattata gtaagtaaaa taagccagtt ttttttaaag 5460 gacaaataaa cactatacga ttctacttaa gtatttaatg ttgtcaaatt tataaatata 5520 gaatgtagaa tagtggttac cctgagctgg gggaaagggg caaaggggaa ttgttatttt 5580 aatgggtata gtttcagttc tgcaaaatga aaaggttctg gaaatctgtt tcacaatgtt 5640 gtaaatataa ttactctgaa attgtacact taaaaatggt taagatgaca aatagagttg 5700 tgatgtcttc ttttgttatt atatagaaaa actttttcat atgataatag tctttgtttt 5760 taagctgact ttgctgatat taatataatc cttccatttt tctttaaaat gctatatgct 5820 ttcacataat tttgctttac gttgatgtat ttatacataa ggtgggtttc ttatagatac 5880 cacgttgtgt gtctttttta tctaagttga tagacttgcc ttttgttagg gtatttaaat 5940 aatttatatt taatgtaatt attgatatag ttgagtgtgt tgatttttgt tttctatttg 6000 ctccatctgt tgttggttct cattattcct ctgtttctac cttcttttgt actaattatt 6060 atattttatt atttttcatc tcaactgttg gcttattagc cacattgctt ttaaaatttt 6120 taatgattgc tctagggttt ataataaaca aaatgttagc attttctacc atcaaatatt 6180 tttacactat tcatgtatac ttcaatttct ttcttcccat cctttgaact atatcttcat 6240 acattttact ctacatttgt tataactcag tgctttgaaa gtcaattatt tttgtctttg 6300 acagtcaatg atttttaaag agtttaacag tgaaaaaaaa tggctttcat ctttttccat 6360 tagatttcat actccttctg cctgaagaat ttcttttaat agaccttgta ctgcgggtct 6420 caggcaagaa attctctcag cctttgttgg tttgaaaaac tgcttattac acctttgttt 6480 ttgaaagata ttttcactag gtatagaagt ctgggttgac agttctcatt gtttgtcaca 6540 gcatttttaa gatgcccatt caattgtctt gtcttgtata attttggatt agtctggtgt 6600 atttcttacc tttgttcctc tctgtgcaat gcttcaacca tcccacttca ggctgccttt 6660 aagatgtttt cttttccctt aatctttagt ttttagctgg ttgacagtga cgcatctaag 6720 tgtagtgtat gaggttgctt ttattgtcac tgttgttg 6758 <210> SEQ ID NO 348 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 348 gaccatgtta tgacatttta gtgcttgcta agcagtaaat actgacttac tttcctgcta 60 cactcttcag agcagaaaga gaaatctaca aaaagggcaa tgtagttggg atccaccaca 120 gccttgagac tgggccatgt ttctacagct tacccacatt ttacccccac tttctctgag 180 aaacaatgca aactggagaa caaggtcaga gaagttatct tggatggtag aagagaagaa 240 aggagaagaa rggataagca gaaaatcaaa aagggcataa aaaaattact ggggaaaata 300 attcttagtc actcaccatt tcttatgttt gtgaaaacag aaacgaggag caagtgttgt 360 tgtaagaatt gttcttgccc ctccccctcc accacccaca tctgtcaagc tatccctgtt 420 tcactgtttc ctctgcactc tctattaact tctttgtcct cctcttttct tttcctacag 480 caaagacttt ttgtcatgtt t 501 <210> SEQ ID NO 349 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 349 tgacttactt tcctgctaca ctcttcagag cagaaagaga aatctacaaa aagggcaatg 60 tagttgggat ccaccacagc cttgagactg ggccatgttt ctacagctta cccacatttt 120

acccccactt tctctgagaa acaatgcaaa ctggagaaca aggtcagaga agttatcttg 180 gatggtagaa gagaagaaag gagaagaaag gataagcaga aaatcaaaaa gggcataaaa 240 aaattactgg rgaaaataat tcttagtcac tcaccatttc ttatgtttgt gaaaacagaa 300 acgaggagca agtgttgttg taagaattgt tcttgcccct ccccctccac cacccacatc 360 tgtcaagcta tccctgtttc actgtttcct ctgcactctc tattaacttc tttgtcctcc 420 tcttttcttt tcctacagca aagacttttt gtcatgtttt gtttcttttt ctattgtttc 480 tttccctttt ctaatccttg a 501 <210> SEQ ID NO 350 <211> LENGTH: 1148 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 350 tatgagattt aatgttaaga aataaaatgt aggatctaaa acgtaatcta tagcataatc 60 tcaaaaatgg tttagaaatg acataataat acagacattt gtgggtggta ggattatgca 120 tatttttata tatttttaaa tatatttttc aaaagcttcc tataaagaat gtaattcttt 180 cccaattcca aatctagctt aaacataatt ttacaaaaat tattctctca gaatgtaaac 240 tagtaccacc tctatggaaa acattatgga gatttcctaa agagttaaaa gtagatctac 300 catttgatcc agcaatctta atactgggta tctacccgga ggaaaagaag tcattgtatg 360 aaaaagacac ttgtacacat atgtttacag gaccacaatt cacaaatgca aagatgcaga 420 accaacctaa gtggccastg actaatgaga ggataaagaa gatgtggcat atatatatca 480 gggactacta ctcagccatt acaaggaaca aaataatgtc ttttgcaaca acttggatag 540 agctggaggc cattattcta agtaaagtaa ttcaggaatt ggaaaaccaa aaaccgtatg 600 ttctctctta taagtgggaa ctaagttagg aataagcaaa ggcacacaga gggacatatt 660 ggactttaga gactcacgag gaggagggta ataggggact agggattaaa agaaaaacta 720 gacattaggt acaaggtacc ctacttaagt gcactaaaat ctcagaattc accactacgt 780 aattcaacta agtaacaaga aaccacttgt accccaaaag ctactgaaat aaaaattatt 840 ctctcaaaaa ttttaagccc taaacttcag ttcctattgt ttatatttac taagaaaaac 900 aacagaaaac actgttttaa aaatggtgga tttttttaag gttaaaggta tataagacag 960 ctgcctaagg aaacgcagat acccctgtac cttgttgttg ttgttgtttt tcactttttt 1020 aaaaaacata gagatgggat ctccttatgc tgcccaggct tgtctcaaac tcctgagctc 1080 aagcaatcct ctgacctcag actctcaaag ttttgggact acaggcgaca gtcaccatgc 1140 cagccaat 1148 <210> SEQ ID NO 351 <211> LENGTH: 1148 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 351 tatgagattt aatgttaaga aataaaatgt aggatctaaa acgtaatcta tagcataatc 60 tcaaaaatgg tttagaaatg acataataat acagacattt gtgggtggta ggattatgca 120 tatttttata tatttttaaa tatatttttc aaaagcttcc tataaagaat gtaattcttt 180 cccaattcca aatctagctt aaacataatt ttacaaaaat tattctctca gaatgtaaac 240 tagtaccacc tctatggaaa acattatgga gatttcctaa agagttaaaa gtagatctac 300 catttgatcc agcaatctta atactgggta tctacccgga ggaaaagaag tcattgtatg 360 aaaaagacac ttgtacacat atgtttacag gaccacaatt cacaaatgca aagatgcaga 420 accaacctaa gtggccactg actaatgaga ggataaagaa gatgtggcat atatayatca 480 gggactacta ctcagccatt acaaggaaca aaataatgtc ttttgcaaca acttggatag 540 agctggaggc cattattcta agtaaagtaa ttcaggaatt ggaaaaccaa aaaccgtatg 600 ttctctctta taagtgggaa ctaagttagg aataagcaaa ggcacacaga gggacatatt 660 ggactttaga gactcacgag gaggagggta ataggggact agggattaaa agaaaaacta 720 gacattaggt acaaggtacc ctacttaagt gcactaaaat ctcagaattc accactacgt 780 aattcaacta agtaacaaga aaccacttgt accccaaaag ctactgaaat aaaaattatt 840 ctctcaaaaa ttttaagccc taaacttcag ttcctattgt ttatatttac taagaaaaac 900 aacagaaaac actgttttaa aaatggtgga tttttttaag gttaaaggta tataagacag 960 ctgcctaagg aaacgcagat acccctgtac cttgttgttg ttgttgtttt tcactttttt 1020 aaaaaacata gagatgggat ctccttatgc tgcccaggct tgtctcaaac tcctgagctc 1080 aagcaatcct ctgacctcag actctcaaag ttttgggact acaggcgaca gtcaccatgc 1140 cagccaat 1148 <210> SEQ ID NO 352 <211> LENGTH: 1148 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 352 tatgagattt aatgttaaga aataaaatgt aggatctaaa acgtaatcta tagcataatc 60 tcaaaaatgg tttagaaatg acataataat acagacattt gtgggtggta ggattatgca 120 tatttttata tatttttaaa tatatttttc aaaagcttcc tataaagaat gtaattcttt 180 cccaattcca aatctagctt aaacataatt ttacaaaaat tattctctca gaatgtaaac 240 tagtaccacc tctatggaaa acattatgga gatttcctaa agagttaaaa gtagatctac 300 catttgatcc agcaatctta atactgggta tctacccgga ggaaaagaag tcattgtatg 360 aaaaagacac ttgtacacat atgtttacag gaccacaatt cacaaatgca aagatgcaga 420 accaacctaa gtggccactg actaatgaga ggataaagaa gatgtggcat atatayatca 480 gggactacta ctcagccatt acaaggaaca aaataatgtc ttttgcaaca acttggatag 540 agctggaggc cattattcta agtaaagtaa ttcaggaatt ggaaaaccaa aaaccgtatg 600 ttctctctta taagtgggaa ctaagttagg aataagcaaa ggcacacaga gggacatatt 660 ggactttaga gactcacgag gaggagggta ataggggact agggattaaa agaaaaacta 720 gacattaggt acaaggtacc ctacttaagt gcactaaaat ctcagaattc accactacgt 780 aattcaacta agtaacaaga aaccacttgt accccaaaag ctactgaaat aaaaattatt 840 ctctcaaaaa ttttaagccc taaacttcag ttcctattgt ttatatttac taagaaaaac 900 aacagaaaac actgttttaa aaatggtgga tttttttaag gttaaaggta tataagacag 960 ctgcctaagg aaacgcagat acccctgtac cttgttgttg ttgttgtttt tcactttttt 1020 aaaaaacata gagatgggat ctccttatgc tgcccaggct tgtctcaaac tcctgagctc 1080 aagcaatcct ctgacctcag actctcaaag ttttgggact acaggcgaca gtcaccatgc 1140 cagccaat 1148 <210> SEQ ID NO 353 <211> LENGTH: 1148 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 353 tatgagattt aatgttaaga aataaaatgt aggatctaaa acgtaatcta tagcataatc 60 tcaaaaatgg tttagaaatg acataataat acagacattt gtgggtggta ggattatgca 120 tatttttata tatttttaaa tatatttttc aaaagcttcc tataaagaat gtaattcttt 180 cccaattcca aatctagctt aaacataatt ttacaaaaat tattctctca gaatgtaaac 240 tagtaccacc tctatggaaa acattatgga gatttcctaa agagttaaaa gtagatctac 300 catttgatcc agcaatctta atactgggta tctacccgga ggaaaagaag tcattgtatg 360 aaaaagacac ttgtacacat atgtttacag gaccacaatt cacaaatgca aagatgcaga 420 accaacctaa gtggccactg actaatgaga ggataaagaa gatgtggcat atatatatca 480 gggactactr ctcagccatt acaaggaaca aaataatgtc ttttgcaaca acttggatag 540 agctggaggc cattattcta agtaaagtaa ttcaggaatt ggaaaaccaa aaaccgtatg 600 ttctctctta taagtgggaa ctaagttagg aataagcaaa ggcacacaga gggacatatt 660 ggactttaga gactcacgag gaggagggta ataggggact agggattaaa agaaaaacta 720 gacattaggt acaaggtacc ctacttaagt gcactaaaat ctcagaattc accactacgt 780 aattcaacta agtaacaaga aaccacttgt accccaaaag ctactgaaat aaaaattatt 840 ctctcaaaaa ttttaagccc taaacttcag ttcctattgt ttatatttac taagaaaaac 900 aacagaaaac actgttttaa aaatggtgga tttttttaag gttaaaggta tataagacag 960 ctgcctaagg aaacgcagat acccctgtac cttgttgttg ttgttgtttt tcactttttt 1020 aaaaaacata gagatgggat ctccttatgc tgcccaggct tgtctcaaac tcctgagctc 1080 aagcaatcct ctgacctcag actctcaaag ttttgggact acaggcgaca gtcaccatgc 1140 cagccaat 1148 <210> SEQ ID NO 354 <211> LENGTH: 611 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 354 caaaacctca accttccaga taagtctaag ggtgagaact tcacacaaga tgaataagaa 60 ccaatttctt ccagggcgat gttgaacctg gaaatgaaag ccaatctctc ttggaaggcc 120 tggtttgtag aaatgtcagt ctttgtttca agctgtggga gaatgagaag caagacttta 180 gggaaagagg aataaaatag atgtgcagaa ataacagagt gagaaagtct tcagggtgtc 240 gctagcccta attgcaggca tccctgaatc ctagaccttg gattgcaaga gactccttaa 300 tatcttccca tgtccacatt tgcttcacat agtttgaatg tggcttctat tatatacaga 360 tacaagattc aaatccaacc tctaygatga ctggtcttgt gaataagcag aagaggcact 420 aacaatatga cgtgagggat tcagggaaga gcactttctt gagcacatat cttccctggt 480 ctgccagctg tagtttatga aattccacaa tgaggatgaa atggaatcac catttacaga 540 gtactctcca gatgtctaac cctaagctag gtaccttcaa aatattatct agtttagata 600 atcaaccctt t 611 <210> SEQ ID NO 355 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 355 ttctctagtc caaagggttg attatctaaa ctagataata ttttgaaggt acctagctta 60 gggttagaca tctggagagt actctgtaaa tggtgattcc atttcatcct cattgtggaa 120 tttcataaac tacagctggc agaccaggga agatatgtgc tcaagaaagt gctcttccct 180

gaatccctca cgtcatattg ttagtgcctc ttctgcttat tcacaagacc agtcatcata 240 gaggttggat ttgaatcttg tatctgtata taatagaagc cacattcaaa ctatgtgaag 300 yaaatgtgga catgggaaga tattaaggag tctcttgcaa tccaaggtct aggattcagg 360 gatgcctgca attagggcta gcgacaccct gaagactttc tcactctgtt atttctgcac 420 atctatttta ttcctctttc cctaaagtct tgcttctcat tctcccacag cttgaaacaa 480 agactgacat ttctacaaac caggccttcc aagagagatt ggctttcatt tccaggttca 540 acatcgccct ggaagaaatt ggttcttatt catcttgtgt gaagttctca cccttagact 600 t 601 <210> SEQ ID NO 356 <211> LENGTH: 527 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 356 gctctagaat atggcattcc agaagtggga tgctacaaat agtctcattg agagtcaact 60 tgcacaatgt atcgtcctac ccttacatca atttctgaaa caacttctct ttgcacttcc 120 cctatagtta catgcataat aaattctgac aactcttatg aagtcatgga ataactttct 180 tcttatgttt cctatcaatg tcattagccc tttatcttgt ttgagtttcc atcagcaatg 240 ttttcaagtc ccaagatcat tcatgtatcc acaagcaatg atacgccaga tttggacaaa 300 taatactgaa tactatctta ttttcactgc catgatcaag gcagtgtgga ttgctgccaa 360 gtccaagaga agtgaggtca gcagctgcaa gccacctccg tcatttagaa aagcttcatg 420 atgtagtgtg tcgtttcgat gtgacactgt ctcacagagt taaaatgatg tgmaaggaac 480 tgttcaatgg aaatttagaa atttctcttt ttctcaattt tagtgta 527 <210> SEQ ID NO 357 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 357 gaacaagatt ttcctgcttt taaaaatact acattaaagc tgaaaattta ggccaaaatt 60 ttcaagtggt aatagttaca ggcaattcat ctttctggtc agaaaagggt gttactgcag 120 ctatttctgc ctgaaactgg gtggcactac tacttttttt tttttttttt taactgagca 180 gacattttcc ttacactaaa attgagaaaa agagaaattt ctaaatttcc attgaacagt 240 tccttgcaca tcattttaac tctgtgagac agtgtcacat cgaaacgaca cactacatca 300 ygaagctttt ctaaatgacg gaggtggctt gcagctgctg acctcacttc tcttggactt 360 ggcagcaatc cacactgcct tgatcatggc agtgaaaata agatagtatt cagtattatt 420 tgtccaaatc tggcgtatca ttgcttgtgg atacatgaat gatcttggga cttgaaaaca 480 ttgctgatgg aaactcaaac aagataaagg gctaatgaca ttgataggaa acataagaag 540 aaagttattc catgacttca taagagttgt cagaatttat tatgcatgta actacagggg 600 a 601 <210> SEQ ID NO 358 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 358 gcttaatacc tgagtgatgg aatattctgt tcaacaaacc cctctgacat aggtttgcct 60 atataataaa cctgttcatg tactcctgaa cctaaaagtt taaaaaagat tatgtagaaa 120 acccaaagga atctataaaa agtctactag agctagagtg attttaacaa gatttcaata 180 cacaaattca aatgtctttc tatatattaa tgacaatcaa caataaaatt ttaaaacatt 240 attaaagtat aatgaaaata tcaactgttt agggagaaat gtaacaagaa tggtgaagga 300 cctatacact aaaaagcttc aatatgttgt tgagattaac tgaagaaggt ctaaatagat 360 ttttttttca tgtctcggaa gacttaatat gtgaagatac caattcttcc ccaaatgatc 420 aacaggtgaa atgcaatccc aatcaaaatc ccagcaatta ttttaagggg gaaattggca 480 atctgattct aaaattcata yggaaaaaaa caatggagtt agaataacta aaacaagtcc 540 gaaaaagaaa aagaaatgga ggactaatgc tacctgattt caagtcttat cgtataaatc 600 tacatcaata aaggacaagt tggtattggg ttaaagatag ataaatacat cagtggaata 660 gaatattgaa tccagaataa atccacacat atatggataa aaataccaga caattcagtg 720 gagatggttt tgtttttaca acaaatgtta ctggaacaaa ttgatatatg tattagtcag 780 atatggctgc cataacaaag aaccacaaac aggtggttta aataatggaa ataaatttcc 840 tcagaattct ggagtatgga agcccaagat caagttgctg ggaggattcg tttcttctga 900 gtgtctcttt ttttgatgac agatgactat cttttaccaa tgtcttcact tggttttccc 960 tctgtgtgtg cctaggtcct attctccaat tcctataagg a 1001 <210> SEQ ID NO 359 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 359 ctaaaagttt aaaaaagatt atgtagaaaa cccaaaggaa tctataaaaa gtctactaga 60 gctagagtga ttttaacaag atttcaatac acaaattcaa atgtctttct atatattaat 120 gacaatcaac aataaaattt taaaacatta ttaaagtata atgaaaatat caactgttta 180 gggagaaatg taacaagaat ggtgaaggac ctatacacta aaaagcttca atatgttgtt 240 gagattaact gaagaaggtc taaatagatt tttttttcat gtctcggaag acttaatatg 300 tgaagatacc aattcttccc caaatgatca acaggtgaaa tgcaatccca atcaaaatcc 360 cagcaattat tttaaggggg aaattggcaa tctgattcta aaattcatat ggaaaaaaac 420 aatggagtta gaataactaa aacaagtccg aaaaagaaaa agaaatggag gactaatgct 480 acctgatttc aagtcttatc rtataaatct acatcaataa aggacaagtt ggtattgggt 540 taaagataga taaatacatc agtggaatag aatattgaat ccagaataaa tccacacata 600 tatggataaa aataccagac aattcagtgg agatggtttt gtttttacaa caaatgttac 660 tggaacaaat tgatatatgt attagtcaga tatggctgcc ataacaaaga accacaaaca 720 ggtggtttaa ataatggaaa taaatttcct cagaattctg gagtatggaa gcccaagatc 780 aagttgctgg gaggattcgt ttcttctgag tgtctctttt tttgatgaca gatgactatc 840 ttttaccaat gtcttcactt ggttttccct ctgtgtgtgc ctaggtccta ttctccaatt 900 cctataagga aaccagtcat attggattag ggcccactct aatggcccca ttttacttgc 960 attatctctt taaagacact atctccagat gtagccacac t 1001 <210> SEQ ID NO 360 <211> LENGTH: 1058 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 360 catgattagc tatgctactt tccactgctc ttagtatact gagaggcagc ataagtaaaa 60 ctaaaatatc tgaagatagc aatagactat ttaaagtaga agaagtatgc tatttttgtt 120 ttgttttcat ttcgaaggaa atatgcaaag gtttattgag tatttcagct tctcttacag 180 taggtttttt ttggattctt tctgtgtttg tctatgttga taaaacattg aaatgccata 240 tagctcaaag gtcattcact taagaaatct aagtactgat aacatcttag ccccgattct 300 tcataggcat tgttaagcct attataattt tggtwcagag agaaggtaaa ctatattcca 360 gacaggcata taaagcaatt tctcctataa ttggagttca cgaaaaattc acatatttct 420 ttttaatagt aactctcaca gcaagaacat atgtttgtaa ataatacatc acagaatctt 480 attggcagac aaggaaattc ctaaaatatt ttttactgcc acatcaatta agatatataa 540 aataccttat atagaagatg tttgcaccca ggccaaacaa atcaaacaag aatagaagca 600 ctgacagtct tatttcaaaa ttggtttaac ttgtatttac aggatattgt agtaccttat 660 aaagttgatt gctgattggc cgtcttttac agaattctgt cagattgtta ttatttcttg 720 taaagattga ttcaaacaaa taaaaattgt caggattgga tatgtcctat agtgaggtgt 780 agttatgtca catgagattt ttaattacaa agaaatggaa aataaaatga gaatagaatt 840 gagactcccc tgtcacctca caaatatgtt gaaatacaat gaaatttcca aagatgttaa 900 agcatataaa gttgaataat tcttattatg tattaaactt acagaaattt aatttcttta 960 ctttataaga ggtagtgaaa atataaaatt aattatgaag acagagtagt cttagtcaga 1020 catggcccta taaagcatat tcccattcgt tacatcaa 1058 <210> SEQ ID NO 361 <211> LENGTH: 1058 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 361 catgattagc tatgctactt tccactgctc ttagtatact gagaggcagc ataagtaaaa 60 ctaaaatatc tgaagatagc aatagactat ttaaagtaga agaagtatgc tatttttgtt 120 ttgttttcat ttcgaaggaa atatgcaaag gtttattgag tatttcagct tctcttacag 180 taggtttttt ttggattctt tctgtgtttg tctatgttga taaaacattg aaatgccaya 240 tagctcaaag gtcattcact taagaaatct aagtactgat aacatcttag ccccgattct 300 tcataggcat tgttaagcct attataattt tggtacagag agaaggtaaa ctatattcca 360 gacaggcata taaagcaatt tctcctataa ttggagttca cgaaaaattc acatatttct 420 ttttaatagt aactctcaca gcaagaacat atgtttgtaa ataatacatc acagaatctt 480 attggcagac aaggaaattc ctaaaatatt ttttactgcc acatcaatta agatatataa 540 aataccttat atagaagatg tttgcaccca ggccaaacaa atcaaacaag aatagaagca 600 ctgacagtct tatttcaaaa ttggtttaac ttgtatttac aggatattgt agtaccttat 660 aaagttgatt gctgattggc cgtcttttac agaattctgt cagattgtta ttatttcttg 720 taaagattga ttcaaacaaa taaaaattgt caggattgga tatgtcctat agtgaggtgt 780 agttatgtca catgagattt ttaattacaa agaaatggaa aataaaatga gaatagaatt 840 gagactcccc tgtcacctca caaatatgtt gaaatacaat gaaatttcca aagatgttaa 900 agcatataaa gttgaataat tcttattatg tattaaactt acagaaattt aatttcttta 960 ctttataaga ggtagtgaaa atataaaatt aattatgaag acagagtagt cttagtcaga 1020 catggcccta taaagcatat tcccattcgt tacatcaa 1058 <210> SEQ ID NO 362 <211> LENGTH: 956 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 362

aaaacaagga acaaacaaac aaaaatgtta caaccgaaca acagactttt gagtcatgtt 60 tcaggccaag aggtgatgag ttactgtagt tgcttgagct ggttggtgaa atattacctg 120 gcaacaaaac tgaaatagaa ggtggcttag taaaatgcag attcagaatg agtgccttaa 180 ggttaaggca tataagacca aactgatttt ctttttcacg aggtcttcag gtaaggccat 240 tgtagaagat accttgtttg cgaacttcag taaattactt cacttgtctc atattttcat 300 tttcaggatg gaggcttgag attgaattgt agtgcaatta ggtaaatttt tacccatttt 360 aaatataata ttaaaatatt aattataaat taccttattt gaatctggaa taatatttat 420 tgcagggcat ataatctaag ctgtaaacgt cctgtyagaa gacaacatat tcatcttgct 480 aaggtataag ctatatgact ggcactgtgc tcaactcaga gtcattgaat gaacagtatt 540 tatttaatct atgaatgaga gcacttcaag tatacagaaa gatatctcaa aagattcagc 600 cttacattgc tcataacttc aatgacttag atgaaaacct cctgaacatt tttatcagtt 660 gtataggtac cccaaatcat aagggaatgt ttatcaatta gatgatgaaa tggggatgca 720 actacatcat ggcaggctaa agcaatagaa tgactttgac aagaggaaat tacatagagg 780 cacctgagtc tcctaaacca atttcaaagg tatgagaggg gggtgatata aataaatagt 840 tgatagatga aaaaactcag aagttatagt tgacagcaat tttaatataa tatgaaaaat 900 gtggttggac ttttagggaa aaaaacctaa taaaatctaa tggaaattag tggtcc 956 <210> SEQ ID NO 363 <211> LENGTH: 956 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 363 caaccgaaca acagactttt gagtcatgtt tcaggccaag aggtgatgag ttactgtagt 60 tgcttgagct ggttggtgaa atattacctg gcaacaaaac tgaaatagaa ggtggcttag 120 taaaatgcag attcagaatg agtgccttaa ggttaaggca tataagacca aactgatttt 180 ctttttcacg aggtcttcag gtaaggccat tgtagaagat accttgtttg cgaacttcag 240 taaattactt cacttgtctc atattttcat tttcaggatg gaggcttgag attgaattgt 300 agtgcaatta ggtaaatttt tacccatttt aaatataata ttaaaatatt aattataaat 360 taccttattt gaatctggaa taatatttat tgcagggcat ataatctaag ctgtaaacgt 420 cctgtcagaa gacaacatat tcatcttgct aaggtrtaag ctatatgact ggcactgtgc 480 tcaactcaga gtcattgaat gaacagtatt tatttaatct atgaatgaga gcacttcaag 540 tatacagaaa gatatctcaa aagattcagc cttacattgc tcataacttc aatgacttag 600 atgaaaacct cctgaacatt tttatcagtt gtataggtac cccaaatcat aagggaatgt 660 ttatcaatta gatgatgaaa tggggatgca actacatcat ggcaggctaa agcaatagaa 720 tgactttgac aagaggaaat tacatagagg cacctgagtc tcctaaacca atttcaaagg 780 tatgagaggg gggtgatata aataaatagt tgatagatga aaaaactcag aagttatagt 840 tgacagcaat tttaatataa tatgaaaaat gtggttggac ttttagggaa aaaaacctaa 900 taaaatctaa tggaaattag tggtccactc atttctccac ctaggatgtt aaaaat 956 <210> SEQ ID NO 364 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 364 gtaaaacaca tagatcgctg tatccttgtt cagtaagcta caacatactc gtatctcctg 60 aaatcctggg cttaaatcga ggtctcaaag gctttgtttt gttttgttgt atggttgtat 120 ggtgagtgtg tgtgtgtgtg tgtgtgtgtg tgtttattct cctgaaattc tcctcctcac 180 ttgacttaag ctaaaagata aacgtcctct tcctttcagc cacagatggt gatggataaa 240 ttgaatgtca ttcacattat tcccttaaaa taaactctct ccctcccctc tcccgtctca 300 wccttgtccc tttctttata taatgggtaa tgcgttaatg tcagcagaat agttttgggg 360 ccataatggc aagtatcacg tggatggttt agcattgttt ttagaatgct gtgaatttgg 420 gtatatgtga gttttgggga aagttttgca actatatgtt tgttaattaa atgaggacta 480 taaagtaata taaaattatg tttctggaac atattttgga agctataaag tcatctgtat 540 ttattatcca cagacataat gtcattgttc aggtcctgca accttcttat aatcaacata 600 c 601 <210> SEQ ID NO 365 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 365 agtaagctac aacatactcg tatctcctga aatcctgggc ttaaatcgag gtctcaaagg 60 ctttgttttg ttttgttgta tggttgtatg gtgagtgtgt gtgtgtgtgt gtgtgtgtgt 120 gtttattctc ctgaaattct cctcctcact tgacttaagc taaaagataa acgtcctctt 180 cctttcagcc acagatggtg atggataaat tgaatgtcat tcacattatt cccttaaaat 240 aaactctctc cctcccctct cccgtctcat ccttgtccct ttctttatat aatgggtaat 300 kcgttaatgt cagcagaata gttttggggc cataatggca agtatcacgt ggatggttta 360 gcattgtttt tagaatgctg tgaatttggg tatatgtgag ttttggggaa agttttgcaa 420 ctatatgttt gttaattaaa tgaggactat aaagtaatat aaaattatgt ttctggaaca 480 tattttggaa gctataaagt catctgtatt tattatccac agacataatg tcattgttca 540 ggtcctgcaa ccttcttata atcaacatac gtgggcccag ggattttatg tatcttcgcc 600 t 601 <210> SEQ ID NO 366 <211> LENGTH: 1079 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 366 gaatttatgg tctgatggag aagggaatca ttaaagttct atgtagtgag atatccccaa 60 ggggtgtatt aggcttacca ccactggaat ctggatagat gaagacagag tggcagggaa 120 gtcgtattaa ggttctgttt ctgctgggag ccacaggtcc tcaggaagca acaagtactg 180 ggcagattga tactgtagct rggctctagc tctatacctc tagaataaag gttacaaact 240 agcaacttga aagctaaacc tggcccacag atatgtttta tttggctctt acactgtttt 300 aaaaaatatt accaacattt aaaactggga agttttatga aaaaacccag acttctggat 360 tctgttgaaa aaaaaaatca gaagatctgg caatactgag ctgacattcc tatatgacaa 420 caattggctg gatctatgca gcttctctcc aaaaagcaaa gaatgtgttc ttgcttaaca 480 cagtccccac cactccctca tattctccaa tcctggacct gagcgtcatt tgctatgtat 540 cgccatttgc catgaagttt tacactctac agaaatataa tttttttgta gaagactatg 600 ctttaatcaa gatcaggata atataaagtg agatctgaaa gtggaaaaaa gataaatgtc 660 caacaatgat agactggatt aagaaaatgt ggcacatata caccgtggag tactatgcag 720 ccaaaaaaaa cgatgagttc atgtcctttg tagggacatg gatgaagctg gaaaccacca 780 ttctcagcaa actatcgcaa ggacaaaaaa ccaaacgccg catgttctca ctcataggtg 840 ggaattgaac aatgagaaca cttgggcaca ggaaggggaa catcacacac cgggccctgt 900 tgtggggtgg ggggaggagg gagggatagc atttggagat atacctaatg ttaaatgact 960 agtttctggg tgcagcacac catcatggca catgtataca tatgtaacta acctgcacat 1020 tgtgcacatg taccctaaaa cttaaagtat aatttttaaa aaaagatatt ttcttatct 1079 <210> SEQ ID NO 367 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 367 ataaattttc tcttccctca agaatttatg gtctgatgga gaagggaatc attaaagttc 60 tatgtagtga gatatcccca aggggtgtat taggcttacc accactggaa tctggataga 120 tgaagacaga gtggcaggga agtcgtatta aggttctgtt tctgctggga gccacaggtc 180 ctcaggaagc aacaagtact gggcagattg atactgtagc tgggctctag ctctatacct 240 ctagaataaa kgttacaaac tagcaacttg aaagctaaac ctggcccaca gatatgtttt 300 atttggctct tacactgttt taaaaaatat taccaacatt taaaactggg aagttttatg 360 aaaaaaccca gacttctgga ttctgttgaa aaaaaaaatc agaagatctg gcaatactga 420 gctgacattc ctatatgaca acaattggct ggatctatgc agcttctctc caaaaagcaa 480 agaatgtgtt cttgcttaac a 501 <210> SEQ ID NO 368 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 368 tgaagaagcc gcctggcttc ttgtttcttc tcatagcaaa atgcaatgag aaagagataa 60 tttgagaaaa gaaccgttta aacaaaaaga aaccaagaca taatgatttt ggaaattctc 120 agtttattca gactgcaaaa gatattaaaa taaagaaact cagtaacagg gatagataat 180 ctaaagaaaa agcctaggac acggctgtag taaccttctg tttttatacc tcagcaattt 240 gctaatgcct caaaaagatc aaaagtactc aaatataaag ggctctttga agagattaga 300 tttcctcaat caaaccaaag agcatcgagg aagcttaagg ttactgtccc tcacatatct 360 cagcagaagg caaaaataga agactgatta tctaagaaag atctctgaaa gagtctcata 420 ttatggagtg aacccctgtg gcatacatgg gagacccact tggttcttga gaattttata 480 tcaggagaaa cactgtcagt ytgtattgaa aggaacagag aaaatacgaa attaaagaag 540 actattaaac ctccaaaatt ctggcaggaa agaagcttac acagctactc agttgcaaag 600 atctgccact tttcatatac atgaaaggac tcagaggagg aagccacagg tttagaagga 660 aaagctaaaa gcaacatcgt attagtcttg gatctaggaa cctaatttct ctagcagaat 720 ctagaaatgg cttgggacaa gtgattgttt ttttacctag gattttctcc ctcttgaaaa 780 caggactgtc tgtaactatt atcctatgcc tgccctacca tcatatttca gaaacaggta 840 acttatgttt tcactttcaa agattcacaa taaagagaaa ttgtacctca gaatggatta 900 taccagagct ttcctcatgc ataaattaaa taatttaggt tatgtgattt gaagcttttg 960 agtgggtgag gtgacatttt ggatgctgag ttggtgccgt a 1001 <210> SEQ ID NO 369 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens

<400> SEQUENCE: 369 tcttctcata gcaaaatgca atgagaaaga gataatttga gaaaagaacc gtttaaacaa 60 aaagaaacca agacataatg attttggaaa ttctcagttt attcagactg caaaagatat 120 taaaataaag aaactcagta acagggatag ataatctaaa gaaaaagcct aggacacggc 180 tgtagtaacc ttctgttttt atacctcagc aatttgctaa tgcctcaaaa agatcaaaag 240 tactcaaata taaagggctc tttgaagaga ttagatttcc tcaatcaaac caaagagcat 300 cgaggaagct taaggttact gtccctcaca tatctcagca gaaggcaaaa atagaagact 360 gattatctaa gaaagatctc tgaaagagtc tcatattatg gagtgaaccc ctgtggcata 420 catgggagac ccacttggtt cttgagaatt ttatatcagg agaaacactg tcagtctgta 480 ttgaaaggaa cagagaaaat rcgaaattaa agaagactat taaacctcca aaattctggc 540 aggaaagaag cttacacagc tactcagttg caaagatctg ccacttttca tatacatgaa 600 aggactcaga ggaggaagcc acaggtttag aaggaaaagc taaaagcaac atcgtattag 660 tcttggatct aggaacctaa tttctctagc agaatctaga aatggcttgg gacaagtgat 720 tgttttttta cctaggattt tctccctctt gaaaacagga ctgtctgtaa ctattatcct 780 atgcctgccc taccatcata tttcagaaac aggtaactta tgttttcact ttcaaagatt 840 cacaataaag agaaattgta cctcagaatg gattatacca gagctttcct catgcataaa 900 ttaaataatt taggttatgt gatttgaagc ttttgagtgg gtgaggtgac attttggatg 960 ctgagttggt gccgtagtga gtccagaatt ctgcggaact t 1001 <210> SEQ ID NO 370 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 370 ctctagactc ctcctgtatt ttaatttagc cactttttta gggcctacaa ttttagatct 60 ccacagggct cttgaaactt cttgaacctc atcagtaaca tgtccattag tggcatgacc 120 caagagttct agaacatcta ttcagcaagt gtgtatctgg taagtgaata ttccttctat 180 gtgttccctt ttgcatcaaa ctacacactg tcattcctcc tttatctcca aaagcttgaa 240 aattcctcac ttgtatctca ttctttctct cttagaaaac tgatcacctc tgatgaatta 300 raacggaatg accaagcttt gggagaggca aaagaatctc ggtgttaaag actcagagtt 360 taagaagcaa caaaaagatt atacagatgt gaatatgtga ccttcctcca ccagggcatg 420 ttgccttgga gtaagataat ctaagcacac acttcatagc ctgagaacaa ttttggaagt 480 ctttgcttta tggatattta cataaagcaa atatggatat ttacctaaag gctggaccaa 540 ggcctaattc ctctagagcc ccttgatcat gaacaccatt cctgtcatga ttcttaaggt 600 c 601 <210> SEQ ID NO 371 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 371 acaagctcca gccatggacg caattccttc tagaagcaaa atttatctct agactcctcc 60 tgtattttaa tttagccact tttttagggc ctacaatttt agatctccac agggctcttg 120 aaacttcttg aacctcatca gtaacatgtc cattagtggc atgacccaag agttctagaa 180 catctattca gcaagtgtgt atctggtaag tgaatattcc ttctatgtgt tcccttttgc 240 atcaaactac acactgtcat tcctccttta tctccaaaag cttgaaaatt cctcacttgt 300 rtctcattct ttctctctta gaaaactgat cacctctgat gaattagaac ggaatgacca 360 agctttggga gaggcaaaag aatctcggtg ttaaagactc agagtttaag aagcaacaaa 420 aagattatac agatgtgaat atgtgacctt cctccaccag ggcatgttgc cttggagtaa 480 gataatctaa gcacacactt catagcctga gaacaatttt ggaagtcttt gctttatgga 540 tatttacata aagcaaatat ggatatttac ctaaaggctg gaccaaggcc taattcctct 600 a 601 <210> SEQ ID NO 372 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 372 gaagatgcac tctaatgttt tttcccagaa gctctgtagg tttagctttt acctttctgg 60 gtttgttttg ttttgttttt tgagatggag tcccactcgt gtcacccagg ctggagtaca 120 atggtgcaat ctcggttcac tgcaacctcc acctcccggg ttcaagcaat tcccctgtct 180 ccacctctcg agtagctggg atgggaggcg cctgccacca tacctggcta attttcatat 240 ttttagtaaa gatagggttt caccatgtta gccaggctgg tctcgaactc ctgacctcaa 300 gtgatccacc cgcctcagct tcccaaagtg ctgggattac aggcgtgagc cactgcgccc 360 agccctagct ttttggtcta tgattcctcc caaattaatt tctgtgaacc attaccttaa 420 gatgttgaga tttaatgtcc agaatctcat ttgttcacct ttgaaaatta agaaaccctg 480 gcacagtgtt gactggagcc wcttacctta atagaaaata aagctcacat atatccataa 540 tgaaaagcag agaccagcac aaccatagtc acctgacagt tttaaaatcc aaggccagga 600 tcttctcaac tcaggcccac tcacttactc cacaacatac ttcttctttc ctcagcatct 660 actacttgtg ctgggacctt ggtcttccca ttgttcatgt c 701 <210> SEQ ID NO 373 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 373 agatggagtc ccactcgtgt cacccaggct ggagtacaat ggtgcaatct cggttcactg 60 caacctccac ctcccgggtt caagcaattc ccctgtctcc acctctcgag tagctgggat 120 gggaggcgcc tgccaccata cctggctaat tttcatattt ttagtaaaga tagggtttca 180 ccatgttagc caggctggtc tcgaactcct gacctcaagt gatccacccg cctcagcttc 240 ccaaagtgct gggattacag gcgtgagcca ctgcgcccag ccctagcttt ttggtctatg 300 attcctccca aattaatttc tgtgaaccat taccttaaga tgttgagatt taatgtccag 360 aatctcattt gttcaccttt gaaaattaag aaaccctggc acagtgttga ctggagccac 420 ttaccttaat agaaaataaa gctcacatat atccataatg aaaagcagag accagcacaa 480 ccatagtcac ctgacagttt waaaatccaa ggccaggatc ttctcaactc aggcccactc 540 acttactcca caacatactt cttctttcct cagcatctac tacttgtgct gggaccttgg 600 tcttcccatt gttcatgtca ttcttttcct cacagttccc attcttttct ccctgaaata 660 aagaaatttc aaaatatacc atgtttcatg aaaaagacaa a 701 <210> SEQ ID NO 374 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 374 gatttccacc ctcaggtgat ggggatggtt gaacatccaa cacctgaaac aggacagacg 60 atattgacag tacttgttag ttgcatataa tcacagacca gtggaaacag atgaaccaca 120 cagggccaca gcggggtttc actggggaac agagtgaaca atcaggaggt gtgggaggca 180 ggtttagtag tttaaagagg ttgaggtgtc cccctggatc ccatgggagg atcacattgg 240 ctcatttgaa ttatcatacg gactggcagg gaactgaaat cttctactca gggataagca 300 gaaactgtcc ctggtttcct tgataaaaag ggttgtttga taggggacct tatccatggg 360 aggaaagtga ggagggaaat ttgtggctaa gccattcaag gccctcccag ttttactaga 420 tgtcaaggca gcacacgtaa tattgggact taattttagc cacataacta ataaatttgt 480 aagtatgtgc aacggctcac rcttgcttcc agaatggcac ctaaaaaaca gatttacctc 540 tccccaaatt cagatatgga attaaatgta atgtcaggaa aattgtctaa gagttggaaa 600 tgggaaaaaa atgttctttt ggtggagtta tggactccag aggttatcag attctattga 660 ataacgtact tttgattgta tttgtaacaa ttaggctatt t 701 <210> SEQ ID NO 375 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 375 gcatataatc acagaccagt ggaaacagat gaaccacaca gggccacagc ggggtttcac 60 tggggaacag agtgaacaat caggaggtgt gggaggcagg tttagtagtt taaagaggtt 120 gaggtgtccc cctggatccc atgggaggat cacattggct catttgaatt atcatacgga 180 ctggcaggga actgaaatct tctactcagg gataagcaga aactgtccct ggtttccttg 240 ataaaaaggg ttgtttgata ggggacctta tccatgggag gaaagtgagg agggaaattt 300 gtggctaagc cattcaaggc cctcccagtt ttactagatg tcaaggcagc acacgtaata 360 ttgggactta attttagcca cataactaat aaatttgtaa gtatgtgcaa cggctcacac 420 ttgcttccag aatggcacct aaaaaacaga tttacctctc cccaaattca gatatggaat 480 taaatgtaat gtcaggaaaa ytgtctaaga gttggaaatg ggaaaaaaat gttcttttgg 540 tggagttatg gactccagag gttatcagat tctattgaat aacgtacttt tgattgtatt 600 tgtaacaatt aggctatttg tgaactcggt aggggtagaa atcgagttgt agaaaatgga 660 tggtaatgca agtgattttt gaccatatca atgcaaatga attctgttgg tagaaatatt 720 catttccaca ctgtagatga ccctaaacat atgtcattac attatatttt attgccttat 780 agactattaa ccaattttga atcatacagt agcaaattta tttcagcatt cttgtgtgta 840 tgtgtttata tatacacgtg catatgtatt taagatatat aattgtatat tcttcaaatt 900 cttctttgaa caggtttgaa cctcttatta gtttcctcat taaggaattt aataagacct 960 ttaatgcatg tttgtatttt catgagagtc attattttac c 1001 <210> SEQ ID NO 376 <211> LENGTH: 695 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 376 tgctccttca ttagtgcaat ggaacagcaa atcaggatac tttcacagtt ctcttaagtg 60 agcctagaag tggggagctg cttgttcaca aacttgaagc ctgaatatgt taatattctt 120 tcagtggccg gacgcggtgg ctcatgcctg taatcccaac actttgggag gccgaggtag 180 gcagatcaac ctgaagtcag gagttcgagg ccagcctggc caacatggtg aaaccccacc 240 tgttggtctg tactaaaaat agaaaaatta gctgggcatg gtggcgcatg cctgtaatcc 300

cagctactca ggaggctgtg gcagaagaat cgcctgcacc tgggaggcag aggttgcttt 360 gagttgatat cgtgtcactg cactccagcc tgggcaacag agtgagatcc tttcagaaac 420 ctgctgtctg tatttggata caattaaaaa aaaaaaaaag atgagacagg caggtgcgaa 480 agaaataaaa gtcamaactg atccagttgg gaaactcaga attgacagtt acgtgtcctt 540 tcatttattg atattttgag attcacaggg gtttaaactt tatttttcca agactgaata 600 gttcccacct cccttccata tataaaattt gagtagctgg ggagatttaa aagaggctcc 660 ccataaactc agaagttaaa agagacaagg gtccc 695 <210> SEQ ID NO 377 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 377 aaccccacct gttggtctgt actaaaaata gaaaaattag ctgggcatgg tggcgcatgc 60 ctgtaatccc agctactcag gaggctgtgg cagaagaatc gcctgcacct gggaggcaga 120 ggttgctttg agttgatatc gtgtcactgc actccagcct gggcaacaga gtgagatcct 180 ttcagaaacc tgctgtctgt atttggatac aattaaaaaa aaaaaaaaga tgagacaggc 240 aggtgcgaaa gaaataaaag tcacaactga tccagttggg aaactcagaa ttgacagtta 300 sgtgtccttt catttattga tattttgaga ttcacagggg tttaaacttt attcttccaa 360 gactgaatag ttcccacctc ccttccatat ataaaatttg agtagctggg gagatttaaa 420 agaggctccc cataaactca gaagttaaaa gagacaaggg tcccagtaaa tacaaaatga 480 ttggggttga ggaggcagat tttctgtcct cagtgaagtt tgttggttgg ttggttggtt 540 ggttggttaa ttggttggtt tttgagtcag ggtctcactt tgtcacccaa gctggagtgc 600 a 601 <210> SEQ ID NO 378 <211> LENGTH: 663 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 378 tgtagcaaca ggagggatga gacccaaagg tctgaaaagc cagtatttta agaagtcttg 60 gaaaatgtgg aggttgaaaa atctaacagg agtgcttgct tcagcagcaa tttagagtag 120 attagcatgg cctctgcgcc aggatgacat gcacattcct aaaagtgttc cgtgttttaa 180 aaaaaagaga gagacagaat ctaaggggat gtgtacattt gctagagcta ctataacaaa 240 gtaccagagg cagggtcact tcaacaacag aaatttattt ctcacagttc tggaggctag 300 acgtccaaga ttaaggtgtt gactgggttg aattcagccc ataacaggaa ataaggagtt 360 aaataaagca cttgcttcta ttgtttgtac ctaaacttaa cagaayacag taagtaacaa 420 gtcattggga tgcagaaaag aaaaaagaga gtgaaggaag gagagaaggt gaagggagaa 480 tggaagagag gaagggaggg aggaaagaaa agtttgatga atgattgcag tctaaactgg 540 ttcaaacaag agatcttgtt taattaagga attcatccca tctctgccta ttaggaggag 600 gaaaaagtct aaaatagaag atggtgaaag ttggatgacc ccaggcatta aggccattca 660 tct 663 <210> SEQ ID NO 379 <211> LENGTH: 662 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 379 ttaagaagtc ttggaaaatg tggaggttga aaaatctaac aggagtgctt gcttcagcag 60 caatttagag tagattagca tggcctctgc gccaggatga catgcacatt cctaaaagtg 120 ttccgtgttt taaaaaaaag agagagacag aatctaaggg gatgtgtaca tttgctagag 180 ctactataac aaagtaccag aggcagggtc acttcaacaa cagaaattta tttctcacag 240 ttctggaggc tagacgtcca agattaaggt gttgactggg ttgaattcag cccataacag 300 gaaataagga gttaaataaa gcacttgctt ctattgtttg tacctaaact taacagaaca 360 cagtaagtaa caagtcattg ggatgcagaa aagaaaaaag agagtgaagg aaggagaraa 420 ggtgaaggga gaatggaaga gaggaaggga gggaggaaag aaaagtttga tgaatgattg 480 cagtctaaac tggttcaaac aagagatctt gtttaattaa ggaattcatc ccatctctgc 540 ctattaggag gaggaaaaag tctaaaatag aagatggtga aagttggatg accccaggca 600 ttaaggccat tcatctttaa ctgttatgct tggatcatgc aaatgtgtct ggtagctaca 660 ag 662 <210> SEQ ID NO 380 <211> LENGTH: 615 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 380 ttccatacat tccttccaca ccattgccct taacctttca aattcctgct taaaactaat 60 cccattttta tggctgacct caccctgtat caaaaactcc gacatccctt tacgacagag 120 agcacaaact agtggtccaa aatgtcatgg gggtcttctc agagttgttt tttcaatcag 180 gaaatttcac ataaaaatat ggatttctga tttctctttt aaaaacagaa aaacgagcca 240 ccagtgggag cactgcaggt atctgtgtga gaccygtact tcacaactcc tgctttccct 300 ccataaagta gcttgcattt tccacattga ctttgcagtt ctttggtatc tgtattggtt 360 ttaagataat ttctactata tcacatatct cctcacagta caaagatatc attttctttc 420 ccttttcttt ttaaaaaatt tgtattttta atttttgtgg gtacacagta gatatttatg 480 gggcatatga ggtattttat aggcatataa tatgtactag ggtaagtggg gtattcatca 540 cctcaagcat ttatcctttc tttgtgtaaa atatagcatt ttctgaacac tatgaatact 600 taagtacaag gatca 615 <210> SEQ ID NO 381 <211> LENGTH: 994 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 381 tcaaagtgta acaaatttcc tttcctcata aactagcaga cattctatcc cctcattatt 60 gtaacacatt tctaatatct ttctcaaatt gtcttcctgt attacaatgc actcaccttg 120 gcttagaatg tctgagacaa gaaaatctat tcaccattcc cacagatgac tccctcactc 180 tcctcccaag tcttccatac attccttcca caccattgcc cttaaccttt caaattcctg 240 cttaaaacta atcccatttt tatggctgac ctcaccctgt atcaaaaact ccgacatccc 300 tttacgacag agagcacaaa ctagtggtcc aaaatgtcat gggggtcttc tcagagttgt 360 tttttcaatc aggaaatttc acataaaaat atggatttct gatttctctt ttaaaaacag 420 aaaaacgagc caccagtggg agcactgcag gtatctgtgt gagacctgta cttcacaact 480 cctgctttcc ctccataaag yagcttgcat tttccacatt gactttgcag ttctttggta 540 tctgtattgg ttttaagata atttctacta tatcacatat ctcctcacag tacaaagata 600 tcattttctt tcccttttct ttttaaaaaa tttgtatttt taatttttgt gggtacacag 660 tagatattta tggggcatat gaggtatttt ataggcatat aatatgtact agggtaagtg 720 gggtattcat cacctcaagc atttatcctt tctttgtgta aaatatagca ttttctgaac 780 actatgaata cttaagtaca aggatcaagt cataggattt ggaattgatt tttaaaatat 840 gttgaccaaa gtgctcttat catcaaactt aacatcacta atgaaggatg aacatcccaa 900 atctgaaaat ccaaaatcca aaatgctcca taatctaaaa cttgttgagc accaacatga 960 tgcttaaagg aaatgctcct ggagcatttc agat 994 <210> SEQ ID NO 382 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 382 ctatgagaaa tatttttaaa gtggttagga acaattcata gcactgacat gttatcagta 60 aaaatagaag aaaataaatt aatattatga aatattaatt atatttcatt aattatgtaa 120 tatgaattat gttttagctc aaatatttcc caagggacaa ttaagtaaat gaaaaataca 180 cacagattaa aataataaat agagaaggag atattaatga ggtacaaaaa gaaaaaatac 240 atgtaatcac atgaaatgct attatttgaa agattaacaa aacttgtaaa ctacctgcta 300 acttgatcaa agaaaaaaat cgagaaacca tatgcgcaat taatagtaag agggaaataa 360 acattgaaac agaagacatt tgaaatacca tataagactg ggtttcagag ctctatgtac 420 gtaaattgat aatgtcctgg agaagtgcag atgaccaaaa tggacacctt tcaacttaga 480 aatcataaac agattcattt ycttaaagtt aatgaaaaga attaacagac cctcctcaaa 540 aaagacatat atgcggccta caatcatatg aaaaaaagtt caacattact gttcattaga 600 gaaatgcaaa tcaaaaccac aatgagatac catctcacac cagtcagaat ggctattatt 660 aagaagtcaa aaaataaaag atgctggcga ggttgtggag aaaaaagaat gcttttatac 720 acttggtggg aatgtaaatt agttcagtca ttgtggaaga ctttgatgat tcctagaaga 780 cctaaataca gaactactat ttgacccaac aatcccatta ctgggtatat actcaaatga 840 ctataaatca ttctattata aagacacatg catggatatg ttcattacag cactatgcac 900 aatagcaaag acttggaatc aacatgaatg tccatcaatg atagactaga taaagaaaat 960 gtggtacaca tataccatgg aatactatgc agccataaaa a 1001 <210> SEQ ID NO 383 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 383 tcagtaaaaa tagaagaaaa taaattaata ttatgaaata ttaattatat ttcattaatt 60 atgtaatatg aattatgttt tagctcaaat atttcccaag ggacaattaa gtaaatgaaa 120 aatacacaca gattaaaata ataaatagag aaggagatat taatgaggta caaaaagaaa 180 aaatacatgt aatcacatga aatgctatta tttgaaagat taacaaaact tgtaaactac 240 ctgctaactt gatcaaagaa aaaaatcgag aaaccatatg cgcaattaat agtaagaggg 300 aaataaacat tgaaacagaa gacatttgaa ataccatata agactgggtt tcagagctct 360 atgtacgtaa attgataatg tcctggagaa gtgcagatga ccaaaatgga cacctttcaa 420 cttagaaatc ataaacagat tcatttcctt aaagttaatg aaaagaatta acagaccctc 480 ctcaaaaaag acatatatgc rgcctacaat catatgaaaa aaagttcaac attactgttc 540 attagagaaa tgcaaatcaa aaccacaatg agataccatc tcacaccagt cagaatggct 600

attattaaga agtcaaaaaa taaaagatgc tggcgaggtt gtggagaaaa aagaatgctt 660 ttatacactt ggtgggaatg taaattagtt cagtcattgt ggaagacttt gatgattcct 720 agaagaccta aatacagaac tactatttga cccaacaatc ccattactgg gtatatactc 780 aaatgactat aaatcattct attataaaga cacatgcatg gatatgttca ttacagcact 840 atgcacaata gcaaagactt ggaatcaaca tgaatgtcca tcaatgatag actagataaa 900 gaaaatgtgg tacacatata ccatggaata ctatgcagcc ataaaaatga aggagatcat 960 gccctttgca gggacacgaa tagaggtgga ggccattatc c 1001 <210> SEQ ID NO 384 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 384 agttgcttga aagcaaagtt ctcgcagtag ctctctatct agaaggaggc attttattta 60 tgtaaggaag tcacctaaaa gaaaattcat ttgttatggt gtggctttaa gagttactta 120 cttttaatgg aatcccccag ataataataa attctgaaaa aaaaaaatca gaatcatggc 180 atgttaaaac tggatacatt cctagaaata gatggaaact gctcttgcaa aaagcttagc 240 acatgttaaa rcattttaga aacaatttgc caaagtttat ttagtctagt gatttcgaca 300 ggttaaatgg accctttgag atcttttttc ctcaagtaca aaggctcact tgcttaatga 360 acacagtccc agaaaagcag ggggctgaac cttggctcta ccatcttacc taagattcta 420 gagttagcaa agggtttcca caagcccaaa ttattatgtt taatcttttc aattatctgt 480 gaagcattag gttggtgcaa a 501 <210> SEQ ID NO 385 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 385 gaggcatttt atttatgtaa ggaagtcacc taaaagaaaa ttcatttgtt atggtgtggc 60 tttaagagtt acttactttt aatggaatcc cccagataat aataaattct gaaaaaaaaa 120 aatcagaatc atggcatgtt aaaactggat acattcctag aaatagatgg aaactgctct 180 tgcaaaaagc ttagcacatg ttaaagcatt ttagaaacaa tttgccaaag tttatttagt 240 ctagtgattt ygacaggtta aatggaccct ttgagatctt ttttcctcaa gtacaaaggc 300 tcacttgctt aatgaacaca gtcccagaaa agcagggggc tgaaccttgg ctctaccatc 360 ttacctaaga ttctagagtt agcaaagggt ttccacaagc ccaaattatt atgtttaatc 420 ttttcaatta tctgtgaagc attaggttgg tgcaaaagta actgcaggtt ttgacattaa 480 aactggcaaa aactgcaata a 501 <210> SEQ ID NO 386 <211> LENGTH: 703 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 386 gacaccagtt agcatattgt cgcgggggag aggggtggga aaggcgagag aacagcatgt 60 ggtccagagg ccatacccag atggaggctg cagtcagctc cccagtcaaa ggcaaagccc 120 aagtcaaagc catgcttccc tcttgcccac ctgctccaat gccacccaca gagagtgcgc 180 cacagctcac aggatgcagg tctggttgaa tcttaacaat aactttgtaa gggaggtgtc 240 attagctcca ttctcctggc aggaggatga ggctcaaggc agctaaaggc ttttgctgaa 300 catcaagtgg tgagccagga ctcaawgcca gatcttcttg tttccctgtt aggtgtatgt 360 agcacaactg gtatctgcag actatgctgc tggaagggct agccgtcact gttatcacag 420 cgactgctgc ctgagatatg ccaggtactg ctgcaagaag tttacaaata taagctcact 480 tgatcttcat aacatactac ctaggtacaa tcattatatt tatttgacag atacagagac 540 agaggggaca cagaaaggat tagtaacttg ccccaaacca cacagccagc aaggtgtaag 600 tgagcacctg cagtctagat gagacaccac tcaaaacgtc atttttctgg cagccccgtg 660 cagttaccac agtggtcacc ccagtggtca gctaaaggcc aag 703 <210> SEQ ID NO 387 <211> LENGTH: 704 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 387 gcatattgtc gcgggggaga ggggtgggaa aggcgagaga acagcatgtg gtccagaggc 60 catacccaga tggaggctgc agtcagctcc ccagtcaaag gcaaagccca agtcaaagcc 120 atgcttccct cttgcccacc tgctccaatg ccacccacag agagtgcgcc acagctcaca 180 ggatgcaggt ctggttgaat cttaacaata actttgtaag ggaggtgtca ttagctccat 240 tctcctggca ggaggatgag gctcaaggca gctaaaggct tttgctgaac atcaagtggt 300 gagccaggac tcaatgccag atcttcttgt ttccctgtta ggtgtwtgta gcacaactgg 360 tatctgcaga ctatgctgct ggaagggcta gccgtcactg ttatcacagc gactgctgcc 420 tgagatatgc caggtactgc tgcaagaagt ttacaaatat aagctcactt gatcttcata 480 acatactacc taggtacaat cattatattt atttgacaga tacagagaca gaggggacac 540 agaaaggatt agtaacttgc cccaaaccac acagccagca aggtgtaagt gagcacctgc 600 agtctagatg agacaccact caaaacgtca tttttctggc agccccgtgc agttaccaca 660 gtggtcaccc cagtggtcag ctaaaggcca agcccaccgt ttct 704 <210> SEQ ID NO 388 <211> LENGTH: 975 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 388 gacttaagac aagggggtct taatttgatt atttttttct gttttatatg atttctatga 60 aaactacaac aaaataaagt taattctatt taagtgactt tttaatgaat tgcctttgtt 120 agaaaaaaaa ttaagtgttt ttgtctcact ctgtcaccca ggctggagca cagtggtgtg 180 atcatggctt actgcagcca tgacctcccg ggctcaggtg atcctcccac ctcagcttcc 240 caaatagatg ggactacagt tgtgtgccac aacgcctggc taatttttgt atttttttgt 300 agagacaggg tctcaccagg ttgcccaggc tgatcttgaa ctccttggct caagcgatcc 360 acccacctca gcctccctga gtgctgggat tacaggcatg agccagcgca cccagccaga 420 attacatttt tttaaatggt actgtcctag aaaatccagg atgtgcagtg atcaygtatg 480 aatgcatgga cctgcacaca caggagtgaa caaaagaccc acccctgcca ggtcaccact 540 catatctcac cccagcccac gctagctcac actcctcccc acacaccact gacctcatca 600 ttgctaggta cccacttgac ttctcaacag gttcaagaca attggccttc ctcgtctctt 660 ctagaaacac cctcttttct gggctttgtg taacacctgg tctttctccc ctctctggcc 720 acttctcagc ttttcttttt ctttctttct tttttttttt tttttttttg ccacttcctc 780 ttcctctaca tcaagcttgt ccaacccaca gcccaggaca gctttgaatg cagcctaaca 840 caaattcgta agctttctta aaacattatg agatgtgtgt gtgtgtgtgt gtgtgtgtgt 900 gtgtgtgtgt gtgtgtgtgt gtttagctca tcagctatcg ttattgttag tgtattttat 960 gtgtggccca agaca 975 <210> SEQ ID NO 389 <211> LENGTH: 976 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 389 gactttttaa tgaattgcct ttgttagaaa aaaaattaag tgtttttgtc tcactctgtc 60 acccaggctg gagcacagtg gtgtgatcat ggcttactgc agccatgacc tcccgggctc 120 aggtgatcct cccacctcag cttcccaaat agatgggact acagttgtgt gccacaacgc 180 ctggctaatt tttgtatttt tttgtagaga cagggtctca ccaggttgcc caggctgatc 240 ttgaactcct tggctcaagc gatccaccca cctcagcctc cctgagtgct gggattacag 300 gcatgagcca gcgcacccag ccagaattac atttttttaa atggtactgt cctagaaaat 360 ccaggatgtg cagtgatcac gtatgaatgc atggacctgc acacacagga gtgaacaaaa 420 gacccacccc tgccaggtca ccactcatat ctcaccccag cccacgctag ctcacrctcc 480 tccccacaca ccactgacct catcattgct aggtacccac ttgacttctc aacaggttca 540 agacaattgg ccttcctcgt ctcttctaga aacaccctct tttctgggct ttgtgtaaca 600 cctggtcttt ctcccctctc tggccacttc tcagcttttc tttttctttc tttctttttt 660 tttttttttt ttttgccact tcctcttcct ctacatcaag cttgtccaac ccacagccca 720 ggacagcttt gaatgcagcc taacacaaat tcgtaagctt tcttaaaaca ttatgagatg 780 tgtgtgtgtg tgtgtgtgtg tgtgtgtgtg tgtgtgtgtg tgtgtgttta gctcatcagc 840 tatcgttatt gttagtgtat tttatgtgtg gcccaagaca tttcttcttc cagtgtggcc 900 cagggaagcc aaaagattgg acacccctgc tctacaacat ctcaatatag gcctttttca 960 tgtttcattc tagatt 976 <210> SEQ ID NO 390 <211> LENGTH: 801 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 390 atccagacgg tgcccatact ccctgctctg tctagatggt gtccacattc cctgctccgt 60 ctagactgtg cccatattcg ctgctggctg caaatgcgag gagttgacag cagcctcccc 120 tttacaaggc aggaggtgcc actgttcgcc attgtctcca cctagggctt cacttgcttt 180 ctatctgcag acatcagagg gacccacatc tctctgttct gacacgctgt gtgttgatgg 240 cagagtttaa ttatccacat gcaatcttac tttccttatt cccaagtccg tggggctgcc 300 tcatcaaagc attgtaagaa ctgataacca tcttctagaa gtatcatagt gatattaaga 360 acacacatca cagatcatag taaatggctt taatttttta rcgaaatctc actactgcaa 420 atgcattgtt gtcctagcta atgaatgcat agagtattgc ctgcaaaata ataattgaga 480 ttctattttt aagaagctta gaacagtaca tggtgcatag caaagactct gtgtatgtga 540 agccagattt taaaatatgg taacaagtgt ctgaaaatat gtggctcaat ttgtctcccg 600 gttacttttc cctctccccc tttaaaatgt agaggaagga gaagaagaga taagaggttt 660 gtgagtgaag acaagggccc tttaaggcct gggaagacta acgccatagg gatctccctc 720 tgccttaaaa ggcacaggaa tcttagtggg gaaaaagaag tggtgataaa tagccagtcc 780 gtgtgcctgg aatatcaaag t 801

<210> SEQ ID NO 391 <211> LENGTH: 801 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 391 ccctgctccg tctagactgt gcccatattc gctgctggct gcaaatgcga ggagttgaca 60 gcagcctccc ctttacaagg caggaggtgc cactgttcgc cattgtctcc acctagggct 120 tcacttgctt tctatctgca gacatcagag ggacccacat ctctctgttc tgacacgctg 180 tgtgttgatg gcagagttta attatccaca tgcaatctta ctttccttat tcccaagtcc 240 gtggggctgc ctcatcaaag cattgtaaga actgataacc atcttctaga agtatcatag 300 tgatattaag aacacacatc acagatcata gtaaatggct ttaatttttt agcgaaatct 360 cactactgca aatgcattgt tgtcctagct aatgaatgca yagagtattg cctgcaaaat 420 aataattgag attctatttt taagaagctt agaacagtac atggtgcata gcaaagactc 480 tgtgtatgtg aagccagatt ttaaaatatg gtaacaagtg tctgaaaata tgtggctcaa 540 tttgtctccc ggttactttt ccctctcccc ctttaaaatg tagaggaagg agaagaagag 600 ataagaggtt tgtgagtgaa gacaagggcc ctttaaggcc tgggaagact aacgccatag 660 ggatctccct ctgccttaaa aggcacagga atcttagtgg ggaaaaagaa gtggtgataa 720 atagccagtc cgtgtgcctg gaatatcaaa gtcagtgcgt gccagggatc acactgcggg 780 tcacgtgcac tctgggtctc t 801 <210> SEQ ID NO 392 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 392 ttggcctggg gctgattcct ccaaagcaat gtgtctcttc gcagagtctc ttagagctgc 60 aaggcagtat gggatcatca gagaggatgc taggaagctt cagaaatgga ggtcctggta 120 gaaagggtcc tttggcgtgg cctctgaaga gtccaaatgt gggacaagac cctccgaaag 180 cggtggcctg gggagccaca ggtggggcag ccagcacgga agagggtggc tttgctacca 240 ttgggaaaac ttatcctcca catcctcatg aggcaaacac ctttcctacc ttaccgctcc 300 ycagtggcct ccctgttgcc ttcttattca agactaagac cctctagaat gttctttatc 360 ctgagtccag ctgattgtct atactaatat cagtacgggg tgtagatgag gacaaccagt 420 gtgcctggct gccaggcacc ccctccccaa accccaggag tttctggaac attccaactc 480 tgcttgaggg tatccatgca gcatctacta ctgtgagcag gtggtctgat ctgtggaaaa 540 cttctatgat tcacctgagg gtaactgccc tttgtgattt gaaagaatga tgctaacaga 600 a 601 <210> SEQ ID NO 393 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 393 gcagagtctc ttagagctgc aaggcagtat gggatcatca gagaggatgc taggaagctt 60 cagaaatgga ggtcctggta gaaagggtcc tttggcgtgg cctctgaaga gtccaaatgt 120 gggacaagac cctccgaaag cggtggcctg gggagccaca ggtggggcag ccagcacgga 180 agagggtggc tttgctacca ttgggaaaac ttatcctcca catcctcatg aggcaaacac 240 ctttcctacc ttaccgctcc tcagtggcct ccctgttgcc ttcttattca agactaagac 300 yctctagaat gttctttatc ctgagtccag ctgattgtct atactaatat cagtacgggg 360 tgtagatgag gacaaccagt gtgcctggct gccaggcacc ccctccccaa accccaggag 420 tttctggaac attccaactc tgcttgaggg tatccatgca gcatctacta ctgtgagcag 480 gtggtctgat ctgtggaaaa cttctatgat tcacctgagg gtaactgccc tttgtgattt 540 gaaagaatga tgctaacaga aagtgttgtc atttctgaac ttttctgaac tctgcagcga 600 g 601 <210> SEQ ID NO 394 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 394 agatttggat ggggacacaa aaccaaacca tatcataggt taaattgtgt ctcccacccc 60 aaaaatgtgt atgttgaagt cctaaccttc agtactcaga atgtgacatt atttggaaat 120 agggtcattg cagatggagt tagttaagat gaggtcatta ggatgagtcc ctaatccaat 180 atgactggtg ctcttacaaa aaggggaagt ttggacacag agccatgcac atgggtggga 240 agaatcccaa atgaacggat aggcagaggg ttggagagat gcatcaacaa ggaacaccaa 300 agattgccag caacccccag aagctggggg agaggcctgg aacagattct ccctcacagc 360 ctgagaggaa ccaagctggc tgacaccttg atctcaggtt accggccttg agaactgaga 420 gaccctgggt ttctgttgtt taagcctctc agggtgcagc actttattat ggaagcctga 480 gctgactaat acaggtgtct ytatatctca ctgagggaaa gtgacaggaa agtaagaacc 540 atttatgtcc aagagtccag aggagtcaac cagattctgg gggaaaagaa ggtacaatgc 600 tggcctctcc atgcagccta gtccccaaca cttgtagggc ccagggcaag atctaaagca 660 ctctctcacc tatgcatcta tatgctgtaa ctcagataaa caaactatta aataatatat 720 gtgtcttgcc tctcaatctg acaattacac ctttataata gcaacatagg aaaataacta 780 aaactatggt ttttaggcaa ccaaatacca gcaaaatgta ataattccta ttattagata 840 tgtttaagtg ttctgctggt gggtcagcat ctttggtaga gtcataaaat taaaatgtac 900 ataattaatt aaatattata tgtttattcc ctaacattta tttctgtcat ttcttttttc 960 tttttttcag acagtctcac tcttttgccc aggccggagt g 1001 <210> SEQ ID NO 395 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 395 ttgtgtctcc caccccaaaa atgtgtatgt tgaagtccta accttcagta ctcagaatgt 60 gacattattt ggaaataggg tcattgcaga tggagttagt taagatgagg tcattaggat 120 gagtccctaa tccaatatga ctggtgctct tacaaaaagg ggaagtttgg acacagagcc 180 atgcacatgg gtgggaagaa tcccaaatga acggataggc agagggttgg agagatgcat 240 caacaaggaa caccaaagat tgccagcaac ccccagaagc tgggggagag gcctggaaca 300 gattctccct cacagcctga gaggaaccaa gctggctgac accttgatct caggttaccg 360 gccttgagaa ctgagagacc ctgggtttct gttgtttaag cctctcaggg tgcagcactt 420 tattatggaa gcctgagctg actaatacag gtgtctctat atctcactga gggaaagtga 480 caggaaagta agaaccattt rtgtccaaga gtccagagga gtcaaccaga ttctggggga 540 aaagaaggta caatgctggc ctctccatgc agcctagtcc ccaacacttg tagggcccag 600 ggcaagatct aaagcactct ctcacctatg catctatatg ctgtaactca gataaacaaa 660 ctattaaata atatatgtgt cttgcctctc aatctgacaa ttacaccttt ataatagcaa 720 cataggaaaa taactaaaac tatggttttt aggcaaccaa ataccagcaa aatgtaataa 780 ttcctattat tagatatgtt taagtgttct gctggtgggt cagcatcttt ggtagagtca 840 taaaattaaa atgtacataa ttaattaaat attatatgtt tattccctaa catttatttc 900 tgtcatttct tttttctttt tttcagacag tctcactctt ttgcccaggc cggagtgcag 960 tggcgtgatc tcagctcact gcaacctccg cctcccaggt t 1001 <210> SEQ ID NO 396 <211> LENGTH: 1218 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 396 gataaagaaa ggtcatcctc aatttcaatt tactttatat attctttgag aggtaaccgt 60 gtcttatctc cccccaaaat tccttttaaa aggaaatttc caaagatgct ctattctgtg 120 aataaagcat tgtgccacag ccgagaggat ccagcaatga acatgagatt gcccttgatt 180 cataaggtct acaagctagt aaggatagag aacactttaa aataaaaaaa aatagttttt 240 ggtatattta tattgtgtat ttggtataat tgagttttct acattctcat atatgtattt 300 catattttga agaatatgca gaaaataatc aagcttccaa ataaacattt ttttttaaga 360 actgcacaag tgagaattta ggagaacaga agatcagagg gctgcacrgg ctaaactaga 420 caatgagccc atgcaagtaa gttaagagga gaagcgggta agtatgcacc tgctttgtct 480 aggtgaccag caagcattta gcaatagtct tttcaaaaca acagctcctt atattgtcaa 540 atctcaagaa gtaatattta tggttaaaaa aatctcagac ccaacagaaa atccatgagg 600 gagatggttt tggaaacgca gaattttcag ctatgatatc cttttataaa caagcagata 660 ctttccccaa atataattca atgcctcagt ctacctcctg ctgaaaccac taacaccacc 720 actaaagctc gactatatgg gaaaatttag gtgtcacttt caaaatatgt cctagcataa 780 aggcaattaa aaaatgtaaa gcaccaaaga tgcaagagag acataaatga ataaaatatc 840 tggcacgaaa gttttcaaaa gcttgggaat ctgattcaaa aaaaaataaa atcagccaag 900 cagtgttagt aagttagcca atcaggtttc aagaaggcag aaagacaaaa tcaacatcac 960 cagcatttga caccgctact gggggaaaaa agggggatgg agttcgttta tggccttttt 1020 aaaaatgcca ttacttggac aagagtcata acagagaagc actgcttatt tcagttctgt 1080 taactgtaaa tatcagagcc aacacccaga aaaagttcac cattagccaa ttggttttgc 1140 ctggccaatt ggagatggta ataggcctgc tatggatgac attctttctg atataagttg 1200 tttcttgctt tttctccc 1218 <210> SEQ ID NO 397 <211> LENGTH: 1218 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 397 gataaagaaa ggtcatcctc aatttcaatt tactttatat attctttgag aggtaaccgt 60 gtcttatctc cccccaaaat tccttttaaa aggaaatttc caaagatgct ctattctgtg 120 aataaagcat tgtgccacag ccgagaggat ccagcaatga acatgagatt gcccttgatt 180 cataaggtct acaagctagt aaggatagag aacactttaa aataaaaaaa aatagttttt 240 ggtatattta tattgtgtat ttggtataat tgagttttct acattctcat atatgtattt 300 catattttga agaatatgca gaaaataatc aagcttccaa ataaacattt ttttttaaga 360 actgcacaag tgagaattta ggagaacaga agatcagagg gctgcacggg ctaaactaga 420

caatgagccc atgcaagtaa gttaagagga gaagcgggta agtatgcacc tgctttgtct 480 aggwgaccag caagcattta gcaatagtct tttcaaaaca acagctcctt atattgtcaa 540 atctcaagaa gtaatattta tggttaaaaa aatctcagac ccaacagaaa atccatgagg 600 gagatggttt tggaaacgca gaattttcag ctatgatatc cttttataaa caagcagata 660 ctttccccaa atataattca atgcctcagt ctacctcctg ctgaaaccac taacaccacc 720 actaaagctc gactatatgg gaaaatttag gtgtcacttt caaaatatgt cctagcataa 780 aggcaattaa aaaatgtaaa gcaccaaaga tgcaagagag acataaatga ataaaatatc 840 tggcacgaaa gttttcaaaa gcttgggaat ctgattcaaa aaaaaataaa atcagccaag 900 cagtgttagt aagttagcca atcaggtttc aagaaggcag aaagacaaaa tcaacatcac 960 cagcatttga caccgctact gggggaaaaa agggggatgg agttcgttta tggccttttt 1020 aaaaatgcca ttacttggac aagagtcata acagagaagc actgcttatt tcagttctgt 1080 taactgtaaa tatcagagcc aacacccaga aaaagttcac cattagccaa ttggttttgc 1140 ctggccaatt ggagatggta ataggcctgc tatggatgac attctttctg atataagttg 1200 tttcttgctt tttctccc 1218 <210> SEQ ID NO 398 <211> LENGTH: 1072 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 398 cacttaaaag ctctggaaac ctacgagatt atctttaaaa tcgtggggac caaatggctg 60 gccaaggact tgtttctgta caggtgcgat tgcttctctg ctgtgttcct ttttattacc 120 caagtaaccg gtatttcagc tcacaagatg agaaaatgac aaacaggcaa aataagcgta 180 gggctgtgtg tgcaacagtt watcataaag ccatcaccag gagacgtcac tgggcgcctt 240 ctggagtcta tccgtcctaa ctttgctttc tttctttttt tttttaaatt taagttctag 300 ggtacatatg cacaacgtgc aggtttgtca cacatgtata catgtgccat gttggtgtgc 360 tgcacccatt aactcgtcat ttacattagg tgtatctcct agtgctatcc ctccccactc 420 ccccgacccc atgacaggcc ccagtgtgtg atgttcccct tcctgtgtcc aagtgttctc 480 attgttcaat ccccacctat gagtgagaac atgccatgtt tggttttttg tccttgcgat 540 agtttgctga gaatgatggt ttccagcttc atccatgtcc ctacaaagga catgaactca 600 tcctttttta tggctacata gtattccatg gtgtatatgt gccacatttt cttaatccag 660 tctatcatcg atggacattt gggttggttc caagtctttg ctattgtgac tagtgttgca 720 ataaatatac gtgtggatgt gtctttatag cagtttgatt tataatcctt tgggtatata 780 cccagtaacg ggatggctgg gtcaaatggt atttctagtt ctagatcctt gaggaatcgc 840 cacactgact tccacaatgg ttgaactagt taacagtccc accaacagtg tgaaagtgtt 900 cctatttctc cacatcctct ccagcacccc attttgactt tgctataagg gaactttagc 960 atctgaacgt gcggacagct tcattgctgg cttgttacgt aacagtgttt tgtgaccatc 1020 tcatgtcata cccacacatc gaaaccagca gtttaaatgg ccagctgttt gc 1072 <210> SEQ ID NO 399 <211> LENGTH: 1072 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 399 agattatctt taaaatcgtg gggaccaaat ggctggccaa ggacttgttt ctgtacaggt 60 gcgattgctt ctctgctgtg ttccttttta ttacccaagt aaccggtatt tcagctcaca 120 agatgagaaa atgacaaaca ggcaaaataa gcgtagggct gtgtgtgcaa cagtttatca 180 taaagccatc accaggagac rtcactgggc gccttctgga gtctatccgt cctaactttg 240 ctttctttct tttttttttt aaatttaagt tctagggtac atatgcacaa cgtgcaggtt 300 tgtcacacat gtatacatgt gccatgttgg tgtgctgcac ccattaactc gtcatttaca 360 ttaggtgtat ctcctagtgc tatccctccc cactcccccg accccatgac aggccccagt 420 gtgtgatgtt ccccttcctg tgtccaagtg ttctcattgt tcaatcccca cctatgagtg 480 agaacatgcc atgtttggtt ttttgtcctt gcgatagttt gctgagaatg atggtttcca 540 gcttcatcca tgtccctaca aaggacatga actcatcctt ttttatggct acatagtatt 600 ccatggtgta tatgtgccac attttcttaa tccagtctat catcgatgga catttgggtt 660 ggttccaagt ctttgctatt gtgactagtg ttgcaataaa tatacgtgtg gatgtgtctt 720 tatagcagtt tgatttataa tcctttgggt atatacccag taacgggatg gctgggtcaa 780 atggtatttc tagttctaga tccttgagga atcgccacac tgacttccac aatggttgaa 840 ctagttaaca gtcccaccaa cagtgtgaaa gtgttcctat ttctccacat cctctccagc 900 accccatttt gactttgcta taagggaact ttagcatctg aacgtgcgga cagcttcatt 960 gctggcttgt tacgtaacag tgttttgtga ccatctcatg tcatacccac acatcgaaac 1020 cagcagttta aatggccagc tgtttgcttg tgaaaactcc cctcggctgg ct 1072 <210> SEQ ID NO 400 <211> LENGTH: 948 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 400 aaattttctt tgctgaagtg tcttttcaaa tttttgcctt ttaaaaaaat tgagttgtct 60 taatattgag tcgtaaggtt ctttatatat tctggctata tgtcctttgt cagatatatg 120 tcttgcaaat attttctccc agtctgtggc ttaccttttc catttttaaa ctgtgtttta 180 taaaaaaaag aagttttttt agatcaaagt ccattttaat cattttttct tttatagttc 240 atgctttttg tgtctcattt aagaaatctt tccctactcc aatgtcacaa atatattctc 300 tgagaagctt aacagttttt gcaactaaat ttaggtctat gatccgtttt gacttaattt 360 ttccatatgg tgtcatgtaa cagttgagat ttttttccta tgcaggcaga tattcaatgg 420 ttcaagtacc atttattgaa atggctatct tttctccact gaatgacctt ggcactttta 480 tcaaacatca actggccaca yacaggtgag tctacttctg gacacttacc ctgttccatt 540 catctgtata tctctatcct tacaccaaca cgcatagtct tgaatactag ggcaagttaa 600 ttttaagatg tctcctggat atgtaaaaat tatatctgag ttgaactaca gtttatttat 660 atatccaggc agcaaataaa tgtgagaatc tggaggtgag ggaagagatc agagatacca 720 ccttggaaac catcaattta gagatgattc ttaaggcagg ggactaaggg acactctgta 780 ggacacagac atagagaagg gaaggggctg cggcctgaac accccacctg catgctcact 840 cacatacttt cgtcggcctg tgttaacgaa gtgctgggtc tccccagcct ctctcatctg 900 taagcagtgc caacaacgtc caacacagtt ccatccaatt tggatctg 948 <210> SEQ ID NO 401 <211> LENGTH: 920 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 401 aatttttgcc ttttaaaaaa attgagttgt cttaatattg agtcgtaagg ttctttatat 60 attctggcta tatgtccttt gtcagatata tgtcttgcaa atattttctc ccagtctgtg 120 gcttaccttt tccattttta aactgtgttt tataaaaaaa agaagttttt ttagatcaaa 180 gtccatttta atcatttttt cttttatagt tcatgctttt tgtgtctcat ttaagaaatc 240 tttccctact ccaatgtcac aaatatattc tctgagaagc ttaacagttt ttgcaactaa 300 atttaggtct atgatccgtt ttgacttaat ttttccatat ggtgtcatgt aacagttgag 360 atttttttcc tatgcaggca gatattcaat ggttcaagta ccatttattg aaatggctat 420 cttttctcca ctgaatgacc ttggcacttt tatcaaacat caactggcca cacacaggtg 480 agtctacttc tggacactta ycctgttcca ttcatctgta tatctctatc cttacaccaa 540 cacgcatagt cttgaatact agggcaagtt aattttaaga tgtctcctgg atatgtaaaa 600 attatatctg agttgaacta cagtttattt atatatccag gcagcaaata aatgtgagaa 660 tctggaggtg agggaagaga tcagagatac caccttggaa accatcaatt tagagatgat 720 tcttaaggca ggggactaag ggacactctg taggacacag acatagagaa gggaaggggc 780 tgcggcctga acaccccacc tgcatgctca ctcacatact ttcgtcggcc tgtgttaacg 840 aagtgctggg tctccccagc ctctctcatc tgtaagcagt gccaacaacg tccaacacag 900 ttccatccaa tttggatctg 920 <210> SEQ ID NO 402 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 402 tgtgctgctt ccattccata ggcacctgat cctaagtgtt aaccaatccc agaactctcc 60 ccttatttct tgctgcatgt tttgaattga tgtgataaac aatgtgattc gagcgtctta 120 actcagccta tgagcctctc tattctgtga ctgctggaat aggctgcttg gccatgttct 180 tggaagctac caccatatca rggtaatttc ccacacaaca ttccagcccc tgctttcccc 240 tctggcctta tctagggcca ttccccaact caggtgaatg cagactccaa atgtactgag 300 ctgtgtgcag gggccaggtg caaatgcttt ctgtgcatct gcacatgctg ttctacctgg 360 gaagtccttt cctcctttca cctattttta ccttaaacct cagacatcat ctaccctgga 420 aagtccttcc tgacctcacg catctaagta ggtccccccc ataatcccta tccatgcctt 480 ctatagtact taacatggtg acctttaatt gttcatttac ttagctctct gctctcccac 540 actgtgaact ccttacaaac agggaatgtc atctctgaat gaatctttca tctccatgta 600 acacatgcct ccaaccctac ctagcacaca atctggcata taacaggcac tcaataaacc 660 ttcaatgaat gccttgatca agtacaagga acataagcaa a 701 <210> SEQ ID NO 403 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 403 ttaaccaatc ccagaactct ccccttattt cttgctgcat gttttgaatt gatgtgataa 60 acaatgtgat tcgagcgtct taactcagcc tatgagcctc tctattctgt gactgctgga 120 ataggctgct tggccatgtt cttggaagct accaccatat cagggtaatt tcccacacaa 180 cattccagcc cctgctttcc yctctggcct tatctagggc cattccccaa ctcaggtgaa 240 tgcagactcc aaatgtactg agctgtgtgc aggggccagg tgcaaatgct ttctgtgcat 300 ctgcacatgc tgttctacct gggaagtcct ttcctccttt cacctatttt taccttaaac 360 ctcagacatc atctaccctg gaaagtcctt cctgacctca cgcatctaag taggtccccc 420 ccataatccc tatccatgcc ttctatagta cttaacatgg tgacctttaa ttgttcattt 480

acttagctct ctgctctccc acactgtgaa ctccttacaa acagggaatg tcatctctga 540 atgaatcttt catctccatg taacacatgc ctccaaccct acctagcaca caatctggca 600 tataacaggc actcaataaa ccttcaatga atgccttgat caagtacaag gaacataagc 660 aaatttcctg tggaaaaaaa gaattgtatt aagttctttg g 701 <210> SEQ ID NO 404 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 404 atgttcactt acacatcttt ctttcactta attgaatcct ttatttttgt cttagaatct 60 tctgaatatt gaaaacagag aactatactg gaagaacata gtgtattaag actcatggag 120 agggagatgt gatactgtgt cactgaggtc gttccagtca taggagaaat gttaccactg 180 gattgaggtc tggtacattt taaaagatga tttaattcta tgatatgtgt tcaacttgca 240 ctaggatagt ttttactttc acctttgttc catgcaccgc gcaaatacct gggaaccctt 300 rttgcccaac tcaagagcca gagtcctctg tcatcatttt gcctctctcc taagtgacag 360 gactgagtgc agacttggtg tttgtgggtg aggcatgtgg actgacaggc aggcttcagt 420 ttatttagcg agtgtgagcc ctggcaggaa gattctcttt ctctgcttgc caggttgagg 480 aggcctcatt aagcagtttg aacttgtggt tttggcgtgt ctagtcctgg tgcaggtggc 540 ttggtatcct cacaggcatt tctttggcct cacccttggg gtgactgttc acttgtgttt 600 g 601 <210> SEQ ID NO 405 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 405 tcttctgaat attgaaaaca gagaactata ctggaagaac atagtgtatt aagactcatg 60 gagagggaga tgtgatactg tgtcactgag gtcgttccag tcataggaga aatgttacca 120 ctggattgag gtctggtaca ttttaaaaga tgatttaatt ctatgatatg tgttcaactt 180 gcactaggat agtttttact ttcacctttg ttccatgcac cgcgcaaata cctgggaacc 240 cttgttgccc aactcaagag ccagagtcct ctgtcatcat tttgcctctc tcctaagtga 300 saggactgag tgcagacttg gtgtttgtgg gtgaggcatg tggactgaca ggcaggcttc 360 agtttattta gcgagtgtga gccctggcag gaagattctc tttctctgct tgccaggttg 420 aggaggcctc attaagcagt ttgaacttgt ggttttggcg tgtctagtcc tggtgcaggt 480 ggcttggtat cctcacaggc atttctttgg cctcaccctt ggggtgactg ttcacttgtg 540 tttgagcggc tgggactcag taggttcact ggagtaggta tttctttaga gccactggcg 600 g 601 <210> SEQ ID NO 406 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 406 cagctccttg gcaagcctgc tccttcccca gcaaatggaa acaccattct gaacacctgg 60 gcattgtctc tgatgtccct tttcatctcc ctactctcac acaatccagc tgcctctctg 120 ccttccacgg atattaagaa cgtccaccat ctcctgagtc caagcccttc tcactcacct 180 ctttcttgaa ctaatttctt yctgtttttt tccagtcctc ccttctgttc atgtctctcc 240 tctgcacact tccattttct ggttcagaaa atgtcaccgt cccagtcaca cttgccttat 300 ggctgttgtg tcataaatac agttgacact tgaacaacat gggtttgaac tgcatggatt 360 cacttataca catatttttt caatacaaat atatttaaaa attttggaga tttgcaacaa 420 tttgaaaaaa cttgcagatg aacagcatag catagaaata ttgaaaaatt aagaaaaagg 480 tatgtcatga atgcataaaa catatgcaga tactagtcta ttttaacctt tactgccata 540 aaatatacac aaatctatta taaaaggtta aagtttatca aagcttatgc acacaaacac 600 ttatagacca tatagggagc cattcagtag agagaaatgt aagcgaacgt aaaggtgtgc 660 tatttaatca caactgcata cacactgtac cactgcacta a 701 <210> SEQ ID NO 407 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 407 gggcattgtc tctgatgtcc cttttcatct ccctactctc acacaatcca gctgcctctc 60 tgccttccac ggatattaag aacgtccacc atctcctgag tccaagccct tctcactcac 120 ctctttcttg aactaatttc tttctgtttt tttccagtcc tcccttctgt tcatgtctct 180 cctctgcaca cttccatttt stggttcaga aaatgtcacc gtcccagtca cacttgcctt 240 atggctgttg tgtcataaat acagttgaca cttgaacaac atgggtttga actgcatgga 300 ttcacttata cacatatttt ttcaatacaa atatatttaa aaattttgga gatttgcaac 360 aatttgaaaa aacttgcaga tgaacagcat agcatagaaa tattgaaaaa ttaagaaaaa 420 ggtatgtcat gaatgcataa aacatatgca gatactagtc tattttaacc tttactgcca 480 taaaatatac acaaatctat tataaaaggt taaagtttat caaagcttat gcacacaaac 540 acttatagac catataggga gccattcagt agagagaaat gtaagcgaac gtaaaggtgt 600 gctatttaat cacaactgca tacacactgt accactgcac taatttcaga gccacctcct 660 gttgtgattg tggtgagccc aagtgttgtg aggatctgct t 701 <210> SEQ ID NO 408 <211> LENGTH: 501 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 408 caggtagggt aagcaaatga acacaaattc aaactcggaa ttcaaaacca gcctctgtgt 60 attcctgagg accatactgt ctgctaagtg tagagaaagg cacatcctgg ttcaacagca 120 gagaaagcaa acaggaggca ctttctgtga gtcatctcca ccacagggcc ctctcttttg 180 tgatccagcg atacttgttc acagtcaaag cccaggaaga gtggaaagat taacctttgt 240 gagccaaacc rtgtgacact tgattacttg acagaactaa tccttctgtc ctgatgacag 300 aaattcaact acacaggtac atgcaagcta atatctgttg taatgcctcc cagtttctct 360 ggagaattcc ttagtttcct ggacatctct gaaatgcaaa gttttggcaa cgagtctctg 420 aattaacctc tgaaaatctc acccagccaa gatggccttc ttgagaagac tgaagaacat 480 ggttggtttc aggctgagct g 501 <210> SEQ ID NO 409 <211> LENGTH: 604 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 409 cactttctgt gagtcatctc caccacaggg ccctctcttt tgtgatccag cgatacttgt 60 tcacagtcaa agcccaggaa gagtggaaag attaaccttt gtgagccaaa ccgtgtgaca 120 cttgattact tgacagaact aatccttctg tcctgatgac agaamttcaa ctacacaggt 180 acatgcaagc taatatctgt tgtaatgcct cccagtttct ctggagaatt ccttagtttc 240 ctggacatct ctgaaatgca aagttttggc aacgagtctc tgaattaacc tctgaaaatc 300 tcacccagcc aagatggcct tcttgagaag actgaagaac atggttggtt tcaggctgag 360 ctggaagtgg tttacctccc aggagaggtt ccccacagtg gtgtttaagg catggggtgg 420 accaacacca ggaagactca gacatcacac cacccacctt caactcagtc acatccacct 480 acattttctg aaaacaaaag gcagtctccc caaaaagcac tgagactctt gtgtaggtaa 540 tctgagcaga caccaacttc ccagggcttc cttttatcca ggagagcttg gctgttcttt 600 ttaa 604 <210> SEQ ID NO 410 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 410 ctccttccgc catggttgta agtttcctga cgcctcccag tcatgcttcc cgtacagcct 60 gcagaactgc gagtcaatga aatccctttt ctccacaaat tacccagtct caggtagttc 120 cttacagcag cgtgggaaca gactcaagag ctgaagcaag caaggccgtt agcaaggagc 180 gggctgggga gagcactcca ggcagaggga acagccaggg ccagggcctt gagacagacg 240 tgagccagga tatctgagga acagcagaga agccagtgtg gccgcagcta aatgaggaac 300 aatgtgtgag ttccctgggg cggccaaaac aaacaccacg gacgggggcc ttcaaccaca 360 gacaccgatt tcctcacagc tctggaggcg aaaagtccaa gaaaactgca cggagtatct 420 atgaggccct gatggagacc tgacctggtc cacacccatg gcctggcaag ctagatgggg 480 tgaattttca cctgccacag ycgcaagtca aagccaccgg cttctctctt ctccctccca 540 ttgctcctga cagccagggt taatattttg cctcatgtaa acagggaggc atccacccga 600 gaatctcccc tcagcccaca taagctctgc agagagggct gtgttgctcc agttcccacc 660 tggacatgag cactttgaag ggcagcttcc ctcccggggt c 701 <210> SEQ ID NO 411 <211> LENGTH: 612 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 411 gggctgggga gagcactcca ggcagaggga acagccaggg ccagggcctt gagacagacg 60 tgagccagga tatctgagga acagcagaga agccagtgtg gccgcagcta aatgaggaac 120 aatgtgtgag ttccctgggg cggccaaaac aaacaccacg gacgggggcc ttcaaccaca 180 gacaccgatt tcctcacagc tctggaggcg aaaagtccaa gaaaactgca cggagtatct 240 atgaggccct gatggagacc tgacctggtc cacacccatg gcctggcaag ctagatgggg 300 tgaattttca cctgccacag tcgcaagtca aagccaccgg cttctctctt ctccctccca 360 ttgctcctga cagccagggt taatattttg cctcatgtaa acagggaggc ayccacccga 420 gaatctcccc tcagcccaca taagctctgc agagagggct gtgttgctcc agttcccacc 480 tggacatgag cactttgaag ggcagcttcc ctcccggggt ctggctgagc tcagggtagg 540 cgtcagtctg catggattgg atggaggaag gctgtgcgtg gcaggagatg acactgccct 600 tgggctgtgt gg 612

<210> SEQ ID NO 412 <211> LENGTH: 1001 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 412 ttggggaagg aagcactggg gggaaggaag cactgggctt gggacagggc tgggcgctgc 60 ctcttcactg gaccatgaca aggttgttac ctcaccaagg agaggtgcaa aaagcttagg 120 ggcttggatt tctagatttc agtgccaact atgccactta ctggctttat ccttggggaa 180 tttatctact ctgtgaccct cagttttttt atcttaatta ttaatacata cctcataatg 240 tgactgtgag gattcactta ataatatatg gaaaaccata gaatagtgcc cagcatctag 300 gaagtgccac agcccccttc agaagctagt gaaacctgca gaccactttt cagagtgata 360 ttattatttt tttctaggtt tactgagtta taattgaaaa aataaaaatg gaatatagat 420 gtacaacatg aagctctgat gcatatatcc attgtgaaat gatgaccaca atcaagctaa 480 ttaatgttat ctatcacttc wcatagttca accttttttt gtggtgagag tactgaagat 540 ctactctctt agcaattttc aaatctaaaa tacattatta ttaacacagt cactgtgccg 600 tacgttagct ctgaggacct tattcatttt atacctaaaa gtctgtatcc tttaaccaac 660 ctctcctaat ttcccactgt catccctact gccacctctg gtaaccagcc ttctgctctg 720 tttctgagtc caaccttctt agattccaca tatgagtgag atcatgctgt gcagtgtttg 780 tttttctgtg tctggcttgc tttcacttag cataatgtcc tccaggtcca cccatgttgt 840 tgcaaatggc agaatcttct tcttgttaaa gactgaataa tatccctgtg tgtgcgtgca 900 tgtgtgtgtg tgtttgtgtg tgtgtgtgta tcacattttc ttcatccatt catccatcaa 960 tggacactaa gcactaaggt tgattccgta tcttggctat t 1001 <210> SEQ ID NO 413 <211> LENGTH: 2480 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 413 aacattactt ggggaaggaa gcactggggg gaaggaagca ctgggcttgg gacagggctg 60 ggcgctgcct cttcactgga ccatgacaag gttgttacct caccaaggag aggtgcaaaa 120 agcttagggg cttggatttc tagatttcag tgccaactat gccacttact ggctttatcc 180 ttggggaatt tatctactct gtgaccctca gtttttttat cttaattatt aatacatacc 240 tcataatgtg actgtgagga ttcacttaat aatatatgga aaaccataga atagtgccca 300 gcatctagga agtgccacag cccccttcag aagctagtga aacctgcaga ccacttttca 360 gagtgatatt attatttttt tctaggttta ctgagttata attgaaaaaa taaaaatgga 420 atatagatgt acaacatgaa gctctgatgc atatatccat tgtgaaatga tgaccacaat 480 caagctaatt aatgttatct atcacttcac atagttcaac ctttttttgt ggtgagagta 540 ctgaagatct actctcttag caattttcaa atctaaaata cattattatt aacacagtca 600 ctgtgccrta cgttagctct gaggacctta ttcattttat acctaaaagt ctgtatcctt 660 taaccaacct ctcctaattt cccactgtca tccctactgc cacctctggt aaccagcctt 720 ctgctctgtt tctgagtcca accttcttag attccacata tgagtgagat catgctgtgc 780 agtgtttgtt tttctgtgtc tggcttgctt tcacttagca taatgtcctc caggtccacc 840 catgttgttg caaatggcag aatcttcttc ttgttaaaga ctgaataata tccctgtgtg 900 tgcgtgcatg tgtgtgtgtg tttgtgtgtg tgtgtgtatc acattttctt catccattca 960 tccatcaatg gacactaagc actaaggttg attccgtatc ttggctattg tgaataatgc 1020 tgcaataaac atatgagtcc agatacctct tcaagatact gatttcattt cctttaaata 1080 tatgcccaga agtgggattg ctggatcata tggtagttct atatttagta tcttgaggaa 1140 tttccatact gtttttcata atgattgtag caatctatat tcccatcaac agtgtacaag 1200 ggttccattt tctacatggc cttaccaacg tttgttatca cttatctttt tgataataga 1260 tattctagca ggtgtgaggt ggtatctcat tgtggtttta atttgcattt tcctgatgat 1320 tagtggtgta gagcatcttt tcatattccc attggtaatt cgtatatctt cctttgagaa 1380 atatttattc agatcttttg cccattgtta gctgagttat atgtgagttg gttttggttt 1440 gttgttgttt tttgtttttg ctattgagct gagttccttg tatattttgg atattaaatc 1500 cttctcagct gtatggttga cagatacatt cttgcattct gtaagttgca tctgtaggtt 1560 gcaacagagt ctctttactc tgttgattgc ttgctttact gtgtgaaagc ttttttagct 1620 tgatgtaatt gtgtttgtct atttttgctt ttgttgcttg tacttttagt gtcatatcca 1680 aaaagttatt gcccagacca gtgtcatccc ctatgttttc ttctagtaat tttaaagttt 1740 caggtcttat gtctatgtct ttaatccatt ttgagttaat ttttgtgtag ggtttaagat 1800 aagaatccaa ttttattttt attttttgta tatggatatc caatttcccc aacaccattt 1860 attgaaaatt ctatcctttc tttgttgtgt attaacatca gaataatatt tttaaataca 1920 taaaattcag aagatgacaa aggaaaccaa ttacattgaa atgcatacag agttataatt 1980 ctgaaagagc aatatatgtg cctctttgta aacacatcat atatcaaact gcagtgaccg 2040 ttctaacaac tattgcaatt tcaaagtcat gttgagtagg aggagtactt tgagattctg 2100 aaacaacgtt cttgtgctat gaaatatcca tgattttgat tggtgatggt atcccaggtc 2160 ttgttaatgc tgctgtaatc tgttgcttcc attccatagt tgaataaaat gcttgatatc 2220 tgttggaaat tagtaaaaat aaaaacgtat ttttttccat ccaagttcat tctcagaccc 2280 tgaagagtca cttctctgga ttctgcagca aagttcccag ctggggcagc aagatttagg 2340 caattgaaaa gaacatacac cttgttctca gtggcaaacc acatggaaag ctttaaatgt 2400 cagagaagaa ttctgccatt ttgctgactt ttttgtagtt ctcctaataa acaagtgtta 2460 agtgacaagc ttttcagagg 2480 <210> SEQ ID NO 414 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 414 cccccccccc ccccgcagat ctcaggtggg catttttgaa cttaactaga taacaaaaca 60 cagctaagac aagtcctttt ctccagcaaa gatggcaatg ctctaataac tctgagcata 120 ttaaagattc tccaagactc tagcctctgc tgcaaaaaca catacaaata cctactacta 180 ctgctgctgt gatgatgatg atgacagcaa tagtgagaat attttaaata tgccaggcac 240 ggtggcaact gctttccaaa tattatcata tttaatctga tcattgccct atgaggtagg 300 ragtattctg attcccattt tataaataag gaacccgagg cttagagagc atcggtgact 360 tgttcaaggt cacccacagc tgtcaagtga cagaacttcg ataaaaatcc agactccttt 420 aatggagtat ggagggaggt cagaaaacat aggaagtaag ggattgtgat tgacaatgtg 480 tccttgcaaa gggacaggtt aagagacaca agggcagctg tctgaggtgt gccattcacc 540 agcttcagga gagaagtggc aggctacctc cagctatcca gccctatcca gccaaggaag 600 c 601 <210> SEQ ID NO 415 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 415 caaaacacag ctaagacaag tccttttctc cagcaaagat ggcaatgctc taataactct 60 gagcatatta aagattctcc aagactctag cctctgctgc aaaaacacat acaaatacct 120 actactactg ctgctgtgat gatgatgatg acagcaatag tgagaatatt ttaaatatgc 180 caggcacggt ggcaactgct ttccaaatat tatcatattt aatctgatca ttgccctatg 240 aggtagggag tattctgatt cccattttat aaataaggaa cccgaggctt agagagcatc 300 rgtgacttgt tcaaggtcac ccacagctgt caagtgacag aacttcgata aaaatccaga 360 ctcctttaat ggagtatgga gggaggtcag aaaacatagg aagtaaggga ttgtgattga 420 caatgtgtcc ttgcaaaggg acaggttaag agacacaagg gcagctgtct gaggtgtgcc 480 attcaccagc ttcaggagag aagtggcagg ctacctccag ctatccagcc ctatccagcc 540 aaggaagctt gggagacatg ttagttcccg ccttcatttc catcagcaac ctcaaagcca 600 c 601 <210> SEQ ID NO 416 <211> LENGTH: 5823 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 416 tatttcaggc tttcttcttt ctatggataa gaaagctcct caggtggcaa caaaggccat 60 ttctttggaa gcaggcatgg catgtgacga aaaaaagaca tctcagaaaa gagccaagaa 120 taagactgga gagccactgt cagagaacag aaactgggct taatcaagga acatctcttg 180 ttcccagagt aggaggctgg caatattttc tcactgaaat ttcagaattg ttatggacca 240 gtgactgctc tatgtgttca atttgttccc ttttcaaatg gaagcattta ttgcagacga 300 cctgcctctg tcccaccatt gtgtattagg tttgtagagy gtagacaact tgccttttta 360 gtttgtaggt ttctgtatca agagaagatg tgtgtgggcc taacctagat tacaggatcc 420 tggacttcaa gtctgatata atgactggat gagactttga ctgtcctaga attgggatga 480 acatattttg ccggtgggag ggcgtgagta attgcggtta gagggcagac tgtccctcac 540 acctattcct tttcatggtg ccttcccaaa ctgcctctgg aggtggccac acaaatggct 600 ttggccattg tgaccatggg aaacttgatg cagaggctgg aaaaagcact tgcatgtttc 660 tgtctcctct cttgttcctc tacaatcaca agaaatgtct aggcaggtct gagcaggccc 720 aggctcatct gccatggaag aagaatggca catggaagag ggtcacattg tcccaaccaa 780 gacgatccta gaccagccag gccccagttc atggttcaag acacatgaac atagttgcac 840 gaaccaagat tagttgtgta tggcccagac tagcagcagc acccatccaa cctacagact 900 ctgagaaata aatactagtt gtcttaagct tccaagtttc agtgtgagca ttaggtagta 960 acagttaatg aataagacag ataatcattt tatctgtctg gatacttata caatgatttc 1020 tattttttat tgatacataa tattttacat attgctgggg tacatgtgac attttgctac 1080 atacatagaa tgtgtaatga tccagtcagg atatctgagg tgtccatcac tttgagaatt 1140 tctcacttct gtgtgttggg aacaattcaa gtcgtctctt ctagttattt taaaatatac 1200 aatacattgt taactgtagt cttttttatt gaatgacagg acttgtacct tttatctaac 1260 tgtatgtttg tatctattaa gctagttctc tttatccctg ccccctccta cccactcact 1320 cttcccaacc tctaacatgt atcatcctat tctatatctc catgagatca acttctttag 1380 ctcccacata tgagcaaaaa catatgatgt ttgtctttct gtgcccggtt tatttcactt 1440 atgacctcca tttccatcca tgttactata aatgacagga tttcattctt tttgtggcca 1500

aacagtattt cattgtgtat atatactaca ttttctttat ccattcatcc attgatgaac 1560 acttacgttg attccatatc tttgctattg tgaatggtgc tgcaataaac atgcacgtgc 1620 agttatccct ttgatacact gatttatttt cctttggata aatacccagt agtgagattg 1680 ctggatcata cggtagttct acttttagtt tttgagacat ttccatactt ttccagtgtt 1740 tgtattaatt tacattccca tcaacaatgt ataagatttc cctttcctcc acatcctcac 1800 cagcatctgc tattttttgt ctttttaata atagtcattc taactggggt gagaggatat 1860 ctcgctatgg ttttgatttg catttccctg atatttaatg atattgagca tttcttcata 1920 taacctattg gccatttgtg tgtctttttt tttttttttt ttttttttga gaattgtcta 1980 ctcatttttg gctttttaaa agatttattt tttgttgttg ttgagtttag tgcatatcct 2040 ggatattagt ctcttatctg atgaagagtt tgccaatatt ttctcccatt caacaggttg 2100 tctcttcatt ctgttgactg tttcctttgc tgtgcagaag cactttatat acagtcccat 2160 ttgtctattt tttagtagtc tatgcattta aggtctcagc cacaaaatct ttgcctagac 2220 cagtcctaaa gtgtttcccc tatattttct tctagtagtt ttattgtttc atgtcttata 2280 tttaagtcta taatccattg tgagttgatt tttgtatatg gtgagatagg ggccttgttt 2340 cattcctctg catatagata tttaattttc tcagcaccat ttattgaagg tgtccttccc 2400 tattgtatgt tcttggtgcc tttgtcaaaa ttcagttggc tataaatatg tgaatttatt 2460 tctgggttct ctatgtggtt ccattagtct atgtgtctat ttttatacca atatcatgct 2520 gttttgatta ccatagcctt gtaatatatt ttgaagtcag gtagtgtgat gcctccagct 2580 ttgttctttt tgctcaggat tgctgtgcat actctggctt tttggttaca tacaaatttc 2640 aggatttttg tatttctgtg aaaaatggca ttagtatttt gataggaatt gcactggatc 2700 tgtatattgt cctggacaac atggtcattt taacaatatt aattcttcta atctatgagt 2760 atgagacgtc ttcccacttg tttgtgtcct cttcaatttc tttcattggt gtttcataat 2820 ctcccttcta caggcctttc acctccttgg ttaaattaat tcctaggtat ttttttgtag 2880 ctactgtaaa tgggactgcc ttctttctca gctagttcat ttttggtgca tagaaaccct 2940 atttttgtat gttcattttc tatcctgcaa cattaccaaa tttgcttatc agctttaagt 3000 gtgtattttg ctttgcttgt agagtcttct ggtttctcta aatgtaagac gatgtcatct 3060 gcaaacgggg acaatttgac ttcctcttaa aaatctgtat gccttttatt cctttctctt 3120 gcctgattgc tctggctcta cctccagtac tatactgaat aaaagtggta aaagtgagca 3180 tccttccttg tcttgctcta gttcttagag gaaatacttt cagtttttcc ccactcagta 3240 tgatgttagc tgtgggtcat atatagcctt tattatgtta agatatgttt cttctgtacc 3300 tggtttgttg acagcttttt atcataaaag gatgtagaat tttatcaaat gttttttctg 3360 catctgttga gataatcata tggtttttgt cattccttct actgttgtga tgtatcatgt 3420 ttattgattt gtgtatgtta aaccatcctt gtgtccttgg tataaattat acttggtcat 3480 ggtgtattat ctttttggca tcctgtcgaa ttgtttgcta gctttttgtt ttgttctttt 3540 tgagaatttt tatgtctagg ttccttagaa acactggcct gtagttctct ttttgtgtgt 3600 gtgtccttgt ctagtttggt gtcagggaaa tggtggtctt gtagaatgag ttgttttttc 3660 tttgattttt ttgcaagagt ttgaggagaa tgggtattag ttcttcttta tgtggttggt 3720 caaattggca gtgaattcat tcagtcatga gcttttcttt ttttgggagg gttctcatta 3780 ctgagttaat cacactgctc attactgatc tgttcagatt ttctatttct tctggaatct 3840 cagtagttgt atgtttccag caatttatcc atttcctcta ggttttctag tttggtagta 3900 tatagctatt cataatagtc tctgatgatc ttttgtattt ctgtgatatc agttgtaatg 3960 tctttttcat ttcctatttt atttgggtct tttcttgttt agtctagcaa ggggtttatc 4020 tattttatct ttttgaagaa ccaacttttt gtttcattga ccctttctac gtctttagtc 4080 tttatttcat ttagatttgc tctgaacttt actatgtctt tccttctaat tttgggtttg 4140 gtttgttctt ttctagttcc ttgaggtgca tcattgaatt gtttctttga tatctatcta 4200 ctcatttgat gtaggtgttt attgctatac actctcccct cctagagctc cttttgttgt 4260 gtcccatagg tcttggtatg ttgtttctat tttcatttgt ttcaaacatt ttatttccat 4320 attaattttt atcattcagg aggagcatat tatttaattc ccatgtattt gtatagtttc 4380 caaagttcct cttatttcta tttttactcc attgtggtct gagaagatac ttcatatgat 4440 ttcaattttt aaaaatttgt caagacttgt tttttgtcct aacatatggt ctatcctgga 4500 gaatgttcca tgtgctgatg agaaaaatgt gtactcagca gttgttgagt aacatgttct 4560 acaaatatct gttagatcca tttggtctaa agtctagttt aaatccaatg agtttttgtt 4620 aattttgtct agatgatcat gatctgagac tgaggtgaag tccccaacaa ttatcgtgtt 4680 ggagtctacc tctcttttta aatctagaaa tatttgcttt ataaatccgg gtggtctagt 4740 gttgggtgca tatatttagt tgttatttcc tcattagatt gatctcttta ctattatata 4800 ataactgttt actgcttctg gcataaagtc tgttttatgt aagtacagcc attcctgctt 4860 gagtttagta ccatgttgac aaagggatgc atagagagtt ggtaaagcat gatttctggg 4920 tgtctgtgtg aaggtgtttt gagaagagtt tagcatgagt ctgtggagtg agtgggaaga 4980 ttctccctca atgtcagcag gaaccatcca tccactgggg gcccaggtag aaaaagatga 5040 agaaatggtg aattctctct ctctcctgga gctgggtcac ccttcttctg cccttgaaca 5100 ggacatcaca actccaggct ctccagcctt tggactccaa gactgacacc agtgcccctc 5160 cccaattacc ccaggccctc aggcctttgg cctaggattg agacttacac catcagcttc 5220 cctggttctg aggcttctgg acttgcactg ggccatacta ccagcatccc agggtctcca 5280 gcttgcagag agcctgttgt gggacttttc agcctccata atcaagtaag ccaatttccc 5340 tggtatctat atagatatac aatcatgttt tgcttaccag cctgaaaaat gtatcgctag 5400 atgagtctgt cattgcataa acatcatagt gtacttacac aaacctagat tctatagcct 5460 actacacacc tagtctataa acatgtacag catgttactg tactgaatat tgtaggcaac 5520 tgtaacacaa tggtgaatat ttgcatattt aaacatatct tatcattaaa aagatacagt 5580 aaacataagg tataaaagac aaaaaccggc acacctatat agggcactta ccataaatgc 5640 agcttgcagg actagaagtc actcagggtg agtcagtgag cgaacgtgaa ggcctaggtt 5700 attactgtcc actacggtag actttatcaa cactgtacac aggctacact aaatttattt 5760 tttaaaaatt tgctctccaa taataaatta atcttcgcat cctttttttg ttgttcactg 5820 tgg 5823 <210> SEQ ID NO 417 <211> LENGTH: 5823 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 417 tatttcaggc tttcttcttt ctatggataa gaaagctcct caggtggcaa caaaggccat 60 ttctttggaa gcaggcatgg catgtgacga aaaaaagaca tctcagaaaa gagccaagaa 120 taagactgga gagccactgt cagagaacag aaactgggct taatcaagga acatctcttg 180 ttcccagagt aggaggctgg caatattttc tcactgaaat ttcagaattg ttatggacca 240 gtgactgctc tatgtgttca atttgttccc ttttcaaatg gaagcattta ttgcagacga 300 cctgcctctg tcccaccatt gtgtattagg tttgtagagt gtagacaact tgccttttta 360 gtttgtaggt ttctgtatca agagaagatg tgtgtrggcc taacctagat tacaggatcc 420 tggacttcaa gtctgatata atgactggat gagactttga ctgtcctaga attgggatga 480 acatattttg ccggtgggag ggcgtgagta attgcggtta gagggcagac tgtccctcac 540 acctattcct tttcatggtg ccttcccaaa ctgcctctgg aggtggccac acaaatggct 600 ttggccattg tgaccatggg aaacttgatg cagaggctgg aaaaagcact tgcatgtttc 660 tgtctcctct cttgttcctc tacaatcaca agaaatgtct aggcaggtct gagcaggccc 720 aggctcatct gccatggaag aagaatggca catggaagag ggtcacattg tcccaaccaa 780 gacgatccta gaccagccag gccccagttc atggttcaag acacatgaac atagttgcac 840 gaaccaagat tagttgtgta tggcccagac tagcagcagc acccatccaa cctacagact 900 ctgagaaata aatactagtt gtcttaagct tccaagtttc agtgtgagca ttaggtagta 960 acagttaatg aataagacag ataatcattt tatctgtctg gatacttata caatgatttc 1020 tattttttat tgatacataa tattttacat attgctgggg tacatgtgac attttgctac 1080 atacatagaa tgtgtaatga tccagtcagg atatctgagg tgtccatcac tttgagaatt 1140 tctcacttct gtgtgttggg aacaattcaa gtcgtctctt ctagttattt taaaatatac 1200 aatacattgt taactgtagt cttttttatt gaatgacagg acttgtacct tttatctaac 1260 tgtatgtttg tatctattaa gctagttctc tttatccctg ccccctccta cccactcact 1320 cttcccaacc tctaacatgt atcatcctat tctatatctc catgagatca acttctttag 1380 ctcccacata tgagcaaaaa catatgatgt ttgtctttct gtgcccggtt tatttcactt 1440 atgacctcca tttccatcca tgttactata aatgacagga tttcattctt tttgtggcca 1500 aacagtattt cattgtgtat atatactaca ttttctttat ccattcatcc attgatgaac 1560 acttacgttg attccatatc tttgctattg tgaatggtgc tgcaataaac atgcacgtgc 1620 agttatccct ttgatacact gatttatttt cctttggata aatacccagt agtgagattg 1680 ctggatcata cggtagttct acttttagtt tttgagacat ttccatactt ttccagtgtt 1740 tgtattaatt tacattccca tcaacaatgt ataagatttc cctttcctcc acatcctcac 1800 cagcatctgc tattttttgt ctttttaata atagtcattc taactggggt gagaggatat 1860 ctcgctatgg ttttgatttg catttccctg atatttaatg atattgagca tttcttcata 1920 taacctattg gccatttgtg tgtctttttt tttttttttt ttttttttga gaattgtcta 1980 ctcatttttg gctttttaaa agatttattt tttgttgttg ttgagtttag tgcatatcct 2040 ggatattagt ctcttatctg atgaagagtt tgccaatatt ttctcccatt caacaggttg 2100 tctcttcatt ctgttgactg tttcctttgc tgtgcagaag cactttatat acagtcccat 2160 ttgtctattt tttagtagtc tatgcattta aggtctcagc cacaaaatct ttgcctagac 2220 cagtcctaaa gtgtttcccc tatattttct tctagtagtt ttattgtttc atgtcttata 2280 tttaagtcta taatccattg tgagttgatt tttgtatatg gtgagatagg ggccttgttt 2340 cattcctctg catatagata tttaattttc tcagcaccat ttattgaagg tgtccttccc 2400 tattgtatgt tcttggtgcc tttgtcaaaa ttcagttggc tataaatatg tgaatttatt 2460 tctgggttct ctatgtggtt ccattagtct atgtgtctat ttttatacca atatcatgct 2520 gttttgatta ccatagcctt gtaatatatt ttgaagtcag gtagtgtgat gcctccagct 2580 ttgttctttt tgctcaggat tgctgtgcat actctggctt tttggttaca tacaaatttc 2640 aggatttttg tatttctgtg aaaaatggca ttagtatttt gataggaatt gcactggatc 2700 tgtatattgt cctggacaac atggtcattt taacaatatt aattcttcta atctatgagt 2760 atgagacgtc ttcccacttg tttgtgtcct cttcaatttc tttcattggt gtttcataat 2820 ctcccttcta caggcctttc acctccttgg ttaaattaat tcctaggtat ttttttgtag 2880

ctactgtaaa tgggactgcc ttctttctca gctagttcat ttttggtgca tagaaaccct 2940 atttttgtat gttcattttc tatcctgcaa cattaccaaa tttgcttatc agctttaagt 3000 gtgtattttg ctttgcttgt agagtcttct ggtttctcta aatgtaagac gatgtcatct 3060 gcaaacgggg acaatttgac ttcctcttaa aaatctgtat gccttttatt cctttctctt 3120 gcctgattgc tctggctcta cctccagtac tatactgaat aaaagtggta aaagtgagca 3180 tccttccttg tcttgctcta gttcttagag gaaatacttt cagtttttcc ccactcagta 3240 tgatgttagc tgtgggtcat atatagcctt tattatgtta agatatgttt cttctgtacc 3300 tggtttgttg acagcttttt atcataaaag gatgtagaat tttatcaaat gttttttctg 3360 catctgttga gataatcata tggtttttgt cattccttct actgttgtga tgtatcatgt 3420 ttattgattt gtgtatgtta aaccatcctt gtgtccttgg tataaattat acttggtcat 3480 ggtgtattat ctttttggca tcctgtcgaa ttgtttgcta gctttttgtt ttgttctttt 3540 tgagaatttt tatgtctagg ttccttagaa acactggcct gtagttctct ttttgtgtgt 3600 gtgtccttgt ctagtttggt gtcagggaaa tggtggtctt gtagaatgag ttgttttttc 3660 tttgattttt ttgcaagagt ttgaggagaa tgggtattag ttcttcttta tgtggttggt 3720 caaattggca gtgaattcat tcagtcatga gcttttcttt ttttgggagg gttctcatta 3780 ctgagttaat cacactgctc attactgatc tgttcagatt ttctatttct tctggaatct 3840 cagtagttgt atgtttccag caatttatcc atttcctcta ggttttctag tttggtagta 3900 tatagctatt cataatagtc tctgatgatc ttttgtattt ctgtgatatc agttgtaatg 3960 tctttttcat ttcctatttt atttgggtct tttcttgttt agtctagcaa ggggtttatc 4020 tattttatct ttttgaagaa ccaacttttt gtttcattga ccctttctac gtctttagtc 4080 tttatttcat ttagatttgc tctgaacttt actatgtctt tccttctaat tttgggtttg 4140 gtttgttctt ttctagttcc ttgaggtgca tcattgaatt gtttctttga tatctatcta 4200 ctcatttgat gtaggtgttt attgctatac actctcccct cctagagctc cttttgttgt 4260 gtcccatagg tcttggtatg ttgtttctat tttcatttgt ttcaaacatt ttatttccat 4320 attaattttt atcattcagg aggagcatat tatttaattc ccatgtattt gtatagtttc 4380 caaagttcct cttatttcta tttttactcc attgtggtct gagaagatac ttcatatgat 4440 ttcaattttt aaaaatttgt caagacttgt tttttgtcct aacatatggt ctatcctgga 4500 gaatgttcca tgtgctgatg agaaaaatgt gtactcagca gttgttgagt aacatgttct 4560 acaaatatct gttagatcca tttggtctaa agtctagttt aaatccaatg agtttttgtt 4620 aattttgtct agatgatcat gatctgagac tgaggtgaag tccccaacaa ttatcgtgtt 4680 ggagtctacc tctcttttta aatctagaaa tatttgcttt ataaatccgg gtggtctagt 4740 gttgggtgca tatatttagt tgttatttcc tcattagatt gatctcttta ctattatata 4800 ataactgttt actgcttctg gcataaagtc tgttttatgt aagtacagcc attcctgctt 4860 gagtttagta ccatgttgac aaagggatgc atagagagtt ggtaaagcat gatttctggg 4920 tgtctgtgtg aaggtgtttt gagaagagtt tagcatgagt ctgtggagtg agtgggaaga 4980 ttctccctca atgtcagcag gaaccatcca tccactgggg gcccaggtag aaaaagatga 5040 agaaatggtg aattctctct ctctcctgga gctgggtcac ccttcttctg cccttgaaca 5100 ggacatcaca actccaggct ctccagcctt tggactccaa gactgacacc agtgcccctc 5160 cccaattacc ccaggccctc aggcctttgg cctaggattg agacttacac catcagcttc 5220 cctggttctg aggcttctgg acttgcactg ggccatacta ccagcatccc agggtctcca 5280 gcttgcagag agcctgttgt gggacttttc agcctccata atcaagtaag ccaatttccc 5340 tggtatctat atagatatac aatcatgttt tgcttaccag cctgaaaaat gtatcgctag 5400 atgagtctgt cattgcataa acatcatagt gtacttacac aaacctagat tctatagcct 5460 actacacacc tagtctataa acatgtacag catgttactg tactgaatat tgtaggcaac 5520 tgtaacacaa tggtgaatat ttgcatattt aaacatatct tatcattaaa aagatacagt 5580 aaacataagg tataaaagac aaaaaccggc acacctatat agggcactta ccataaatgc 5640 agcttgcagg actagaagtc actcagggtg agtcagtgag cgaacgtgaa ggcctaggtt 5700 attactgtcc actacggtag actttatcaa cactgtacac aggctacact aaatttattt 5760 tttaaaaatt tgctctccaa taataaatta atcttcgcat cctttttttg ttgttcactg 5820 tgg 5823 <210> SEQ ID NO 418 <211> LENGTH: 707 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 418 aacggtgtca gctggagtga actcctgtgt gtgcaaggcc tgggtctcct ggtcagacta 60 ctttctatgg gaaaggcata gtgtatagtc tatatactat acataggggt gctgggagga 120 actggggttt tcacagccag ctttggtttt cattaggttt gtttagtttc cattgcttca 180 ggggtgttag ttttgtgttc mcaactagat tataaactcc tcttgcattc ctgatggcag 240 tgacttgaag gcatttattt gaagaataat agacatacag aaaggggcgc atgtcataaa 300 ggtacagctg gacgactttt cacaaagtga gcacatttgt atgatcgatg ttgagaccaa 360 gagcattcag tggacaactc ctttccagtt actccacccc actcccagtg accatcattc 420 tgacttctaa ctgtgtagac atgttttgct tgttttgtac tttacaaaca tatctactct 480 attttaggtg gctagacaat gtgttttaca atgctggcca tgacagtgtt tgaaagaata 540 aaatggaatc aaatagaatg ggcagtatca gagtgtgttg cctgcctaag aaatgttttg 600 tgacattttg gctttgggtc tatttacaca ttaaatctaa gagcaccaga atgtggtgtc 660 aaaatgtgtt tggggatgaa gatattctaa agtcctgtag taagcaa 707 <210> SEQ ID NO 419 <211> LENGTH: 712 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 419 cagactactt tctatgggaa aggcatagtg tatagtctat atactataca taggggtgct 60 gggaggaact ggggttttca cagccagctt tggttttcat taggtttgtt tagtttccat 120 tgcttcaggg gtgttagttt tgtgttccca actagattat aaactcctct tgcattcctg 180 atggcagtga cttgaaggca tttatttgaa gaataataga catacagaaa ggggcrcatg 240 tcataaaggt acagctggac gacttttcac aaagtgagca catttgtatg atcgatgttg 300 agaccaagag cattcagtgg acaactcctt tccagttact ccaccccact cccagtgacc 360 atcattctga cttctaactg tgtagacatg ttttgcttgt tttgtacttt acaaacatat 420 ctactctatt ttaggtggct agacaatgtg ttttacaatg ctggccatga cagtgtttga 480 aagaataaaa tggaatcaaa tagaatgggc agtatcagag tgtgttgcct gcctaagaaa 540 tgttttgtga cattttggct ttgggtctat ttacacatta aatctaagag caccagaatg 600 tggtgtcaaa atgtgtttgg ggatgaagat attctaaagt cctgtagtaa gcaatgcaaa 660 acgttctgga ggtgtttatt aaacatttgt ttgtagaatg gagaggaaga ca 712 <210> SEQ ID NO 420 <211> LENGTH: 1210 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 420 aaagcagcac tgctctgcat tcagccttgc tacgtctcct tcagatgggc gcactagata 60 ctgagtgatg atcatgcctt gtctaggatc tcaccaagac agttcatgaa agagacagtg 120 cagctcatgg aggagatggt gcagctcaca gagaggatgg tgccatcatg gaaagcatgg 180 ggcagtcatg gagatgacgg rgtagctcat ggagaatata atgccatcat ggaaggcata 240 gtgcagtcat ggagatgatg gtgcagctca tggagaagat ggtgccatca tggaaggcat 300 ggtgcaatca tggagtagac agtgcagctg ggccaagatt ctccctgact aagctcttct 360 caggcacctc tgagccgtcg tcttaactag gcctccagct tggcttgtga aaactgcaga 420 ctctcagcac aaatgatttg cctcctacat taagagactt aaataaacac ttgcatggct 480 gtgtttattt aaacagctca aggctgtgtc cctgggatga caatgactcc agcccctaaa 540 attcctgctt gtgaaagctc attgctgaca gaaggatcta ccatttgttc cagccaacac 600 ctggtggcag gcagataggc cctgagcccc atttaagagc agttccttta gaaagcttgc 660 aattgtaaat cttttctctg cccatttgag atgtaaatct tctaccacct agaactgtct 720 tctcaaggac ctgtgagctg actcactgaa atgcaaacat tcagggagat aactccactc 780 ctgtccccat gcgacggcga ggccctgact ttggtgggca ccttgctctt atttgcacca 840 ccacctcctg tcctaaagac atgagacgtt tgtctctcct ctggataagt gcctattaac 900 caacccaggt gtcctggtca catgaaccag tccagcctag cacctggcac tgcctttccc 960 tcagcacact ccagtctgta aaagtctcct tatggttgtt ttggcaaagt tgagcttagt 1020 taatgctaga ccccttctct actgcaatag ttactgctga ataaagtcta tccttaccac 1080 tttaactagt gttgggcttt gtttctcttt cataagctca tggagaagac aatgcagttc 1140 catcaagttt ctggctctta cactgctaac agtcagctct ggggtccctg agagggacag 1200 actcacacca 1210 <210> SEQ ID NO 421 <211> LENGTH: 1194 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 421 gcattcagcc ttgctacgtc tccttcagat gggcgcacta gatactgagt gatgatcatg 60 ccttgtctag gatctcacca agacagttca tgaaagagac agtgcagctc atggaggaga 120 tggtgcagct cacagagagg atggtgccat catggaaagc atggggcagt catggagatg 180 acggagtagc tcatggagaa kataatgcca tcatggaagg catagtgcag tcatggagat 240 gatggtgcag ctcatggaga agatggtgcc atcatggaag gcatggtgca atcatggagt 300 agacagtgca gctgggccaa gattctccct gactaagctc ttctcaggca cctctgagcc 360 gtcgtcttaa ctaggcctcc agcttggctt gtgaaaactg cagactctca gcacaaatga 420 tttgcctcct acattaagag acttaaataa acacttgcat ggctgtgttt atttaaacag 480 ctcaaggctg tgtccctggg atgacaatga ctccagcccc taaaattcct gcttgtgaaa 540 gctcattgct gacagaagga tctaccattt gttccagcca acacctggtg gcaggcagat 600 aggccctgag ccccatttaa gagcagttcc tttagaaagc ttgcaattgt aaatcttttc 660 tctgcccatt tgagatgtaa atcttctacc acctagaact gtcttctcaa ggacctgtga 720 gctgactcac tgaaatgcaa acattcaggg agataactcc actcctgtcc ccatgcgacg 780 gcgaggccct gactttggtg ggcaccttgc tcttatttgc accaccacct cctgtcctaa 840 agacatgaga cgtttgtctc tcctctggat aagtgcctat taaccaaccc aggtgtcctg 900

gtcacatgaa ccagtccagc ctagcacctg gcactgcctt tccctcagca cactccagtc 960 tgtaaaagtc tccttatggt tgttttggca aagttgagct tagttaatgc tagacccctt 1020 ctctactgca atagttactg ctgaataaag tctatcctta ccactttaac tagtgttggg 1080 ctttgtttct ctttcataag ctcatggaga agacaatgca gttccatcaa gtttctggct 1140 cttacactgc taacagtcag ctctggggtc cctgagaggg acagactcac acca 1194 <210> SEQ ID NO 422 <211> LENGTH: 1194 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 422 gcattcagcc ttgctacgtc tccttcagat gggcgcacta gatactgagt gatgatcatg 60 ccttgtctag gatctcacca agacagttca tgaaagagac agtgcagctc atggaggaga 120 tggtgcagct cacagagagg atggtgccat catggaaagc atggggcagt catggagatg 180 acggagtagc tcatggagaa kataatgcca tcatggaagg catagtgcag tcatggagat 240 gatggtgcag ctcatggaga agatggtgcc atcatggaag gcatggtgca atcatggagt 300 agacagtgca gctgggccaa gattctccct gactaagctc ttctcaggca cctctgagcc 360 gtcgtcttaa ctaggcctcc agcttggctt gtgaaaactg cagactctca gcacaaatga 420 tttgcctcct acattaagag acttaaataa acacttgcat ggctgtgttt atttaaacag 480 ctcaaggctg tgtccctggg atgacaatga ctccagcccc taaaattcct gcttgtgaaa 540 gctcattgct gacagaagga tctaccattt gttccagcca acacctggtg gcaggcagat 600 aggccctgag ccccatttaa gagcagttcc tttagaaagc ttgcaattgt aaatcttttc 660 tctgcccatt tgagatgtaa atcttctacc acctagaact gtcttctcaa ggacctgtga 720 gctgactcac tgaaatgcaa acattcaggg agataactcc actcctgtcc ccatgcgacg 780 gcgaggccct gactttggtg ggcaccttgc tcttatttgc accaccacct cctgtcctaa 840 agacatgaga cgtttgtctc tcctctggat aagtgcctat taaccaaccc aggtgtcctg 900 gtcacatgaa ccagtccagc ctagcacctg gcactgcctt tccctcagca cactccagtc 960 tgtaaaagtc tccttatggt tgttttggca aagttgagct tagttaatgc tagacccctt 1020 ctctactgca atagttactg ctgaataaag tctatcctta ccactttaac tagtgttggg 1080 ctttgtttct ctttcataag ctcatggaga agacaatgca gttccatcaa gtttctggct 1140 cttacactgc taacagtcag ctctggggtc cctgagaggg acagactcac acca 1194 <210> SEQ ID NO 423 <211> LENGTH: 1118 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 423 accaagacag ttcatgaaag agacagtgca gctcatggag gagatggtgc agctcacaga 60 gaggatggtg ccatcatgga aagcatgggg cagtcatgga gatgacggag tagctcatgg 120 agaagataat gccatcatgg aaggcatagt gcagtcatgg agatgatggt gcagctcatg 180 gagaagatgg tgccatcatg raaggcatgg tgcaatcatg gagtagacag tgcagctggg 240 ccaagattct ccctgactaa gctcttctca ggcacctctg agccgtcgtc ttaactaggc 300 ctccagcttg gcttgtgaaa actgcagact ctcagcacaa atgatttgcc tcctacatta 360 agagacttaa ataaacactt gcatggctgt gtttatttaa acagctcaag gctgtgtccc 420 tgggatgaca atgactccag cccctaaaat tcctgcttgt gaaagctcat tgctgacaga 480 aggatctacc atttgttcca gccaacacct ggtggcaggc agataggccc tgagccccat 540 ttaagagcag ttcctttaga aagcttgcaa ttgtaaatct tttctctgcc catttgagat 600 gtaaatcttc taccacctag aactgtcttc tcaaggacct gtgagctgac tcactgaaat 660 gcaaacattc agggagataa ctccactcct gtccccatgc gacggcgagg ccctgacttt 720 ggtgggcacc ttgctcttat ttgcaccacc acctcctgtc ctaaagacat gagacgtttg 780 tctctcctct ggataagtgc ctattaacca acccaggtgt cctggtcaca tgaaccagtc 840 cagcctagca cctggcactg cctttccctc agcacactcc agtctgtaaa agtctcctta 900 tggttgtttt ggcaaagttg agcttagtta atgctagacc ccttctctac tgcaatagtt 960 actgctgaat aaagtctatc cttaccactt taactagtgt tgggctttgt ttctctttca 1020 taagctcatg gagaagacaa tgcagttcca tcaagtttct ggctcttaca ctgctaacag 1080 tcagctctgg ggtccctgag agggacagac tcacacca 1118 <210> SEQ ID NO 424 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 424 gtaggggcac tgtctatact ggctgcactc tggccagtgc tgtcccaacg ctgacccctc 60 tggaagctaa tctggcttat aatgaggatg ctttctttag aggggactct ccatgcacag 120 cagaaaatcc caatggagtg gttcttccct atgtccccaa gggactggga atattctttc 180 agtaacaatg gcccattggg ggaagaagga tgaaagtggg gtgagagacg tgaaatttgg 240 agaggtccct caaagattgt gatgtgcctc tcttgttcca atcacaggac aggggtataa 300 yggctttcct ttgaaacacg gggatgaatt taactattca cttcccaggt agattcatca 360 gggtctagag cttcagctaa cagcatgagg aagattccaa atgtgccccc atcagcatag 420 gaactgggta tgttgagtct atggtctcat aaaaccagaa gaaggacaag ggattgtggc 480 tccaggcttg ggagcacctt ttccttacca tgggctacag tatttattta gggtaaagga 540 aggaaactcc tgaggtgcta tggggtgcca gcaatttgga gcatcagtaa ttcaatgtcc 600 c 601 <210> SEQ ID NO 425 <211> LENGTH: 601 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 425 acgctgaccc ctctggaagc taatctggct tataatgagg atgctttctt tagaggggac 60 tctccatgca cagcagaaaa tcccaatgga gtggttcttc cctatgtccc caagggactg 120 ggaatattct ttcagtaaca atggcccatt gggggaagaa ggatgaaagt ggggtgagag 180 acgtgaaatt tggagaggtc cctcaaagat tgtgatgtgc ctctcttgtt ccaatcacag 240 gacaggggta taacggcttt cctttgaaac acggggatga atttaactat tcacttccca 300 rgtagattca tcagggtcta gagcttcagc taacagcatg aggaagattc caaatgtgcc 360 cccatcagca taggaactgg gtatgttgag tctatggtct cataaaacca gaagaaggac 420 aagggattgt ggctccaggc ttgggagcac cttttcctta ccatgggcta cagtatttat 480 ttagggtaaa ggaaggaaac tcctgaggtg ctatggggtg ccagcaattt ggagcatcag 540 taattcaatg tcccttcagc catgtgtatt caactcctgc tgtgggtgtg gacttggtgc 600 a 601 <210> SEQ ID NO 426 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 426 ttcctgggca tcgtcatatt ctgtaaaaca aggaagctca gcccagtgtg ttctaacatg 60 acctcctttc tacatcctta ggtgttgtta tgcgtgaatc acgtcccccc aaaagacatg 120 ttcatgtcct aacccccagg acctcagaat gtgtgatctg gtttggaaat aaggtcatca 180 cagatgaaat tagctaagac aaggtcatat tggaataggg ttggccctta atccactgtg 240 actggtgtcc ttttaagaag aggacacaga cacaggaggg gagagggcca tgggatgatg 300 caggtggaga ctggagtgct acagctgcaa gcaaatacat ttctgtgctg tgaagccacc 360 catttggtgg tactacgtta aaacagctct aggaaattaa tacagatgtt gcctgtattt 420 ttgtttctca tattactact cattgtttta atgatgactg ttttattcat taagttgaaa 480 gctcctaaag cagagggacc rtatttttat gtcccaactc tccttaaggc cttgcctatg 540 atagcacatc tcttcaatag aattgtccta actttaacag agacaacttg ggttatttaa 600 tatggagaac aaagggttaa gctggtgcca gatgggtttc attttctcta aatctggaac 660 caaaggcagc aagtctatgg ggtggacgga gttcttagct c 701 <210> SEQ ID NO 427 <211> LENGTH: 701 <212> TYPE: DNA <213> ORGANISM: Homo sapiens <400> SEQUENCE: 427 caaggaagct cagcccagtg tgttctaaca tgacctcctt tctacatcct taggtgttgt 60 tatgcgtgaa tcacgtcccc ccaaaagaca tgttcatgtc ctaaccccca ggacctcaga 120 atgtgtgatc tggtttggaa ataaggtcat cacagatgaa attagctaag acaaggtcat 180 attggaatag ggttggccct taatccactg tgactggtgt ccttttaaga agaggacaca 240 gacacaggag gggagagggc catgggatga tgcaggtgga gactggagtg ctacagctgc 300 aagcaaatac atttctgtgc tgtgaagcca cccatttggt ggtactacgt taaaacagct 360 ctaggaaatt aatacagatg ttgcctgtat ttttgtttct catattacta ctcattgttt 420 taatgatgac tgttttattc attaagttga aagctcctaa agcagaggga ccatattttt 480 atgtcccaac tctccttaag sccttgccta tgatagcaca tctcttcaat agaattgtcc 540 taactttaac agagacaact tgggttattt aatatggaga acaaagggtt aagctggtgc 600 cagatgggtt tcattttctc taaatctgga accaaaggca gcaagtctat ggggtggacg 660 gagttcttag ctcaaccctt tggtgaggta agaagaagga t 701

Claims

1. A method for determining the fraction of fetal nucleic acids in a maternal sample comprising a mixture of fetal and maternal genomic DNA, said method comprising: (a) amplifying a plurality of polymorphic target nucleic acids in said mixture; (b) performing massively parallel sequencing of at least a portion of the amplified product obtained in (a), wherein said sequencing comprises providing a plurality of sequence tags); and (c) based on said sequencing, determining said fraction.

2. The method of claim 1, wherein each of said plurality of polymorphic target nucleic acids comprises at least one single nucleotide polymorphism (SNP).

3. The method of claim 1, wherein each of said plurality of polymorphic target nucleic acid comprises at least one short tandem repeat (STR).

4. The method of claim 1, wherein said massively parallel sequencing is sequencing-by-synthesis with reversible dye terminators.

5. The method of claim 1, wherein said massively parallel sequencing is sequencing-by-ligation.

6. The method of claim 1, wherein said sequencing is single molecule sequencing.

7. The method of claim 1, wherein said sequencing comprises an amplification.

8. The method of claim 1, wherein said maternal sample is selected from blood, plasma, serum, urine and saliva.

9. The method of claim 1, wherein said fetal and maternal genomic DNA is cell-free DNA (cfDNA).

10. The method of claim 1, wherein determining said fraction comprises determining the number of fetal and maternal sequence tags mapped to a reference genome comprising said at least one polymorphic nucleic acid.

11. The method of claim 2, wherein said at least one SNP is a single SNP selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56).

12. The method of claim 2, wherein said at least one SNP is a tandem SNP selected from tandem SNP pairs rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427).

13. The method of claim 3, wherein said at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16S539, D18S51, D21S11, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113.

14. A method for determining the fraction of fetal nucleic acids in a maternal plasma sample comprising a mixture of fetal and maternal genomic DNA, said method comprising: (a) amplifying a plurality of polymorphic nucleic acids in said mixture of fetal and maternal nucleic acids, wherein each of said at least one polymorphic nucleic acid comprises an STR; (b) determining the amount of fetal and maternal STR alleles at least one polymorphic nucleic acid; and (c) determining said fraction using said amount of fetal and maternal STR alleles.

15. The method of claim 14, further comprising preamplifying said mixture of fetal and maternal nucleic acids.

16. The method of claim 14, further comprising resolving the size of the STRs using capillary electrophoresis.

17. The method of claim 14, said at least one STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113.

18. The method of claim 1 or claim 14, wherein said at least one STR is the panel of STRs comprising CSF1PO, D13S317, D16 S539, D18S51, D21S11, D2S1338, D7S820 and FGA.

19. The method of claim 1 or claim 14, wherein said method is a fetal gender-independent method.

20. The method of claim 1 or claim 14, wherein said plurality of polymorphic nucleic acids are located on a plurality of different chromosomes.

21. The method of claim 1 or claim 14, wherein said plurality of polymorphic sites are located on a chromosome other than chromosome 13, 18, 21, X or Y.

22. The method of claim 1 or claim 14, wherein said plurality of polymorphic nucleic acids comprises at least 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30 or 40 polymorphic sites.

23. A composition for determining the fraction of fetal cIDNA in a maternal sample, said composition comprising at least one set of primers for amplifying at least one polymorphic nucleic acid in said mixture.

24. The composition of claim 23, wherein said sample is a plasma sample.

25. The composition of claim 23, wherein said polymorphic nucleic acid comprises an STR, a SNP and/or a tandem SNP.

26. The composition of claim 23, wherein said STR is selected from CSF1PO, FGA, TH01, vWA, D3S1358, D5S818, D7S820, D8S1179, D13S317, D16 S539, D18S51, D2S1338, Penta D, Penta E, D22S1045, D20 S1082, D20 S482, D18S853, D17S1301, D175974, D14S1434, D12ATA63, D11S4463, D10S1435, D10S1248, D9S2157, D9S1122, D8S1115, D6S1017, D6S474, D5S2500, D4S2408, D4S2364, D3S4529, D3S3053, D2S1776, D2S441, D1S1677, D1S1627, and D1GATA113.

27. The composition of claim 23, wherein said SNP is selected from rs560681 (SEQ ID NOS 1 & 2), rs1109037 (SEQ ID NOS 3 & 4), rs9866013 (SEQ ID NOS 5 & 6), rs13182883 (SEQ ID NOS 7 & 8), rs13218440 (SEQ ID NOS 9 & 10), rs7041158 (SEQ ID NOS 11 & 12), rs740598 (SEQ ID NOS 13 & 14), rs10773760 (SEQ ID NOS 15 & 16), rs4530059 (SEQ ID NOS 17 & 18), rs7205345 (SEQ ID NOS 19 & 20), rs8078417 (SEQ ID NOS 21 & 22), rs576261 (SEQ ID NOS 23 & 24), rs2567608 (SEQ ID NOS 25 & 26), rs430046 (SEQ ID NOS 27 & 28), rs9951171 (SEQ ID NOS 29 & 30), rs338882 (SEQ ID NOS 31 & 32), rs10776839 (SEQ ID NOS 33 & 34), rs9905977 (SEQ ID NOS 35 & 36), rs1277284 (SEQ ID NOS 37 & 38), rs258684 (SEQ ID NOS 39 & 40), rs1347696 (SEQ ID NOS 41 & 42), rs508485 (SEQ ID NOS 43 & 44), rs9788670 (SEQ ID NOS 45 & 46), rs8137254 (SEQ ID NOS 47 & 48), rs3143 (SEQ ID NOS 49 & 50), rs2182957 (SEQ ID NOS 51 & 52), rs3739005 (SEQ ID NOS 53 & 54), and rs530022 (SEQ ID NOS 55 & 56).

28. The composition of claim 23, wherein said tandem SNP is selected from rs7277033-rs2110153 (SEQ ID NOS 312 & 313); rs2822654-rs1882882 (SEQ ID NOS 314 & 315); rs368657-rs376635 (SEQ ID NOS 316 & 317); rs2822731-rs2822732 (SEQ ID NOS 318 & 319); rs1475881-rs7275487 (SEQ ID NOS 320 & 321); rs1735976-rs2827016 (SEQ ID NOS 322 & 323); rs447340-rs2824097 (SEQ ID NOS 324 & 325); rs418989-rs13047336 (SEQ ID NOS 326 & 327); rs987980-rs987981 (SEQ ID NOS 328 & 329); rs4143392-rs4143391 (SEQ ID NOS 330 & 331); rs1691324-rs13050434 (SEQ ID NOS 332 & 333); rs11909758-rs9980111 (SEQ ID NOS 334 & 335); rs2826842-rs232414 (SEQ ID NOS 336 & 337); rs1980969-rs1980970 (SEQ ID NOS 338 & 339); rs9978999-rs9979175 (SEQ ID NOS 340 & 341); rs1034346-rs12481852 (SEQ ID NOS 342 & 343); rs7509629-rs2828358 (SEQ ID NOS 344 & 345); rs4817013-rs7277036 (SEQ ID NOS 346 & 347); rs9981121-rs2829696 (SEQ ID NOS 348 & 349); rs455921-rs2898102 (SEQ ID NOS 350 & 351); rs2898102-rs458848 (SEQ ID NOS 352 & 353); rs961301-rs2830208 (SEQ ID NOS 354 & 355); rs2174536-rs458076 (SEQ ID NOS 356 & 357); rs11088023-rs11088024 (SEQ ID NOS 358 & 359); rs1011734-rs1011733 (SEQ ID NOS 360 & 361); rs2831244-rs9789838 (SEQ ID NOS 362 & 363); rs8132769-rs2831440 (SEQ ID NOS 364 & 365); rs8134080-rs2831524 (SEQ ID NOS 366 & 367); rs4817219-rs4817220 (SEQ ID NOS 368 & 369); rs2250911-rs2250997 (SEQ ID NOS 370 & 371); rs2831899-rs2831900 (SEQ ID NOS 372 & 373); rs2831902-rs2831903 (SEQ ID NOS 374 & 375); rs11088086-rs2251447 (SEQ ID NOS 376 & 377); rs2832040-rs11088088 (SEQ ID NOS 378 & 379); rs2832141-rs2246777 (SEQ ID NOS 380 & 381); rs2832959-rs9980934 (SEQ ID NOS 382 & 383); rs2833734-rs2833735 (SEQ ID NOS 384 & 385); rs933121-rs933122 (SEQ ID NOS 386 & 387); rs2834140-rs12626953 (SEQ ID NOS 388 & 389); rs2834485-rs3453 (SEQ ID NOS 390 & 391); rs9974986-rs2834703 (SEQ ID NOS 392 & 393); rs2776266-rs2835001 (SEQ ID NOS 394 & 395); rs1984014-rs1984015 (SEQ ID NOS 396 & 397); rs7281674-rs2835316 (SEQ ID NOS 398 & 399); rs13047304-rs13047322 (SEQ ID NOS 400 & 401); rs2835545-rs4816551 (SEQ ID NOS 402 & 403); rs2835735-rs2835736 (SEQ ID NOS 404 & 405); rs13047608-rs2835826 (SEQ ID NOS 406 & 407); rs2836550-rs2212596 (SEQ ID NOS 408 & 409); rs2836660-rs2836661 (SEQ ID NOS 410 & 411); rs465612-rs8131220 (SEQ ID NOS 412 & 413); rs9980072-rs8130031 (SEQ ID NOS 414 & 415); rs418359-rs2836926 (SEQ ID NOS 416 & 417); rs7278447-rs7278858 (SEQ ID NOS 418 & 419); rs385787-rs367001 (SEQ ID NOS 420 & 421); rs367001-rs386095 (SEQ ID NOS 422 & 423); rs2837296-rs2837297 (SEQ ID NOS 424 & 425); and rs2837381-rs4816672 (SEQ ID NOS 426 & 427).

29. The composition of claim 23, wherein said determining comprises massively parallel sequencing of fetal and maternal cfDNA.

30. The composition of claim 23, wherein said at least one set of primers does not amplify a sequence on the Y chromosome.

31. A kit comprising the composition of claim 23.